>ZF Recording 2016-03-18; tW: 300s; Start: 121304; End: 121804;
Recording: 1-1; Individual: 1; Drug: Control
bLebLsbRcbRoLebLsLsLsmmbRsbLebLsLsLgLsmbLhbLeLsbLsbLsbLgbLsbLsbLgLgbLs
bLsLsmbLsLsmbLsbRebRibRsRsmbRgbRgRsRsRgmmbRibRsRsmbRsRsRsmmbRsbRsRsmbR
sRsRsRsRgmmmbLgbRcRobLgLgbRsLsLsmbLsLsLgmbLgbRoLsbLiLsbRcRsRsRsmmmbRib
LgbLcRgRsmbRebLoLsRjmbLobLsLsLsLsLsmmmmbLsbLsLgbLsbLsbLsLebLsb

>ZF Recording 2016-03-18; tW: 300s; Start: 121304; End: 121804;
Recording: 1-1; Individual: 2; Drug: Control
bRibRibRibLjbRgbLcbLjLgbRsbLsLsmbLsbLgbLgbLsLsmbLibLgLsbLibLgbLsbRsbLi
LsbLsbLiLsbLgbLgbLgbLgbLsbLgbLgLsLsmbLibLgbLgLsbLibLsbLsLsmbLgbLgLsbLg
bLeLiLsLgbRsbLsRsbLibRsRsmbLgLsbRsLsbLgbLsLsmbLsbLibLsbLgbLgbLsbLgbLgL
sbLgbLgbLgbLgLsLgbLsbLiRsbLgLsbLgLsbLiLgbLiLsbLsLibLgbLsbLsLsmbLgLsbLg
LsLibLgbLgbLibLhLsbLebLiLgLeLiLsLebLibLgLibLiLsbLiLsbLiLsbLgRsLeLsbLgb
LiLsLsmbLgbLgbLgLsbLgbLgLgbLiLsbLgLgbLgLsbLgbLgLsbLgRsbLgbLjLsmbRcbsbR
oLsbRobRcbLibLcLsmbRcbRobRcbRibRiLsbLgbLgbLhbLsbLgbLsbLgLsLgLeLsbsbRcb
RobLcbRsRobRobRcbRcbRcbRcbRhbRiRsmbLcLsmbLcLsLsmmbLibRsbRhbRcbRcRsmbRh
LsRsbRoLsReRsmbRcbLcLsLsLsmmmbRcLsbRobsbRcbRcbRcbRcbLsLsLembRsRsRsRsRs
RsmmmmmbLsRsbLeRgLgLsbLebLcLsmbLcbLebLeLsbLibLsLeLsLsmbLgLeReRsmbRgLsb
RcbRobReRsRoRsmmbRgRsmbRsbRcbRsRsRsmmbRsRsRsLsmmbRsbRsbRhLsbRcRcRsRsmm
bRiReRsRsmmbRgbRgRcbRibRgbRsbLebLebLebLcbLcbLgLebLsRcbLcLebRcbRiRsRimb
RgRsRsmmbRcbRgRsRsmmbRoRcbRcRcRsmbRsRsmbRebRcb

>ZF Recording 2016-03-18; tW: 300s; Start: 121304; End: 121804;
Recording: 1-1; Individual: 3; Drug: Control
bLgbLgbLibLgLsbLsbLibLgbLgbRibLibLgbLsbLgbLsbLsbLgbLsbLgLsbRsbLsbLsLsm
bLgbRjLsRsbLgbLsbLsLsmbLgbLgbLsbRsbLibLgbLgbRsbLgbLgbRsLsbLgbLsbLsLsmb
RsbLgLsbLgLsbLoLsmbLibLibRgbLobLgbRsbLsbRobLgLsbLibRsLsLsmbLsbLgbRsbLo
bLcLsmbLhbLiLsLsmbRsbLibsbLobLsRsbLebLgbLsLsmbLgbLgbLgLsbLgbLsbLgbLsbL
sLsmbLgbLgbLsLsmbLsLsLsmmbRsbLgbLsLsmbLibLgbRsbLgbLhLsbLgbLgbLgbLsbRib
LjbLcbLsRsbLgbLsbLobLsbRsbRobRibLgbLibLobRsbLgbLgbLsbLibLibLobRibLcbLs
bLgLsbLgbLibLsbLsbLsbLgbRgbLgLsbLsbLgLsbLsLsmbLgbLgbLibLhbRcbRcbRiRoLs
bRhbRgLsLsmbRibLgbRsbLgbRcLsbRobLibLoRsbRibLgbLgbLgbLgbRsbLibLgbLgbLgb
RgbRebRcbRibLsbLsbLcbLobLobLgbLsbRsbRjbRcbLibLgbRoLsLsmbRgbLobLsbRibLj
bLgbLgLsbRebLibRebRibRcLsbLjbsbLcbLcbRcbLcbRjbLoRsbRsbLgLsbLsbLsbLgbLs
bLsbRsLsbRsLsbLsLsmbLibRgbLsLsmbLgLsRsRsLsmbLgLsbLsbLgbRsbLsbsbLgLsbLg
LsRsbLsLsmbLsbLgbLsLsmbLgbLsLsmbLgbLsbLgLsbRsbLsbRsbLiLsbLsbLgbLsbLgLs
bLgbLgbLgbLsbLgbLgbLgbLgLsbLsbRsbLiLsbRgbLgbLibRjbLibLobLcbLiLsbLoRgbL
gbLoLsmbRobRoLsbRebRobRgbLibLgLsbRsRsLsmbRoRsmbRiLsbRobLsbLgbLibLiLsbL
gLsbRsbRobRobRhbLibRsbRibLibLhbRsbRobRibLibRobLiLhbsbLiLsbRsLsbLiLsbLg
bLsLsmbRsbLgLsbLsLsmbLgbLsLsmbLgbRsbLibRcbRcbRiLsbRsLsbRobRjbLobLcbRcb
LgLsbLgLsbRsbLibRsbLibRsbLcLsLgmbLsbLgbRsbLhLsbLgbLsLsmbRgbLibRsLsLsmb
LibLgbLsbLsbLgLsLgbLobLgbLcbLobLsbLcbLcbLobLjbLiLgLsLgLsLibLgLsLgbLsLe
bLibLiRsbLibLcbLsbLobLiLobRhbLjbLobLobRcbRcbLobLobLgbRcbRebLsbLsbRibRh
bRgLsbLsbLgLsbLsbLsbRebLobLobLjbLsRsRgRebRebRebRebRebRoRsmbRobRob

>ZF Recording 2016-03-18; tW: 300s; Start: 121304; End: 121804;
Recording: 1-1; Individual: 4; Drug: Control
bLcbLibLobRsbLsbLcbRgbRsbRgbRhbLibLcbRgbLobRcbRgbRiRsmbRsbLsbRibLibRsb
RgbRgbLgRsbRsbRsbRgbLsbLebLibLsLsmbLhbRibLobRgbLjbLibRiRsmbLgbRhbLcLsL
smmbRsbRjRhbRsbRoLsRsRsmbLibRsbLgbLibsbLibRjbLgbLsLcRsRsmbRgbLcbLsbLgb
LgbLebLsLsmbLiLsbRsbLibLibRsbLgRsLsbLsLsmbLgRsbLgbRsbLsbLgbLiLsbLsbLgR
sbRsRsmbLibLgRsbLgbLsbLgbLgLsbLgbLsbRgbLhbLgbLgLsbLgbRsbLhbRgbLibLobLi
RsbLgbRgbRgRsmbRcbRcbLibLgbLibLgbLiRsbRgbLibLibRjbRcbRgbLsRsbLibLibRgb
LiLsbRgbRoLsbLjbLjbRobRobLibLobLgbLobLsbLibLobLiRsbLsLsmbLibLibLgbLsbR
sbLgbLcbRgLsbLibRgbLiRsbLgbLsbLsbLsbLgbLgLsbRgbLibRsLsbLgbRjbRjbRibLjb
LoRsRjbRobRcbLibLgbRgbRgbRgbRibLibLobRcbLgbRoLsbLgLsbRibLcbLoLsRsRsmmb
RebLcRsbRgbRsbRhbLhbRibRibRgbRobRobRibLcbRibRsbLgbRhLsbLibLobRoRsmbLib
RibLebLeLgbLgLsbLgLsbLibLcRsbRobLibLobLcbLsbLobRgbLibLhRsbLobLoRsbRibL
iLsbLibRcbRcRsmbLcLsmbLgb

>ZF Recording 2016-03-18; tW: 300s; Start: 121304; End: 121804;
Recording: 1-1; Individual: 5; Drug: Control
bRcbLsLsmbLsbRgbRsRsmbRhLsbRiLsbRsbRgbRsbLiLsbLsbLibRobRsRgbLgbLsbLibL
sLsmbLgLsbLsLsmbLgbRsbLgbRsbLgbRsbRsbLsbLgLsRsbLsbLgbLgbLgbLsbLsbLgbLs
RsbLgbLgbLibRsbLgbLgbRsbLgbLgbLgbRsbLsLsmbLsbLsRsLsbLsbLsbLgbRsbLsbLgb
LgbLsbLsbLgbRsbLgbLgbLgbLsbLsbLsbLgbRsbLcbLiLsbLibRibRsbLgbRibRibLgbRs
bRibRgRsmbRhbLsbLiLsbRiRsmbLsbRsbLsbRobRsbsbRibLjbRebRibLsbRsbRsLsbRsb
RhbLgbRhbRebLibRebRibLgbLcbRsbRcLsbRhbLgbLobLsbLgRsbLsLcbLgLsbRibLsbLi
bLibRobRiLsLsmbRibLgbRibLcbLgLsbRjRcbLcbRjbRhbRobLsLsmbLgbLgbRgbRsbLsb
RobLgbRcbRoLsbRjLsbRjbRhbLgbRcbRibLibLcbLjbRcbLcbLcbRgbLsbRsbLibLgbLib
LgbLgbRsbLgbRsbLgbRsbLgLsbLgRsbRebLhbRsbLiRsbRgbRcbRcbLibLibRcbRiLsbsb
LsbRgbRibLgbRsbRibRgbRgbRibRsbLiLsbLhbLibRibLcbLibLibLibRsbLiRsbRjbRib
RhbLgLsbLibRoRsmbLcbRibLcbRebRoRsmbRcbRcbRcbLsbRsbRibLsbLgLsbRibRsRsmb
RibLjbRcbLibRibRgRsmbLobLibLhbLiRsbLsLsLsLsmmmbLsRsbRsRsmbRgRsmbRgbRsb
RibRoRsmbLibRsbRebLhbLobLgbLsbLibRgbRhbLgbLibRjbLsRibRcbRebRhbLsLsLsmm
bLibLcbLgbLibLiLsbLibRsbLoRsbLibRobLsbRgbRibLsbRiLsbRsbRgbLsbRgbRoRsmb
LibLgbLibLhbLibRibRibRcbLibLgRsbLsbLibRobRibLgbRhbLebLibLhLsRsbLhbLjLs
mbRgRsmbRgbRhbLgbRsLsbRiRsmbRgbRibLibRsbRoLgLsbLgbRcbRibRibLgLsbRibLgb
LhbLcbLibLsbReRsmbLcbLgbLiLsbLibLibLsbLgLsRsb

>ZF Recording 2016-03-18; tW: 300s; Start: 121304; End: 121804;
Recording: 1-1; Individual: 6; Drug: Control
bLcLsmbLobRgbRibLsLsmbLhbLibLsbRsbLibLcbLiLsbLibRibRebLgbRsLsbRgbRsbLi
bRobLcbRjRsmbRcbLjbRobLebRcbRiRsmbRebRibRoLsbRcbLgLsbLeLsbLhLsbLgbLsbL
ibRgbLibLobRjbRobLhbLhbLibLgbLcbRgbRgbLcbRsbLobRibRjbLgbLeLibLcRsbLjbL
eLjbRhbRoRcbLjbLcLsmbLibRcbLsLibRsbRibRgbRgbLsRsbRiLgbRobRgbLiLsLgLgLs
bLsRsbRgbRibRjbLsbLsbRibRibLibRhLsbLcbLcbLcLsLhmbRibRgLsbsbLjLsmbLcbLe
bLebLebLebLebLebLibRobRobRcLgLebRobRcbRsbLobLebRcRiRebRsbRsbRsbLsbRsLs
bRsRsRsRsmmmbLgbRgRsRsRsRgRgRemmmbReLgbLsRiRgReRsRsmmbLoRsbLoLsmbLoLsL
sLsmmmbLhbLcLcLoLebLsbLgLsbRoReRgbLsLsLsLsmmmbLcbRebRhRgbRsbRsLsbRsbLs
bRgRsRsRsRsRsRgRsRsRsRgRgmmmmmmmmbRsRsmbRsbRcRebLsLsmbRebRgbReLcLsLsmm
bLebReRsmbRgRsRsmmb

>ZF Recording 2016-03-18; tW: 300s; Start: 121304; End: 121804;
Recording: 1-1; Individual: 7; Drug: NDMC 1 µM
bRgbRsRsmbRsLsbRsbRsbRgbRsbRsbRsbLsRsbRgbRgbRsbRsbRsbRgbLcbLibLibRibRi
bLgbRcbRcbRgbRebRebRgbLcbLcbLjbLcbRsbLsLsmbLsbRsRsmbLibLgbLjRsbLcbRjbR
sbLsbRsbRsRsmbLsbRgbLsRsbRsbRsRsmbLsbRgRsmbRsRsmbRsRsmbLcbLhbLcbRgbRsR
sRsmmbRgbRgRsmbRjbRgbRsbRcbRcbRjbLcbRgRsmbLoRsbLgbRsbLjbRibRibRgLsbLsb
RsbLjLsmbRcbRcbRgbLjbLobRibRgbRcbLebRiRsmbLibRhbRcRsmbRcbRcbRcLsLsmbsb
LsbRgbRsbRoLsRsRsmbLjbRjRsmbRcbRcbRsbLsbRsbLgbLcbRsbRgbRjRsmbRibLsRsbL
jbLibLobLsbLgbRsbRsbRsRobLgbLcRsbRjbRcRsmbRgbLsbLsbLgbRhbRsbRsbLjbLoRs
bLcbRgbRsbRsbRgbRsbRibRsbRgRsmbRsbRsRsmbRsbRsbRsbRsbRsRsRsmmbRsbRsbRgb
RsRsmbLebLiRsRsRsmmbRgRsmbLcbLibRsbLibLibLsbLgbRebRiLsbLgLsbLgbLibRobR
gbRgbLgLsbLgbLsbRobLgbRobRgbLjbRibRibLjbLcbLebLgbRibRoRsmbRgbLcbRgbRsb
RgbLsbRsbRsbLsLjbRgbLoRsbLiRsbRjRsmbRibRsRsmbRibRgRsmbRsbLsbRsbLjbLebL
ibRgbRgbLebLcbLibRsbRsbLsbLsbRhRsRsmmbLgbLsbRsLebLgLsbLgbRsbLgbLibLcbL
hbLgbRsbRibRsRsmbRibLjbLcbRjbRcbRcbLsRsbLsbLiLsbLsLsmbRgbLebLhRsbRgbRs
bLgbLsbRsLsbLgLibRjbRjbRibRgRsmbRgRsmbRgbRsbRgbRgRsmbLibRoRsmbRcbRgbLg
bLibRjbLebLiLsbLibLcbRjbRcbRhbLjbLebRibLgbRsbLsbLsLsmbLibRsRsmbLoLsmbL
ibLcbRgbLsLsmbLgbRsbLcRsRgRgbRjbRibsbLsbLoLsmbRcbRcbLgbRgbRsRsmbRsRsmb
LibRjbRhbLobLcbLobLcLsRsmbRgbRsRsmbRsbLibLobRsRsmbLobRjbRcbLcbLoRsbRjb
RcbRgLsbLcLsmbLibRsbRgbRsbRsbLiLsRsbLoLsmbLcLsmbLjLsLsmmbLgbRsbLoRsbRg
RsmbRsbLcbRgbRsLiRsRsmbLjbLhbLgbRgbLsbLgbRjRcRcLsbRcbRcbLibLsLsmbLibLs
bRsRsmbRsbLibRjbLibLsbLgLsbLhbLibRgRsmbRgbRibRgbLibLcLgLsbLgLsRsbLibLs
bLhbLoRsbLobLcbLgbLgbRoLsLsmbLibRcbRiRobLgbLgbRcbRcLsbRibRsbRgRsmbRgRs
mbLjLjbLibRgbLjLgbLgRsbLibLibRsbLiRsRgbRjRcLsbLjbRcLsbLgbRcbRibRibLgbL
sbRebLjLcbLgbRsbRgbLcbRsbLibLgbLsbLgbLgLgLsbLsLsmbLiRsbLgLsLgRsbLgLsLs
LiLsLgmbLiRsbLcLsmbLibLibLebLhbLebRcbRcbRcbRhbRsbRhbRgRsRsLgmmbLibLsRs
bLiLsbLsbLiRsbRsbLibRgbLibRgRsmbLcRsRsRsLsmmbRsRcbRcLsbRibLsbRibRgbRsb
LsbLsbLibLibRgRsmbLibRgbLcbRsbLsbLcbLobLibRhRsmbRsRsmbRsbRcbLsLsmbRsbR
eLsLsmbLgbRsLjbRcbRebRibRibRgbLsbLsRsbLoLsmbLgbLibRgbLiLibRgbLibRgbRcR
ibRgbLebLhbLcbLibLebRsbRsRsmbLsbRoRsmbRgbRgRsRsmmbRibLsbLsbRib

>ZF Recording 2016-03-18; tW: 300s; Start: 121304; End: 121804;
Recording: 1-1; Individual: 8; Drug: NDMC 1 µM
bRhRsmbRhbRibLibLgbRhbLibLobLcbLobLiLsbLsLsmbRobRobLibRsbLibRibLjbLibL
ebLcbRgRsmbRgbLgbRgbRobLibRobRoLsbRcbRibRsLsRsbRsbRjbRsRsRsmmbRhbLgbRh
bLjbRoRsLimbRgbRcbLobRgbLcbRsbRsbLibRgbLsRsLsLibRgbLgbLgbRsRsmbLgbLsRs
bLgLsbLgbRsLsbLsLsmbRsLsLsmbLsRsbLgbRsLsbLgbLgbLsLsmbLsbLgbLsbRsbLgbLg
bLgbLibLobLibLiLsbLsRsbLgbRsbLgRsbLibRgbRibLcbRiLsbLcbLiLsbLiRsbRgbLgb
RsbRsbLgbLsbLgbLsbLsbLgbRgbLgLsbLgLsbRsbLgbLgLgbLgbLsbLsbLgbLgbRsbLgbR
sbLiLsRsbLgbRsLgbLgbRgbLgbLgbRsbLgbLgbLsbsbRsbLibLsbLgbLsbLgRsbLgbRsbL
gbLsbLsbLgbRsbLibLgbRsbLgbLsbLsbLsbLgbLgbLsbRsLgbLgbReRsmbRibLhbLgbReb
LgbLjbLobLsbLgbLgbLgbRsbLgbLsbLsbLjbsbLsbLsbLsRsbLgbRsbLgbLgbRcbLhbRib
LgbRsLsbLoRibLgbRebRibRibLibRobRebRibLjbRiLsbLjLsmbRibRsbRgbRhbRcbRobL
ibLibRsbRsbLgbRsLsbLibRsbLiRsbLgbRsbLgbLsLsmbLgbRsbLgbRsbLgbLsbLsbRsbL
gbLgRsbLgbLgbRibRhbLsRibRobRobRcbRcbRobLhbRibLcbLcbRgbLgLsbLibLiLsbRsb
LgbRsbLsLsmbLgbLsRsbLsRsbLgbLgbLsLsmbLsbRsbLibLgbLibRgbLiLsbLgbLsbRjRj
bRiLsbRgbRobRcbRebRjbRobRhbRjbLibLgbLsbLgRsLsbLjbRsbLsRsbLgbRobLobRhbL
oRsbLobLhbRgbLobLibLsbLgbsbLibLgbLsbLhRsbRibRobRhbRobRcbLgbRcbRhbRcbRi
bLibLgbRibRobLgbLcbLiRsbRgbLsbLibRsLsRsbLsLibRgbLiRsLsbLgbRebLobRcbRhL
sbRcbRcbRobLsbLgbLgbRoLsLsmbRcbRcRsmbRjbLcbLcLsmbLobRjbRobLibLibRcbRgb
RjbLsRsbLsRsbLsLiRsbLeRsbLgbRhbRibLgbRcbLgbRhbRgbLgbRhbLsRsbRibLgLsbLg
bRhbLjbRoLgbRhbRgRgbRgLgbLebLsbLhbLobLobLhbRsLsbLgbLgbLibRgbLgbLcbRgbL
obRgbLgbLsbLgRsbLgRsbLgbLgbLsbLibLsbLsbLgLsbLgbLsbLibRgbRjbLoRsRsLsmbL
ibRcbRcLsbRebRoLsbRcRsmbLsbRoLsbRoLsbRgbLgbLgLsbLgbRsLcbRiRsmbLgLiRsbL
gLsbLgbLgLsbLgbLgbLgbLgbLsbLiRsLeLgbLgbLgRsbLgLsLsmbLgLgbLgbLsbLiLsbLi
LsLebLgLgbLgLsb

>ZF Recording 2016-03-18; tW: 300s; Start: 121304; End: 121804;
Recording: 1-1; Individual: 9; Drug: NDMC 1 µM
bLiLsbLibLibLsLgbLibLgLsRsbLjbRcbRhbLgLsbLgbRcbLsbLgbLgLsbRobRgbRcbLsb
LgLsbLsLsmbLgLsbLsbLgbRjbLibLibLiLsbLsbLsbLsLsmbLsbRsbRsbRobRcRsmbRhRs
RsmmbLjLgbRhbRibRiLsbRcbRcbRibRgbRcbLjLsmbRoLsLsLgLgLiLgmbRjbRibLsbRib
LsLsmbRsbRcLsbLgLsLsLgmbRsRsmbRibRibLgbLoLsmbRcbRibRsbRcRsRsmmbRsbLgLs
bLgbLgbLsbLsbLcbLobRcbRgbLgbLsbLsLsmbLsbLjbRjbLibLsbRsLsbLibLsLsmbRsRs
mbsbLgbRsRsmbLsLsmbLgRsbRsRsmbRjbRcRsmbLsbLsLsmbRoRcbRcbLsLgbLjLjbLcbR
ebRiRsmbRcbLjbLsRsbRcbRcbRcRsmbLiLsbLhbLcbLhbLjbLiLsbRsbLsbLgbRsbLgbLi
RsRsLsmbRgbLibLgLsRsRsLsRsmbLgbLgbLgLgbLgbRsbLgRsbRsRsRsmmbLsLsmbLgbRs
bLibLgbLgLsbRsRsmbLiLsbLgLsLsLgmbLgbRgbLgLsbLibRsRebRibRcRsmbRcbRcbRcb
RcbRobLiLgbRsbRobLgLsLsLjLsmmbRcbLhbRcbRobLgbLibLjbLibLsbRsLsbLibLsLsm
bLsLsLsLiLgmmbLgLsbRsbLgbLsbLsbRgbLhbLsbRcbRoRsmbRoLsbLiLiLsLiLsbLgbRh
bRcbRobRsbLcbRobRobLgbRobRobLiLsbLibRiLsbRibLhbLcbLcbLcbLibLiLsbRibLoR
gbLcbLcbLcbLhLsbLsbRsbRsbLcbLcbLcbLoLsmbLgbRibRobRibLsLgbRibRgbRsbRibR
sbRoLgLgbLiLsLsRsRsmmbLgbLsbLgbLsLsmbLsLgLsbLsRsbLiLibLsLsLsLimmbLgLgb
LiLsbLgRsRsmbLiRsbLgRsRsmbRobRcbRcbLsLsmbRibRcbRibRcbLgLsLsLsmmbRcLsLs
mbLhbLcRsbLhbLcbRcRsmbRcLsbLibLcLsmbLcbLhLsbLsbLcbLibRcLsbLgRsbRoLsRsb
LhLsRsbLoLsmbLoLsmbLoLsmbRsLsbLobLobLgLsbRgbRcbRsbRcbRsbLsbLcbLcbLcbLe
bRebRsRsLsmbLsbRoRsmbLsbRebLgbRebRibRcbLgbRebRjbLsbLgbRcRsRimbRebRebRe
bRebRebRcbRibLebRobRiRsRsRsRsmmmmbRebLebLebLebLiLiLsLsRcmbLcbLcLsmbLcL
smbLiLsbLsLsmbLiLgLsLoRgRsmbRibsbLcLsmbLibLiLsbLgbLsbLhbLobLgbRcbRobRg
bLsbLcbLcbLgbRiRiRsmbLsbLcLsLombLsbLoRiRsRiRsRgmmbRsbLcLsmb

>ZF Recording 2016-03-18; tW: 300s; Start: 121304; End: 121804;
Recording: 1-1; Individual: 10; Drug: NDMC 1 µM
bLcbRibLibRsbLibLibLsbLibLgbRjbRibRibRibRgbRgbRsRsmbRsbRgbLsLsmbRiLsbR
cbRobRgbLibRgbRgRsmbLsbLsbRebLobLiLsRgbLgbLsLsmbLcbRibRsbRcbRgbRiRsmbL
gLsLibLgLsLsmbRsbRjbReLgbRsRsRsmmbLsbRibRsbLgbRgbLsbRhbRibRjRsmbLcbRsR
sLsmbRhbLiRsbRibLibRsbLibRsbLebLjbLgRsbLsLobLgRsbLsbRgRsRsmmbRsbRgRsmb
RgbRibsbLgLsbRjbRobLgbRcRsmbRcbRibRobLiLsbLibLhLsLsLsmmbRcbRiRsRsLsmmb
RiRsmbRgRsmbRcbLgRsbRhbRgbLebLcbLsbLiLsbLhbLjbRhbLcbLibRiRgbRsRsmbRcLs
LsmbLibLobLcbLiLsLsmbRgLsbLoLsmbRcLoRsbLobLsbLsbLhbsbLobRcbRibLeRsbRsb
LgRhbLgbLgbLibRsLsRsbLgLgbRebLeRsRsmbLgLsbLgbLibRsbRjbRobLsbRiRsmbRsRs
mbRcRsmbRcRsRsmmb

>ZF Recording 2016-03-18; tW: 300s; Start: 121304; End: 121804;
Recording: 1-1; Individual: 11; Drug: NDMC 1 µM
bRebLebLgbLsbLcbRgbLibRgbLgbsbLsbLsbLgbLsLsLsLsmmmbLgbRsLsbLsRsbLgbRsb
LgbLibRsLsbLiLsbLgLsbRgbLgbLsbLsLsmbLsLsmbLsLsmbLsbLsLsmbRsbLgLsbRsbLg
bLsLsmbLsbLsbLibLsbLsbLgbLsLsmbLgbLgLsbLgbLgbLsbLgbLsbLsbLsbLgbLgbLgbR
sbLiLsbLsLgbLgLsbLsbLsbLgbLibRsbLsbLsLgbLgbLgLsbRsbRsLsbLgbRsLsbRsbLib
LsbLsbLgbLgbRsbLsbLgbLsbLgbLsLsLsmmbRsLsbLsbLgbLsLsmbLgbLgLsbLgbRsbLgL
sLsmbLsLsmbLhbLsbLgbLsbLibsbLgbRsbRcLsbRiLsbRibLjbRcbLhbRibLcLsmbLibRi
bRjbRibLibLcbRibRsbRhbRgbLhLsbLibRgbLgbRsLsbLgbLgbLgbRsLsbLsbLgRsbRsLg
LgLsLsmbRsRsmbLibLsLsmbLsLsmbLgbLsRsbRsLsbLsbLsLibRsbLgRsbLsLsmbLgLsLs
mbLsbRsLsbLsLsmbRsbLgLsbLsLsmbLsLsmbLsLsmbRsLsbLsLsmbLsLgbLsLiLgbLgbLg
bLsbRsbLibLsbLsbLsbLgLsbLsbLgbLsRsbLgLsbLgRsbRsbLgbRsbLsLsmbLiLsbLsbLs
LsLsmmbLgLebLiLibLsRsbLhbLiLsbLgbLgLsbLgRsbLgbLsbLsLsmbLsbLgbLgbLgLsbL
sLgLsLsmbLsLsmbLsbLiLsLsmbLibRgbLobLhLsbLcLsmbLhLsbRhbRibRgbLgLsLsmbLc
bLcbRibLhbLgbRsbRsbLibRsbLgLsbLsRsbLgbRsRsmbLgbLgRsbRsLsbLgbLsRsbLgLsL
smbLsbLsLsmbLgLsLsmbLgbLsLsmbLsbLiLsLsmbRsLsLsLiLsLsmmbLiLsbLsLsmbLsLs
LimbLgbsbLgLsbLsLibLgbLgLsbLgLsLsmbLsbRsLsbLgLsbLgbLgLsbRsbLsbLsbLgLsb
LsLibRsbLgLsLsmbLsRsbLgbRsbLiLsLsmbLsLiLsbLgLsLsLgLsmbLsLsmbLiLgLsRsbL
gLsLsLsLsmmmbRsLsbLiLsLsmbLibRsbLiLsLsmbLgbRgbLiLsbRsbLibRgLsbLibRsRsm
bLibLgRgbRsLibRsbLgbLgbRgbLibLcLsmbRgbRsbLibRsbLiLsbLsbRsbLiRsbRsRsmbL
oRsbLgbLhbLhRsbRgbLhbRgbLgLsbLsbLhRgbLebLgbLsbLiLsbLsbLsbLgbLgLsLsmbLg
LsRsbRsLibLsLsmbLsLsmbLiRsbLsRsbLgLsbLgRsbLgbLsbLsLsLgLsmbLsbLiLsbRsbL
ibLsbLgLsLsLiLsRsmbLgLsbLsbLgbLsbLibLiLsLsLsRsmmbLibLiRsLsbLgRibRcLsbR
gLsbRcbRhbRhbLhbLcbRibRhbLcbRgbLcbRgLsRsbLibLsbRgbRhbRiRsmbRibRibRobLj
bRcbRibRhbLcbRibRcbRcbRibRgbRhbLibLcbRibRjRhbRibRhbRibRsbRgbRhbRgbRgbR
hbRobRcbRibRcbLjbRoLgbRibRibLsRsbRgbRgbLgbLibRjRgbRibLhbRcbLsbRibRgbRs
RsmbRsRsmbLsbLsLsmbLsRiLsbsbsbsbLsRibLgbRgRsmbRgRsmbLsbRgRsRsRiRsRimmm
bRgRgbRgRsmbRgbRgbRgRsmbLsbRibRsRsmbRgbRsRsRimbLsRibLgbRgbRgbLcbLobRib
LcbLcbRibRiRsmbLgbRcbLcbLhbRjbRcbRcLsbRcbRcbLcbLobLcbRhbLcbRibRgbRsbRi
bRsRsmbRgbRsRsmbLsbRgRsmbRsbRgLsRsRsmbRiRsRsmmbRgbLgbRiLgbRibLgbRibRsb
RgbRgbRibRgbRgbRgbRgbRiLsbRgbRhbRcbRcbRcbRcbRcbLcbLobLcbRcbLjbLobRcbRo
bRibRgbLibRcbLcbLcbLiLsbRsRsmbRibRhbLcbRsRsmbLobRibLoLobLcbLcbRhbRibRi
bLhbRcbLsbRhbRcbLobLeLsbLibLhbRgbRibRcb

>ZF Recording 2016-03-18; tW: 300s; Start: 121304; End: 121804;
Recording: 1-1; Individual: 12; Drug: NDMC 1 µM
bLgbLgbLgbRibLjbLibLibRcbRcRsmbLibRibLgRsbLjbRjbRibLebLibLgbLgRsbRsbLg
RsbRebRhbRsbLsbRjRsmbRiRsmbRiRsmbRgbRjRsmbRgbRgbRsbLjLcbLibRobRgRsmbLi
bLjLsmbLgbLsbLsbLgbRgbLgbLibRgbLgLsbRjLsbLsLsmbRhbLcbLibLsbLgbRibLobLg
bRsbRgbRibLcbLibLibLcLsmbLibLjbLibLsLsmbLibRgbLgLsbLgbLgbLgbRsbLibRibR
obRobRsbRgRsRsmmbRgbRgLsbRgbRsbRgbRgbRsbRsbRsbRibRobRobRibRgbRsbRgbLsb
LhRsbLsbRgLsbRobRobRgbRibRiRibRgbRobLsbLgLsbLgbRsbRcbRobLgbRibRsbLibLi
bLcbLhbLgbLgbLcbRcbRobRhRsmbLgbRjbRsLiRsbLibRgbLiLsbRsbLibLsRsbRgRsmbL
obLibLibLsLsmbLgbLibLsLiRsLsbLibLsbRibRibRebLibRiLsbRibLgbLgbRgRibLgbR
obLsbLsbLcLsmbLcbLsLsmbLsbRsbRibLcLsmbRcbLcbLibLibRjbRcbLcLsmbLobLibLg
bLsLgbLibRsbLibLibLsRsRsmbLgbLiLsbRsbRiRgbLcbLibRgbLiRsbLgbLibLiRsbLsb
sbLhbLcbLiRsbRgRsmbLhLibLsbLgbLibRjbRebRoLsbRcbLcbLibLgbRsbReRhbRsbLgb
LebRobLebRoLsbLjbLiLsbLjLsmbRgbRebLjLsLeLsLiLsLsmmbRsbLsbRjbLobLobRoRs
mbLoRsbRibRibLsLibRsbRobRobRobLibRgRsmbLgbRcbRibRiRsRsmmbsbRibRcbLeLsb
LsLebLsLsLsmmbLsbLgLsLgbRebRgRsRiRsmmbRgRsmbRiLgbLsbRsRsmbsbRsRsmbRebR
cbRebRobLhbLebLebLebLgLsbLsLsLsLsLemmmbLebLhbLgbLcbLsbsbLsbLsbLeLsbLeb
LsbLsbLiLsLsLsmmbLsLsmbLgbRcbLiLgbLebLsLsLsLsmmmbLgbLsLsmbLsbLobRcReRo
RsmbRsLsbRsb

>ZF Recording 2016-03-18; tW: 300s; Start: 121304; End: 121804;
Recording: 1-1; Individual: 13; Drug: NDMC 3 µM
bLgbLgLsbRgbLsbLibLibLoRsbLgbRjbLgbLgbLibLibRcbRibRcRsmbLgbRgbRsbLobRi
bLcbLhbRibRsbLgbsbLoRsbRsbRsLsbLcbRcbLobRibRoRsmbRsbRhbRsbRcbRhbRgbRgb
RsbLsbRcbRcbRgbRcbRibRsLsbRgbLgRsbRibRibRgbLsbRsbRoLsbLibLcRsbRsbLsbRg
bsbRobRibRsbRibRsbRoRsmbLsbLgbRsbRcbLgbLhbRgRsmbLsLcbLibRgbRgbLsbLobRg
RsLsmbLibRgbLiLsLsRgmbLgbLsbLgbLsbLgbLgbLibRcLsbRibRcLsbRcbRcbRhbRebRc
bLjbLhbLibRibRcbLsbLgbRjbLjbRibLjbLibRsRsmbLgbLsbLibRsbRobLsbLgLsbLsbL
ibLsbLgbRsbRsbRibLcbRobRhbRjbLsLsLsmmbLibLibLibRgbRcbRgbLcbLhLsbRcbRcb
RjbRcbRsLsbLsbLcbLoRsbLsbLgLsbLgRsbRgbLibRsbLgbRsbLgbLgbRsbLjbLobLcbLi
bRsbLibLsbRsbRgLsbLibRsbLgbLsbLgbLsbLsRsbRobLjbRobRiLsbRjbLsbsbRjbLcRs
bRhbLibLibLsRsbLibLgbRcbRebLcLsmbLibRcbLobLobLobLibRhbRebRoLsbRibLsbLi
LsbRebRhbRsbRcbRobRsLsbLgbLgbRebLobRjbRebLhbLhbLgbLhbRgbRebRiRsmbRgbLi
bLsbsbRcbLgbLhbLibRebLibRibRgbRhLsbRibLsbLgbRobRibRcbRhbRgRsmbRsbLsbLo
bLiLsbLsbRgbRgbRgbRiRsmbsbLgbRjbRcbRibRibRobRibLcbLhbLsbRcbLjbLobRsbLg
bLsbLjLgRgbLoLsmbLgbRsbLgbLgbRoLsbRsRcLsbRsbRsbRibRibLibLibRcbRsbLgbLg
LsbLiRsLsbLsbLhbLsbLibLsbRsRsmbRsbRgbRibRiLsbLsLsLsmmbLgbRibLjbRhbRsbL
cLsRsmbLcbRcbLsbLcbRobRgbRcLsLgLgbRjbLibLsLsmbLsbLsbLsbLgbLsbLsLsmbRsL
sbLgbLgbLgLsbLsLsmbLsbLgbLgbLgbLgbLgbLgbLsLsmbRibRcbRcbRcbRobRcbRibLjb
LibLoLsLsmmbLhbLsbLsbLcbLobRcbRjbRobRhbRiRsmbRsbRiLsLsmbLibRjbRibRibLs
RsbRibRgbRsRsmbLsbRgbRgbRgRsmbRgbRgbLgLsbLjbRobLhbRibRcbLgRsbRcbRobLib
LibRcbRhRsmbLsbLcbRcbRgbRsbLjLoRsRjbRcbLhbLcbLcbLgbLsbLgbLsLsmbLibLibR
jRcbLjbLcbLibRhRsmbRgbRobRoLsbRcbRgbLcbLibLcbLibLsbLibLibLiLsbLibLcbLi
bLgbRcLsbRobLcLsmbLiLgbRoLsbRobRcbRcbRoLsbRhbRgbLibRgbRsbLiLsbLobLibLg
bRsbLgbLibLiLsRsbRsRsmbRsbLsRsbsbLgbLibRsbLgLsbLsbLsbLsbLib

>ZF Recording 2016-03-18; tW: 300s; Start: 121304; End: 121804;
Recording: 1-1; Individual: 14; Drug: NDMC 3 µM
bRsbLcbRgbRiLsbRgbRcLsbLsRsbLobRjbRibRgRsmbLgbRgbLgbRsbRsbRcbLgbRobRcb
RhbRibLsLsmbLsRsbLcbLibLcbLebRgRsmbRcbLibLjbRibRgbRgbRoLgbLgbLibLsbLgb
RgbLobRhbLsbLcRsbRhLsRsbRibRoLsbLgbLgbRobLsbLgbRobLgbRsbRobRsbRoLgbRsb
LibRibRhbRoLsbRjRsmbRibRgbRhbRoLsbRjbRobLgbRgbRgbRgbRsbRgbLsbLsbRibRgb
RsbRgbRgRsRsmmbRgbRgbRsRsmbRgLsbRgRsmbRsbLsbRiRsmbRgbRgbRgbRgRsmbRgRsR
gmbRgbRgLsbRibRsbRiLsRsbRgbRgbRgbRgRsmbRibRgbRgbRsbRibRibLgbRcRsmbRsbL
gbLgbLcbLcLsmbLhbRhbRibRgbRsbLsbRgbRoRsmbRgbRgbRibRibLcLsmbLoRsbRgbRib
LoRsbLsbLsRsbLhLsbLgbLgbLgbRgbLobRsRsmbRgLsbLcbRsbLgbLsbLiLsbRcbRebRcb
RcbRjbRoLsLsRsmbRibLgbLsbLjbLcbLsbLsbLsbLobRgbLcbRcbRsbLgbRebLsbLibLsb
RebRoLsbLsRibLcbLobLcbLsbRebLeRsbRibLgLobRebRsbRjbRsbRcLsbRebRhbRgRsmb
RoRsmbRcbRgbRsbLsRoRsmbRcbLcbRgbLsbLsbLsbRhbRibRsbRibLsbLobsbLhbLcbLcR
gbLobRibRsLsbRjbLcbRebRobLcbLcbLsRsbRcRsmbLcLsmbLcbRjbRibLsLsmbLsbRebR
cbRcbRgbLcbRgRsmbLoLsmbLcbLcRsbLcbLobRgbLobRsbRjbRobRcbRcbRebRobRcbRoL
sbRcbRebLcbRibLgbLgbRebLcbRibLobLcbRjbRobLibRgbLsbLsRoRsmbRcRsmbRibRgb
RgbLgbRobRcRcbRibRobRcRsmbRsbLobRsbRgbRjbRobLcbLcbRiLcbRgbRcRibRsRiRsL
embLobRcbRoRsRhRsmmbRsRsmbRsbLcbLobLgLsbLgbRobRhbRhbRcbRcbRibRiRgbRsRs
RhReRimbRsRgRsmbRsbLsbRsLsbLobLcRsRgbRiRgbRobLcLcbRcbRsRebRgRgbRiRsmbR
gbLcLcLsRsmbLsLsmbLcbLcbLhb

>ZF Recording 2016-03-18; tW: 300s; Start: 121304; End: 121804;
Recording: 1-1; Individual: 15; Drug: NDMC 3 µM
bRsbRgbRgbLsLsRsmbRgbRgbLsLsmbRgbRibRibLiLsbRibLiLsbLgLsbLibLgbLgbLgLs
bLsbLcbRgbRsbLiLsbRgbRsbRibLobRjbRiRsmbLsbRgbLsbRibLgLsRsbRibRobRgbLib
RjbRibLcLsmbRcbRibLgbRibRibRobRgbRsbRgRsRcLsLsmmbRsbRgRsmbRgbRibRgLsbL
gbLgbRhbRhbRiRsmbLibRgbRgbRgbLgbRibLsbRgbRsbRgbRibRsbRsbLsbRiLsbRibRiR
smbRsbRgbRibLgbRibRgbRgbLsbLsRsLsbRhbRsLsbRgbRobRibRsbRibRibLjLsmbRgbR
sRsRgLsmbRgbLsbRgbRgbLsbRgbRgbRsLcbLiRsbLibLiLsbRgbRgbLsbLgbLgbLgLsbLg
bLgbRsbLgbLsbLgRsbLgLgbLibLcbLsbLsbLgbLgLsbLcbRgbLgbLgbLsbLgbRsRsmbLib
RsbLsbLiLsbLgbLsbLgLsLsmbRgbRgLsbRsLibLsbRsLsbLgbLgbLgRsLibRgbLiRsbLgL
gbLibRsbLgbRsbLiRsbRgLsbLibRgRsmbLgbLgbLsbLgbRsbLgLsRsbLgbLibRsbRgbRcb
RiLsbLibRibLcLsmbLgbLibRjbLibLgbRgbLhbRsbRgbLibLgbLsbLcbRibRgbLcbLoRsb
sbLsbLsbRgbRobLibRcbLgbRgbRgbRcRobRgbRjbLjbRcbRiRsmbRgRsmbRgbRsLsbRibL
sbRiLsbLiLsbLibLsLibRgbLsLsmbLibRsbLgbLgbRsbLgbRsbLgbLibRobRhbRibRibRi
bRsbRibLsbRgbRibLgbLhbRiRsmbLcbRcbLsbLcLsmbRsbLsLibLcbLibLhLsbRcbLiLsb
LibLsbLsLsmbLhbLgbLhRsbLcLgbLgLsbLibLgLsbRgbLobLibLibRsbLgbLsbRjRsmbRi
bLjbRibRsbRobRibLgbRiRsmbRsbRibRsbRgbRgbLsbRobRcbRgbRgbRsbRibLsbRiRsmb
RgbRsbRgbLjbLhbLobRibRobRgbLcbRjRgRsmbRiLsbRhbLsLsmbRibRibLsbRsbRobLgb
RibRibLsbRibLjbRgRibLsbRiLsbRsRgbRgbRgRsmbRsbRsbRgbLsbRgbRgbRsbRsbRgbL
sLsRgmbRgRsmbRsbRgbRgbRgbLjbRgbRcbRcbRibLibLiLsbRibRsbLgLgbLgbLgbRsbLg
LsbLsbLgLsbLsbLsLsmbLsbLgbLgLsbRgbLgbRsbsbLgbRsLsbLgbRgLsbLgbLgbLiRibL
gbLgLsbLgRsLsbLgbLgLsLsmbLgbRsbLhbLobRoRsmbLsbRjbLcbLibRibRhRsmbLcRsbR
jbRobLiLsbLhbRhRsmbRcbRsbLsLsmbLsRibRiRgLsbRgbRgbRibLgbRgbRobRibLgbRib
RibLcbRcRsmbRhbRcbRgbLgbRiLsbLebLcbRibRhbRgbRobRsbRsbLsLsmbRobRgbRhbRh
bRcbRhbRhRsmbLsbLibRsRcbLgLsbLebLsbLgbRcbRhbRgbLgbLgbRsbLobLcbRsbLgLsR
sbLhbLgbRcbRobRibLjLsmbLobLgLsbRgLsLsmbRibLgbRobRsbRibRibLibLebLcLsmbL
ibLgbRsbRiRsmbRcbRibRgbRibRibRibRgbRsbRgbRibLhLoRsbRcbLoLsmbLhbLobLibL
obRsbRiRsmbRibRibRsLsbRhLsbLgbLhLsbLgbRjbRsRcbLebLhLsbRgLsbRcbLcLsmbLi
bLgLsb

>ZF Recording 2016-03-18; tW: 300s; Start: 121304; End: 121804;
Recording: 1-1; Individual: 16; Drug: NDMC 3 µM
bLibLgbRsbRobLobLobRgbRibRsRsmbRhbLgRsbRsRsmbRiRsmbRgbLsbLsbRgbRgbRsbR
gbRgbLsbLjbRjbLcbRcbLcbRcbLcLsmbRiLsbLgbRhbLgbLsbRibRsbRsbRgRsmbRsRsmb
RgbRgbRsbRsRgRsmbRgbRsbRhbRobReLsbRibRsbRgRsmbRgbRsbRcbLgLsbLsbLgbLibR
cbLebLebLcbRibLcbRobRsbRsbRhbLsbLgbRibLgbRibLgbRsbRibLgRsbRibLsbRgbRgR
smbRsRsRgmbRgbRsbRgLsbLgLsbLsbRebRgbLobRibLobLobRibLsRsbLcbRsbRobLibRi
bLsRsbRgbRsbRiRsmbRsRsmbRsRsmbRsbRgbRgRsmbRsbRgbRgbLsbRibRibLibRibLsbR
ibRgbRsbLgbRiRgRsmbRsbRsbRgRsmbRsbRgRsmbLsRgRiRsmbRjLsbLgLsbRibRiRsmbR
sbRsbRibLcRsbLibRcbRcbLsbRobRsbLsbRiRsmbLsbLcbRobLhbRibRiLsbRsbLsRsbRg
bRgbRgbRsbRsbRsbLsbRgbRsRsmbRgbRgbRgRgRsmbRgRsRsmmbRgRsmbLsbRibRiLsRsb
RsbRhRibRsbLgbRibLjbRibRsbLsbRgbLcbRebLhbRgbRsbLobLgRsbLhbLibRsbLobRgb
RsbLobRcbLhbLobRcbLcbLobLcbLiLsbRjbRoLsbLgbLgbLjbLcbLoRsbLobLibRgbLhbR
sbRgbRsLibLibLgbLsLsmbLsLsLsLgmmbLgbLsRsbLoRsRiRjbRiRsmbRsbLsLoRgbLiLs
bRjRhbLibLgRsRsmbLibLsbLiLgbLjRcbLobRcbRobRsbRcRsmbRsbRiRsRsmmbRibRsbR
hRsmbLsbRsbRgRsmbRgbRgbRsbRgbLsbRiRsmbRsbRgbRgRsRgmbRsRsRsRgmmbRgRsmbL
sbRhbLiRsbRgbRgRsmbRsbRiLsLsmbLsbLobLcbLobLcbLcbLibLgbLsbRsbRgbRsRsRim
bRgbRsbRgLgRsbRsbRgbRsRsmbRgbRsbRgRgLsbLgbLebRcbRcLsbLcbLgbRcbRsbLjbRi
RsmbRsbRibRobRcRsmbRiRsmbRgLsbRsRsmbRgbRsbLsbLsbRgbRgbRgbRgbRgRsmbLsRs
bLobRcRsmbLjbRcbRsRsmbRiRsmbRibLsbRsbRoLsbRsRsmbRgRsmbLsbLgbRobLgRsbLj
bRcbRsbRgRsmbRsbLcbRsbRobRgbRsbRsbLobRebRsbLobLoLsmbLobLsbLibLcRsRsRsm
mbLgbLgbRgbRcbRgbRiRobLcbLsbRsRsmbRgbLgbRsbLcbLsbRcbRibLobRobRgbRgbLsb
RoLsbRobRgbRsbRsbLsbRsbRgRsmbRgRsmbRsRsmbRgRsmbRgbRsRsmbRsbRgbRiRsmbRg
RsmbRsbLgbRgRiRsmbRsbRgbRgbRsRsmbRhbLiRsbRibLsbRiRgLsbRhLsRsRgRgRsmbRg
ReRsmbRgbRgRsmbRgbRgbLgbLsRiRsmbLsRsbLobLoRsbRcbRcbLobLcbLiLsbRiRsmbLh
LeLsLgLcbLgRsLhLgLebLiRsLeRsLsbLgLgbLsbLobLobLobRgbLcbRhbRibRcRsLsmbRo
bRhbRcbRsbLibLgbLibLsLiLsLgbLsbRsbLgLsLeLeLhLgLgbLgRgbLibRobRcbRobRcRs
mbRobLcbLgRsRiRiReRiReRsRsRsLsmmmbLcbLcbLhbLcbRgRsmbLjbRgRsmbRgRsmbLsb
RiLsbRsbRsRsmbLebRcbRibRiRiRsmbLhbRgRoLsRgbRibLsbLgbRiReRebLgLcbLiLgbL
obRibLibLiLsbLobLcbRibRibRsbRcb

>ZF Recording 2016-03-18; tW: 300s; Start: 121304; End: 121804;
Recording: 1-1; Individual: 17; Drug: NDMC 3 µM
bLgLsbLgbLhbRgbLsbRibRibRobLgbRsbRibRibLgbRgRsmbLsbRibRsbLgLsbRibRgbLc
bRgbRibRgbLsbRsbRsbRgRsmbRsbRgbLsbRsbRgbRgbLsbRsRsmbRgbLsbRsbLsbRibLsb
RoLsbLiLsbLgbLsbRsbLcbRgLsbLhbLcRsbRsbRgbLhbRgbLcbLibLgbRsbLcbLhbLcbLc
bLebLibLgbRgbRgbRsbLjLsmbLcbLibLgbLgbLgbLsbLgbRjbRibRgbRsbRibLsbLsbRib
RsbRgbLsbRsbRsbRsbRgbsbRsbLjbLsbLsbRibRgbLsbRgbLobLcbRcLsbLgbRgbRcbRsb
RhbRcbRsbRgbRgbLcbLibRsbLibRgbLcbRgRjbLibLhbRgbRobLcbLcbLebRcbLcbRjbRc
bLebLiLsbLgbRgRsmbLcLsLsmmbLcbLibLgbLobRibRcbLebRjbRcbLibLgbLcLsmbLhbR
ibRgbLobRgbLibRgRsmbLgbLibRgbLgbLiRsbRgbLgbLgbLgRsbLsbRjbRcbLjbLobLgbL
sbLcbLgbLibLsbLebLgRsLsbLgbLgbLgbLsLsmbLgbLsbRsbLiLsbRsRsmbLibLsLsmbLg
bRibLibLibRsbRgbLibLgbLgbLsLiRsbRsbRgLibRibLsbLsbLebLgbRjbRcbLcbLcbRob
RhbRcbRobLcbLgbRhbRgbRsbLoLsRsRsmmbLibRsbRgbLsLibRjbRibRobRhbRgbLsbReb
sbRobRibRibLibLcbRibLobRsRsmbRsbLsRsLsbLjbLobLjLsmbLjbLsbLibLibRibLobR
cLsbLibRcbRibRgbLgbLgbLsLgbLibLcLsmbRhRsmbRibRgbRoLsbRsbRgRsmbRgbLsbLj
bLobLcbLibLgbRcbLhbLobLcLsmbRobLcbRobLibLobRibLsLsmbRibRcbLcbLobRebRob
LcbRcbRsLobRebLcLsmbLibRcbLibRhLsbRcRsmbRibRibRobRibRibRiRsmbLsLcbLcbL
ibLcbRhRsmbRibRcbRoRsmbRcRsmbRibLobRiLsbLcRsbRgbRebRhbRhbRhbLgbLibLiLs
bLcLcbRobLobLcbLhbLcbLcLsLsmmbLgLsbRsbRgbRgbLjbRiRiRiRsmbRgbRgLsRsbRiR
gbRcRsmbLibLiLsbLcLsmbLcbLhLsbLiLsbLgbLibRibLcLsmbRsRsmbLsbRibRhbRgLsR
sbRhbLgb

>ZF Recording 2016-03-18; tW: 300s; Start: 121304; End: 121804;
Recording: 1-1; Individual: 18; Drug: NDMC 3 µM
bLcbLcbLhbRobRoLsbLhbLhbLibLobLcbLcbLcbRibLibLobRibLcbLgLsbRcbRobRgbRi
bLgbRhbRobRcbRobRibRobRibLcbLcbRibLcbLcbLibRibRjRsmbRcLsbRgbRgbRiRobRs
RsLsmbLsbLjbLhbLhbRgbRsbRsLobRsLsbLibLiLsbLsbLgbRgbRjbLobRibLobLhbLebL
cbLsLsmbLgLsbLgLsLgbLsRsbLoRsbLsLsmbLiLsbLgbLgbLgbLgbLgLsLgbLgbLgLsLoR
sbLibLiLsbLobLibRiLsbRhRsRimbRoRsmbRibRibRcRsmbRibRoLsbLcbLobLibRhRibR
gLsRgLsbRgbRgbRebLibLiRsbRsLsRsbRebLjLcbLcbRgLsbRcRcLsbRobRsbRsbLiLsbL
gbLgRsbLcbRsbLgbLibRgLsbLobLcbLobRiRsmbLcbRobRoRsmbLgbLibRgbLsLsLhmbLs
LgbLgbLobRsbRcbLibRsbRibLcbLiRsbRjbLhbLobRhbRobRgbRoLsbRoLsLsmbLgbLobL
cLsmbLsRsbLgbRgbRiLsbRcbLjbLcbReLsbRhbRgbLgbRsRgRiRsmbRobRsLgbLoLsRsmb
RsbRibRsbRobRcbRhbRcLsbRcbLcbLcLsLsmmbLobRiLsbLsLsmbLgbRcbRhbRibLgbRsR
obRgLsbRsbRsbRhLsbLjbLsLcbLhbLoRsbLjbLcbLhbRgbLoLsmbLibRibLjbRcbLjbLgb
LibLsLsLsLsmmmbLgLsLsmbLcbLobRebRiRcbRgbLeLsbLcbLsbLoLsmbRjbLibLjbRgbL
obRsbRsLsbRcRibLebRhbRcbRebLobLibLibsbRebRhbLhLcLsmbLcbLcbRcbRobLebLib
LcbRibRgbLsbRoRsRiRsmmbLiLsLibRiRibLebRjbRcLsbRibRobLiLsbLsbLibRgbLoLs
mbLoLsLsLcmmbLoRsbRsbLsbLhbLcbRcReRsmbRoLsRsbRcRsmbRcbLjbLcLsmbLibLgbL
cLiLsLsLsLsLsLsLsLsmmmmmmmbRcRsmbRiLsbRgbLiLgRibRiLgLsbRebRhRebRebRebR
hLgLgbLoLoRibReb

>ZF Recording 2016-03-18; tW: 300s; Start: 121304; End: 121804;
Recording: 1-1; Individual: 19; Drug: NDMC 10 µM
bLcLsmbRibLgLsbRgbRoLsLsmbRcbRhbRgbRgbRibRcbLjLsmbLobLcbRsbRgRsmbRgbRg
bLcbLhLsbRgLsbLibRhRsmbLobRhbRhbRcbRsbLsbRibLsbLgbRibRsbRobLibLoLsmbRi
bLsbRsbLcbLgbRgbRgbLcbLobLiLsbRsbRibLsbLsbRibRobLcbRsbRobLsbRsbRibRgbL
sbRgbRcLgLsbRsRsmbRobRobRcbRoLsbLgbLsbLgbRcbLcbLibRgbLsbLiRsbLgLsbLsbR
sbLgLsbLsbLgbLgbLgLsLhLgLsbLgLsbLsbLgbLgLsbRsbRjbRibRsbRobRcbRoLsbLcbL
cbRhbRgbRsLsbLobLcbLibRibRsbRcbLgLsbLgbRcbLobLiLsbRsbRoLsbLjbLcbLhLsbL
gbLgbRgbLsbRobRgLsbRhbRhbLgbRobRibRgLsRsbRgbLibLibRjbLgbRsLsbLiLsRsbLs
bLgbLsLsmbLibLsbLsbLiLsLsLiLgLimbLgLibRobRobRobLobLobLobRhbLoLsmbRcbLs
RobRcLsbLgbRoLsbRgbRibRgLsRsbLsbRjbLjbRcbRgRiLsbLgLsbLsbRoLsbLgbRcbRcL
sLsRsmbRgbRgbRibLsbRibRibRgbRiLsbRcbRsbRgbLobRibLibRgbLobLsbRgbLibRsbL
ibLobRgLsbRgLsbRsbsbRibLjbRibLsRgRsRiRsmmbRgbRgbLsbRgbRgbRsLsRibRgbRsR
ibRgRsRimbRgbRgbRgbRgRsmbRgbRsRgRsmbRgRsmbLjbRhbRcbLcRsbRhbRsbLsbLgbRc
bLsbRiRsmbRibRcbLcbRobRgbRsbLcbRgLsbRgbRgRsmbLoRsRgbLobLcbRhbLsbLsbLoR
gLsLsmbLgbLhbRsbLobRsbRcbLcbLoRsbRgbLobLcbLibRgbRjRsmbRcbRcbRhbRobRgRs
mbLgbRsLgbLobRibLcbRsbRebLcbLsbLoRsRsmbRsRsmbLgbRsbLcbLsbRsLsbLoLsLsmm
bLibsbLsbLjbLhbLgbLibRsbLsbLgbLiLsLsmbLgLsLsmbLsbRgbRebLcbLibRsbLiRsbR
sbLgbLgbRoLsbRoRsmbRgbLsbLhbLsbLobLibLsbRibLobLcbLsbRsbLibLibLgbRobRgR
smbRsbLobLgLsbLcbLsbRsbLsLsmbRobRcbRgbRsbRobRoLsRsbRibRibLobLibLgLsbRs
LsbRsbRoRsRsmmbRcbRibRobRibRsbLsbLcbLibLgbLgRsbRgbRobRibLsbRoRsmbRibRc
bRgbRoLsbRhbRgbRhbLcLsmbLgbLsbLoLsmbLibLhbRsRsmbLibRsbLiRsLsbRgbRobRhb
LiLsbLcLsmbRsRsmbRoLgbLibLsbLiRsRsmbLgbRsbRcbLcbLebRsbLcbRsLsbLibLobLo
bLobRobRjbRebLoRsbLcbLiLsbRgbLcRsRsRsRgmmbRebLiLeLeRsLsLsmbLob

>ZF Recording 2016-03-18; tW: 300s; Start: 121304; End: 121804;
Recording: 1-1; Individual: 20; Drug: NDMC 10 µM
bLgRsbLgbRjLsbRjbLcbRgbLgbRobRobRsbRibRibLcLsmbLibLgLsbRjbRiLsbLsbRibL
gLsbRsbRibLgbRebRobRiRsmbRcbRibLsbLgbRebRiLsbRibRcbLibLgbRebLgbLcbLibR
ibLibRibRsbLobLjbLcbLgbRgbLsbLgLsbLgbRjbRebLgbRgbLsbRobRibRsbRsbLcRsbL
cbLgbLsbLgbRgbRoLsbLgbRcLsbLcLsmbLibLcRsbRcRsmbRibRcbLsbLgbRibRgbRoLsL
sRsmbLgbRsLsbLgbRoLsbLsRsbLgbRobRibLibLgbLsbLgbLibLcRsbLjbLobLibRsbLsL
smbLgbLsbLsbRebRoLsbRcbRsbsbRcLsbLgbRsbRsRgRsmbRgbRgbLgbRebRobRibRebLo
LsmbRgbLgbRibRebLoRsbLsbRjbLhbLcbRsRsmbLibRgbLsbRhbRibLibLgbRsbRoLsbRc
bRhLsbRsRhLsbLiLsbRgbRoLsbLgbRobLgbRsbLibRoLsbLjRsbRgbRibRgbRibRobRiLs
bLibLgbLgbRsbRsbLgbLoRsbRcbRcbLgbLjRsbRhbLhbLibLobLsbLibRsbRibLsbRobRi
bLibRjbLcRsbRobRibLjbRoLsbRcLsbRgbRhbLibLhRsbRibRcLsbRhbLgLsbLsbRibRsR
ibLsbRoLsbRibLsbLgbRebRibLhbLjbRebRsReLsbLjbRgbLcbLcbLhbLsbLgbRhbLcbLg
bRibLcbLcRsbLgbLcbLhbRgbRsRsmbLcRsbLsLjbLobLiRsbLcbsbLibLcbRsbRibLcRsb
LibLcbRsbRsbRcbRebRobRibRebLsbRsbRsRsmbRgbRsRsmbRobLsLsmbRibLsLsmbRebL
iRsbRiLsbLcbLibRiLsbLibLsbLsbLsLgRsbLibLcbLhbLibLjbLibLgbLgbLcbLoRsbLi
bLcbRgbLsRsbLcbRibLgbRcbRobRobRhbLcLsmbLsbLjLsmbRsRsmbLgbLgbRcbRibLiLs
Rsb

>ZF Recording 2016-03-18; tW: 300s; Start: 121304; End: 121804;
Recording: 1-1; Individual: 21; Drug: NDMC 10 µM
bRobRobRsLsbRsbLobLibLoRsbRibLsbLobRobRobRobRobLobRcLsbRibRcbRibRobRob
LgbLibLobRcbRgbLobRibLjbRobLhbLjbLobLsbRobRobLgbRobRibRgbRgbRsbRibLsbL
gbRiLsbRibLgRsbRgbRgbLsbRgbRgbRsbRgbRgbRgbRoLsLsmbLobLibRsbLgLsbLsbRoL
sbRgbLibRhbRjbLjbLobRcRsLsmbLiLsbLibRsbLgRsbLsbLgbLsbLiRsbRobRhbLsRsbR
ibLsbRcbLsRsbRsbRsbRibRibRgbLsbRibLgbLjbLcbRobRgbRgbRiLsbRgbLiRsbLoLsm
bLoRsbLjbLcbRcbLcbRcbRhbRjbRsRsmbLsbRobRiRgbRsRgRiRibRgRgbLhRsLsbRcRsm
bLobLcbLobRsRsmbLsbRiRsmbRobLoRgRsmbRebLsLsLsRsmmbRsbRsbRiLgbRsRiRibLj
LcbLcbRobRoLsLgbRgbRgbRiRsmbRgRsmbRgbRgRgRiRiRiRibRiRsmbRiLsReRiRiRsmb
RiRgRsmbRgbLcbRobRobLebRoLsLsmbRobLcbRobLiLsbLibLsLsLiLgmbLcRsbLobLobL
obLiRsbRcbRhbLsbRobLibRebLsRsbLcbLobRsRsmbRibLgbLcbRcbRoLsbLgLgLgLgbRo
bRoLsbRobRhbRoLsLsmbRoLsbRgRsmbRiRhbRobRgbLgRsbLgbRcbRoLsbRgRsmbLibLsL
oRgRsLoRsmbRgRiRibRgRsmbRhLsLsmbRiRsmbLiLsbLgbLobRibRcbRobRobRobLhbLgb
RiRsmbsbLobRibLobLsbRgbRiRsmbRcLsbLibLibRsbRjbRcbLibLjbRhbLgbRhLgbRiLs
bLeLsRsbRobRebRhRsmbRebRgRsRsmmbRcbRobLibLcLsmbLhbLsbRibRhRsmbRhbLcRsb
RobRobRob

>ZF Recording 2016-03-18; tW: 300s; Start: 121304; End: 121804;
Recording: 1-1; Individual: 22; Drug: NDMC 10 µM
bLibLibRsRsRsmmbRgbRgbLoRsRsmbLibRibLgbRgbLgbLibLsLsmbLgbLgbLsLsmbRsbL
sLsLsmmbLgbRgLsRsbLgLsbRsLsbLgbRsRsLsmbLiLsbLgLsbsbLgbLsbLgbRsbLgbLgbs
bLgbLgbRgLsbLibLgbLgbRsbRgbLibRsbLgRsbLgbRsbLgbLibLgbRsbLibRgRsmbLiRsb
RsbLgLsbLibRsRsmbLgLsbLsbLgbLsbLiLsbLsbLgLsLsmbRsbLiLsbRsbLgLsbRsRsmbL
sbLsbLibRsRsmbLibLsLsmbLgbLsbLgbLsbLgbLsLsmbLgbLgLsbRsbLgbLsLoRiLsbRgb
RibRibRgRsmbRsbRgbRsbRobRcbLiLsbRobLgbRoRsRsmmbLgbLsbLjbLibLgbLgbLgbLs
bRgbRsbLgbLgLsLsmbLgLsbLgLsLsmbLgLebLgbLgRsRsmbsbRgbLsLsmbLiRsbLgLsbRs
bLobLobRiRsmbLobLobLgLsbLsLsmbLcbRjbLibsbLgbRsbLsbLsbLgLsLsmbLgbRsbLiL
sbLobLobLibRjbLibRsbLibRsbRjbRgbRsbRibRgbLgbRcbLhbRoLsbLibLgbRcbRibRib
LibLsbLhbLiRsbLcbRgbRgbRsRgbRobRsbLsbLhRsbLsRsbLsLibRsbLiLsbRgbLsLsmbR
gbLibRgbLibRsbLcbLibRiRsmbLiRsbLgbRsbLgbLsbRsbLiLsbRsLsbLiLsbLgLsbRsbL
ibRobRcRsmbRcbLgbLibRsbRsRsmbLobRjbsbRsbLibLhbRcbRsbRsbLjbLsbLsbsbLgbL
ibLibLoRsbLibLibRebLgRsbRsbRsbRsbRcbLcbLgbLgLsbLibLgbRgLsbLhbRibLibLgb
LgbRsbLgLsbLsbLgbsbLgbLibRibRsbsbLibLgLsbLsLhbRgRsRsmmbLsbLobLobLibLcb
RebRsRsLhLsLsmmbLibLgbRsbLsbLsbLjbLsLsmbLgRsbLibLgLsbRsbLgLsbLgbLsbLgL
sLsmbLgbRsRsmbLiLsbRibRiRhbLjbRoRsmbRiLsbLsLeRsbRibLsbLjLgbLgbLgLsbLsb
LgbsbRsbLsLsLsmmbRgbsbRibLebReRsmbLcbsbLibRsbLsbLibLibLsLsmbLiLsbRgRsm
bRjb

>ZF Recording 2016-03-18; tW: 300s; Start: 121304; End: 121804;
Recording: 1-1; Individual: 23; Drug: NDMC 10 µM
bRsbLsbRsbLgLsLsRsmbLsbLsbLsLsmbLsLsmbLgbLsbLsbLsbLcRsbLcbLibLcLsmbRsR
smbLiLsbRsbLibLsbLcbRhbLsLibLhbLibLibLibLgLsbLgbRsLsbLhbRiRsRsmmbLcbRs
bLsbLgbLsbLgbLsbLgbLsbLgbLsbRebRsRibRibRibLgRsbRibLsLsmbLcRsbLibRobRcR
smbLebLjbLiRsbLsbLsbLcbRhbRiRsmbRibLcbLibRibRgbLcbRgbRsLsbLgbRsRsmbLsb
LsbLgLsRsbsbLgLsLgbLgLsbLsRsbLsRsbLgbLjbLobRibLiLsbLhbLgbRsbLhbRsbsbLi
bRsbLgbRjbLibRgRsmbLibLgLsbLgbLgLsLsRsmbLgLsbLsbRgbLcbRgbLcbRgLoLsLsLs
mmmbLiRsbLibRsbRobRibLebLhbLcRsbLoRsbLibLhbLibRhbRsLsbLhbLsbRsLsbLibRg
LsbsbLgLsbLibLsLsmbLsbLsLsmbLsbLsbLsbLibLgLsLgbLsRsbRoLsRgbRoRsmbLibLg
bRcbLjbRibRiLsbLsbLhbLibRsbLibLhbRsbRsbLibLsbLsbLgbRsbLibLcbLibLsbLsRo
LsbLsbRgbRgRsmbLcbLibLiLsbLobLcbLibLhLsRsbLibRcbLibLiLsbRhbLobRgbRgbLc
bsbRibLsbLobRcbLsbsbLcLsmbRhbsbLsRsbRsRsmbRgbLebLiLsbRjbRjbRhLsbLibRib
RoLsbRibRsbRsbRibLibRcbLsbLgbLgbLiLobRcbRibLiLsbLobLcLsmbRcbLcbLhbRibR
cbLjbLcbLsLiLsbRsbRebLjbLibLgbLgbLsLsmbLgbLsbLgbLsbRsLsLsmbLcbRgbLsbLo
bLsbRsRsmbLibRcbRsbRjbRcbRcRebLibLgbLsbRebLiLcbLgbRcbRcbLjbRjbLjbLcbRg
LsbLsbLcbRsbLhbRgbLgLsbLsbLgLsbLiLsRsLgRsbLibRgLjbLgbLgbRsRsmbLibLsbLg
bLsLgbLgLgLsbLgLgbLebLgLebLebLhbLjbLcbRebRhbLobLhLsbLjbLibLibLsbLibLjb
LcbLiLsbLjbLgLsbLiLsbRobRiRsmbRgbRebRgbLsbRgbRgbLjbRibLsbLsbRibLjbLcbL
cbLcbLsLiLgLiLsbLcbLebLcbLebLobLebLebLebLibLsLsRgmbLcLgbLcbLcbLhLsbLsL
smbRsLsbsbLcbLsRebRgRcRsmbLibRsbLsLsmbLsbRsbLgbLcbLcLhLsLhLsLgLsLsLgRs
LiLgmbLsLsLsmmbRsLiLebLgLsLsLsLsLgLsLsLsLsmmmmmmbLsLgbLsLsmbLsbLsLsmbL
sLsmbsbsbLsLsmbLsLsLsmmbRsLsbsbsb

>ZF Recording 2016-03-18; tW: 300s; Start: 121304; End: 121804;
Recording: 1-1; Individual: 24; Drug: NDMC 10 µM
bLgLsbLsbLgRsbLsbRsbLgbLgbLobLibLjbLcLsLsmmbLsRsbRsbRsRsmbLibLsbLgbLsb
RjbLsbLsLsmbLgbLgbLsbLsbLsLsmbLgbLsbLsbLsbsbLsbLgbLgbLsbsbRsbLjbLsLsmb
LgLsbLgbRsbLsbLgbLsbLoLsLsmmbLcbLibLsbLiLsbRsbLibLgbLsbLibRsbLibRgRsmb
LobLsbLgbLgbLsbLiLsbRsLsbLibRgbLibsbRsbRsbRsbLgbRsLsbLsLsLsmmbLgbRobLs
bRibLsbLsbRsRsLsLsmmbRsRsmbRsbLsRsbsbLsRsbLsbRsbRsbLobLibLsbLsbLgbLsbL
sbLsbLsbLgbLgbRsbLibLsbRjbLgbsbsbsbLgbRsbLjbsbLsbLsLjbLsLsmbLsbsbLsbLs
bsbsbLgbRsbRcbRgbLobLsbLsbLsbLsbLgbLcbLibLsbRsbLsLsmbLsbLcLsmbLhbLibRs
bRsbRsbLibLgbLibLsbLsbRsbLsbLibLsbLsbLgbLibLibLgbLsbRsbLsbLibLobLsbLsb
LsbLibLhRsbLibLsbLsbLsbLsbLiLsbLsLsmbLobLibLgbLgbLiLsbLsbLibLsLsmbLsbL
sLsmbLsLsmbLsbLgRsbLibLsLsmbRgbLobLiLsbLsbLgbLibLibRsbRsbRgbLsbLgbLsbL
gbLsbLsLsmbLsbLgbLsbLgLsbLsbRsLgbLgbRgbLoRsRsmbLhbLsLsmbLsRsbLcbLibRgb
RsbLsbLhbsbLsbLgbLsbLsbLgbLgbLsbLsbLgbLsLsmbLgbLibRgbRsbLiRsbLibLgbRib
LibLibLsbLsbLibLsbLgbLsbLgbLgbLgLsbLsbLoLsmbLgbRcbRgbRsbRsRsmbRsbRoRsm
bRjbLsbsbRibRgbRsbRgbRiRsmbLcbLsbLsbRsbLiLsbRiRsmbRibRjbRibRgbRsRsRsmm
bRgRsmbLsbRgbRsbRgRsmbRsbRgbLcbLcbRebLebRgbLibLgRsbLgbLgbLhbLsbRgbRebL
hbLsbLgbRsbLcbRebRgbRcbRibRhbLibRobRobRhbRibRobRibLibLgbLgbLsbRibRsbRj
bRobRcbRibRibRcbLcLsmbLgRsbRgbLobLcbLsbLgbLsbRcbLhbLibRsbLibLgLsbLsbLg
LsbLsLsmbLsbLoRsbLibLibRibRsbRibRgbLibRibRhbRgbLsbLgLsbRobRcbRhbRcLsbR
ibRsLsbLgbRiRsmbRsbLsbLgRsbRcbRsLsRgRgLsbRibRsbRgbLjLobLoLsmb

>ZF Recording 2016-03-18; tW: 300s; Start: 121304; End: 121804;
Recording: 1-1; Individual: 25; Drug: Control
bRgbLjbLcbLsbRsbLgbLiRsbRgbLgbLhbRgRsmbLcbRgbLcRsbRgbLibRsbLgbRsbLiRsL
sbLsbLgbLhbRibLebLcbLibRsbRibRsLsbRgbReRibLhbRjbRhbLgbLcbRhbLcbRcbRjRs
mbLcbLcbRibRebRgbRgbRgbRsbRgbLsRsbRgLgbRiLsbRsRibRiRsmbRgbRhbLsbRobRib
RobRibLcbRgbRgLsbLsbLsbLjbLobRgbLibRgRsmbLhbRgbRcbRsbRibRjbRjRsmbLibLi
bLoLsmbRibRgbLcbRgbLcLsmbRgbLibRsbLgbLiRsbLibLibLgbLiLsbLgbLibLibLibRi
RsmbLibLibLibRsbRibRibRgbRibRgbLibLjbLibRcbLibRcbRiLsbRhRsmbRibLgbLibR
gbLgbLhbsbLiRsLsbLgbLibRgLsbLibRsbLsbLibLibRsbLibLibLgbLgbLobLiRsbLibL
sLsmbRgLsbLsbLsbRhRsmbRgbLgbsbLiLcbRiRsmbRsbLsbLjbsbRsbLjbLsbLibRgRsmb
LiLsLsmbRjbLiLsbRsbRsbLiLsLsmbLgbRsbLgbLsbLgLsLsmbLiRsbLgbLgLsbLibRiLs
RsbLibRibRibLjLoRibRcbLsLsmbRibRgbLcbLhbRsbRcRsmbRibLgbRgbLcbLhbLcbLib
LgbLsRsbRcRsRsmmbLjbLcbRcbLsbRiRhbLibRibLgbLjbLibLsbLgbRgbLibLiRsbLiLs
bLiLsLgLibLsbRsbLiLgLsbLibLgbLgLsbLgbLgbLibLgbRsbLsbLobRcbRobLhbLcbLcb
LebRgbLibRsbLibRgbLibLgLjbLgbLsbLgbLgbLgLsbLgRgbLgbLsLsmbLiLgLsLsmbLib
RsbLiRsbRsbLiRjbLiLsLiLsbLgLsbLiRgLebLiRsRsmbLibRgbLiRsbLibRgbRgbLibRj
bLcRsbRsRsmbLibLjbRjRgbRjRsmbRibLjbLsLsmbLhbLcLsmbLibLgbLgbLiLsbLgLibL
sbLgbLeLiLeLsLsLsRsmmbLhbRebRcbLebRcbRoRebLcbLhbRcbRhbRcbsbRcbRcbRebLh
LcLob

>ZF Recording 2016-03-18; tW: 300s; Start: 121304; End: 121804;
Recording: 1-1; Individual: 26; Drug: Control
bRjbRcbRgbLibRcbLibRsbLgbLgbLgLsbLgbLgRsbRibLjbRjbRobRcbRgbRoLsbLibLoL
smbLcbLibRsRsmbLiLsbLsbLsbLgbLgbLibRsbRgbLgbLgLsbLsbLsbLgbLsbLcbRjbLsb
RibLsbRgbRgRsmbLsLsmbRibRsbRgbRjbRgRsmbRgbRgbRgRsmbRgbRsbLsLcbLjbRjbLj
bLcLsmbLibRibRsbLjbLibLibLiRsbRgbRhbRsbRjbLjLsmbLoRsbRibLobLoRsbLjbLcR
sLsbLgbLgbLgbLhbLibLsbRcbRsbLgLsbLobRgbLsbLgLiRsbRobLibLobLcbRsbLgbLib
RsbLoRgbLibRsRsmbLobRebRebLibRebRcbRobLhbRobLhbLsbRgbRiLsbRjbRsRsmbRib
LibRoLsbRsbRobLcbLgbRgbRgbLobLcLsmbLebLcbLsbLobRsbLgbLobLsbRgbRgbRsRgb
LsbRoLsbLgbRcbRjbLiLsbLoRsbRcbLobRobLoRsbRjbLibLsbLsbRsbLiLsbLgbRobRob
LcbLcbLjbLibLgLsbRgbLsbLgbRibRebLsLsLhLsmbLiLgbRebRcbRjbRhbLgbRcbRcLsb
LibLibLjbRobRibRebLibRhbLibRsRsLsmbRsbRsbLsbLibLsbLobRsbRcbLobLobLobRg
bRoRsmbLibLiRsbLgbLibLibLobRibLobLgbLoRgRsmbRsLsbLsbLjbLoRsbRgbLebRcbR
ebLibLgbLibLobLobLjbRoRcbLibRgbLhbRibRjbLcLsLsmmbRobLjbRobLgbRjbRsLiLh
RsLibRcbLjbRobRobRjbLcLcbRibRcbLebRobRcbLgbLcbRcbRobRsLsbLsLsmbLibRsbL
jbRsRsmbLgbRgbLjbLhbRgbRgbLsRsbRoRsmbRcbLcbLjbLobRcRsmbLjRsbRebReRibLo
bLcb

>ZF Recording 2016-03-18; tW: 300s; Start: 121304; End: 121804;
Recording: 1-1; Individual: 27; Drug: Control
bRjRebRhbRgbRgbLjbLobLibRhbRibLibLcbRsbLsbLibRgbLsbLgbRjbLibRibLibLgbR
jbLibLjbRobRhbLibRsbLjLhbLibRjbLjbRcbRgbRibLhbLcbLgbLgbLcbRgRsmbRsbLsb
LiRsbLgbLsbRsRsmbLgbLsbLgLgbLsLsmbLsLsmbLsLibLgbLgLsbRsLsbLgLsbLibLgRs
bLhbLiRsbLcbLcbLhbLgbLgRsbRibRibLsbRgbRcLsLiLgbLhbLiRsbRiRgbRhRsmbLobL
obLibLhbLebLcbRibRhbLibRhbRibRcbRobLibRiRgRsRsmmbRoRsmbRgbRgbLgbRiRsmb
RoLiLsRebRoLsLsLsLsmmmbLiRsbRebRobLcbLhbRjbRibLjbLcRsbRobRcbLibLibLoRs
bRjbRobReRsmbRiRebRsRsReRembRiRsmbLcbRhbLhbRcRsmbRcbRiLgbRjbRibLeLeLsb
LgbLeLsLeLebLoLsLgmbRebRebRcRsRsRsRcmmmbLebLcbLibLoLsLsmmbLcbLhbRjbRcb
RhbLcbLcbLcRsbLobLiRsbLoLsmbLsLcbLcbLobRiRsmbRobRcbLsLibLoLsLsmmbLcLsm
bRiLsbRiLsbRcRebRoLgRiRsmbLobLobRibLibLibRjbRcbRsbRobRcbRhbRcbLjbRibRc
bRiLsbRgRcbRsRsRsRsmmmbRhRsmbRoRcRebRcRsmbRoRsLsRoRembRcRsmbRoRhbLebLg
bLsLsRsRombRsLsbLsRsbsbLsbsbsbsbsbsbsbsbsbsbsbsbsbLsbRsbsbsbsbsbsbsbsb
RoRobLsLsLsmmbLebRcbRiRsLimbLgbRcLsRsRsRsmmbLgbLhbLoRsbLobLcLsmb

>ZF Recording 2016-03-18; tW: 300s; Start: 121304; End: 121804;
Recording: 1-1; Individual: 28; Drug: Control
bRobRsbRhRsRsmmbLibRsbLoRsbRsbRgbRibLcbRebRibRibLjbLsbLgbLgbRsRsRgmbLi
LsbLgRsLgbLgLgRsbLsbRebRgRsmbLebRsbRcbLjbLcbRcbLcbLobLobRgbRebLcbRcbRs
RsmbLcbLjbsbRcbRcbRiLsbRsbLcbRibLobRcbRibLgbRcbRobLgbRcbLibRoLsbLsRsbR
obRibLhbRcbLiRsbLiLsbLoRsbRsbRgbLiLsbLgbRgbLibLsbLgRgRsmbLgbLsbLgbLgRs
bRhbRsbLjRsbRobLibLsLhbRiRsmbLobRcbLoRsbRcbRcRsmbLhLsbRcbLcLsmbRhbLgbR
obRsbRibLgRsbLsbLhbRsbRgbLgbLgbLiRsbRjbLiRsbRjbRjbReRsmbLcbRiRiRsmbLcb
LibLibRiRsRimbRgbRibRebReRibRebRebRebLgbLobLsbsbRjRibLobLcbLobRobRibLi
bRsbLgbRcRsmbLsRsbLhbLobRgbLcbLcbLcbRsRsmbLebLebLebLebLgLsbLiLibLebLiL
sLsmbsbRsLsRsbLebLebLobLebLsbLibRsbRiRsmbRobRgbRoRebRsRsmbRsRsRsmmbRsb
RsbRiRsmbRibLiLiLsbLobLcLsmbRobRgLsbLoLsReRsRsRsmmmmbRgbLsRsRsRsRgmmbR
sbLoRsLsLoLcbLoLsmbRoLebLobLgbLiRsRsLsmbLibLiRjbLcbLhRgbLcRsRsLsLsmmb

>ZF Recording 2016-03-18; tW: 300s; Start: 121304; End: 121804;
Recording: 1-1; Individual: 29; Drug: Control
bRoLsRsbRobRcbRcbRcbRhbRibRebLcbReRcbLobLibLoRsbLcbRgRsmbRibLobLibRgbL
sbLibLibLgLsbLibRibRibLibLoRgbRibRcbRoLsLsmbRobRibRhbLgbLcbLobRhbRcbLg
bLgbLjbLobRibRibLcRjbLoRsRgbLoLgbRjbRibLebLgLsbLeRiRgbRobRcbLhbLcbRiRs
mbRgbRhbLjbRobLhbRobLsbRibLcbLgbLoReLsbLcLsLgLsmbLiRsbLsbLibLibLcLhLsb
RgbLjLsmbLoRsbRcbRibRiLibLgbRcLsbRcbRibRibLsLsmbLibLhRiRsRsmmbLgLsLibL
gLgbLiRsbLsbLibRgbRgbLgbRiRiRgbLcbLibLgbReRsmbRcRsmbLgRsbRcRibLsbRoRsm
bLgLjbRcRobLgbLibLibLiLsRgRgbLibLibRjbLcbLibRiRsmbRcbRhbLhbLgbRjRibRcR
smbLgLgbLoRsbLsLsmbLhRibLiRsLsbLobLgbLoLsmbLgLsbLhbLsRsbLoRsbLcLsmbLib
LibLgbRoRcbLebLibLibRcRcbRobLibLcbLeRjbRhRiRsmbLjLjbLhRsbRsbRhbLcbLcbR
obRgRgbRgRebRebRebRebRebLobLcbRebRebRcbRebRsRiRhLsLsmbLgbLebLobLcbLhbL
cbLcRsbLcbReRsmbRiLsbLjbRcLiLoRgbLoRcRebLebRibLibLibLibRebRjbRiRsmbRhb
RjbLgLcbLgbLjbLibLsLgbLcbRhbRhbRjbLebRcbRebLibLhbLcbLhbLcLsLsmmbLebRsb
LcbRcRjbLgLsbRjbRjbRcbRgLsbRobRebLiLcbRcbRsbLgbLhbRcbRjbLhLobRebRebReb
LobLsbRebRsbRobLgLsLsmbLobRobLebLebLcbLsbLcbLgbRjbLcbRjbRebRjbRcbRjbLi
bRibRcbRcbRibLibRebLgbRebRebRebRsRgRgbRebLebRcbLebLsbLcbLobLobLsLsLemb

>ZF Recording 2016-03-18; tW: 300s; Start: 121304; End: 121804;
Recording: 1-1; Individual: 30; Drug: Control
bRobRgbRsLsbLiLsbLsbLgbRsbRgbLiLsbRsLsbLgbLsbsbRsbRibLoRebRibRobRibRib
RgbLibLibRgLsbRibRiLsbLsbRibLsbRsbRcbLgbRsbRgbRhRsmbRcLsRsbRoLsbRsbRgb
RgbLibLgbLobRgbLsbLcbRgbLsbLjbLobLcLsmbLibLgLsbRgRibRoRsRsmmbRhbLgbLcb
LibRsbLiLsbRsbLibLobRcbRhLsbLgbRibLobLcLsLsmmbRgbRgbRsbRsbRhbRibRibLgb
RobLcbLibRjRibRgLsRsbRcbRibLgbRsbLibRobRoLsbLgbLgbLgbRsbLoLhbRsbLsbLoR
sbRibRcRoRhbRoLsbRibRsbRibLgbRgbRobLcbLcbLibRibLcbLibLgbRgbLgbLhbRgbLo
bLibRibRgbLgbLhbRjbLcbLiRsbRgbRibRgbLgbLobLcbLsbRsbRsLobRiRsmbRobRcbLc
RgbLibRjbRobLobRibRobLgbRhbLgbRobRebRibRcbLsbRebLsRsbRoLsbLgbRoLsRgbRe
bLcbRebLoRsbLsbRjbLobLcbLobLibRgbRcbRebLsbLgbRebRcRsmbRgbRcbRgbLcbLobR
sbLsLsmbLgbLsLsmbLiLsbLsLgbLgLsLsmbRsRsmbLsbRsbLsbRjbLobLgLsbRsLsbLcbL
iRsbRjbLobRgLsbLoLsLsmmbRibRibLsLsmbLsbLsbRibLsLobLgbRgLsbLsbLcbLiRsbR
jbLsbLsbLcbRibRebRobLcbRsbLibLgLsbLsbLeLgbRsLcbLibLsbRsLoRsbRcbLsbLiLs
bLgbLcbRgbLsbRgbRibLcbRebLcbLhbLhbRobLibLgLsbLsbLgLsbLgLsLsmbLgbLgLsLi
LebLsRgbLoRsbRobRobLsbRobRcLsbRcbRoLsLsmbRcRsmbRcbLcbLcbLcbLcbLgLsbLib
RgbLoLgLsbLsLsmbLoLsmbLgbLiLhLsbLcLsmbLgbLiLsbRsbRcbRcbRhbLibLibRgbLib
RebRjbRcbRhRiLgLsLebLobRoRsRsmmbRcbRobRcbRibLgbRsRcRsmbRhbRhbRsRcbRgbL
cLcLiLibLjLibRcbRobRobRhLsbRcbRobRcbRcbRcbRhbLgbLcbLcLsmbLhLcLsmbLibLh
bLibRsLsbRjbLoLsLsmmbLobRcbRcbRcbRsbRoLibLebLibLsLsmbLcbRebRobRcLsbLiL
sbLhbLsbRsbRgbLcbLoRsbRsbLcbLobRcbRebLhbLcbLjbLoLsmbLcbLoLsRsRgmbLibLs
bLibLiRsbRsbLgLsRjbLhbLobLcbRebRcbRgLsbRibRibRhbRibLgbLebLcbRebRobRoLs
LsLsmmbRebLcbRgbLsbRjbLobRjbRebLobLibLjbLcbRsbLgbLgbLgLibLgbRiLsLsRomb
RibRcLsRgbLsbLhbLobLcbLobLcLcbLibLibLibRobRhbRibRibLebLsLsmbRiLsbLibLi
bLsbRsbRobLsRsLsbRsLsbRcRobLgLibLoRsbLsLsmbRibRhbLgbLibRoRsmbRebRibLgb
RhLsbLobRsbRcRibLobLoLsmbRgLsLobLhRsbLgbRsbRsb

>ZF Recording 2016-03-18; tW: 300s; Start: 121304; End: 121804;
Recording: 1-1; Individual: 31; Drug: NDMC 1 µM
bLibRiLsbRsbLsbLcLsmbLhRsbLsbRgLsbLgLsbLsbLhbRgbLibLobLibRibRgbRsbLsbR
ibRjbLhbLiLsbLibRhbRibLjbLiLsbLiRsbLcbRhbLgbLibLsbRjbRebRobLgbLgbRibRg
bRsbRgbRgbRgbRgRsLsmbRgbRgbLebLibRsbLibRsbLiLsbRgbLgbLiRsbRgbLiRgbLgLs
LibLsbLgbLgbLgLsbRsLsbLibLsbLgbLsbLsLsmbLgLsbLsbLibLibRibLobReRsmbLcLs
mbLcbRibLobLcbLcbRibRibLcbLibLgLsbLgbLibLgbLsbLgbLobRiRsmbRsbRgbLcbRoL
sLsmbLgLsLsmbRibRgbLobRhbLsLsmbRcbRjbsbRibLibLsbRgbRcbLcbRhbLobLibLhbL
cbRibLobLibLcLsmbLibRhLsbLsbRgbRjbLgbLobRebLeLsbLjbRibLhbLiLsbRcLsbRib
LcLsmbRcRsmbLcbRgbLiLsbRebLcLsLsmmbRgbRgbRibRebRibLsbRjRibRgRsmbRgbRgR
smbLsbLcbRcbLcbLibRjbRcbLeLsbLoLsmbLcbRibLgbLibLiLsbLibLsLsmbLibRsbRsb
RsbLcbRiLsbRjbLhLiLsbRsbLiLsbLibLsbRsbLgbRsbRjbLibRgRsmbLeLsbRjbLhLsbR
sbLsbLgbLibLibLcLsmbLgbRibRgbRsLsbRsRsRsmmbRibRgRsRiReRiRsmmbRsbRcLsbR
hbRobLcbLobRgbLobRhbLobLoLsRiLgmbLgLsLiLiLgLiLgbLgLibLgLiLgLgbLiLiLsLg
LgbLgLsLgbLeLiLiRsLhbLhLsRsRsmbLobRsbRjbLcbLhbLibLibLcLsmbRiLsbLcbLibL
gLsbLoRsbLsbLoLobLgbLcLsmbRhLsbRoRsmbRcRsmbRcbRibLgbLhbRgbLiLiLsLsmbRs
LobReRgbRsRiRibRibRgRsmbRibRibRgbRibLcbLiLsbRhbLobLobLibLcLsRsmbRsbLib
RobRhLsbRcbLgbRcbRibLcbLoLsLsRsmmbRiRsmb

>ZF Recording 2016-03-18; tW: 300s; Start: 121304; End: 121804;
Recording: 1-1; Individual: 32; Drug: NDMC 1 µM
bRibLsbRsbRsbLcbRcbLiRsbRjbLibLibRibLgbLibRgbLibRebLcbRjbRiLsbLsbLhbLh
bLibRibRjbLobLibLobLsbLgbRsbLgbLgbLgRsbRsbRsbLhbLhbLgbLibLsbLcbRsbLobR
hbLobRibRsbLsRsbLibRsLsbLgbRjbRcbLsbRsbRgbRsbRgRsmbRsbRsbRibLsbLsbRgbL
cbLcbLebLcbLcbLgLsbLgbLsbLsbRsRsmbRhbRibLsLibLibLibLsbRgRsmbLgbRcbLgbR
iRsmbRsbLsbRsbRgbLjbLcbLcRsbsbRsbRsbLibLsbLibRsbRsbLibRsbRgbLoRsbRgbRi
bLsbLsbLibLgbRsbLgbLibRgbLibRsbReRsmbLsbLcbRsbRjbRiRsmbLgbRibLoLsmbLgb
LgbLsbLsRsRsmbLcbLibRsbLobLgbLsRsbRsbLibLcbLobLgbLjbLhbLsbLibRiRsmbLcb
RgbLobLgbRgRsmbLhbLhbLibLgRsbRcRsmbLebLgbLgbLsLsLsLsLsmmmmbRsbRibLjbLe
LibRoLsbLcLsmbLsbLibLiLsbLiLsbLgbLhbLsLsmb

>ZF Recording 2016-03-18; tW: 300s; Start: 121304; End: 121804;
Recording: 1-1; Individual: 33; Drug: NDMC 1 µM
bLcbRcbLcbLoRsbLhbLobRcbRibLibRgbRhbLcbLoRsRsmbLcbRobLgbRobLibRibRibLg
RsbLgbRsRsmbRsRibLgbRiRsmbLgbRoRsmbRsRsmbRibRcbRgRsLsmbLgbLsbRgRsmbLjL
smbLcbLcbRcbLoRsbLobLoRsLsbLcbLiRsbLcbLibLcbRebRsbRiRsmbRibRcbRcbLcbRi
RsmbLoRsbRhRsmbLibRjbRcbLgbRgbRoLsbRcbRibRhbLgRsbRgbRsRsmbRsRsmbRgbRgb
RgbsbRsbRsRsmbRsbRgbLsbRibRgbLsbRgbRiRsmbRsbRsRsmbRgRsmbRgRsmbLibLhbLc
bRobRoLsRsbRhbLgbRgRsmbRibRgbLsbRgbRgbLsbRgRsmbRgRsmbLsbRgbRgLsbLjbRib
RsRsmbRibRgbRibsbLsbsbRsbRgbRobLhLhbLibLobLibRebRcbLgbRgRsmbRsRsmbRgbL
sbRgRsmbLsRsbRgbRsbRgRsmbRgRsmbRgRsRgmbRsRsRsmmbRsbRsbRgRsmbRsRsmbLsbR
sRsmbRsbRsLsbLjRcLsbLgbLiRsbLibLhbLobRiRsmbLcbLobLhbsbRsbLsbLibLibLcbR
ibRgRsmbRobRobRibRsbRsLhbLibRjbRobLsbRibRsbRibRhbLsbRibLibLibRcRsmbRiR
smbLcLsLsLhRsmmbLcbLgRsbRsbRsbLiLsbLibLgbLibRobRiLsbRsRsmbLsRsbRibRgRs
RhLsmbLibLgLsbLibLgbLoRsbLhbLgbRcbRgbRobLcbLhbLgLibLiRgbLcbRhbRibRoRgb
LgbLgbLobRibRobRhbLgbRsRsmbRibRibRsbRgbRhbLobLoRsbLibLhbLcbLsbLoRsbLoR
sbRcbLsRsbRiRsmbLibRcbLjLsmbRsRsmbRsRsmbRibLsbRibRsbRiLsRcLsLsmbLhbRoR
smbRcbLibRgbLsbLibLibLoRsbLcbRhbRgRsmbLsbLgbLibRibRebLsbRgbRgbRgRsRsRs
mmmbRgRsmbLsbRgRsmbRibLgbRgbRibRgLsbRibRobRobRcbLcbRobRobRobRcbRobRiRs
mbLsbLhbRjbLcbLibRcRsmbRcbLcbLcbLiRsRsmbRgbRiRiRsmbsbsbLsRsbRiLgbRgRib
RgbRsbRgRsmbRgRsmbRgRsmbRgbRgRgbRgRsmbRgRsmbRgRsmbRibRsbRgRsmbRgLsRsbR
gbRiLgbLsbLobLhbRoRsmbRobLcbLoRsbRhRiRsmbLhRsbLibLibLcbLiRsbRsRsmbRhbR
ebRcbRcbRibRcRsmbRibLsLsmbRgbRibRgLgbRcbRhbLibLsbRib

>ZF Recording 2016-03-18; tW: 300s; Start: 121304; End: 121804;
Recording: 1-1; Individual: 34; Drug: NDMC 1 µM
bLibLgbLsbRgbLiLsbRgbRsbLsbLgbLsLsmbRsbLgbLgbLgLsLsmbLsbRsRsmbRcbLhbRo
bLjbRibLcbRsbLibRsbLhbRibLgbRjbRsbLsbRgbRsbLjbRiRsmbRjbRgbLibRgbLoRsbR
hbRibLsbLsbLsbRiRgbLcbLjbRobRjbLobLjbRcbRibRibRhRsmbRgbLgbLgbRebLhbLgb
LjbLgbLgbLsbLsbLibLgbLgbRsbLgbLsbLgbLsbLibLobRcbRibRsbLgbLgbLobReRsmbL
gbRgbLsbRsRsmbLsbRjbRgbLhbLjbLjbRoRsmbRhbLjLsmbLgbLibLsbLibRsbLgLsbLsb
LsLsmbLobLiRsbRcbLibLebRcbLoRsRsmbRobRibLcbRobRjbLiLsLgbRibLsLsmbRgbRg
bLcbLibRjbLgRsbLjbLibLsbRgbLsLsmbLcbRgbLobRcbRebLobRgbLibLibRibLibLsLs
mbLgLsRcbLobLhbRgbLibLcbRhbLgbLsbRsbLhbRsbLgbLgbLibLcbRobRibLsLibLgbLi
bLgbRsbLgLjbLobRgbRebLcbRgbRjbLgbLsbLjbLibLsbLcbRiLjbLgRsbLgbLsbLgLsbR
gbLgLsbRsbLgbLgLsbLsLgbLobLhRsRsmbLibLhbRibRibLsbLcbRibRebLebLiLgbRobL
cbLgbLsbLgbRgbRjbLibLgbLibRibLcbRibRebLjbLobRcbRebRcbRiRsmbRibRcbLobLs
bLsbLsbLcbLibRiRibLsbLgbRgbRjbLgbLiLibLgbLgbRsRsmbLjbRsRsmbRsRsmbLibRe
bLsbLibRibLcbLobLibRsbLcbLcbRjbLhbLiRgbLjbLibLsbRjbLhbRgLsbRsbRjbRgbRo
LsbLcbLjbLobLibRibLjbLobRobRobLobLobLobRiRsLsmbRgbRcbLoLsmbLibRgbLibLi
RibLgLsbLsbLgbLsLgLsbLgLgLiLsbLibRgbLgbLsbLibLibRsRsmbRsbRgbLebRcbRebL
ibLhbLgbRobRobRebLgRsbLibRsbRsbLiLsbLsbLgbLsbLjbRgbLgbLcbLibLgRsbLcbLc
bLjbRsRsmbLobLhbLibRgbRgbLgbLhbLibLgbLobLcbRiLgbLcLsmbRsbLgbRsbLsbLiRs
RsmbLibLjbRsbRcbLsbLjbLebLibRsbLjbRebLgbRcRsmbLcRsbLcLsLsmmbRobRjbRibR
obRhbLhbLobLsbLsbRibRsbLcRsbLibLoRgbLcbLiLsLiLsbRjRhbRoLsRsbLibRsbLcRs
bLibLgbRgbRgbLibLiLsLgbLcbRhbRgbRhbLcbRsLsbReRibRcbLcbRebLebLobRiLsbLo
RsbLhbLcbRcRsmbRibLhbLibLcbLiRsLsLgbLobRgbRibRibLibRibLcbLsLobLcbLcbLi
LiLeRsbLibLiLebLsbRcb

>ZF Recording 2016-03-18; tW: 300s; Start: 121304; End: 121804;
Recording: 1-1; Individual: 35; Drug: NDMC 1 µM
bRgbLoRsbRibLibLobRibRgbRibRhbRcLsbLibLibLibRgbLjbLibRsbLibLgbRgbLjbRo
LsbLgbLjbLibRcbRcbLhbRoRsmbRebReRsmbRibRibLibRsbRgbLibRjbRibLsbRiLsbLg
bRsbRiRsmbRsbRsbRibRsRsmbLsbRgbRibLsbRsbRhRsLsmbRgbRjbLobRcbRcbRibRhbL
sbLgbLsRsbRiRsmbRebRibLoLsmbLobLebRhbRsbLoRgRibRgLsbRibRiLsLsRsmbRsRsm
bRgRgbRibRibLsbRhbRcbLjbLcbRiRsmbRcbLcbLibRsbRobLhbRsbRiRsmbRsRibLiRob
RsbLsLsmbLsLsmbReLgbRcbLsbRsbRibRcbLgbLsbRgbLhRcbRiRsRsmmbLibRhbRsbLsb
RibRsRsmbLsbRsRsmbLjbRsbLcRsbLhbRcbLobLoRsbRcbRgbRsbRibLsbRgbRsbRgRsRs
LsmmbRsRiRsmbRgRgbRibRgbLobLcbLcbRcbRibRebRebLcbLcbLibRebLobLibRsRsmbR
ibRibRgbLsbLjbLhRsLsbLibRjbLibLibRjbRoRsmbLcbLcbRhRsmbRgbRoRsRsmmbLcbL
cbLcbLsbRibLobRgbLhRsRsRsmmbRsbLoRsbLcbLcbRsbRibRcLsbLjbLgbRibRhbLibRg
bRoRsLgmbLsbRhbsbRhRgRsmbLsLsmbLsRibRibRsLsbRgLsbRiRsRsRgReRimmbRiRsRi
mbRibRhRsmbRiRsRhmbRgbRjbLjbLoLsmbLcbLcbLobRebRjbRcbLibLcbLcLsmbRcbRgb
LjbLibRhbReRgRebRgRsmbReRibRoLiLgLsbLibRsLibRcbLcbLiRsbLobLobRhbLobLoR
sbLibRibLcbLobLcbLhRsbLgbRjbLcbLoRgbLobLibRsbLcbLcbLcLsmbLcbLebLhLsbLj
bRhRsRiRsmmbLgRiRsRsRgmmbRgLsRsbLsbRibRsRsmbRsbRgRsmbRiLgbRcbLibLgbLhb
LsRcbReRsRgmbRgbRiRsRsmmbLcbRcLsbRibRgRibLhLsbRsRsmbRsbLsbRibRiRgRiReb
RiLsbRibLobLobLcbLcbLcbLgbLhbRcbLobLcbLcbLsbLobLhbLcbLibLhbLcbRibRibLi
bLgRsbLibLoRsRsmbRjbLcbLcbLhbRibRhbLgRsbRgbLcbLcbLcbRibRcbRgbLgLsbRibL
gbRcbLgLsbRsRobLibRsLobLobLcLsmbLhbLcbLiLsbRgbRebLhbLibRibRiRsmbRibRcb
LebLebLhbRhbRebRsbLoLobRcRsmbRcRsmbRcbRcRsmbRcRsRsmmbRcbRcbLibLobLcbLg
bLibLcbLibRibLgbRsbRsbLobRjbLoRsbLcbLibLibRiLsbRiLsRsRsReReRimbRgLsbRs
RcRiRsmbRiRsRcmbLcRsbLcbRoLsbRobRobRobLcbRibLcbRcbReRsRimbLcbLcbLcbLoL
smbLcbLhbRebRcReRiRsRimbRibLcbRcRgbLobLcbLcbLcbLcbRibRsRsmbRsbRgRgRsRg
RsmmbRoRsmbLgbRgbRobRhbLcbLobLobLcbLobLcLsLsmmbRebRibRsRsmbLibRjbRoLsb

>ZF Recording 2016-03-18; tW: 300s; Start: 121304; End: 121804;
Recording: 1-1; Individual: 36; Drug: NDMC 1 µM
bRiRsmbLibLiRsbLiRsbRibLsbLibRgbLcbLsbLgbLcRsbLibRgbLiRsbLcRsRsmbLsLcb
LhbRhbRsRibLcbLcbLsbRibLjbsbLobLibRgbLobLibRjbLibRgbRjRjbRiLsbLoLsmbLg
RsbLibLcRsbRsRibLebLiRsbRsbLibRjLsbLcbLsRsbLcbRsbLibLibLibLibRgbLsbLcb
LcbRgbLgbLibLibRgbLiLsbLiLsbLibLsbLgbLsbLcLsmbRcbLsbLiRsLsbRgbLcbLgbRs
bLhbRgbLgbRcbRibRcbLcbLhbLibRgRsmbLibLsbLgbLibRsbLibRsRsmbLobRgRsmbRgb
LsbLibRjbLcbLcRgbLobRiRsmbRjRibLcRsbLhbRsbLeLsbRhRsmbRoRsmbRgbLebRibLo
bLebRibLeLhbReLgbRiRsmbLgbRibLjbLobRcbLibRiLsbRsbRcbRoLsbRgLsbLebLsLsm
bLibLibRibLgbLgbLhbLibLoRsbRoRsmbRibRhbRibRiLsbLcbLoRsRibLsbRjbLcbRcbR
gLsbRgbLobLoLsmbLobRjbLobRgLsbLibRgLsbLobRsRgRsmbLgbLibRgbLcRgbLsbLobR
cbLhbRibRgbLhbLhbLgbLgbLgLsbLsbRibLgbRebRibLobLobRiLsbLibRiRsmbLcbLcbR
cbLcRsbRsbRibLcbRibRcbRhLsLsLsmmbLcbLsLsmbLcbRgbLibLibRgRsmbLhbRibLhbR
gbLibRgLsbLobLiLsbLcRsbRsbRcbLcbLobLcbRiLsbRibLgLsbRgbRobRobRcbRebLebR
cRsmbLjLsmbRcbLgRcRsRsmmbLsbLobLobRcbLsbLgRsbRgbLobLcbRhbLgbLibLobRiRs
mbRjbLcbRibLobLhbRibLibLibRjbLcbRsbLibRibLhbRibLiLsbLibLibLibLibLibRob
LcbLobLcbRobLeLsbLibLobRcbLgbRcbRgbRoLsbRcLgbLgbLibLibLibLiRsLgbRgbLib
LgbRebLsRsbLgLgbRgbRebLcbRoRcbRoRsmbRobRobLgbRobRobRcLibLcbLgbLibLgbRe
bLcbRiRibRsbRebLiLgbLjbLsbLobRcbLcbRebRiLsbLobRibLgbRobLcbLcbLibRcbLiL
sbLebLibLsbLgLsLcLsLgRsRsmmbLcRsbLobRoRsmbLobLcbRiRsLsmbRibLebRobLgbLi
bLeLsLeLsbLibRibRgbRcbLcbRjbRcLsbLsbLcbLobRcRsmbLjbRjRibRiRsmbLsbRobRe
bLcbLobRhbRebRebLiReReRebRsLcbLoRsbLobLcbLobRobRobRob

>ZF Recording 2016-03-18; tW: 300s; Start: 121304; End: 121804;
Recording: 1-1; Individual: 37; Drug: NDMC 3 µM
bLjLsmbRhbRjbLcbRjbLhbRoRsmbRibLcbRcbLobRibRibLcbLcbLcbLoLsmbRibLcbRjb
LibLsbLgbRgbRsbRgbLibLgbRsbRibRibLibRiRsmbLhbRobLgbRobRsbRgbsbRsbRoLsb
RgbLsbRibLibLsbRhbRibLgLsbRobRibLgbRibRibRsbRgbLsbLgbLsbRcbRcbRibLibRo
bLgbRoLsbLiLsbRiRsmbsbLibLcbLcbRiLsbRsbLsLsmbLsLsmbLhbRgbRgbLiLibLibLg
LgRsbLiLeLsLsmbLobRiRsmbRgbLobLcbRjbLobRobRoLsbRiLsbRcbLebRobLgLsbLgbR
obLobRgbLoRsbRiRjbRjbLgbRibRsRsmbLsbRsRibRoLsbRsbLibRjbRsRcbRgRsLsmbRi
bRiLsReRebRcLsbRibRcbLhbRcRsmbLhbLebRibRebRibLebLcbLibLsbLgbLcbLoRsbLh
bLsbRsbLobRgbLiLsbLcbLcbReRsRiRgRgRembLebRjbRobRobLibRobRhLsbRibRibRib
LgbLibRibRobLibLcLsmbRsRgbRsbRcRebLoLsLsLsLsLsLgLimmmmmbLoReb

>ZF Recording 2016-03-18; tW: 300s; Start: 121304; End: 121804;
Recording: 1-1; Individual: 38; Drug: NDMC 3 µM
bRhRsmbRiRsmbRibRgbRgbLhbLibRsbLobRgbLobRgRsmbRibLibLcbRjbLibLobRsbRsb
LobLgbRgbRgbRjRsmbRhbRgbLsbsbRhbLsbRhbRibRgbRiRsmbRibRhbRibRibRibRsbRc
bRibLibRiRsmbRiRsmbLgbLsbRcbLjbRibRsbRsbRsRsmbRsbRgbRgbRgRsmbRgRsmbRgb
RsbRiLsLsmbRibRsRsmbRibRhRsmbRibRiRsmbLgbRgRsmbRibRsbRgbLsbRgRsmbRgbRs
bRsbRsbRebLhbLgbLsbRibLobLhbLcbRgRsmbRgbRibRgbLsbLobLibRsLsbLibRibLibL
cbRiRsmbRjbRibLhbRhbRibLsbRgbRgLsbRsLobLiRsbRgbLgLsbLibLibRcbRcbLibRcb
RcbRgbRibRobRsbRsbLsRsbRsRibRcbRiRsmbRgbLsbLibRiRsRsmmbRhbRibRibRgbRgb
RsbRibRobLhbRgbRsRsRiRsmmbRsRsmbRsRsmbRgbRsbRsbRgbRgbRiLsbRibRgRsRgmbL
gbLsbLjLsLimbRsLobLhbLsbLebLibRgbLgbLibRiRsmbLiLsbRsRsmbLibLgbLibLibLi
bRsbLgbLjbRsRsmbLiRjbLibLgbLgbRsRsmbLibRsRsmbLjbRgbLcbRgbLjbRsbRobRcbR
gbRibRibRibRhbLgbRgbRibRgbRcbsbLsbLcbRibRgRsmbRebLsRsbRhLsbRhbRgbRgbRo
bRhbRebRibRgRsRiLsmbRcbRgbRgbLsbRobLcbLobRsbRcbLoRsbLgbRjbLibLcbLgbRgR
smbRgbRcbLsbRibLibLobLsbRsLsbLoRgRsLsmbRsbRgbRiRsmbLsRsbRsRsmbRgbRgbLs
bRgbRsbRgbRobLgbRibRobRibRsRsmbLibRgRsRcRsmmbRsbRiRsmbLgRsLsbLgLsbRgbR
obRiRsmbLibLcbRgbRsbRobRhbRsRsmbRhbLibRcbRobLsbLibRcbRcbRibRcbLgLsbRib
RgRobRgLsbLgbsbRgbRibRibLgbRgRsmbRgRgbRsbRiLsLsmbRobLcbLhbLcbRsbRsLobR
gbLgbRsbLjbLhRgbLiLsbLgbLsbRsLsbLiRsRsRsRiRhmmbRsRsmbRsRsRgmbRgbRsRgbR
gbRgRsmbRgRsmbRgRgRsmbRgRsmbRgbRgLsbLsbRibRibLsbLsbRcbRcbRcbLjbRhbRcbR
ebLoRgbLcbRiRsLombRibLgbRjRhbRibLsbLobLhRsbLgbRgbLoRgRsRsRsmmmbRiRgbRj
RiRjbRcRsmbRgbLgbLgbLjbRhbRobLsbRibRhRsmbLgLsLgbRebRcbRgbRsbRgbRgbRcbL
gbRcRsmbRgbLibLhbLiRsbLjbRgbRcbLibLcbLoRsbLsbLobLjbRsRiRibRsbRjbLsRsbR
ebRebReRgbLhLeLgLsLeLgLsLsLsmmbLcLsLeLsLsLsLsmmmmbLsRsb

>ZF Recording 2016-03-18; tW: 300s; Start: 121304; End: 121804;
Recording: 1-1; Individual: 39; Drug: NDMC 3 µM
bRcbLsbRgLsbLsbLibLgbRsbLibLsbLgRsbLgbLoRsbLiRsbLjbLgbRcbRgRgbRsbRsbRg
bLsbRsbRgbRgLsbRibRgbRibRcLsbLcbLibLibLsbLgbRsbLgLsbRsbLsbLgbLgbLsbLgL
sbLgbLgbLgbLgbLibLgbLgbLgbLsbLjbLiLsbRsbLgbRsbLibLsbLgbLgLsbLhRsRibLgb
RobLjbLibRibLiLsbLgbLobRiRsmbLsbLibLobLibLcbLcbLiLsbLgLsbLibLibLsbLsbL
gbRcbRobLsLsmbRcbLebLcbLsbLgbRsbLgbRsbRjbRcbRobRibRoLsbLjbRcbLgbRobLiL
sbLibLgLibRsRsmbRsbLgbLgbLsbLgLsbLgbLsbLgbLsLgbLgbLgLsLsLsLgLsmmbLgbRs
RsmbLgbLgbLsbLgbLiLsbLsbLsbRgbLgbRobRcbLobLobRsbRoLsbRibLhbLgbLjbLcbRh
bLsLsmbLhbRhbLsbLibLobLcbLibLibLibLsbLobLsbLgbRgbRjbLhLiLsbLsLgLsLsLeL
gmbLiLibLgbRjbLgLsbLsLsmbLiRsbLgbLgbLgbLiLsbRgbLsbLgbLsbRsbLsbLibRsRsm
bRsbLibLgbLsbLsbLgbRsbLibLgLsbLgLsbLgbLgLsRsLsbLiLsbLsLsmbLgLsbLgbRgbL
ibRsbLgbLsbLgLsLsLsmmbLgLibLibLgbRibLgbLobRcRsmbLoLsmbRcbLcbRsbRcbRobR
oLsbRcLsbRobRcbRoLsbLcbLibRsLsbLgbLgbLsbRcbRiLsLsmbLjbLibLibLsbLgbLsbL
gLsbRsbLoLsmbRcbRcbLgbLobRsRgbLsbLoRsbLobRsbLibLcbRsbLibRsbLsLsmbLgLsb
LgLsbLsbLiLgLsLgLsbLibLgbLgLsbLsbLibLibLsbLobLobRcbRcbRoLsbLgLsbLebRcb
RhLsbRebRsbLgbRsbLgbLsLsmbLobRibRgLsRsbRgbRebLiLsbLgbLsbLgbLsbLsbLgbLi
bLgLsRsbRgbRibRebRcbRobRjbRobLibLjbLobRebLsbRobRcbLsLsLiLimbLgLgLgLsbL
obRgLsbRibLcbLgRibRibRgRsLsmbRibRjbLgLgbLebLgLsbLsLcbLobRcbRoLsbRcbRoL
sbLiLsbRiLsbLgbRiRcbRgbRgbRibLgbRcbRcbRcbLoRsRhbLcbRsRebLobLcbLcbRjbRj
bRcbRcbLhbLcbRobLhLsbLgbRsbRibLibLibRibRibRibRcLgLsLibRoLgbRibLjbRobRe
bLibRjbRsLsbLgRobRsbRibRgbLgLsbRobRiLsbLgbRgLgLeLsbRobRcRsmbRcbLcLcLsm
bLobRiRgRsmbRobRobRebRibRhbRgLsbReRsmbRhbRcbLhbLcLsmbLeb

>ZF Recording 2016-03-18; tW: 300s; Start: 121304; End: 121804;
Recording: 1-1; Individual: 40; Drug: NDMC 3 µM
bRsLsRsLiLsbLsLsmbLgLsLsmbLibLhLsbLhLsbRgbLcbLhbRgbLibLsbLgbRgbLgbLcRs
bLgbLiRsbReRsmbLibRgbLibLiLsbLoRsRibRsbRgRsmbRgbRibRibLhbLgRsbRcbRibRi
RsmbRiRsmbRcbRhbRsRsmbRsRsmbLibRobLibRsbRibRgbRsbRgLsbLsbRgbRsRsmbRsbR
gbRsRgbRgbRsbRgbRiLsbLgbLoRsbLsbRsbLgbLgbLgbLiRsbLgbRiRsmbRsbLobRsbLib
RsbLibLgbLhbRhbRsbLibLibLsbsbLibLibLobLibLibLibRgbLhbLiRsbRsbLibRgbRjb
RhLsbRgbLibLobLgbLiRsbLgbRgRsmbRsbLgRsbLgbLgbLgbRgbReRsmbRsbRhbLobLobR
gbLsbLcbLsbRjbLcbRgbLgbLcbRgRsmbRcbRibRibLhbRiRsmbLsbRsbRibRcbRcRsmbRi
bRgbRgbLsbRibLsRsbRgbRsLsbRsRsmbRgbRobRgbLsbRgbLobLobRgRsmbRgRsmbRgbRg
RsmbRibRsbRgRsmbRgbRsbRiLsbRsLsbLsRsbRibRgbRobLibLcbRgbRsbRoRsmbRgbRib
RgbRgbLgbLgbRcbRobRibLibRsbRobLhRsbRcbRibLgRsbRsbRgRsmbRgbRsLsbRiRsmbL
sbLsbRiRsmbRsRsmbRsbRsRsmbRgbLsbRgRsmbRsbRgRsmbRgRsmbRgRsmbRsRsLsLsmmb
RsbRgRsRsmmbRsbRgbRgbRibLgbLsbRibRibRibRgbLcbRobLibLibLcbRcbRibsbRcbRi
bRiLsbLsbLgbLcbLiRsbLobRcbRibLsbLoLsmbLibLibLibRgRsmbLcbRebRgbRsbRsbRg
bRjRsmbLjbRcbRobRcbRibRiRsmbLsbRgRsmbLjbLoLsmbLobLjbRsRsmbLsbLgbRcbLgb
RcbRobLhbLgbLibLhbRibRibLgLjbLgbLsbLgbLsLsmbLsbLsLsmbLsbLibRsbRsbLhbRg
LiLsbLgbLibRsbLgbRgbLibLhbRgbRgRsmbLjbLcRsbLiRsbLgbLsbLsbLhbRhbRcbRhRs
mbRibRgbLgbLhLsbRsRsmbRsbLibLgbLgbLcbRsLsbLibLiRsRoRsRsmmbLcbLoLsmbLcb
LibLsbLiLsbsbsbLsbsbRobRcbRcbRibLjLsmbLhbLhbRgRsmbRgbRibRibRsbRgbLsbRs
bLsbRhbRsbRsbRsRsmbRiLsbLgbRhbRibLobLiRsbLibLgRsbLgbLebRibRiRsmbRhbLcL
hbLobLcbLcbLibRjbRobRibLgbLsLsLsmmbRgbRsRsmbRibRibLibLgbRibLsRsRobLiLs
bLgbLgbLgbLibRhbRsRcbRhLsbRibRibRibLibLhbsbRgbRobRibRibLgbLibRoLsbLgRs
RhbRgbRhRcbLibLibLcbLobLoRsbRsbRsbRhbRobLobLibRcbLcRsbLibLgbRsbLgbRsbL
obRhbRcRsmbLhbRhbLgbRibRsbRibRgRsmbRgbRibLgbLebRjbRcbRibRcbLcbLibRsbLg
bRgbRcRsmbLgb

>ZF Recording 2016-03-18; tW: 300s; Start: 121304; End: 121804;
Recording: 1-1; Individual: 41; Drug: NDMC 3 µM
bRcbLgbRibRsLcbLsbLobRcbRibRsbRgbRsbRibRsbRgLsbRsbRibRiLsbLjbRibRgbRhb
LgbRgbLsbLibLibRsbLgbLsLsmbLgbRjbLobRsbRsbRibLcbRsbLgbRcbRibLjbRiRsmbR
cbLiLsLsmbLgbRobRgbRgLsbLgbRhbRgRsmbRgbLcbLibRgRsmbLibRobLgLsbRibLgbRi
bRibLsbLibRibRsRsmbRgbRgbLsbRgbRsRsmbRgRsmbLgbRgbRsbRgRsmbRsbRgRsmbRsb
RibLsbRibRibRsRgbLsbRgbRgbRgbRgRsmbRsbRsbRcLsLsRsmbLibRsbRibRgbRsLsbRi
bLjbRibRsbRibLgbLibRsbLibRjbLhbRsbRgbLgLsbRsbLgRsbLsLsmbLhbRobRobRcbLi
bLgbLibRgbLgbLiLsbLgbLcLsmbRgbRgbRgbRebLobRjbLgbLcbLgLsbLjbRibRgbRgbRs
bLgbLibRjbLcbRgbLibRebLcbLhLsbRsbRibLgLsbLibRsbLgLsbLgbRgbLcbRgbRhRsmb
LibRibRjbLgbLcbRcRsmbLobLjbLcbLebRobLsLsmbRgRgRsmbRgbRgRsmbRgbRgbLjRib
RiRsmbLjRibLjbLsbRibRgRsRsmmbRibLibRsbLgbLhbRjbLibRobLsLsmbLibLibLsLsm
bLjbLsbLsbRgbLjbRsLsLgbLgLgbLcbRgRgbRhbRebLibLobRsbLibLiLsbRibLibRcbLc
bLcbLgbLiRgbLgLsbLgRgLsbLibRsbRsbRcbRjbLsRsbLobLobLcbRebLobLcbLgbRsbLg
bRibRibLjbRoLsLsmbRsRcbRgbLsbLcbLcbRgRsmbLcbLgbLgbRsbLibLiRsLsbRgLsbLs
bRsbLibRsLebLcbRcbLobRcbRcbRoLsbRoLsbRobRebRhbRhbRhbRibRgLsLgbRhbRobLh
bLobLcbLcbRiRiReRsRgRsmmbRsRoRibLsReb

>ZF Recording 2016-03-18; tW: 300s; Start: 121304; End: 121804;
Recording: 1-1; Individual: 42; Drug: NDMC 3 µM
bRobRsbRgbRcbLsbsbRiLsbRiRsmbRsbRsbRgbRobRgbRibRgbLgbLibLgRsbLgLsbLhLs
bLsLsmbLcbLsbRsbLcbLsbLsbLgbLsbLgbLiRsRsRsmmbLgbLsbRsbLibLgbLsbLgbLgbL
gbRsbLgbLgbLoLsmbLcbLgbLcLsmbRgbLsbLgbLgbLcbLibRsbLgbRgRcbRgbRcLsbRsbR
ibRsbRjbRgbRibRsbRgLsbRgbRsbRgLsbRsbRibRiLsbRsbLsLsmbRsbRsbRcbRsRsmbRs
RsmbRsRsmbRibRiLsbLsbRsbRcbRgbLsRsbRiRsRgmbRgbRgbRgRsmbRgRsmbRgbRgbRgb
RgbLsRsbRoLsbRgbLibLgbLgbLgLsbLiLsbRgbLsbLgbLsbLsbLobLiRsbLcRsbRsbLsRs
bLibLgLsbLgbLsRsbLibLcLsLgLsmbRgRsmbRgRsmbRjbRsLsbRgbRsbRgRsRsmmbRsRsm
bRgbRgbRibRgbRiLsbRhbLsLsmbRsRsmbRibRgRsmbRsbLsbLiRsbRiRsmbRsbRjbRjbRc
LsbRsbLcbLiLsbLsbLebLobLiLsbLsbLgbLsbLsbRebRiLsbLcbRibRgRsmbRgbRgbLsbR
sbRibRibRhbRsbLgbRhbRibsbRcLsbRcbRgLsbLsbsbLsbLsbLcbLibLgbRsbRsbRebRoR
smbLsRcbRgRsmbRsbRgbRsbRibRgbRjbLsbRoRsmbRcbRgbRsbRcbRjbsbLsbLibLhbLob
RjbLibLsbLgbLsbLgbRgLsbLiLobLcLsmbLgbLsbLibLsLsmbLsLsLsmmbLgLsRsbLgLsb
RsLgbLsbRgRsmbLibLgbLgbLgLsbLgbLgbLgLsbLgLsbLgRsbRibRcbLgbLjbRiLsbRoLs
LsmbRsbRhbRebRcbLcbRgRsRembLsbRsRsmbLsbRebRobRsbRcbRsbRibLgbLsbRobLgbR
sbLhbLjbRhRsRimbLcbRsbLjbLoRsbRebRjbRsbRjbLsRsRsRsRgRsmmmbRsbRsRsmbRsb
RgbRsbRgbRsbRgbRgLsRsRgbRsbLsRsLsRsbRgRsRsmmbRsLsbRgLsRibRebLeLsbLgLsL
sLsLsmmmbLgLgbLsLsLsmmbLsbLgbLsbLgbLjbRsRsmbLobLsLjbRoRsRsRsmmmbRebRob
RiRsmbRcbRsbLcbRcbLcbRibLhbLcbLibRiRsmbLobLcbLibRsbLsbLobLeLsbLibRcLsb
RcbRcbLcbRibRobRsbRsRsmbRcLsLsRsRiRimbRibLsbLsLsmbRiRiRsRgRsLsRsRgRsmm
mbRjLsbRsbRsbsbRobLcbLcbLibLobRcLsbRcbReLsbRoLsbRebRsRsmbRgbLjbLoLoLsL
smmbLcbLobLcbLibLsLsmbRibRoRsRsmmbRobRiRibRiRsmbRsbRiLsbRibLsbRsbRgbRo
RsmbRcbsbRcbLibRsRoLsLsLsmmbRiRgRgbRsbLobLobLcbLgLsbLcbRhbLcLsmbLobLeb
LoLsmbRibRibRibRobRoRobRhbRiRsmbRcbRibRobRsLiLsLsmbLobRiRsmbLiLsbRibRc
RsmbRcbRcbRibRiRgRgbLsbLoLobLobReRsmbLobLibLgRjbRhbRoLsRsbLgLgRgbLibLc
bLcbRibLobLhbLoRsbRsbRcbRoLsLsLsmmbRcRhLsbLibLjbLobRsbLjbRhbLobLgbRsbR
cbRsbRobLibRibRgbRoLsbRobRibRjb

>ZF Recording 2016-03-18; tW: 300s; Start: 121304; End: 121804;
Recording: 1-1; Individual: 43; Drug: NDMC 10 µM
bRgRsmbLsbRgbRcbRcbLoRsRsmbLobLsbLcbLsRsbLsbRgbRgbLobRgRsmbRgbLhbRsbLc
bRibRgRsmbRgbRsRsRsmmbRjRibRgbRsbRgbRgbRsRsmbRgRsRsmmbRsbRgbRsRsmbRgRs
mbRgbRgRsmbRgbRgbLsbRoRsmbRoRsmbRcbLsbLsbRsbRobLgbLjRsbRibRsbRibRcbRsb
RsRsmbRgbRgbRgLsbRgbRsbRsbRgRsmbRsbRsbRsRsmbRsRsmbRsbRgbRsbRgbRibLgbRo
bLgbLibRobLsbRsbRgbRgbLsbRcbLgbRgbRsbLsbRcbRgbLsbLsbsbRibRgbRgRsmbRsbR
sRgbRsbRgRsRsmmbRgLsbRibLgbLsbRibLgbLsbRgbRsRgbLsRsbRsbRgRsmbRgbRobLib
RsbRsbLsbLoRsbLiLsbLgbLibRiRsmbLhbLoRsbLcbRsbRsbLgbRjRhbLgbRgRsmbRgRsm
bRsbRhLsLsmbLibLsbRcbRhbRgbRsLsbLgbRgbRobLhbLiLsbLibRsLsbLcbRgbRsbLibR
sbLobRsbRgbRsbRcbRcbRsbRgbRhbRibRsLobRjbRobRibRsbRgbRsbRgbLjbLiRsbRjbL
oLsLsmmbLcbRsbLsbLsbLjbLgbLgbLhbLsRsbLsbLcLsmbRsbLobRgbLcbRgRsmbRcbRib
RsbRibLsbLsRsbRcbRcbRhbRsbLcbLcbRgbLgbRsbRsbRgbRsbRobRcbLibLsbRsbLgbLg
RsbLsbLgbRgbRcbLsbRsbLcbLsbLoRsbLcbRsbLsbLsbLibLobRsbRsRsmbLibLgbLgbLg
bLsbLobLcbLcbRsbRsbLsRsbLibLcLibRibRiRsmbRgbRgbRibRgbLsbLobRjbLgbLcbLi
bRgRibLibRjbRcbLgLsbRhbRgbRsRsmbRgRsmbLsLsmbRgRsRsmmbRsRsmbRgLsbRgbLgR
sRsmbRgRsmbRgbRhRibRibLsbLgbRibLsRsbLsbLjLibLoLsmbRebLhLsbLibRcbLsbRsb
LgLsbLibRsRsmbLgbLiRgbLgbLibRsbLgbLcRsRiRsRgmbRibRgbLsLsmbRgbLgbRiRgRs
RgRgmbReRsRsRsRsRsReRemmmmmbLobLobRiRsmbRcRsRcRsRsmmmbRiRsRgmbRgRgRiRg
RsmbRgRgRgbLsLeRsbLobRibRsbLoRgRgbLoRsbRsLsLiLeLgLgRjbRsbLoRsRsRsRgLgL
cLgLcLgmmbLiLebLoRsbRcbLjLsmbReRcRsRimbRcbLibRcbRgRsRiRsmmbRobLibLsbRg
bRhbRibRsRsRgReRsmmbRiRsRgReRsRsmmmbRgRgLsbLobLoRsbLobLhRsbLcLsmbLhbRs
bRgRsRgRimbLsRebLhbLoLgRsLeLcLcbLsLsLsmmbLsb

>ZF Recording 2016-03-18; tW: 300s; Start: 121304; End: 121804;
Recording: 1-1; Individual: 44; Drug: NDMC 10 µM
bRgbRibLsbLobLgbLsLsLsmmbLsbRsbLgbRobRibRhbRgbLsbLgbLibLgbRsbLgbRobRgb
LsLsmbLcbLibsbRsbRgRsmbRsbRgbRibRsRsmbLsbLsLsmbRcbRcbRgbLsbLcbLibRebLs
bLgbLibLobLsbLgbLsLsmbLgbLgLsbLcbLcbLebLgLsbReLsbRobRgRsmbRsbRsbRcbRsb
RsbRobRibLsbLcbRgLsbLiLsbRgbLobLsbRsbRsbLcbLibLibRebLsRsbLsRsbLobLcbLg
bRsbRsbLcRsbRgbRobLgbRcbRobLsbRjbRcbLgbRcbRibRcbLcbsbLsbLsLsmbRsbRobRs
bRsbLgbRsbRhbRgRsmbLsbRibRibLsLsmbRsbRsbLgbLobRibLibRsbLgbLsLsmbLsbLsL
smbLsLgLoLsmbLsbLobRcbLcbLsbLcbLcLsmbRsbLsbRibLsbLoRsRsmbRsRsmbLjbLgbL
sbLgbsbLgbLsbLgbLoLsRsmbRsRsRsmmbRgbRgbRsRsmbRibRcbRcbRcRsmbLibLhbRgbL
obRgbRsbLsLsmbLebRgbLgbLgLsbRsbLgbRsbLibLsbLgbLgbLibRgbLgbLgbLsbLsLsmb
LgbRsbLgbLoRsbRsbLobLcLsmbRjRsmbLcLsmbLsbLgbLibLsbLsbLsbLoRsbLsbRsbRgb
LibRsbLibRsRsmbLibLsLsmbLiRsbRgLsbLgbLsLiLsbLgLsRsbLibLiLgRsbLgLibLgbL
gRsLgLibLgbLibRgbLsLsmbRsbLcbLcbLcbLebRebRcbLcbLcbRhbLhbLsbLsLsmbLsbLg
LsbRsLsbLibLsbLsbLgbRsbLiRsRsLsLsmmbLsRsbLiLiLsLgLsLiLsLibLgbLgbLibLib
LgbLibLhbRcbRoLsbLhbLcbLibLgbRgbRiRsLsmbRsbRgLsLsRiRgmbRgRsmbRoLsbLobL
cbRgbRjbRobLibLhRsbRsbRiLsbRibRgRsmbRobRobRiLsbRsLsbRcbLgbLibLhbRgLiLi
LgLibLcLsmbRhbLibLibLsbLsLsmbLgbLgLsLsmbLgLgbLgbLiLsRsbLibRsbLoLsmbRgR
smbLibLhbRcbLobLcbLiLsbLcLsmbRcbLhbRhbLsbLgbLiLsLsLgLsmbLgbLoRsRsLgLsm
bLsbRcbRcLgLsbRobRcbLibLsbLeLiLhLebLoLsmbRcRsmbLobLhLsbLgbLiLsLsLsmmbL
iLgLsLhLebLebRoRsmbRcbLibLsbLgLsbRhRsmbRibLcbLibRibRiLsb

>ZF Recording 2016-03-18; tW: 300s; Start: 121304; End: 121804;
Recording: 1-1; Individual: 45; Drug: NDMC 10 µM
bRsbLibLgbLsbRsRsmbRsbLcbRgbLobRsbRgbLibLhLsbLcRsbRsbRsbRgbRsbRsbRsRsm
bRsbLsbRsbRobRjbRcRsmbRjbRsbRcbRcbRibRgbLsbRcbRhbRsbLcbLhbLgbRsbRsbRsb
RhbLsbLsbRobLsbLgbLgbLsbLsbLgbLjLsmbLibRibRgbLgbRobLsbRgbRibRcRsmbRibR
sbLsbLhbLcbRsbRsRsmbLsbLcbLhbRgbLgbLgbLgbLgbLsbLgbRsRsmbLgbLgbLgLsbLsb
LgbLsbLjLsmbLibRgRsmbLgbRsbLobLjLsmbLjbRgbRjbRhbRcbRcRsmbLsbLsbRsbRcbR
obRhbRgLsbRsbRsbLcbRgRsmbLcbRiRsmbLhbRjbLgbLgbRgRsmbLgbLsRsbLsbLgbLgbR
jbRjbLgbLibRibRcbsbRobRsbRgbRsbRsbRibRiRsmbRgbRcbRibRgbRoLsRsbLgbLsbLs
bLcbLgbLgbRcbRibRcbRiRsmbRgbRibRsRsmbRcbRibRibRgRsmbRgbRsbRibRibRsbRsb
RsbRhbRibRgbLsRsbRsbRsbRcLsbLgbLjbLsbLcRsbLcbLsRsbLsbRgbRcbRcbRibRgbRc
bLsbRoRsmbRgLsbRibRcbLsbLsbRibRibRcbRhbLsbRobLjbRobLsbRsbRgRsmbRsbRibL
jbRjbRobLgbRsbRsbLibLiRsbRgbRsbLsbLibLibLgbLsRsbLhbRibLcbLcbLibRibRsbL
sbRhbRcRsmbRiRsmbRgbRcbRsbRobLgLsbRsbRgbRgbRibRsRgbRgRsmbLsbRobRobRsbR
cbLgbLobLsbLgbLsbLibRgbLgLgLgbLgRsRibRhbLjbRgbRgbRiRsLsmbLjbLcbLibLgbL
iRsbLcRsbLibLjLsmbLgbLgbLsbRibRsRobLibLgbLsbRjbRibRiRsmbLgbLsbRiRsmbLs
RgRgRsRsmmbRobRcbRcRsmbRcRsmbRcbRhRsmbRcbLgLgbRsbLcbLjbLoRsbRgbRsLsbLg
RsbLiRsbRibRjbLcbRsbsbLhbLcLoLsmbRiRsmbLeLsbLsLcLgLsLsLsmmbLobLcbLcLjb
LsbRoLiLsLgbRiRsmbRsbRobRebRcbRcbRgRsmbRsRsmbRiRsmbRoRsmbRgRsmbLsbRibR
obRcbRibRsbRgbsbRibLsLsmbLsbRibRibRibLsbRsbRgbRgRsmbRibRibLsbLgbRobLsb
RsRsmbRobRcbRibRibRiRsmbRgbRgLsbLsbLsbLhbLibRgbLcbRgbLsbLiRsbRsbLgbLoR
sbLgbLibLgbLhbLgbLibLibLibLhbLsLsmbRsbLobLgbRebRcbLobLcLiLgRsLsLsmbLgb
LiLsLeLgLebLsbRoRibRobRoRsmb

>ZF Recording 2016-03-18; tW: 300s; Start: 121304; End: 121804;
Recording: 1-1; Individual: 46; Drug: NDMC 10 µM
bLiRsbLgbLibLgbLgbRibLgbLsbLjbRjbRobRcbLsbLgbLsbRsbRobLjbLjbLiLsbRobRi
RsmbLibLsbRgbRsbRibLsbRiRsRsmmbRgbRgbRsbRgRsmbRgbRsRsmbRgbRgRsmbRgbRsb
RobLhbRgbRgbRgbRobRebRgbLsbRgRsmbRsbRgLsbLsbRibLgbRgRsRsmmbRsbRsbRgRsm
bLibRcbLjbLibRsbLgRsbLgbLgbLgbLsLsmbLgbRgbLsbRgbRjbRgRsmbRiRsmbRsbRgbR
gbRgLsbRgbLsbRgbRgbRgbRgbRsRsRsmmbRsbRsbRjbLobLcbLcbRhbLibRsbLgLsbLgbL
gLsbRsbRsbLgbLgbLibLobRgbRibLgbLgbLgbLgRsbRjbLgbLgbLgLsbLsLsmbLgbLgbRc
RsmbRebLgLsbLgbLsbRsbsbRjbLcbRjbRobLgbRcbRebLgbLiLsbLibLgbLsbLgRsbLgLs
bRsbLsbLebRcbRebRjbRsbRgbRgbRiRsmbLgbRsbRgbRgLsLcbRgbRsbLoRsbRgbRsRsmb
RebRsLsbRcRsmbRiRsmbRjbRiRsmbLsRsbRibRgbRjbRsbLjbLgbLcRsLsbLhbRgbRhbRi
bRobLgRsbLgbRhbRjbRobRibRibRsbLobLobRsbRgRsmbRgLsbRgLsbRgbLcbRsbLsbRib
RgbRgbRebRoLsbLjbRcbRibRsbLebLobLsbRibRoRsmbRebRcbRhRsmbRgbLgbLgbLibLj
bLcLsmbRsLsbLgbLjLsmbLsbRjbRebRcRgbRebRcbRebRcbRgbRsbRebRoRsRcRsRsRsmm
mmbRibRiRsmbRgRsmbLjbRsRobRebReRsmbRobRsbRcRcRsmbLcbLcbLcbLibLcRsRsRsR
sRsmmmmbLcRsbRsbLgbLgbLgLsbLcbLhbRsbRhbLcbRsbLhLsbLcbLgbLsbLjbLibRgbRs
bRebRibRobRobRebLsbRcRcbRsbLcbLibLoLsLsmmbLoLsmbLobRibRiLsbRiRsmbRsRsR
smmbRiRsmbRsbRgbRgbRgbRgbLjbLobLgbLhbLgLsbLcbRcbRhRcbRobRcbRiRsmbLcbLg
LsbRoRsmbLsLsmbRgbRcbReb

>ZF Recording 2016-03-18; tW: 300s; Start: 121304; End: 121804;
Recording: 1-1; Individual: 47; Drug: NDMC 10 µM
bLjbLgbLibRgbLcbRgbRgbLgLsbLgbLcbLcRsbRibLsbLcbLcbRsbRjbRcRsmbLhbRjbLo
bRebLgbLibRiLsbRibRsLsbRibLsbRsbLgbRobLjbLgbLcbRhbRibLsLsmbRsRsmbRgRsm
bRsRsmbRiRsmbRobRebRibLjbRiRsmbRoLsLsRgRsmmbLobLobRgbLsbRoRsmbRgbRgbRc
bRsbRibLgbRibRebLhLsbLobRgbRebLcbRjbLobLsRsbRhbRjbLibLibLgbLcbRibRgbLi
bLcbLoRsbRibRgbLgbLobRgbLiRsbRgbsbLibLsbLgbLsbLjbRsbRjbRhbRebLcbLsbLcb
LcbRibLsbRsbRobLsbRibRibRcLsbLiLsbRsRsmbLoRjbLibLibLgRsbRjbLibRgbLobRi
bRoRsmbLgbLgbLsbRoLsbLcbLsbRobRcbRsbRibRsRsmbLobRsbRjbLibLibLiRibLoRib
RjbLhbLcLsmbRcbRibLcLsRsmbsbLeRiRgbRhRsmbRgbRsRgRsmbRgbRgbLsRsbRgRsmbR
gbLsbLsbRobRsbRsbLsbLjbLhbRgbLhbRgbLcbLobLeLsbRsbLobRsbRgRsmbRsbLhbRgb
LsLgbLsbRjbRibRgbLsRiRgRsmbRgbRgbLsRiRsmbRsRsRiRsmmbRgRgbRgRgbRgbRgbRg
bLgbRibRgRsRgmbRgRsRsRgmmbRiRiRibRsRsmbRgLsbRsbRgRsRgmbRiRgRsRgmbLcbLo
bLcbLibLebLhbRgbLobRgbRsbRsLsbLibRsLsbRiRiLsRsRsRiRgRembRgLsbLcbLcbRcb
LcbLcbLcbRgbLsRsbLsRsLobLgRsbLsLsmbRcbRobRoLsbRibRoLsbLibLibLsbLibLcbR
ibRibRebRoRsmbRsRsRoRsRsRsRsmmmmmbRgRgRhLsbRibRgRsRimbRhbRiRsmbRgbLcbL
hbRgbLhbRgRsmbLhRibRgbLcRsbRgRjbLibRsbLibLhReRsmbRsbRiRiRgRsmbLsRiRiRe
RhReRgbRiRsmbLobLcbLcbLcbRcbRcbRjbRibRhbRibRebRiRsRsRsLsRsmmmbLgbRiReR
smbRebRgRebLcbRsRsmbRgbsbsbLcbLcbLeLsbLibLsbRcbRcRiRsmbRcRsmbRobRsRsmb
RoRgbRgbRiRgRsmbRsbLebLcbLcbLhbLcbLsbLhbLhbLcbLsbLibLobRsbLibRibLsbRob
RobLcbLoLsmbLcbLhbRsLsbRibRgbRsbLobRjLiRibReLcb

>ZF Recording 2016-03-18; tW: 300s; Start: 121304; End: 121804;
Recording: 1-1; Individual: 48; Drug: NDMC 10 µM
bLsbRoLsRsbLgLsbLibLsLsmbLoRsbLjbRgRsmbRgbRjRsmbLcLcbLhbLobLcbRjbLibRs
bLgbLgLsbLsLsmbLsLsmbLcLsmbLhbLoLsmbLiRsbLsLsmbLgbLibLsbLsbLgbLsbLhLsb
LgbLobLcbLcbRgbLgbLgbLgLsLsmbLsbLibRiRsmbLobLhbLiLsbLibLsbLiLsbLgLsbLg
bLsbLsbLibRcbRgbLhLsbRsbLgbLgLsbLgbRgLsbRsbLoLsLsmmbsbLgbLcbLgLsbLibLs
bLgbLibLibLhbLsLsmbLgbLsbLcLsmbLibLcbRibRsbLibRsbLsbLobLjLsmbRibRsbRsb
LobLibLibLsbLjbLhLsbLibRsbLsbLsbLsLsLimbLgbLsLsmbLsbLsbLibLibRsbLgbLgb
LiLsbRsRsmbRsLsbLsLcbLgRsbLsbRsbLgbLgbLsbLcbLibLibLhbLhbLibRjbLoLsmbRe
RsmbRsbLgbRsbLiLsbLgLsbLsLsmbLgbLsLsmbLgbLsbRsLsLsmbLibLiLsbLibLiLsbLi
bRsbLibLibLsbLhbLobRsbRcbRobRgbLgbRebRibRoLsbRgbLsRsLsbRhbsbRgbLjbRobL
jbLcLsmbRjbRiRsmbLjbLgLsbLsbLsbLsbLibRebRjbRjbRhRsmbRcbRgbRibRibRsbLcb
LjbLhbLgLsbLhbRcbLebLcbLibLjbLibLjLsmbLiLsbLibLibLgbLoRsbRjbRjbLobLjbL
hLsbLiLsbRhbRgRsmbLjbRgbRcbRjbsbRjbRsbLsbLjbLobLibLsbLgbLgbLobRibLcLsm
bLgbRiRsmbRibRhLsbLjbLcbLcbRhbRgbRsRsRsmmbRhbLcbRebRibLibLjbReRobRobRe
bLcbLcbLcbLhbsbLcbLiLsbLiLsbLgbLsLsmbLibLcbLoLsmbRoRsmbLhb

>ZF Recording 2016-03-18; tW: 300s; Start: 121805; End: 122305;
Recording: 2-1; Individual: 1; Drug: Control
bRoLoReRsmbRiRebRgRsRgmbRebReLsLgLsbLiLsbRcbRcbLsbLgbLsRsbRsbRgbLcbLcL
sLhmbLeLsbLsLgbLgLsRebRibLeLsbLsLsmbLsLsmbLgbLsLgbLsbLsLsmbLsbLsbLgLsb
LsLsmbLsRsbLibLsLsmbLgLsLsLgmbLsLsmbLibLsLsmbLgLgbLsLsmbLsLsLsmmbRcbLs
RsRjbLcLsmbLsLoRsbRebRibLgLsbLgbLcLjbRgRsRsmmbRobLgRsbRgRsRhmbLgbRsbLs
bLsbLsLgbLibLsRjbRgLsbLgbLcbLcbLoLibLibLgbLibLgbLsLsmbLcbRiLsLsLsmmbLg
LsbRibLibLgLsbLgb

>ZF Recording 2016-03-18; tW: 300s; Start: 121805; End: 122305;
Recording: 2-1; Individual: 2; Drug: Control
bLobLobRsLebLcbsbRoRhRsmbRcRsLsLcmbLcLsmbLibLcRsRsmbRgRsRgRembsbLobLob
LsLhbReLsbLsLebReLgbLcLebLebLsLsmbLsLsLsLsLsLeReLsmmmmbRcbLeLsbLsbLebL
sLsLgLhmbLsLibRsLsbLobLiLobRgbRiRebRsRgRebRsRsRgRsmmbLgLebLgbLeLebLebL
cRebReRsRsmmbRhLobLebLjLebRjbRgRjbRjbLsbLebLibRebRcbRiRebRcbReLcbRcLjb
LhbLebRcbLebLjLsmbRibRebLsbLeLgRjbLobLeLsLsmb

>ZF Recording 2016-03-18; tW: 300s; Start: 121805; End: 122305;
Recording: 2-1; Individual: 3; Drug: Control
bLobLoLsmbLobRibRhbRibLibLgRsbLobLobRjbLgbLobLcbRobLcLgRsbLobRibLcbLhL
sLiLsbRcLsbRgRsmbRgbRoLsLeLsLgLebLoRsbLgLsbLobLjbRebRcRsmbRebRiReRsRsR
sRsmmmmbRobRcRgbRsRcReLsbRsbRobLobLsbLoLobLoLoLsLombLobLoRsLsbLcLhLeLs
bRoRsmbRebRiRhbRgbRsLsbRoRoRcRsRsRcmmbReRhLeLsLsmbLoRsbLjbLcRcRgbRsbsb
sbRoLeRcLcRsbRcRsmbLebRebRobRebRebRebReRsRembRoRsmbLgLsbRsRsmbLsRsb

>ZF Recording 2016-03-18; tW: 300s; Start: 121805; End: 122305;
Recording: 2-1; Individual: 4; Drug: Control
bLibRobRoLsbRebRobRobRcbLsLsLimbRobRiRsRsmmbLgbRiRgbRibReRgRebRcbRsbRs
bRhRiLsbLsbLsLsLoLgLsmbLsbRsbRiRsmbRsRsRsRsRsRgRsRsLsmmmmmmbRgRsLsRsmb
LsLsmbRsRsRsmmbLsLgLsLsLsLsRsLsLsLsmmmmmbLcLsmbLsLsRsmbLsbRsbLsbLsbRsR
sRsRsRsRsRsRsRgRgRsmmmmmmmmbLsRsLsbLsbRiRsRsLeLsRsmmbLebLsLsmbRsRsmbLg
LsbLsLsLsLsLsLsReLsmmmmmbLcbLsbLibLebLebLgbRsb

>ZF Recording 2016-03-18; tW: 300s; Start: 121805; End: 122305;
Recording: 2-1; Individual: 5; Drug: Control
bLgLsbLsbLsbRsbLgbLgLsbRgbLibRsbLgRsLsbRsRcbRhLsbRiRsmbRibLgLsbRibLgbR
cbRhbLibLibRebLcbLibLcLsmbLcLsmbLcLsmbLiRsbLgLsbLgRsRgbRgbLoRsbRobLcbL
ibLhbLhbRcRsmbRhbLcbRcbRcbRibRcbLibLiRsbLibRgRsRsRsmmmbLoRsbRcRsmbRoLs
bRgbRibLcbLcLsmbLcbLgLsbRgbLibLiLsbLsbLiLgLsLebLcbRcbRebRobRhbLcLsmbLj
bLhLsbLhbLiLsbRobLhLsLsmbLhLsbLjbLebLebLebLebLgbLebLebLobLcbRcbRsbRiRs
RsmmbRebRgbRjbRcbRoRsmbRebRebRebRobRebRebRobLsLsLsmmbLobLebLsLobsbRcbL
gLgLsLcbLebLebLgbLsbLsLsRsRsmmbRebRsb

>ZF Recording 2016-03-18; tW: 300s; Start: 121805; End: 122305;
Recording: 2-1; Individual: 6; Drug: Control
bRebRsLgbRgbRsbReRsmbRcLgLibRiRsmbsbLoRsbLobRebRsbRcbLcbRebRsbRjbRgbRc
bRoRebRoRsRgRsRgmmbRiRsRcmbRgRsmbRsRsRsRcmmbLobLgbLebLcLgLsbLcbLcbLhbL
iLsbLhLsbLebLcbLobLcbLiLhRgbRgRebRobRebRcbRcRsmbReRsmbRjbRebRebRgbRcbL
cLsLombRsbLoLobReRsmbLcLsmbLoLsLcmbLgbLibLoLsmbLcLoRsLsbLebLhLcbLcReRs
mbLcbLhbLobLeLsbLcbLcLsLsmmbLeLibLebLcLiLsbLcLobLobLiLsbLiLeLgbLcLsmbL
cbLsbLoLsLsmmbLcbLgLsbLiRibRebRobRebRcLsbRiRcRsRsmmbReRsmbRsRsRsRsmmmb
RcbRcRebRsRsReRimbLoRebLoRsLoLsLcLsmmbLiLebLibLebLcReRsmbLobRcRsRsRsmm
mb

>ZF Recording 2016-03-18; tW: 300s; Start: 121805; End: 122305;
Recording: 2-1; Individual: 7; Drug: NDMC 1 µM
bLibRoRibRibRcbRcbRibRgbLibLebRjRsmbRoRibRhbRsbRgbLgbRsbRibRoRcbRhbRcb
RibLiLgbLcbLibLcRsbRsbLgbLcbLibRgbLiLsbRsbLiRsLsLiLgLgbLgRsLgbLiRsbRiR
smbLcbLibLibLibLibRsbLcLgbRcRcbRcbRiRsmbLibRobLibRcbLgbLsbLsbRoLsbLsLs
mbRobLsbRsbRgbRcbLgbRhbRcbLcbLobLiLsbRsbLiLsbLsbLcbRsbLsbLcbRgbLgbLibR
iRsmbRgbRcbLgLgbRhLsbLsbRcbLgLgLsRibRiRsmbRgbLgRsbRibLjbLcbLebLsLgLsbL
iRsLsbLsLiRsbRsRsmbRgbLcbLobLcbLibLcbLcLcbLibLibLsbLsbRsRiLsbRsbLsRgbR
ibRgRsRsmmbRcbRsbLsLgRsbRhbLsbRibLsRsbRiRsLsmbRgbRsRsmbRibRibLgbRobReb
RhbRgbRgRsmbRsbRcRsmbLsbRsbLeLibLgbRgbRhbRiLsbLibRcbRcbRibRgbRhbLgbRcb
LcbLobLcLsmbLibRsbRsbLjLcRsLsbRcbRcbLgRsbRcbLibLcbLhbRgbLibLcRsbRgRjbL
oRsbLsbLibLsLsLimbLgbLibLgRsbLibLcRsbLcbLcbLibLsbRsRsmbLoLsLsLsmmmbRiR
smbLgbLgRsbLcbLcbLhbLibLsLsmbLcbRibLebLiLsLsmbRsbRcbRcbRhbRibRoLsbRhbR
hbRcbLsbLgbRgbLsbRsbRoLsRsbRcLsbRsRsRsmmbLgbLsRsbLgbLsLibRgbLhbRsbLibR
gbLobRgRsRsmmbRsbLcbRcbRcbRcbRibRsbRcbRibRiRsmbRsbRibRsbRgbRobLiRsbRob
LsbRgRsmbRibRiLsbLsbLsbLgbRoRsmbRcbLsbRjRsmbRhLsbRiRcbRcbRiRsmbRibRiRs
mbRebRobRibRobRiRhbRibRsbRcbLebLibLgbRsLsbRsbLobLibLibLibLgbLsbLsbLibL
gbLiRsbLgbLsbLibLsbLgbLcbLibLcLsmbLebLcbLibLibLobLibRsbRsbLibRsRjbRsRo
RsLsLsmmbRcbRcbRiLsbRcbRcRsmbRiRsRsmmbRiLsRsLsbRsbRobRhbLsbRiLsbLcLobL
cbRcbRcbRgbRibLgbRcRsLsmbRcRsmbLgbRcbRcRoLsbLgbRcbRcbRcbRsbRsbRsbLsbLo
RsbRgbLsbRobLsbRgbLgbLibLgbLgbLsbLsLcbRgbRgbLcbLhRsbLhLsbLcbLhbLcbLibR
sRsmbRsbLebRhRsmbRcbRcRsmbLsbLsbLgbLcbRhbRjRibLiLcbRibLoLsmbLoLsmbLhRs
bLsbRsLsbRsbLoRsbRsRsmbLobLobLibRcRcLsbRcbRobRcbRcbRcbRcLsbRjRebLsbLgL
sbLsbRcRsmbLgbLgbRsbRibLsbRsbRoLsbRibRsLsbLsLibReRcbRcbRibRibReRsmbRib
RhbRsbRsbRsbRsbRoRsmbLibLgbLiLsbLcRsbLgbLsbLgbLibLebLeLsbLibLibRsLsbLs
LsLcmbLgbLgbLgbRgRsRsmmbRgbRsRsRsmmbLsbReRsRcmbLjLsmbRoLsbLhbRcLjbRsbR
cRsmbRibRoLsLsmbsbLiLsLebRsbRiRebRebRebRsbLgbRebRcbRcbRgbRoRsRsmmbRsbs
bRsbLgbRgbLibLcbRcRcRsmbLibRcRsmbRsb

>ZF Recording 2016-03-18; tW: 300s; Start: 121805; End: 122305;
Recording: 2-1; Individual: 8; Drug: NDMC 1 µM
bRhbLgbRibRibLibRhLsbRcbRoLsbLsRobRobsbRcRsmbRobLgbRsbRoRcLsLsRsmbLgbR
ibRgRcRsmbRibLibLobLhbLoLsmbRgRsmbRibLcbLibLibRgbRcbRibLjbRobLhLsbLcbL
hbLcbLibLcbRsbLoLsmbRgRsmbRebLgbRcbRibLcbLsbLibRibLoRgRsmbLsbLgLibLiLs
LebRibLcbLgbLobRsLsbLcbLcLsmbLgbLibLgbRobRcbLsbLhLsbRoLsbRsbRibRibLiLs
bRoLsbRobRcRsmbLsbLhbRibRcbLobLsRsbLsRsLsbLoLsmbLsbRgbLcbRcRoLsbLsbRcb
RibRhbRhbRcbRcRsmbRibLibRibLobLobLcbRiRsmbLgbLobLsRsbRsbLcRsbRhbLiLsbL
iRsbLgLsbLgbLsbRsbLebRsbRebRobRebLiLsbLibLiRsLsbRsRsmbRcbRebLobLobLobR
gbLgbLgbRobRhbRhbLiLsbRcRsLsmbLibLibLcbLcbLobRcbLjbLsLsmbRebRcbRobsbRc
bRcRsmbLebRhbLobRibLgbRgbLjbLibsbLobRebRcbRhbRgbRsbLsbLgbLgbRsLsbLiRsb
RsLsbLgbLgbRcbRiRoLsbRcbRibRcbRcbRibRcRgbRoRsmbRcbRebLsbLgbLhbLsbLobRc
bRcbRsbRjbLgbLjbLgbRcbLcbLobLhLsbLcRsbLcbLgbLibLgbLcbLebLcbLjbRcbRgRsm
bLcbLhLsLsmbRsbLibLibRiRsLsmbRcbRiLsbLgbLhLcbRebLobLobRcbLcbLhbLibRcbR
cRsmbLhLsRsbLcbLgbRebLhbLibLcbLgRsbLiLsbRiRobLibRibLiLsbLcbRsbRhbRibLs
bRibLgbLibRobLibLhbLcbRcbLebLsLgbLgLsLsmbLiLsLibLeLhbRcbRoRsmbRebRobLj
bRobRhbRibLgbRcbRobRoLsbRcbRobRsRsmbRcbLgbLebLhbRsbLsbLsbLsLsmbRsbReRg
bRibLobRibRoRsmbRcRsmbRcbLeLsbRcRsmbLcbLobLibRcRsmbLoRsbLcbLibLhbLhbLs
LsmbLcbLcLsmbLoLsmbLibLsbLobLibLsbLsb

>ZF Recording 2016-03-18; tW: 300s; Start: 121805; End: 122305;
Recording: 2-1; Individual: 9; Drug: NDMC 1 µM
bRobRcbLjbLcRsbRobLsbRibRibLsbLgbRcbLcLsLgLeLgLiLsLsLgLeLimmbLsLsLsLgL
sLiLsmmbLsLsLsLgmmbLeLsLhRsRsmbRobLoLsmbLcbRoRoRcLeRoRsRiRgmbLsbLhbLoR
sbRsLcbLgRsRsRsRsRcmmmbRsRsRsLsRsLsRsmmbRcbLibLcLsmbLcbRgbLcLsLcRsmbLh
LsRsLsbRoRobLcRcbLcLsmbLeLsbLgLsLsmbLibLcRcbReLsbLiLsLebLsLsLgLsRsmbLc
LsmbLgLsbRgbRiRsRcRoRsmmbRcRsmbRiRsLsmbRcRsRsmmbLsRcbRcRsmbLgbRcbLeLhR
ibLcLoLoLhbRcRsmbRsbsbsbRiLsLsRombLcLobLsLsmbLsLcbRiRoRsmbLcLsLsLiRsmm
bLgbLcRcRsLgmbLcLcLgbLsLsLsLsLsLsLsLsLsmmmmmmmmbLsLgLsLsLsmmbLsLsLoLsm
mbLsLsLsLsLemmmbLoLsmbLsLsLsLsLsLsmmmmmbReRoRoRsmbRsLeLsLsmbLoLsmbRsbs
bLjLsmbLcLobRsRsRsRsRsmmmmbRsbReLobLsLsmbLcLsLoLsmmbRoRob

>ZF Recording 2016-03-18; tW: 300s; Start: 121805; End: 122305;
Recording: 2-1; Individual: 10; Drug: NDMC 1 µM
bRgLsLsmbLoLsmbLgLsbRgbLgbRcReRsmbRcbRibRibRoRsmbRebRgbRebLsLeLeLeRsLc
RgbLobLsLsLsLsRsLimmmbLebLebLgLgLibLobLcbLobLiLsbRibLgbReRsmbLobRebRiL
gLsbLobRgbLgbRebReRibRiRsRsRsmmmbLsbLcbRsbRoRsmbLgRsbLoLsLsRemmbReLgLs
bRsbRibLgbLsLebRoRsmbRhLsLsLimbRebRgbRsbRgbLgbRobRgbLibLcbRsbRcbLoLsmb
RebRgRebLsLsLsLimmbLhbLebLsbLeLjbLcbLgRsLsbRiRsRcmbLsbRsbRsRsRgmbLobLo
RsbReLcbLsLeLoLcbLhbLeLebLebLsLsLiLsmbLsbLsLebLgLeLeLsbRebLgLsbLebLcbL
sRsb

>ZF Recording 2016-03-18; tW: 300s; Start: 121805; End: 122305;
Recording: 2-1; Individual: 11; Drug: NDMC 1 µM
bRibRibRhbLeLsbRhbRcbRhbRcbRibRibLobLoLgLsbRsbRgbRibRibLebRebRoLobLcbR
hbLjLhLsbLsbRjRsmbRiRsmbLebLiLsLeLsbLsLgLsbLsLsLsmmbRsRobRcRobLcbRgbRi
bLcbRibRobRoLsLobRibRhRcbLibRibLhLsbsbRiRsmbRibRgRsRsRimmbRjLsRibLhLsb
RcRoRsmbRcRoRoRobRobRobRjRsmbRiRsRsRsmmmbRibLhbLoLsLcLsLsmmmbLebLobLoR
sbRjbLcbLcbLiRsbLcbRiRsRsmmbRhbRcbRoRsLsmbRcbRobRoLsLsmbRibRjRhbRhbRhR
cRsmbRobRibRjRsmbRcbRsbRhbLsLebLiRsbLobRcbLcbRibRibLcLsRembRcLsLsLsmmb
RgbRgRsmbRsRebRcbLhbLcbRibRobRcbLcbRibRibRobLoLsmbLhbLobLsLsmbLcLsmbRc
bRhRsmbRibRibRhbRcbRibRibRibRgLsbLibLsLsmbLcbLcbRcbRibRibRibRgRgbRgRsm
bLsLcRsbRsRoLsbRcbLcLsmbRibRcbLcLsmbRiRsmbLebRcbLsRibLoLsmbLobRsbRcRsm
bRsRsRsmmbRcbRobRhbRcbLcbLobLobLibLoRsRsRembLoLibLjbLsbLcRsRsmbReRcLeb

>ZF Recording 2016-03-18; tW: 300s; Start: 121805; End: 122305;
Recording: 2-1; Individual: 12; Drug: NDMC 1 µM
bLsLsmbRsLsbLgbLsLsLiLsLeLgRimbRgRsmbRsLsbLobLsLgLgLibLibRiRsRsmmbLibL
ibLsLebRsLsLgbRsLsbLsLgbLsbLsbLsLsmbLsbLiLsLgLsbLsbLsLsRsmbsbsbsbsbLoR
sLoRobRebReRgbRhRsmbRobLobRiRsmbRgbRsbRsLsRsbRobLebLsLiLsbsbLiRgbLobLc
bRgRsmbLcbRcbRoRsmbLoLhLsRobLsbLjbLibRcbRsRsmbRgbRebRoLebRebRoRcbLoRsb
RsbRebRgbRcbRebRibRcbLebLiLsbRsbRibRiRibRebLobLiLgbLsbLeLsbsbLsRcRsmbR
iRsRsReRsmmmbReRsRgRsmmbLcbRibsbRibRobRsRsmbLsRsbLsLsRsmbLsbsbRsReRsRo
RgmbLobLgbsbLsLsLsLgmmbLgbLeLebLoLcbLsLsLgLsLgmbLsbRibRoLsbLgLiLgbLhbL
gRgLsbLsRsbRsbRhRsRcRcRsRsmmmbRcLsLhLcLgLoRsbLoLsLcRhmbRcLsLsmb

>ZF Recording 2016-03-18; tW: 300s; Start: 121805; End: 122305;
Recording: 2-1; Individual: 13; Drug: NDMC 3 µM
bRsbLgbRibRcRsmbLibLgbRiLsbRobLibLsLsLsmmbRsbRcbRcbRgbRsbRgbRgRibLjbRs
LcRsRsmbLcbLebsbLgbLsbRsbRobLibRsLcbRcbRobRobLgbRibLcbLobLsbLiLsbLibLc
bLhbRgbLsbLcbLgLsbLiLsbRsbLibsbRsbLsRsbLcRsbRiRsmbRgbLcRsbLcLsmbLhLsbL
sbLibLibRhbRoRsmbRebLeLsLsmbLebLsLsmbLhbRcbRcbRcRsmbRjRsmbLibRsbsbRgbR
cbLgbRibRobRsbLsbLibRjbRcRsmbRcbLcbLiLsbRcbLcbLibLgbLoLsmbRgbLcbRebRoR
smbRcbRobLebLcRsbLcbLgbLibLsbLgbLibLibLcbRjRsmbLcLsmbRibRcbRobRobsbRsb
LhLgbLsbRcbRcbRcbRibRgbRebRobLsbLgbLcbRibLhbsbLobRobRcbRebRcbRcbLobLcL
sRsLsmbRsRsmbRcbRiRsmbRobRobRibRobsbRcbRebRebRoRsmbRebRgbLcbLibLibLgbL
sbLsLoRgbLibLhbRsbLobRibRgbRoRsmbLgbLcLsLsLsLsLsmmmmmbLibLgLsbLsLsLsLs
LsmmmmbLcbRgbRibRgbRoRsmbLibRibRibLsbLgbLiLgbLcRsRsmbLhbLsLsmbLsbLgLsL
smbRjRsRoLsLsmmbLjLsLcLombRsbLcbLhbLcbLjLsmbLibLiLgLsbLcRsRgbLgbRsbLsb
LsLgLsLsmbLgRsRsmbLobRcbRjbLcbLiLsbRsLibLsLsRsmbRobLsbRcLeLeLebRoRcbRc
RebRoLcLcbLsbLsbLibLcLsmbLoLsmbLcRgRcbRsbLoLsmb

>ZF Recording 2016-03-18; tW: 300s; Start: 121805; End: 122305;
Recording: 2-1; Individual: 14; Drug: NDMC 3 µM
bLcLsmbLcbLibLsbLcbLcbLsbRsbRcbRcbRebRhbLsbRcbLcLcLsLsmmbLsbLsbLibRjRs
RombRcbRibRiLsbRiRsmbRcLsbRsLsbRgbLcbLcbLiLsbLcbLcbLcLsmbRsbLsbRibRcbR
cbRsbRibLcbLcbLibLgLsbLsLsmbLsLoRgRhbLsbRibRcbRcbRiLsbLcbLcLsmbLsbLcbR
hbRcbRsbLcbLoRsbLcbLcbRiRsmbLcbLcbLhbLcbLcbLgbRsbRibRibRcRsmbRcRsmbRib
LhLoLsmbLhbRhbRibRcbRcbRhbRibRcbRibLsbLiLcbLcbRibRgbRiRcLsbLsRobRgbRib
LcLsmbLhbRsLebRgLgbRoRhRsRsmmbRgLsLsmbLsRiRsmbsbRcLiLgLcLeLebLobRcRcRs
RsmmbRcbRibRcbRsbsbRcRsmbRobLsbRsbLsRsbRsbLcbLcbLsLsmbLsbRcRsRcLsmbLeb
LebLebLsLsmbLcbRcRsmbRiRiRgbRgRsRsmmbRoRobRoLsLsLiLsmbLsRsLsbRcRsmbRcb
RcbRsbRsbRsRsmbRsbRhRsmbRibRsbRgRsmbRcbRsLsbRsbReRsRsmmbRsbRhLsbRhRcbR
sRsmbRoRsmbRsRsmbRhRsmbRcRsmbRsbRsbLcLsmbLcbLiLsLcbLgLobLsbLsbLhLsbLiL
sbLsbRsbLhRsbLiLsbLibLsbLhbLgbLsLoLoLsmbLcbLobRhbRcRsmbRobRibRoRsmbLcb
LcbRsLsbLcbRcReLebLobLcLsmbRiReRebRebRcReLsLsmbLsLsmbLiRsLsbRgLsbLsbLo
RcLsRsbRoRsLsRcRsRsmmmbRsRsmbRcRebLeLsLebLsLcReRsmbRgRgRgRsRsReRoLsmmb
RibLcLobReRoRcRsmbRiRsmbRiReLcbLiLgbLcLcLoLsLsmmbLsRsbLoRhbReRcbRebRhR
cb

>ZF Recording 2016-03-18; tW: 300s; Start: 121805; End: 122305;
Recording: 2-1; Individual: 15; Drug: NDMC 3 µM
bLsLgbLgLsbLgRsbLobRsbLcLsmbLibRcLsbRobRjbRhbRcbLcbLhbLcLsmbLcLsRsmbRg
bRoLsbRobRibRgbRsbRgRiLsbLsbRjbRobRgbRsbRcbRibRebRhbRibRiRibLiRobLgbRo
LsbRsRhbRgbRibRiLsbRhbRhbRibRcbRcRsmbLsLsmbLsLgLsLsmbLiLsbLgbLibLobLib
LcbLibLibLiLsbRgbLoRsbLibLebRiRobLjbRhbLgbRhLsLgbRibRebLsLsmbRebLjbLob
LcbRsbLjbReRgbLhbLsbRgRsmbLiLsbLsbLgbRsLsbRoLgbRhRsmbRebLgbLibLsbRsbLg
LgRsbLiRsbLgLsbLgbLgbLsbLgbLgRsbLcbRibLgbRcRgbRgbRobRjbLebLebRgbsbRcbs
bRsRsmbLcbRibLgRcRibRebRebRebRebRebRebRebLebRibRsLsbReRsmbRibRiRsRgRom
bRebRebRebRebRgRhbRebRcbRsRebLebLebLebRcbLjbLsLsLsmmbRebRebRebRebRebRe
LcLobRsb

>ZF Recording 2016-03-18; tW: 300s; Start: 121805; End: 122305;
Recording: 2-1; Individual: 16; Drug: NDMC 3 µM
bRcRsReRimbLcbLsbLjLcLeRebRsRsmbRsRsmbLoLsmbRoRsmbRcbRhbLiLsLsmbLcLsmb
LiLsbRibRiRsmbLcbLiLgLsLeLsbLiLeLsLeLgbLoLsmbLcbLcbLibRiRsmbRsbRiRiReR
eReRsRsRimmbRsbLcbRjbLcbLcbLiLebReRsmbRcbRcRsmbRcRsmbRhbRsRsmbLsbLsbRs
LsbRcbLcbLhLhbRobRobRsbRcRsmbRibRibRsbLibLcLsmbRebRcRsRembRebRhRsRsmmb
LibLsLcbLsRsbRoRsmbRcbRcRcRsRimbRobRebLcLsLcLcmbLcLsLcmbLcLcbLobRgbLcb
LeLobRibRgRsmbRsRsRsRgmmbRgbLobLoRsbRebRgbLobRhbRcbRcRsmbRibRsRsmbRiLs
bLsbRoRcReRsmbLcbLoLsmbLcLsmbLcLcbLcbLhbRhbRsbRcRsmbRibRobLsLcLcbRgRsm
bLcbRjRsmbRcbRibRibRgbRsLebLsRsLsLsmbRoRebLibLeLhLsLibLsbRcRsRsmmbLobR
oRsmbLebRgRsmbLobLjLgLsbLhLgbRoLsbRibRib

>ZF Recording 2016-03-18; tW: 300s; Start: 121805; End: 122305;
Recording: 2-1; Individual: 17; Drug: NDMC 3 µM
bLgLsbLsbRobLgbRgbLsbRoLsbReRsmbLgbRibRhbLcbLobLcbLgbLobLsbLebLibLgbLs
bLoLsmbRcbLcLcRsbRibRjbRhbRcbRhbRjbRcLsbLibRobRcbRsLsbRcbRibRibRcRsmbR
cRsmbRgbRsbLcbLhbLcbLcbRgbRhRsmbRibLiLgbLoRsbLobRebRiRsmbRobLhLsbLebRc
bRcLoLsmbRjbRcRibLcbLcLsmbRiLibLiLsbLsbLebLebLhLsbLobReRcbReLsbRgbRgRs
LsmbRcbRibLibLgbLhLsbLobLebRobRoRsRsmmbRibRgRsRsmmbRgbLsRsbLsbLcbLsbLo
LsLsmmbLhbLcLsmbLhbLcbLcbRebLeLsLsmbLibLoLsLsmmbLcbLoRsbLibLebRobRcbLg
bLebRcbRibRiLsbLibReRebLobLoRsbLcLsmbRcRsRoRsRsRsRsRsmmmmmmbRsRsRsmmbR
sRsmbLoLobRcRsRiRembRgLsLsmbLiLsLsRsmbLsRsLgbRhbRiLsbRibLoRsbRoLoLhbRc
bRcbRiRsmbLgLsbRobRiReRsRsmmbRcbRhRsRsmmbRcbLjbLoLsmbLcbLoLsLcmbLhLsLs
LsmmbLcbLebLebLebLhLsbRibLcbLcLsmbLiLsbLcLsLcmbLcLsmbReRobRcbRiRsmbRib
RibRhbRhbLsbRhReRobLsbRgbRcbLsbRibsbLeLsbLcLsmbLibLibLibRibRhRsmbLiRoR
smbRsbRobLibLcbLhbLoLoLsmbRjbRgRgRsmbRhLsbRsbLhbLcLcbRcRsmbRcbRibRgRsm
bLsbRibRibRsbRsbRhbRobRibRcb

>ZF Recording 2016-03-18; tW: 300s; Start: 121805; End: 122305;
Recording: 2-1; Individual: 18; Drug: NDMC 3 µM
bRcbLcbLoLsLoReRimbLhLsbLcLsLsmmbLcLsLcRiRembRsLsbLebLcbLebRibRsbsbRoR
smbRoRoRhbRsRibReRsmbLsbLsbLibLebLebLebLsLsLembRjbReLeLgLsLsLsLsLsLsmm
mmmbRebLebLsLiLsbLobLgLiLsbLiRsbLcLhbLiLsbLcLsmbLebLiLcLsLsmmbLoLsLsLo
LcLcmmbRoRcbLcbLeRsbLgbRcRebRsReLcbLibLsLsLcLcLeLombLgbLoLibLebRebRsbL
gLeRsbRgRsRsRsRhRcRimmmbRgbRebRsbReRsLembLibLsLsLgRsLsLsmmbRoLsLibRcLs
bLcbLobReRsRsRsmmmbRgRsmbRebLobLgLsbLcbLoLcbLsbLiLsbRcRibRiRsmbRiRcRcL
sb

>ZF Recording 2016-03-18; tW: 300s; Start: 121805; End: 122305;
Recording: 2-1; Individual: 19; Drug: NDMC 10 µM
bRcRiReRebReRsRiLsLgmbRebLjbRsRcbRsRiRobLgRsbRibLhRcLsLsmbLsbLsLgb

>ZF Recording 2016-03-18; tW: 300s; Start: 121805; End: 122305;
Recording: 2-1; Individual: 20; Drug: NDMC 10 µM
bLgbRcRsmbRcbRhbRibLjLsmbRjRsmbLebLcbRobLibLsLsmbRcbRcLsbRobRobLsbRgbL
cbLebRcbRcbLibLgbRobRcbRibLsbReRsmbLoLsmbLibLgLsbLsbRgbRhbRibLgbRcbRcb
RcbRibRebLhbRcbRcbRhbLsbRgbRhbRobRcbLsbLsbLibRoRobLjbLcbLeLsbLobLcLsmb
LibLibLgbLoLsmbLibRsRsmbRobRiRsmbRibsbRibLibRobRibLibRsbRgbLibLjbLoLsm
bRgbLcbLibLibRsbLibRgbLibLsbLiRsbLgbLhbLcbLibRgLsbLsbLibRobRobRhbRibLg
bLgbRobRobRobRoLsbRibLsbLjbLibRjbRcbLjbRhbLebRjbLjbsbLoLsmbLcLsmbsbRib
LjLsmbLsLsmbLgLsbLgbLsbLobLsLsmbLobRhbLibLcbLgbLsbRsbLobLsbLobRcbRebRi
bRsbRsbLjbRobLgLsbLiLgbLgbRjbRoRsmbRsbRobRebRsbRobRibReRsmbRiLsbRoLsbR
ibRjbRcbLibLoRsbRibRsRsmbRibRoLgLsLjbLebRsRcbRsbRcRsmbLeLeLeLsbRoRobRi
bRobLsbLobLgbLobLgbRhbRcbLgLsb

>ZF Recording 2016-03-18; tW: 300s; Start: 121805; End: 122305;
Recording: 2-1; Individual: 21; Drug: NDMC 10 µM
bLoRsbLoRsbLobRibRoRsmbLobLcbRobRoRebLoLgLhbLobRsRsmbLobRobRebLibRebRo
bLjbLcbLsbLibRgbRobLhbLsbRibRebRebRebRgbLsbLiLsRebLibRsbLsbRhLsRsRgbLo
RsbRgbLibLobRcbRobRebRgbRebRebRebLoLgbRsbLsbsbRsRsmbRsbRsbLsRsbsbRsLsb
RebRoLsLobLobLoRebRobRgRsmbLcRsReRsRgmbRhbRobReRcLoRsbLhLgbLcReRsmbReR
gbLsRsb

>ZF Recording 2016-03-18; tW: 300s; Start: 121805; End: 122305;
Recording: 2-1; Individual: 22; Drug: NDMC 10 µM
bRiRsmbLjbLcbLcbRcbLebLiLsbLcbLeLsbLiLsLsmbLiLsbRcbRgRsmbRobRcbLgRsbLc
bLiLsbLibRjbLhbLibLcbRcbRcRiRsRsRsLsRsmmmbLsbLsLsmbRsbRsLsbLjbRcbRsRsm
bLibLgLsbLcbRcRsmbRcReRsRoRsmmbRsbLhbLibLobLhRsbRibLoLsmbRcRsRsmmbLebR
cRsmbReRsRcRgRsmmbsbRsLsRsbLibLcbRcReReReb

>ZF Recording 2016-03-18; tW: 300s; Start: 121805; End: 122305;
Recording: 2-1; Individual: 23; Drug: NDMC 10 µM
bLiRsbLcLcLcLhRebLeLgLeLibLsLsmbLsLsmbsbRjbRoRgLcLsmbLibRgbLsLsLsmmbLg
LibLsLsLsmmbLeLcLhRobRsbLgLsbLgLoRsbLgbLgLsLgLiLsLsLgRsmbLoRsRiRgRsRcm
bRsRsRsmmbRsbLebLcRsbRcRobLebLiLcLiLebReRcbLcLeRsbLgLsLsLsmmbLsLsLsLsL
smmmmbLgLiLgbLsLsLsmmbLsbLcbLibRsRsRsmmbRsbLcLsLombLcLcLsmbLiLsbLibLiL
sbLsLsLsLgLcLoRsRsmmmbLsLcLsLsmmbLcLsLcLcmbLiLsbsbRsbRcRoRsmbLiLgLcLsm
bLiLsLsmbLobRjbLcbLsRsbLsLgLsLsLcLiLimbLhRgbRcLcbLhbLcLcRebRsbRsRsRemb
RsRiRsmbRiRebLcbLgLcLcbLebRebRobLjbRhbRcbRsLsRebLebLsbLebRcbRsLeLhLcbL
sbReRsmbRobRcRsmbLcbLsLsmbLeLcLsLeRsRsmmbLsRsbLibLgLsbLsLsmbLsbLsLibsb
sbLcLsLsLcLsmmmbReReRoLsbRsRsRsRsRsmmmmbRgRsmbLgLgLobRob

>ZF Recording 2016-03-18; tW: 300s; Start: 121805; End: 122305;
Recording: 2-1; Individual: 24; Drug: NDMC 10 µM
bRoLsbRoRsmbLobLoRsLsbLhRsbRsbRgbRjRsmbLjbLobLsLsmbLsbRgbLgLsbRjbLcRsb
LobRcbRcbRcbLcLoLsmbLiLsLsmbRjbLobLibLhbRoRsmbRebRcbRcbRebLibLobLobLgL
sLsLcmbRgbsbRsbsbRsbLsRsbsbRjbRobLiLsLsmbRebRobLgLcbRjbRcbRsbRibLgbLeb
LsRsbLsbLcbLibLoLobRiReRsRsLcRsmmbLsLsmbLobRoRebLsbLsRsLsbLsbLsbLgLsLg
LsLgbLebLebLhLcbLgbLgLeLsbLsLsLsmmbLsLsmbRcbRobRgbRobRebRebLsLsmbRsLsL
sLsmmbRsbLebLebLcLsmbLsLsLsLsLsLsmmmmmbLsLsLsLsLsmmmmbLsbLobRcbLoLgb

>ZF Recording 2016-03-18; tW: 300s; Start: 121805; End: 122305;
Recording: 2-1; Individual: 25; Drug: Control
bRiRsmbRcRobRobLiLsbLgbRobRcbRcbRjbLhbLebLibLgRsbLibLcRsbLibLjbRcRgbLh
LobLibLsbRjbRcRibLgbLcbRcbLcbReRsRgmbLcbLibLibLibLgbRgbRgbLgbLcbRcRobL
ibLebLcLsRsmbRhbRcbRiRsmbLsRcbRebLsbRoRsLcLiRembLcbLebLebRcbLsbRsRsmbL
sbLcbLebLjbsbLibLiLsbLcbRsRsmbRhbRiRebLhbLobRhbLcbLiRsRsmbRgbLiLsbLobR
iRsmbRcRsRembRhRsmbLcbLoLhLiLcbRgbLobLcbRsbLgbLcbLiRsRsmbLhbLeLgbReRsR
smmbRoLsbRoRsRsRsmmmbRiLgRoRcLcbLebLgbLcReRsmbRcbRhbRcbRibLibRhbLcbLhR
sbRcbRcbLhLeRsbRebLebRebRcRsRsmmbRcbRcbRibLsLsmbRiLsbRcRsRiRsmmbLcLiLg
LibRjRcbRcLobLcLsLgLiLoRsRsLsmmbLibLsbLsLsmbLiLsLiRsLsLoRgRsmbLcbLcbLs
bLcReRsmbRebRiLsbLhbLhbLcLsmbLcLsRoLsmbRcbRiLsbRcRsmbLsLgbLgbLeLiLsbLc
RebReRsmbRsRgbLcbLhbRhRsmbLcLgLsbLhLsLsLsLgmmbRhbRoRsmbRcbLibLgLgbLcbL
hLsLobRiLsbRcRsRimbReRsmbRoRcRsRsRsmmmbRcbRcRsmbRgbReRsmbLobLobRebLebL
hLiLcbLhLiLsRsbRsRcRoRibRcRoRcbRcRsmbRibLeLebLoRsbRiRgRiRcbLebLcbLobRi
bRcLsbRcbRiLsbsbRcRsRsLsmmbLebLcbLsbLcbLcbLiLsbRoRsmbRgbRebRcRgb

>ZF Recording 2016-03-18; tW: 300s; Start: 121805; End: 122305;
Recording: 2-1; Individual: 26; Drug: Control
bLoLsmbLjLsmbRsRcbLcbLcbLibRcbRoRsmbRoLsbRcbRobRebLobLobRgbLobLoRsbLob
LcbRobRgbLhRsbRobRoLsLsmbLoRsbRhbLcbLibRebLcbRebRhbLcbLcbRgbRobRsbRcbR
cbRjRsmbLsbRobLiLebLebReRgbRsbLoLgbLhbRobLjbLcbLibLcbLoRsbLebLgRsbRebR
ebRebLobLcbLobLebReRsmbLhRgbLebRsbLebRiRsmbRgLsbRsbLsRibRobRoRsmbRoLgL
sbLsLsmbRoLgLgbReRgbRhbRoRsmbLobRcbLibLoReRoRsmbRcbRgbLjbLebLebRibRobL
obLobRobLebLebLebRiLjbLibsbLgbRsLsbLjLgLobRoRobLobLoLsLoRhmbLoLsmbLcLo
RcRiRiLib

>ZF Recording 2016-03-18; tW: 300s; Start: 121805; End: 122305;
Recording: 2-1; Individual: 27; Drug: Control
bLcLgbLoRsRgRcbRsbLcbRcbRjRsmbLoLcbLcbLcbLcbLoLsmbLcbLhbLcbLcbLcbRebRh
RsmbRcLsbRibRcbRcbRebRcRsmbRsLsLsmbRobRibReRsmbLibLcbLcbLcbLebLcbLcRsR
smbLoRsbLoLhLsbLobLobRebLobLebLobLobLcbRibRcbRcbRebRcbRcbRebLsRsbRcRjb
LiRsbRebRobRjbRhbLebLebLobLcLsmbLjbRobLcLobLobLcLsLsLsRsmmmbRsbLcLsmbR
obRcbRhbRcbRiRsmbRcbRcRsRsmmbRcRsRsRsRsmmmmbRsLsbRoRsRsmmbRcbRoLsbLibR
hbRcbLjbRcbLhbLobLcbLcRsbLcbRjRsmbRhRsmbRibLobLcbLcRsbLcLsmbLcbReRgRsm
bRcLsLsmbRobRibRcLsbRiLsbRobsbLebRcLsbRoRsmbRhbRcbRgbLcbRcbRiLsbRobLib
LhRsbLibLhbLcLsmbLoRsbLcbLcbLcLeLsLsmbLiLebLibRobRcReRsRhmbRcRcRsmbRhR
sRembLhLcbLcLsLsLsmmmbLcbLiRsbRjbRcbRibRhRibLcbRibRcbRcbReRsmbRcbReRsm
bRcbRcbRcbLsbRcRsmbRcbRcRsmbRcRsmbRcbRiRsmbRhRsmbLibRobRobRobLcbLeLsbL
obLoLsLcLgLsLsmmbLgRsbLcbRcRsRoRsmmbRobRcLsbRibRcbLiRsLsbRcRsmbRhbRcbL
ebLebLobLcbLhRsbLcRsbRiRsRimbRobRhbReRsmbRhbRhRobRcRgRsmbRcRcRsRsmmbRc
RsmbRhRsmbRiRsmbRibRsbLjbLcLgLsLsmbLcbLcbLeLhbLoRsbLcLiRsbLoRsbReRebLc
bRcbLobRcbRcLgbRoRsmbLsbRcLsbLsLsmbRiRgRsmbRcbLibLhbRcRsmbRcRsRcRsmmbL
hbLoRsbLcRsbLibLsbLiLoRsbLhbLcLcbLobLhbRiRsmbRebRcbRcbRgbLiLsbRiRsmbRh
bLebRcbRcbRcbRgbLibRibRiRsmbRcRsmbRcRsmbLiRsb

>ZF Recording 2016-03-18; tW: 300s; Start: 121805; End: 122305;
Recording: 2-1; Individual: 28; Drug: Control
bRibRoRsRombLcLsLsmmbLobLcbLoRsbRobRhRebRsRsmbRsRsmbLsbRgRcLiLeLibLsRs
bRoRsRsRsRsmmmmbRobRcLsbRgbRsRsRsmmbLobLobRebRgbLgbLeLjbRsRsmbRobLobLh
LsLsmbLhbLobRsRsmbRcbLgbLsLsLsRcmmbLibReRsmbRgbRgbRoRebRgRsmbLoRsRsRsR
smmmbLiRsbRebRcbLcbRgRsmbRcbRhRsRsmmbLjbRgbRobLeRjRebLiLiLsbLibLcbLcLs
mbLcbLjbLsLsLcmbRebRibRebLgbRobLgbLcLsmbLobRgbLobRoRebRcbRiRsmbRebRobR
eRsRgmbLeRsbLcbLcLcRsbLsLsmbLhLsRsbLobLoRibRsbRhRsRsmmbLiLsLsLsmmbRcRi
bRoRobRcbRhRgLsbRcLgbLiLsLsLsRsmmbLhRsRsRiRsmmbLeLsbLoRsLoLsLhLcmbLibL
sRsbLhRsRgRebRobLcLsmbLcbRsRcRsmbRcbRoRiLsbLcRebRobLoLsLombRobLcLibLib
LobReRebRcbRobReRsmbRcRsRsRsmmmbRobLsLiLibLgLsbLcbLcbLcLoRjbLcRsbLsRsb
RebRebLsRsbLobRebLsbRgLsRsbLcLobLsLsLsmmbRcRsRcRimbLibRoReRsmbRcRgRsmb
RcRiRgRsReRsmmb

>ZF Recording 2016-03-18; tW: 300s; Start: 121805; End: 122305;
Recording: 2-1; Individual: 29; Drug: Control
bLobRhLibsbLsRsbRsbsbRsbRsbLhLebRgbRgbRoLebLsbLsLsLcmbLoLcRobRcLcbLobL
eLobLhbRcbLeLsbRcLebLcLeLcbLebLibLhbLjbRsbLcRebRebLibLoLsmbRcbRgRsmbLg
bLebRebRgRsmbLcbLgRebRebReRsmbRebLiLcbLgbLobLeLsbLcbLcbLoLsmbLsbLobLiL
cbLgbRcbRibLcbLsLebLcbsbLcbLobRgbRoLcbLobLcbLhLsbRebLobLobLobLoRcbLcbL
obLibRgbRcRjbLsLeLsbRcbRobRebLebLcbRibLhbLobLoLsLsmmbLsLsLsLsLsLsmmmmm
bLobRebRoLsbRcbLebRjbLebLcbRcbRcbRhbRjbRcRobLebLcbRcbLcbRobLsLgbLiLobL
ebLsReRgbRobLhLeb

>ZF Recording 2016-03-18; tW: 300s; Start: 121805; End: 122305;
Recording: 2-1; Individual: 30; Drug: Control
bsbRsbLgbLoLsmbRcbLcLsmbLiLhbRgbLobLobRgbRcbRcbLibLibLgbRsbRoRsmbRcbRh
LsbLsbLibLsLsmbLgLsbLsbLibRsbLcRsRsmbLibLhbLcbRsLsbLobLhbRhLsbRiLsbLib
LhbLiLsbLsLsmbLiRsbLgbLsbLgbLhbRgbRgLsbLibLgLsLsLsmmbLibLsLsmbLsbRcRib
RcLsbRhbLgbLhbRsLsbRobRiLsLsmbLcLsLcLsmmbRoLsbRcbLcbLsbRcbLoLcbLobLoLs
LsmmbRobRibRgbRcLsbRibLgbLibRebLcRsbLibRibLcLsmbLiLsbRsLsbRibLgbRobRcb
RgbLsbRgbRhRiLgbLjbLobLoRsbLsbRibRcbRcbRhbLcbLhbRibLibLsbRebRhbRhLsbRc
bLgbRcbRcbRgbLsbRsbRjbRcRcbRebsbReRebLsLsLombRcbLgbLibRsbRebLjbLcbRgbR
sbRgRebLgbLiLsLsmbRebLobLibRsbLibLobRiLsLsmbRobRobLhLcbLibLibRhRsmbRjR
ibRcRsmbLcLoLsmbLhbLsbRjbLjLsmbRsLcbRebRhbLsLgbLjbLgLsbsbLjLsLsmmbLgbL
ibLcbRhbRoLsRsbRcLsbRoRsmbRcbRsRiLsRsbRibLjbLcbRcRsmbRoRsmbLcbLhbLiLgL
sLsRsmbRgbRgLsbRhbLcbLoLsmbRsLsbLgbLobLcbRsLsLsLsmmbRsbsbLsRsLsRsbLsRc
RsmbRoLsbRobRcLsLsmbRsLsbRoLsLsmbRoRsmbRobRibRhbLsLsLgLsmbLobRhLsbRoRs
mbRobLsbLgbRibRibLebLoLsLsLcmmbLgLibLgbLsLsmbLsbLiLgLsbRsbLobLibRgbRsL
sbRgRgbLebRcbRcRsmbLcbLcRsbLsbRebLobLibLhbRgbLibLsbLiLsbLsbRobRhbRibLi
bLgLsbRibRcbLsLsmbLeLsbLcbRcbRcbRhLsbLsbRcbRhRcbRsLgbLcLsLgLsmbRsbRsbs
bRjRsmbRhbLoRsbLobRhbLhLsbLgLsbRobRcbLsbLibLebLsLsmbLsbLsbLobRgbRgbLcb
LhbLhLsLsmbRibLhbLgbLgbLgLsbLcbRiRsmbRibLsLsmbLiLsbLsbRebRcLsLsLsmmbRo
bRgbLsLsmbRibRobRobRoLsbLeLsbRgRsLsmbLgbLsLsLgLgmbRobRoLsbLiLiLgbLobLc
bLcbLibLgLsLhLsbLsLsmbRsbRcLsbRoLsbRibRibRsRiRobRhbLebLgbLsLsmbLibLgbR
sbLoLsLombRsbRhbLgbRoRsmbLibLiLsbLiLsbLsbRsbRoLsbLibLgLsbLoRsbRoRsmbLs
LsLsmmbRgbRcbRibLgLebRibRcbRobRobRoLsRsbLgbRobRcbRiRsmbLibLeLcLsmbLhLi
LcbRsLsbRgbLcbRjbLoLsLsmmbRibLsbRiRsmbLobLcRsbLobLcLsmbLsLsLsLsLsLsLsm
mmmmmbLcbLgbLcbRgbRsbLhbRsLsLoRsbRobLiLibRsbRcbRcbLsbRcbRhbLgbLiLgbLsb
LsbRsLsLeLebLsbLsbRob

>ZF Recording 2016-03-18; tW: 300s; Start: 121805; End: 122305;
Recording: 2-1; Individual: 31; Drug: NDMC 1 µM
bLsLibRgLiRsLiLeLsLsmbLibLiLgbLgLsLsLiLimbLiLsLeRsLsbLgbLebLoRsbLiLsLs
mbRobLsbRcLsbRoLsbRoRsmbRcbRcbRibRibRobRibRibLgbLiLhLgbLgLsLsmbLgLgbLi
LeLiLsbLibLibRsbRoLsLeLebLoRsbLcbLcLsmbLiLsLsmbRibLsLsmbLobLcbLcbLobLi
bLobLhbLhbRgbLcLsLembRcbRsRsRgLsRimbLebLcLsmbLcLsmbRiLsLiLgbLcbLgLsbRc
bRibRhbRcbRcbRhbLsLsLimbLeLeLeLsLibLiLiLeLsbLiRsRsmbRobLjbRcbRgLsbRhbL
ebLibRjbLeLeLeLeLebRoLsbLoLsmbLeLsLsmbLcLsmbRibLgbRcRsmbLcLsmbRcbLcbLc
bRsRiLsRsRiLgbRcbRcLsLsmbLcLsmbLiLsbLiLiLsbLcbLgLebRiLsLsLeReRsmmbLcbL
gLsbRsRcbRsRsmbLjbRoRsmbLoLcbRcbRhLsLgbRcLsRoLsLsmbRcbLsRiLsbRhRsmbLeL
oLebLgLsbReRsmbLcLsLsmmb

>ZF Recording 2016-03-18; tW: 300s; Start: 121805; End: 122305;
Recording: 2-1; Individual: 32; Drug: NDMC 1 µM
bLgbLoLeLgLebLiLibReLgbLsbLeRsbReReRcRibRsbLsLsRsmbRibRsRsLsmbRobLeRsb
RebLobLcLeLgLgLsLsRjRcmbRsLsLsRoLsmbRoRebRgbLsLgbLeLgLoReLobRobRsLsbLs
LsmbRcbRoRcbRcbRcbRebLsbLobLebLebLebLeRsbRcbRsbLsbLgbRsbRibLsbLgLibLoR
cbRcRsLsLombLeLcLebLsLsLsLsmmmbLsbLebLob

>ZF Recording 2016-03-18; tW: 300s; Start: 121805; End: 122305;
Recording: 2-1; Individual: 33; Drug: NDMC 1 µM
bLsbRobLcbLcbLhbLhbLibLiRgbLcbLcbRibRiLsbLgbRibRcLgLsbRibLoRsLibLhbLob
LebLcLsmbLoRsbRobRcbRhbRibRcbLgRsbLgbsbRgbRiRsmbRcbRibRhbRiRsmbRhbRcbL
cbLcRsbRjbLhbLibLjbLcbRcRsmbRobLgbRcLsbRiRsmbLobLcRsbLhLsLcRsbLiLsLhLs
bLcbRcbRobRcLcRsLibLobLgbRsRgbLibRcRsmbLobLobLoRiRsmbRcRsmbLoLibLoLhbL
obLcLcRsbRcRoRsRcmbRsRoLgbRoRsmbLcLcRsbRibRiRsmbRobLiLhLibRiRsRiRsRsRe
mmmbRobLoLoRsbLobLcbLiLebRcRiRsRembRobLibRjbLcLcRsbRsbRibRgRsmbRsbRgbR
ebRcRjbLcLgLebRobLcLgRsRebRcbRhRsmbRebLhbRebRgRoRsRembReRsmbRebLcLebLc
LcbLibsbLibLhbLiLibRibRibRebRobRiRsmbRobRcRsRcmbRgRibLjbLhbLiLcbLhLcbR
eLeLsLcLsLeLcLsLsLgLsmmmbLgLsbLsLsmbLsbRebLebLoLcLsmb

>ZF Recording 2016-03-18; tW: 300s; Start: 121805; End: 122305;
Recording: 2-1; Individual: 34; Drug: NDMC 1 µM
bRobRcLsLebLebRobRoLsbRobRibLoLsLombLobRobLcbLcLcbLobRcRhbRoRgbRcbRobR
cRsmbLcbRcbRcRebLcRsbRoRoLsbLcLcLsmbRibRcbRiRsmbLobRcbLcbLobLcbLcbLgLs
LiLiLgbLebLebLebLebLiLjLeLsLcbLsLgLsLgLsLsLsRsmmbRoRsmbRoRcbRcRsRsRsmm
mbRcbRibLcLgLobLsbRgbRcLeRsLsbLcbLgbLoLsLsmmbLebLgbLgLsbReLsbRoRsRsmmb
LobLsLsLsmmbLiRsbLoLebRcbRoLsbRoRobRoLsbLoLsLombLcbLoLsLsLsmmmbRobRgbR
oLsLsmbLcbRcRcbRibLibRobRiLsLgLsbRoRsRsmmbRibRibRoRobRcbRsRoRsmbLhLsbL
eLeLsbLcbRgbLsLsmbRsbLcLcRsbRcbRibRsLsbLibLsbRiRsmbRoLsbRcRsmbLcLsmbLc
bLcbRcbLcbLibLcbLoLoLsmbLoLsmbsbLhRsRsLsmbLiLsbLgLsbRsLsbRsbRebLcbLobL
cLsLimb

>ZF Recording 2016-03-18; tW: 300s; Start: 121805; End: 122305;
Recording: 2-1; Individual: 35; Drug: NDMC 1 µM
bRsbLibLobRcRsmbLcbLoLsmbLcbLcLiLsbRsRsRgRsReRsmmmbRobRobLcRsbLhbRcbLe
bLcbRobLobRcbRibLibLjLsmbLoLsmbRiRsmbRjbReRsLsmbRcbRgbLibLcbLcbLcbLibL
cLsmbRjbRcRsRsmmbLhbLibLcbLhbRgRgbLcbLobLobRcbLcbLhbLhbLibLcbRhRibLcbL
oRsRsmbRhbRcRsmbLgLsLgLebLsLsLiLsmbLcbLobLobLobRobLiRsbRcReRsRhRsRsRsm
mmmbRcRsmbLcbLsLcLsmbLobLobReRsReRiRgmbRobRoRsmbRcRsmbLsbLcbRcRsmbRebR
ibLgbLsbRebRhLsbRobLibLcbLobLcbLibLcbLcLsmbLcbLibLebLcbLobLoRsLsbRibLh
bRoRsmbRcbRibRgbRoLsbLhbRcReRiRsmbRgRebRgRgbRsRsmbRsRsmbRobRcRsRcmbLcb
LcbRcRsmbRcbLcLcbLhbRsbLoLsRsmbRsRsmbRsbLibLiLebLibLobLcbRibRcRhRgRgbL
cbLcbRsbRcbLcRsbRcbLobLobRjbRcbRcRsmbLjLsmbLcbLsLsmbLobLcbLoRgRsReRimb
LoRsRsmbRjbLobLoLsmbLcLcbRcbLobLobLcLcbRibLcbLcbLsbRsRgRoRsRsLgmmbRhbL
gbRiRibRsbRgLsbRobReRibRobLgbLcLsmbRebLcRsRsmbRhbLobLcRsLsbLcLebLibLgb
LobLcbLibRhbRibRhRhRebLjbRoRsmbRcbRcbLjbLgbRjbLcRsbLobRsbLcbLhbRcbRsRe
bRebRebReRsRgRgRimbLgLobReRsmbRoRsRjmbLobLcbRcRebLoLsmbLobRsbRcRebLcLs
mbLcbRebRebRebReRsRsmmbsbLsbLsbRsRsmbRibRsReLeReRsmbRhRiLjbRcRcbRsRsmb

>ZF Recording 2016-03-18; tW: 300s; Start: 121805; End: 122305;
Recording: 2-1; Individual: 36; Drug: NDMC 1 µM
bLoRiRsmbRgbRcbLcRsbLobLobLobRebLcbLcbRhLsbLibRoLsRsRgbLcbLibLebLebLcR
ebLebLoRsbRibLjbRcbRoLsbLcbLhLsbsbsbLebRobRebRobRhbRebLhbLobRsbLcbRjRg
bLhbLjbLobLobRibLjbLcbRobRcLsbRhbRibRgbLcRsbRibLjbLcRsRsmbLobLobLcbRcb
LjbLobLcLsmbLoRsRsmbLcbLoRgbLibRibLobRobRobRebLgLeLsRsbRsRsLsmbRebLcbL
sbRgbsbRcbRobsbRsbRcLsbRcbRebRcbRebLcbLobLcbRjbLoRsbLobLobLcbRcbLjLsmb
LobRoRebRcbLjbRoLsbRebLgbLoRsbRcbRebLibLsbRebLiLsbLcRhRgbRebLjbRcbRhRo
bRcbLebLibLcbRobLebLibRgbRibLcRsbsbLcbLebLebLcbLcRsbRoLsbRcbLeLiLsLiLi
LsLgbRibRcbLibRcLsbLcLsmbLobLoRsbLobRsRsLsmbRcLsbRoLsbRcLsbLcbLiLsbLhb
LsbLiRsbRibLibLgLebLeLsbLibRcbLcbRobRcbRiRsmbLhbLhbLoLsLsmmbLcLsLsLcLc
mmbRcbRobRobRoLsLoRsbLcRsRsmbRhbRiLsbLibLhbLcbRjb

>ZF Recording 2016-03-18; tW: 300s; Start: 121805; End: 122305;
Recording: 2-1; Individual: 37; Drug: NDMC 3 µM
bLoRibRobRobRobRcRsRsRsRsRiLemmmmbLsbLobLgLgLsLsLsLsLgLsRsmmmbRoLsRibR
ebRcbLcLsLsmmbLeLsLgLsbLoLhbLoReRsmbLobLcbRobRoLcbLoLobRcRiLhbLcLsmbLi
bLobRgLobLcbLhLsbLgbRebRsRebRcRcbLoLsLjmbReRebRcRsRcmbsbRgRsRcmbRjbRib
RcRsRjmbLebLgbRobRcbRebLgLgLsLebLgbRebLjbLsLsLsLsLimmmbLsLsLsmmbLsLsLs
LsLsLsmmmmmbLsbLoLsRsLeLsmbLcLsmbLcLgRsRcbRhbRoLsLsmbLsLsLgLsLsLsmmmbL
oRobRebLobLhbRsbLeLoRsRsmbRgbRgbLiLsLsLsLsLsLsLsLsLsmmmmmmmmb

>ZF Recording 2016-03-18; tW: 300s; Start: 121805; End: 122305;
Recording: 2-1; Individual: 38; Drug: NDMC 3 µM
bLoLobReLoLhLibLcLsmbLsLsLsLsmmmbRcRsmbRoRgbRsbsbRcbLibLibRobLsLeRobRs
bRgbRibLjbLoLiLsbLobLobRjbRhbRoLcLsLiLeLsmbLebRgLebRcLsbLsbLcbLhRgbRoR
smbLiLsbLcbLobLcLgLsbRiLsRcbRgbsbRgbRcbRsbRibRjbRhRsRembRcbRcbRhbRsbRi
bRibRiRsmbRsbRiRsmbRcRiRcRsmbRsRsmbRgbRsbRgRsmbRcRsmbRsbRsbRgbRiRsmbRg
bLsbRcbRsbReRsmbRibRibRsbRibRhRhbLiLoLsmbRsbLcbLcbLibLgLcRsbRgLoRsbLsb
RsbRiRsmbLcLhRiRoRebRsbRoRsLsmbLhRcRsRembRsRsRsRsRsRsLsmmmmmbRebLeRsRg
bLsLcLobRjbReLsbRgbReRgRsLjmbLcLoLoLsmbLsLsRgmbRsbRsbsbsbRsbRsLsRsbRsR
sLsRsmbReb

>ZF Recording 2016-03-18; tW: 300s; Start: 121805; End: 122305;
Recording: 2-1; Individual: 39; Drug: NDMC 3 µM
bLcbLeLsbLibLiLeRgRsmbRoLsLsmbLsbLsbRibRibLgbRgbRiLsbRibRiLsbLcLoRsbLo
bLobLobLiLibLhbRiRsmbRsRhRsRsmmbRobRcLsRcbRgRobRiLsbRgbRiLsLsmbRsbRcLs
bRibRcbLcLsRsmbLibLsLiLsbLsbRobRcLsbLcbLobLcLcbRiRsmbRobRibRhbRibRibRg
bRibRgLsbRsbLiLsbLibLcbLhbRgLsbRibRcbRhbRcLsRcRiRiRhbLeLcLeLcLoLsLsLsL
sLsLsLsLsmmmmmmmmbLobLobLcLsLsLsmmmbsbsbRjbRcbRhbLibLcLsLcRsmbLcLsmbLc
bRcRoLsLsmbRcbRiRsmbRhbRgbLgLsbRgbRhRsmbRibLjLsmbLoLsLombRgbRiRsmbLsRi
RibLcLsLsmmbLiLsbRhbRsbRoLsbLibRcbRcbLeLhLcLsmbLsLsmbLoLsLsmmbLobLcbLo
bLcbRibRhRiRsmbRgLibRhRcbRibRibLiLsLsLsmmbLiLsbLsbLsRoLsRcbsbRiLsbRibR
ibRsbRgbRcLsLsmbLjbRcbRobRibRgbRoLsLsmbsbRiRgLsbLiLcLobRjLsbsbRgRsmbRh
LsbRibRiLsbRcRgbRiRgbLiLsbLibLiLsbLsbLibLibLsbLiLoRgbRiLsbRibLoLsLsmmb
LhbLsLsLiLsmbLsLcLoLsLcLhLsmbLsLsRsmbLoLeLgLsLsmbLebLiRibRobLcReLgb

>ZF Recording 2016-03-18; tW: 300s; Start: 121805; End: 122305;
Recording: 2-1; Individual: 40; Drug: NDMC 3 µM
bsbRhbLhbLcbRibRibRobLibsbRgbLgLobLobRcLsbRhRsmbRibRhbRibRibLsbRsLoRsR
smbLcLsLombRhbRcbRibRgbRibRcRcbLibLhbLibRiRsmbRgbRgRsmbRgbRgbRsbRibRcR
smbRhbRgbLcbRjRsRombRcbRcbLobRcbRobRgbRibRiRsmbLsbRibLsbRobLoLeLgLibLs
LsmbRoRsLsRiRsRsmmmbLcLsmbRebRebRcbRebLebRebRsRsmbLsbsbRcLoRsbLiLsLibL
ebLeLsbLeRcbRcRcbRebRgRcbRebLoRsbRsRiRsmbLcbRcbRebRebLoLsmbRcbRgbLebLs
LgLiLobLjLsmbLcRiLsbLhbLjbLiLgLobRcRsmbRcbRiRsmbRcRcRsmbRsbRsRcRebRsRs
mbRcbRcLcLsmb

>ZF Recording 2016-03-18; tW: 300s; Start: 121805; End: 122305;
Recording: 2-1; Individual: 41; Drug: NDMC 3 µM
bRcbLebLebLobRsRgbRiRsRsRgRsRsRsmmmmmbLobRsRebLoRsReLobLhbLoLsmbRobRoL
eRiRgReRsRsmmbRsbRobLeRsbLsLgLsbRoRobRcbRcReb

>ZF Recording 2016-03-18; tW: 300s; Start: 121805; End: 122305;
Recording: 2-1; Individual: 42; Drug: NDMC 3 µM
bRcbLcRsbLgbLgLsbRgbLoRsRsLsLsLcLsLsLsmmmmmbLobRgRgRsmbRiReRiLebLebLcb
LebLsbLsbLsLsmbLsLsmbRebRibRebLgbLebLebLhLgLsbsbLsLgLibLgbRcbRcbsbRebR
ibLeRcbLsbLebLebLebLgbLebLiLsLsLsLsmmmbLgLsbRebLoLcbLobLcbLjbLcbRebReb
LsbLobLcbRcRsRembRjbRhbRjbLobRcRibRsRgbRcbRsLsbRjRsmbRgRsmbRiRiRsmbRsb
LobLibLebRcRcRebLobsbLcbLebRebRcRgbRcLsLsLcmbLobLcbRebRhRsRsRiRsmmmbRg
RhbRsbRcRsReLsLombLsbLibLoLsLombLobLeLsLiLsbLsbRhbRibRibRiRsmbRiRsRsRe
mmbRsbRiRsRiRsmmbRsRsRsRsmmmbRjbRcbReLsRsLsbRjbLebLebRsLsLebLsLsLsmmbL
oLsRiRembLgLsLsLsmmbRoLsb

>ZF Recording 2016-03-18; tW: 300s; Start: 121805; End: 122305;
Recording: 2-1; Individual: 43; Drug: NDMC 10 µM
bRgRsRsReRcRsReLsLsRsRgRsRhLcLsRemmmmmmbRsbsbLgLsbRcbLsRsbLcLcLibLsLsL
smmbLobRsRsRsRsRoReRsRcRgRemmmmbRiRebRsbsbsbLcLsmbLcLcLiLibLoLsmbLcRsR
hReReRebLoRcbRoLjbLoLsmbRgRsRgRiRgLsmbRgbLjRhRhRcRebRhLobLiLsbRsLsbLiL
sLcReRoLoLcLhbLsbLsbRcRoLsRobRgRsRsRgRgmmbRebsbRsRsRsmmbRsbsbLsLeLeLsL
sRsmbLoRsLoLsLoLiRsRsmmbLcLsLiLombLsLsmbLsRsbRsbLsRsb

>ZF Recording 2016-03-18; tW: 300s; Start: 121805; End: 122305;
Recording: 2-1; Individual: 44; Drug: NDMC 10 µM
bReLsbRsRsmbLoLsLsmmbLcLhLsbLhbRoLsLeLebLeLcLgbLgbLsLsmbLoLsmbRibLcbLo
bLeLsbLiLebRsbRoRsmbLebRebLcbLoLsmbLcLgbLsLeLsbLobRhbRcLgbLcLcRsbRebRc
LsbLsLsmbLcLcLsmbLgLsLcLibLgbLcbLebLhbLcLsmbLiLiLcbRobRhbRibRobsbLsbLs
LsLsLsLsmmmmbLcLsLoLoLoLombLsbLoLhLsbLoLgbLsLsLsmmbLiLiLsLebLsLsmbLcLh
LiLsLsRsLsmbRoRsLsRiRjmbLsRsRsmbRsbRiRsmbRebRhRebLsRsbLsRsbLeLebLoLobL
oLibLgLsLsLsmmbRcbRobRsbRebRebRibRsbRiLgLgbRebLcLsLsLsLsLsLsLjmmmmmmbL
ebLcbLibRjRsmbRsRsRsmmbRsRsRembRobRsbRgLgbLgLibRebLeLcRsbLsLsmbLgLiLgL
sLsRembLoLsLsRsmmb

>ZF Recording 2016-03-18; tW: 300s; Start: 121805; End: 122305;
Recording: 2-1; Individual: 45; Drug: NDMC 10 µM
bRoRcRebReRsmbsbLobLoRgbRgReRebLsbRsbsbRsbsbLsLsLsmmbRsbRsbLsbRebRsRib
RoRsRsmmbRsbLcbRibLcLsLsLsmmmbLcbRcbRoRebLoLsLcmbLsbLcbLcLsLsmmbLibLcb
RcRebRcbLcbLhLcbRgRgRsRcmbLhbRcbRgRsmbLjbLoLobLcbRebRgLsbRiRiRsmbRjbRo
LiLcbRhRsRsmmbRsbLhbLcbLhbLhbLcLsLgLiLiLgmbLjLiLhLsLgLiLebLcbRibReRsmb
RcRsRsRsRiRcmmmbLcLsmbRsRsmbRoRcRibRcRsRsmmbLoLiRcbRgbRsbRoLcRsRobRobR
sRgbLcLsLiLcmbRhbRgbRibRsRsRsmmbRiRgRsRhRsRcReRsmmmbRebRsRsmbRsbLsbLoL
oRsbRsLsbLhbLoLcRsbLoLsLiLgLsLsLsmmmbsbLibLcLsmbLibLgbLibLoRsRsLsmbLsb
LiLibRcbReRiRiRhbRoRobRobRcRsmbRhRsmbRiRsmbRgRiRsRsmmbLiRsbLiLsbLoRsbL
sbLcbLhLgLsLsmbLhb

>ZF Recording 2016-03-18; tW: 300s; Start: 121805; End: 122305;
Recording: 2-1; Individual: 46; Drug: NDMC 10 µM
bRcRsRimbLcbLobLsbsbLcLsLimbLsLsLsmmbLsbLgbLsbLgbLibLsbLibLoLsmbLcLcbL
obLcLsmbRsbLcLcLsmbRgbRoRsRsRsmmmbRebRobRobRcRsmbRsRsRsRsmmmbRibLsbRcb
RcbRhbRcbRcRsmbsbLobLibRgbLgbRobLibRibRgbLsbRgbRgbRcbLebLebLcbLobLoRsR
smbLgbLsbLibLhbLjbLebLgbLcbRibRobRcRgRsmbRoLsbRcbRibLibLcLsLsmmbLcbLiL
sbLsbRibRiRsmbLobLiLsbLgbLgLgbLgbRsbRibRcbLobLoRsbRsbLsLsLsmmbLobRobRj
bReRsmbRcbRjRiRhbRsbRsbLsLsmbLoRsbLsLsmbLsbLsbRsRjbRebLsRgbRgbRcRsmbRc
RcLgbLsReRsmbRiLebLgbRoRsRoLembRsbLsbRsRsmbLjbLeLsbLsLgbLsbRsLibReRsmb
RhbRcRcbRoRsRcRgmbRoRsmbRcRcRsRsmmbRibRhRsmbRebRhbRiRibRgbRgbRiRebLcLs
mbLebLcLsmbLsRsbLcLoLsmbLsbRcRjRgLebLobLsLgbLsLgbRcLsbLgLsbsbLsbLsbRsb
RsbLebLoRsRobRsRsRsRsRsmmmmb

>ZF Recording 2016-03-18; tW: 300s; Start: 121805; End: 122305;
Recording: 2-1; Individual: 47; Drug: NDMC 10 µM
bRobRobLsbLibRcbRoRobRsRsRgmbRsRsRsRsmmmbRoRoRoRiRsmbLsbRcbLobLsRiRcbR
sRsRimbRoLgLsbLoRsbRebRoReLhbLsRsbRibRsbRgbRgReRcbRgRsmbRobRoRsmbRhbRc
RoRgReRsmbRibReRsLemb

>ZF Recording 2016-03-18; tW: 300s; Start: 121805; End: 122305;
Recording: 2-1; Individual: 48; Drug: NDMC 10 µM
bRibRiRsmbRcRsmbLobLcbLhbLcLsmbRjbLobLobLcbRsRsmbsbsbLibLhbLibRobRobRo
bLoRsRsmbReRibLibLgLsbLsLsRsmbLsLsLsLsmmmbLsLcbRhLsbRobLsLsmbLgbRobRcb
RsbLcbLsbRgbLcbLibRibRoRsmbRoRebLsbRibLcbLoLsmbRobLobRcbRibRobRsRobsbL
sbRsRsmbRoRsmbLsLcbRsbLgbLebRcRsmbRobLoLoLsLsmmbLobLjLsmbRiRcLsbLeLsbL
iLsbLibRoLsbRcbRjbLsbLibRoRibRgbRiLsbLcLiLsbLiRsLsRsLsbLsbLobRiRoLgLoR
sbRebLgLsLjbRebReRgbRoRoRoLsLibRebReLeLeLebLiLsb

>ZF Recording 2016-03-18; tW: 300s; Start: 122307; End: 122807;
Recording: 3-1; Individual: 1; Drug: Control
bRcRsmbRebRiLgLsbRobLcbLiLgLsbLgLibLhbLibLibRiRsmbRibRsRgReRsmbRebLsbR
sLiLibLsLsLgmbLiLgbLiRsbLsRcbRebRibRibRcLsbRgbRebLeLsLsmbLiLsbLgbLsLgR
sbLgbLhLhbLgbLgLsRsbLgLgLgbLgbRgbRcLsLsRsmbRsRsmbRsRsmbRobLgLsLsmbRsbL
gbLsLgLsbLgbLiLsbLsbLibLsLsLgLsmbLsLgLgbLsLiLsbLibLoRsbLebLgLsbLsLsLiL
smbLsLsLsmmbLsbLcRsb

>ZF Recording 2016-03-18; tW: 300s; Start: 122307; End: 122807;
Recording: 3-1; Individual: 2; Drug: Control
bLebRsbRebRebRsRsRembReRsmbRsRsLsmbLsRiRsRsmmbLeLsLcbLeLsLcLcLcLsmbRjR
gRsRembRcbRebRsRebRgRsmbRsbLgbLsLsmbRsbRebLebLsbRebRebRhbRebRgbRgbRsRs
mbRebLeLebLgbRsbLsbRsLsbRebLsbLibLobLsbLebLebRgRebRsbRsRgbRsRsmb

>ZF Recording 2016-03-18; tW: 300s; Start: 122307; End: 122807;
Recording: 3-1; Individual: 3; Drug: Control
bRobRsRcbLoLsLimbRgbLsLgbRsbRsbsbReRsmbRiRsRsRsmmmbRsRsRsRsmmmbRsRsmbR
sRsRsRsmmmbRsbRsRsRsRsRsmmmmbLsRsRsmbRsRsRsRgReLsLsmmmbRibRsbRobLcLsmb
RcRsRsRsRgReRommmbRsRsLsmbRcLgbLsLcRsbRsbRsRsmbRsRgRsmbRsbRsRsLembLibR
sRsmbsbLoLhRcbRiRsReLsLeLsmbLebLsLsmbLsbRsRsmbLcLobRcbReLebRsRsRsRgmmb
RcLobRoRcbRsbRsRsRsmmbRsRsmbRoLcbLsb

>ZF Recording 2016-03-18; tW: 300s; Start: 122307; End: 122807;
Recording: 3-1; Individual: 4; Drug: Control
bLiLgLcLebRsRcbLsLsmbRsRsmbLsLsmbRsRsmbLeLcLsmbLgRsLsbLsLibRsLsbRiLsbL
iRibLeLcbLsbLiLsLsRoLsRcmbRsbRiRsRsmmbRcReLsbLcLsReRsmmbRiRsLsmbReRsRs
mmbLebRgbLobLgbLsLsLsRsRsmmmbRgRgRsRsRsLeLgLsmmmbLsbRsLsLsLeLsmbRhRcLs
LebLiLsbRebRcbRsRsmbRsRsRgmbRsRsRhmbRsbsbRsRsRombLgLsLsLsLsmmmbLgb

>ZF Recording 2016-03-18; tW: 300s; Start: 122307; End: 122807;
Recording: 3-1; Individual: 5; Drug: Control
bLebRiLiRsbLsRsbRhbLgLsbLsbLgbLebLebLsbRcbRcbRebRsRsmbRobRgRcbRobLoLgb
RsLsRhLsRebLsLsLsRsRsmmmbRoRoLsbRobRcRobRebRebReRsmbLoLebRebRibLgLsLsL
embLcbLhRsbRsbRcRsLhmbLibLibLsLgbLsLsLsmmbsbLjbLcbRebRebRsbRcbLebLobRe
bRebLcbRsLebRebRebRsRsRcmbRgbsbLsbRjbLcbRebRebLebRsbRjbLebLibReLsbReRs
mbRsbReLsReReRsRsRcmmbLibLgRebRebLeLhbLgLgbRsRcRsmb

>ZF Recording 2016-03-18; tW: 300s; Start: 122307; End: 122807;
Recording: 3-1; Individual: 6; Drug: Control
bRcLeRebLeLgLgLsLsLsLsLsLsLsLimmmmmmbLgbLsRsbLsLsmbLsLsLsLsLsLsLgLsLsL
sLsLsLsmmmmmmmmmmbLcbRgRsmbsbLeLibLebLeLebLgLsLgLsLgLsLiLebLsLgLsRsLsb
LobLobLoLcbRcbRcbReRsmbRebReRsRembRsbRibLobRebReRsmbRsRsRsRsRsRsRemmmm
mbLibRcbRcRsmbRcRsReRsRemmbRgRsRembRibLoLsLsmmbLeLsbLgLcbLcbLcbLebLeLo
LsReReRembReb

>ZF Recording 2016-03-18; tW: 300s; Start: 122307; End: 122807;
Recording: 3-1; Individual: 7; Drug: NDMC 1 µM
bLsbRibRsbLsRiRsmbRibRhRsmbRgbLsRsbRhbRobRcbRiRsmbLcbLebLibRjRgbLcLsmb
LcbLhLsbLiLsbRsbsbRsRsmbRgRsmbRsRsRsRsRsmmmmbLjbLobsbLibLsRsbLgbLgLsbR
sRsmbLoLsmbLgbLobRhRebRcbLsbLibLgLsbLiLsbLsRsbLsRsbLsbRsbLoRsRsmbsbRgb
LjbRibRcbRebRobRhbRhRsRhmbLhbRgbRgRsmbRsbLsbRcRsRcLsmbRsbRgbRgRsmbRgRs
mbRsbRebRgbRgbRsbLsbLsLsmbLgbLcbRsbRibRcRobRcRobLibLjLsmbRgbRgbRobRibL
iLsbLgbRgbLibLgLsbRsbRibRgbRibRibRcbLhbLeLsbLoRsbLcbLcbLcbLebRebRcbRcb
RsbsbRsLsbLsbRsbRoLsbLsbRsbRibRobLsbRibRiRsmbRsbRgbLgbRcbRcRobRoRsmbRe
bRgbRsbLsRsbRsbRsbRobLsbLgbLibRsbLibLobLcbLcbRgbLsbRsbLsLoRsRsmbLibLiL
gLsbLiLgbLsLsmbLiLgbLibLsLsLgLsmbRgRsmbRsbLoLsmbLobRcbLobRcbRcRsmbRsbL
ibLsbRoLsRsbLgbLsRsbRsbLcbLgbRsbLgRsbLgLsLibRibLcLobLoRsbLcbLeLsbRsbRs
bRsbRgbRsbRsbRobLibRsbLibRsbRobLgRobRcbRibRcRcbRcbRiLsbRgRsmbRgbLibLsR
oLsbLoLcbLcbLcbLiLsbRibRjbRsbRgbRjbRgbRsbLgbRsbRsRsmbRgbRjRsRsmmbLibRh
bLcLobLcRsRsRsRsmmmbRobLoRsRsRsmmbLobsbRsbLcRsbRobRoLsbLsRsbRcbRibLgbR
ebReRgRobLsbRsRsmbRgRsmbRgRgRibRsbLhLsLsmbLsLgLsLsLsLsLgmmmbLhLsLgLsLi
bRibRcbRibLoRsRsmbRhRsLeRsmbLibRgbRibLcbLobLcbLebLsbRsbRsbRsbRsbRhbLsb
RsLsRsbLsbRibRibRiRsmbLebLibLgLgbLsbRebLcLsmbLcLsmbLoRsbRoRsmbLiLsLgbL
iLsLsmbLsLsLsLsLsmmmmbRhRcbRcRsReRsmmbRsbRiRsmbRsbsbRsbRjRgRsRsRsmmmbL
oLsmbLsRsbLiLsbRsbReLsRsbRobRobRobsbLibsbsbLsbRoRsmbLhLsLcLsmbLjbLibRs
RsmbRgbLcbLoLsmbLoLsmbLeLsbLhbLcbLebRjbReb

>ZF Recording 2016-03-18; tW: 300s; Start: 122307; End: 122807;
Recording: 3-1; Individual: 8; Drug: NDMC 1 µM
bLibRibRobRhbRibRsbRibRcLsbRcbRcbLsRsbRibLcbLobRsbLoRsbRobRcbRobRcRcbL
gbLobRhRsmbRebRobRebRobLibRobLiRsLsbRgbLibLhbLobLhbLobLhbLibLsbRgbLjbL
oRsbLobReLsbRobLibRobRcbLibRobLjbRoLsbLjbRobRebLhbLcRsbLobLobRibRcbRcb
LibRebLsbLibLhbLjbLsbLcbRcbLobLobLhbRjbLibLcbRcbRebsbRcbRjRgbRsbRgbLcb
RsRebRebRebRebRjRgbLobLoRsbLobLobLcbRcbRebRoLsbLsbLgbLobLoRsbLhbLjbLob
RcRsmbRebRobLsRcbLibLiLsLibLsbRcbRhRsmbRebRgRebLiLsbRebRobRobLhbLcbLcR
sLsbLiRsLobLobLeLgbRjbLoRsRebRsRsRsLsmmbLoLsReRsmmbLgbRsRsmb

>ZF Recording 2016-03-18; tW: 300s; Start: 122307; End: 122807;
Recording: 3-1; Individual: 9; Drug: NDMC 1 µM
bLjLsLcLsmmbLsLgLgbRcLgbLeRsbRsLsRsRsRsRsRiRsmmmmbLsRsRsRsRgmmbLoReLjb
LsLsmbLebRsbLiLibRcRsmbRebRobRobLjbLhLcbRobRebRoLcbLgLcLsmbLgbLcRibRob
LsbRjbLibLcbLsbLsLebLcbRebRebRcbRebRebRebLibReReRsRsRsReRsmmmmbRsRsRsm
mbRsRsRgRsRemmbRsRsRsRemmbLebLoLoLcbRsbRcbRsRebLebRcLebLiRcLcbRebRebRe
bReRsmbRsRgbRobsbRsRsRsRsRgmmmbRsRcbRcbLcLsLgmbRcbLcbLobReRsRsmmbRiRsR
oLsLsRsmmbLsLsLgLiLsmbLsLsLgLsmbLsLsLsLommb

>ZF Recording 2016-03-18; tW: 300s; Start: 122307; End: 122807;
Recording: 3-1; Individual: 10; Drug: NDMC 1 µM
bRebLeLobRjbRsbRgRebLebRebLeLsbLgLgLiLcbRiRsRiRsmmbRsRgRsRoLsLjmbRsbRs
RsRimbRcbLeLsRsbLhbLgbLcbLebLgLebLsLebLebLeLsbLebLebLebLgbLhLsbLibRhbR
ibLjbLcbLiLsbLebRsbRebRgbRsRsRgRsRsRsRsRgRgRsmmmmmmbRebRjbRsRsRgmbRsRg
RibLhbLebLeLsbLebLgbRgbRcbRgbRsReLsbLibRsbLeRsbLebLsLsLsLcmmbLgRgbLsRe
bRsbRsLsLsLembLgLebRsbLebRgLjbRsbRebRcLsbLgbRcRsReRsmmbRebRsRsRsReLsmm
b

>ZF Recording 2016-03-18; tW: 300s; Start: 122307; End: 122807;
Recording: 3-1; Individual: 11; Drug: NDMC 1 µM
bReReReReRiRiRsRhRgRsReRsRsRgmmmmbRsRsReRgRsRimmbRgRsRgRcmbRjbRoRcLsbR
eLsbLsbRsbRsbsbLeRcbRgbLsLsLgLiLombRsRibRoRoRsmbRiRsRsRoRsmmmbRebRsRsR
smmbRjRcLoRcbRgRsReLoLombRcRcbRiRcLcLgRcRsmbLiLeLsbLebLiLsLsLiLsRsLsmb
LsLsRsRsmmbRebReRcRoLcLsLsmmbLsbLsLcbRcRcbRsbRibReRcbLoRsbRsbRobRcRiRs
mbRiLsLoLsmbLsLsLiRsRcRsRsmmmbLjbLoLhLsRebRcbRiRcRsRombLeRsRjbLoLsRsmb
ReReRobsbRcRcRcbRcbRgRsmbRcbRobRhbRibLcbLcRsbLcbRsRsmbReLsRsbReRsRcmbR
ibRibLebLhbRebRcRcRsLsmbRcLcLebLiRsbRebLoLoLoLebRgRsmbRjRcRcLsbRoRiLsR
hbRibRiRsmbReRsRcmbRiRsRcRsLsmmbRcbLcLebRsbLcRsLobLhbLcRsbRsRibRcLcRoR
eRcbReRsRiLsRsmbRcRsLsmbRebLibRibLgbLcRebRoLobLibRebLobRjRgRsmbRebRebR
ebRjbRhLcbLiLobLhbLgbLhbLgbLcLcbLoRebRjbLeRsLcLsmbLsLsLsLsLsLsLsLcLcRe
RsmmmmmmmbRsRsRsRsRsRsmmmmmbLiLobLcbLhReReRsmbRsRsRsRsmmmbRhRcbRcRcLeb
Lsb

>ZF Recording 2016-03-18; tW: 300s; Start: 122307; End: 122807;
Recording: 3-1; Individual: 12; Drug: NDMC 1 µM
bLcLcbRcLiRcReLsLebLebLeLgLeLsLsmbLsLeRsLcbLhbLeRsbLgLsLibLibLsbLsbLeb
LsLsmbLsLgbLsLgLsbLsLsmbLsbLsLgbLgLcLsLsLimmbLsbRgbRsRjbRibRobRcbRcbRc
bLsbLoRsbLsRsbRebRobLgbLgRsLsbLcbLgLsLgLgbLebLeLiLsLcbLsbLsRsLsbLsLsmb
LsLsLhLgRembRoLsRsbsbsbLsbRsbLsbRsbsbRsbLsRsbLsRsbRsbLsbRsbLsbRsLsRsbR
sbLsLsLeRsRcRgReLimbRsbLsbLebReRsRsmmbRebReRsRombLsbLsRsbLsLsmbLibLgbL
sbLsbLeReLebLeLsbLgLgLsbsbLcLsmbLsLgbLiLsbLebLgbLsbLsLgbLgLebLiLsLebLc
LsLembLsLsLsLemmbRsRsRgmbRobLsbLsbsbLsbLebRsLsLsmbLsbLhLsbLsLcRsRgbReb
RgRsmbRoRebRgbRsbRcbRsbRsRsRsmmbRoLsbReRsmbRgbRsLsRsbRobRibLsbLgLsbLgb
LsLsmbLoLsLsmmbRsbReRcRobRgRsmbRsbRhRcRcbLsbRsRsLembsbLsbLgbLebRcRsLsm
bRsbRsbLeLsbLjbLobLcbLcbRsbRobLsbLsLgbRobRebRebRgRsRsRgRsmmmbRsRsLsmbL
jb

>ZF Recording 2016-03-18; tW: 300s; Start: 122307; End: 122807;
Recording: 3-1; Individual: 13; Drug: NDMC 3 µM
bReRsRcRsRhmmbRsbRcRhbRibRiRsmbsbRcbRcbRibRiLsLsmbRgbRebLcbLobLcbRcRoR
smbLobLjbRoRiRsmbRjRiReRiRsRsmmbRoRsLgLsmbReLeLsRoRobRoRgbRcbRoRhRiRsR
cmbLsRobRobLsLiLsLsmb

>ZF Recording 2016-03-18; tW: 300s; Start: 122307; End: 122807;
Recording: 3-1; Individual: 14; Drug: NDMC 3 µM
bLsLsmbLiLgbLcbLsbLcLsLcmbLsbLobLsLsmbLcLsmbLgLsbLiLobLiLsbRgRsmbRcbRc
RibRoLsbRsbLsRobRibRibRiRibRibRibReLsRgbRcbRhbRsbRsbRcbRhLsbRsbRiRsmbL
sRibRhRcbRsbRobRsRsmbLeLsbLsbLsLoLsmbLsbLcRsRoRsRhLsmbLcbLibLgbLgLobRe
RhRsmbLsLoLsmbLoLsmbLcLsLiLcmbRebRhbRhbRiRsmbRiRobRsRoLgLsbLsbLcbLcLob
ReLsLsmbRjbRobRsRsRsLsmmbRcRsRcLsmbLcbLsLsmbLiLiLsbLsbLoLsmbLsRsbLcLib
RsRsmbLhLcLsmbLcLsLsLoRsRsmmmbLhLsLgbLsLsRjmbLhLiLsbLgbLsbLebRcbRoLsbR
cRsmbRiRsLsmbRiRgRsmbRibRibRhRsmbRhRebRobLcLeLeLebLsbLcRsbRcbRcbRjbRiL
ibLhbRobRsRsmbRiRsRgmbRobRobRebRsLsLsmbRiRsLcmbLcbRsLsbLsLsmbLeLiLsbLs
bLsbLeLgLcLsmbLsbRsLsbLcLhbLsLsmbLhbLcLsmbLibLibLcLibRsbRobRsRsRembRib
RiReRsmbRoLsbLgbRibRhRgbLgLsLobRsRsmbLsRsbLgLsbRjRsmbRcRgRsmbRhRgRsmbR
hRebLcLcbLgbLcLgLsbLhLgbLcLibRgRsLsRsmbRjbRoLsLsmbRebsbRcbRoRcbRsRsmbL
jbLoLsRsmbLobLsRsbLobRcbLoLcbRsLebLibRgbLiLcbRsbRoRsmbRebRgbRhRcbRebRo
bRcbRebLebLsLsLsmmbLcbRcRebRcbLeLgbLcLsmbReRsRembLcbLsbRibReRsmbRsbLsb
RoLsbLcLcbLcbLiLsbLcLgbLibLcLsmbLcLcbRsbLoLsmbLebLsLsmbLsLsmbReLsbRgbR
ebLsbsbRsbRobRcRhbRiRgbRobLsbRiRsRsmmbRibRiRsRoLsLgmbLebRiLobRsLsbLcLo
RsRsmbLsbLoLsLsmmbLiLsbLiLsbLcLsmbLgLsLcbLsbLoLsRsRsmmbRibRcRsmbLsRsRs
mbRoLsbRiLsbRiRoLsbRcRsRsmmbLcbLoRsRsmbRoRsmbRgRsRsmmbRcRsRsmmbRgbRcbR
cRcbLcLcbRsbRhbRgbRiRsRoLsmbLcRsLoRsRsmbLcLobLcbRsLcbLcRsb

>ZF Recording 2016-03-18; tW: 300s; Start: 122307; End: 122807;
Recording: 3-1; Individual: 15; Drug: NDMC 3 µM
bRsLebLeLgLsLsLsmmbLsRsbLsbLsLsLsLsmmmbLeRobLsbRsbsbRsLsbRsbRsbRsbsbLs
bLsbsbLcLsLombRebLibRiRcRoLjbRsbsbsbsbsbRsbRsbsbsbLsLsRsRsmmbsbsbsbRsb
LsLsmbLsLsmbLsbRsbLsbLsbRsbsbLsbLsbLsbLsbsbsbRsbsbRiRoLeRjbLebReLjbLjb
sbRsbLsLsmbsbRibRgbLsLsLsLsmmmbRsRsmbLgbRsLsbRsbRsbLeLsbLeLsLsLsLsmmmb
RsbRcbLsbLsbsbLebRjbLsbRsbRsbRsbLsbRsbLsbLsbRsbsbsbsbsbsbLsRsbsbsbsbsb
sbsbLsbsbRsbRsbsbRsbLsRsbRsbRebReReRsmbLsLsmbLsLsmbLcRgbLsbLsbRsbRsbsb
LsLsmb

>ZF Recording 2016-03-18; tW: 300s; Start: 122307; End: 122807;
Recording: 3-1; Individual: 16; Drug: NDMC 3 µM
bRgRoReRsRimbRsbRsRsmbRsRsRsmmbLobLeLjbRcReReLcbReRsmbLsbRoLoRsbRsbLcL
sLcRiRgRcRgRiLombLsLsLsLsmmmbLibLsLcLcbLoLsmbRiRgRsmbReRsmbRcRcRcLeLib
LibRsbLjLsLsmmbLcLiRsRcReRsLjmbLcbLoLcbRhbReRsmbLibLibLebRcLsbRebRcReb
LhbRgbRoLgLsbLobLobLsLsLsmmbLobLebLeLsRgRobRoRobRgRsRgRgmbLcbLoLiLsbLs
LsLgLsLgLsLsmmbLsLgb

>ZF Recording 2016-03-18; tW: 300s; Start: 122307; End: 122807;
Recording: 3-1; Individual: 17; Drug: NDMC 3 µM
bLsLgbLebLcbLibLibLcLsmbLibLgLsbRsbLhbLcLsmbLcbRibRibRcbRcRcbRiRsmbRgL
sLsLeLsmbRsLgLsLsmbLcbLcbLcLsmbLobLcbLoRebRcbRcLsbReRgRsmbRhbRcRhRebRe
RgRsmbRsRsRsmmbLoLoLsLsRsmmbLoLsLsLcLsRsmmmbRhRsRsmmbLoLsLsmmbLeRsRcbR
iRebReRsmbLobRcRsRcmbRcRcbLebRebRiRsmbRgbRsbRibRgRsRsRsLemmmbLgRebRobR
obRoLsbLebLgbRjbRjbRiLsRcbRgbLebLcLcbLjbLiLsLhLsLsmbLiLsbLgbLiLsbLeLsL
smbsbLhbLgLsbLgbLcbLsLsmbLiLsbLibRibLebReRsmbRcbRiRcbReRsmbRiLsbLsLsmb
RsLsbRcRsmbRibLcbLjbRsRsmbRobRiRgRsmbRsRiLsbLjbLcLsmbLibLcbLcbLcLsmbLj
bRebRebRjbRsRsRsmmbLjbLcLsLcmbLiLsbsbRibRcbLgbRiRebRiRsRcmbRebRgLsbLjb
RsLsRibRebRsRebReRsmbLsbRsbRsbRgbRebLobLibLsLsLsmmbLobLcbLhbLiLsbRoRcb
RcRsmbRgbRcbLiLsLsmbRcbRcbLebLcLcLsmbRebRhRsmbRcLsbRcbRiLsbRcRsRsmmbRc
RsRsmmbReRcbLiLsbLiLgLsLsmbLcLcLsLsmmbLsLsLgLsLgRsmbReRsRsRsmmmb

>ZF Recording 2016-03-18; tW: 300s; Start: 122307; End: 122807;
Recording: 3-1; Individual: 18; Drug: NDMC 3 µM
bLsLsLsLsLsLsLsLemmmmmmbReRiLoLoLibRsbRsReRebReRebLeLgLoLjRsbLibLhbRgR
smbRcbRgbRibRsRsRgmbLsbRsRsRsmmbRsbLsbRcbRsbRibRebRsbRebRcbLsLgLgbLsLs
LsLgLommbLcRiLoLcRjbLgRsbRsbLeLoLobLcbRobRcbLsRgbRobLebRebLoLsmbLobLsb
RebLsLgLsRjb

>ZF Recording 2016-03-18; tW: 300s; Start: 122307; End: 122807;
Recording: 3-1; Individual: 19; Drug: NDMC 10 µM
bLgbLobRoLobRebRsLsRsbLsbRjbLgbLsLsmbLsLsmbLsbLcRsbLoRsbRebRcbRgbRcbRg
RebLcLsmbRjbRcbLoLsmbLsLgLcRsbRsbRoRsmbRcbRsRsRombRsRoLsLobRsLsbLsLsLs
mmbRsbReRsRsLsmmbRsRsmbLcLsmbRgRebRcRsRgRsRommbRjb

>ZF Recording 2016-03-18; tW: 300s; Start: 122307; End: 122807;
Recording: 3-1; Individual: 20; Drug: NDMC 10 µM
bRhbReRcLhLeLeLeRsbLsbRobRoLsRobLebRobRiRsLsmbRsbLgbLsbLobRibRcbLgLsLg
LgLiLibRebRoLsbLsbRoLsbRcbRcbRgbRcbRobRhbRibRgRsmbRgbRsRsmbRcRsRsmmbRo
bRcRsmbRsRsmbRoLsbLcbRsRgbLcbLsLsmbLgLhLcRsLsbLcbRsbLsbLsRsbLsbLsLsLsm
mbRsbLsbRjbRoLsRcLsbRobLsLsmbLsLsmbRoLsbRgbRgRsmbRhRsmbRebRgbLobLibLsb
LsbLiLhLgReRgRsmbsbRgRsmbRibLsbRsRsRsmmbRebLcLiRsbRsbRcLgbRsbRoRibRebR
ebRebRcRsmbRibRcLsRebRcRsmbRhLgbRsbsbLsbRiRgReLebLhbLsLeLsbLgbLgLsLsmb
LoRsLsRsLibRobLsbLoLsmbLibLcbRsRsmbRsRsRsmmbRsRsmbRsRgRsRgRsRsLeLsmmmb
LcbLcLsLoRsmbsbRsbRsb

>ZF Recording 2016-03-18; tW: 300s; Start: 122307; End: 122807;
Recording: 3-1; Individual: 21; Drug: NDMC 10 µM
bRsRsLsLsLsRsmmmbRhbRgLsbLeRsbLgLsbLsLsLsLeLsmmbLobLeLsLcRgbReRgbLobLe
LebRjLsbRgRgRsRsRsRsLgmmmmbRgbLcbLgbLibLgbLcbRoRcbRsbReRsmbRiRsmbLiLgR
sLsbLhbLjbRsRsmbRiRibRjbLgLebLcLsRgmbRebLcbLeLoLsmbLiLsLsmbLgLibLsb

>ZF Recording 2016-03-18; tW: 300s; Start: 122307; End: 122807;
Recording: 3-1; Individual: 22; Drug: NDMC 10 µM
bLoRgRsmbLsRoLiRhRsmbLebLiRcbRebRcRsRsmmbReLeLsLsmbLsbRcLcLibRcRsRembR
ebRcbReRcbRebsbLsRsLsRsbLsbsbsbLsbLsbsbsbsbsbsbsbLsbLsbsbsbLsbsbLsbsbs
bsbsbsbRebRoRcbReRgbRgbLsbRcbRcRsmbRiLsb

>ZF Recording 2016-03-18; tW: 300s; Start: 122307; End: 122807;
Recording: 3-1; Individual: 23; Drug: NDMC 10 µM
bRiRcbLobLeLcRcRobRcbLsRsRgRobLsLsmbLcbRcLcbLsLsLsLsLsLsLsLsLsmmmmmmmm
bsbReRsmbRsRsRembRgRhRsLembRcbLebLcbLeRebLsLsLsLsLsmmmmbLsRsLsLgReRoLs
bRhRhRcRsmbRebRcRibLeLebRsbRoRgRsmbLsbLsbLsbLsbRsbRebRebRcRsmbRcRsRomb
RsbLebRobRsbLcLsmbRgbRcbRebRebLeLobLebLhRsbRsbLsLsmbLcbLhbRcbRcRibLgbL
hLsbLsLsmbRoRsLombRoRsmbRsRhLsRsLsRsbLebLsLsmbLsLgbLsLsLsLsLsLsmmmmmbL
gLsLsRsReRsmmbReLcbLsbLsLsLsLsLsLgLhLcmmmmbRib

>ZF Recording 2016-03-18; tW: 300s; Start: 122307; End: 122807;
Recording: 3-1; Individual: 24; Drug: NDMC 10 µM
bRcbLgbRebRebLgbRgRsRgRgmbRiRobLibLobRsbLsRsbRobLsLobLebLgLoLsmbLgLsLs
LgmbLgbLobLsRhbLeLcLcbRsLsLiLsRoRsRsmmbRsbRebReRgRgRgbRgbRsRsRsRsRsmmm
mbRsbLobLibLsb

>ZF Recording 2016-03-18; tW: 300s; Start: 122307; End: 122807;
Recording: 3-1; Individual: 25; Drug: Control
bLcLebLiLiLeLobRiRcbRebRibRhLsbsbRcbLcbLcRsRibRcbRcLsbRcLsbLsbLcbLcbLg
LgLcbReRebRgRsmbRcbRebRobLcbLebLibLhbLcbLcbLcRsbLeLobRcRsmbRebRebRebRe
bRebLeLsbRoRobRcRsmbLcbRcbLcLsmbLobLcbLcLsRsLimbLhRsLiLsLsmbLcbLiLgbLh
LgRsLeLsbRebRcbLoLsmbLcbLcLgReRsmbRhbLhbLeRhbRcLcbRcbRcRobRiRcbLsLeLeb
LcbRebRcbRibLjbRsbRibLebLgbLgRsbLcbRebRebRebRgRsmbRsRsmbRsbLcbLebLcLib
LiLgLsbRjRsmbRhRgbReRhbLsbRebRsRebRebRcbRcRjbLgLsbLcLjbRsbLiLsLcbLebLc
bLiLiLsLjbLsLgbLiLgLsbLjbLcbRibLcbLgbRcRsmbRebLeLeLsbRibRsLcLsReRcmbRe
bRcRgLcbLcbRcbLeLsbsbRibRebRiRsmbRcRsLeLombRebLgbRhbRsbLcLsmbLsLobRebR
ebRcbRsbLibRcRhbLcLebRibLoLsLembLgb

>ZF Recording 2016-03-18; tW: 300s; Start: 122307; End: 122807;
Recording: 3-1; Individual: 26; Drug: Control
bLgLsLsLsmmbLeRjbRebLeRsbLgbRcbLcRibRobLcbLiRsbLgRsbLobRebLcRsbRcRsRcL
smbLcLsmbRibRcbLcbLcLiLsLsmbLgRsLsLobLeLcbLcbLhRsRsRsRsmmmbLcbRiLebLgL
sLcbLgbLsbLsbRcbReRsLeRcmbLobRobLebLebLgbLebLcLsmbLsLeRgLsRsLsbsbRsbsb
sbsbsbLcbLoRcbLgbLebLebRobRibLgLsRibRgRcbRgbRoRjbLobLjbLibLcbLgbRsRsLo
mbLcLsmbLcLsmbRsbsbLcbLebRjbLgbRcbRcbLeLcbLsLsLgLsLsmmbRebLiRsbLoRhbLg
bLgbLiLgLsbLjbLcbLcbLcbLcLgRsRsReLsmb

>ZF Recording 2016-03-18; tW: 300s; Start: 122307; End: 122807;
Recording: 3-1; Individual: 27; Drug: Control
bsbLcbRcbRhRsmbRcRsmbRiRsmbRibLsRobRcbRebLhbRcbReLibLcLebRcRsRhRcRsmmb
RiRsRsmmbLeLgLsbRhLsLsLsLgLsmmbLsbLsbLsLsLsLsLsRsmmmmbLoRsbLobLcbLhbLc
bRebLiLsbLiLsLsLgLsmbRcRebLibLebRiRsRgmbRcbRobRebLobsbLebRebRebLoLsRsm
bLcbLcbLiLsbRsbRebRjbLeLgbLoRsbLhbLcbsbLebLoRsbLoLibLcbLcLeLcbReRsRhmb
LsbRobLhLsLeLgbLobLebLebLgLsLgbLsbLobRcRsRsRemmbRhRsmbRcRjbLsbRjRcRebR
ebRcRsmbLcbLcLsmbRhRibRgbRhRsmbRiRsmbLsLjbLhLsLsLsmmbRcRoLsLsmbLiLgbLc
LsmbLsRsbLcbLcLsLcmbLhLsLsmbLibLibLcbLcLibLibLibLcbLiLgbRibRiRsRsRsmmm
bRibRibRibLsLsmbLcbLcbRiRsmbRhbRhRgRsRhmbLcbLiLgbLibLcLsmbLibRiRiRsmbL
ebRcRsRimbLjLoLsLsmmbLoRsbLcbLibLcbReRibRcbRgRsmbRebLibReRsRiRcmbRgRsm
bRcLsbLcbRhbRhbRhbRhRcbRcbRcRebLiRsLsbRhRsRsRsmmmbRcbLgRsbRhbRebLibLiL
eRcReLoLsmbLgRsbLcLoLeLgLsbLcbLhbRsLcbLgbLibReRhbRcRibLobLsLcLiLsbLiRs
bLcbLiLsLsLsmmbRibLcLcbLoLsRsmbLiLsLsmbLhbLcRiLsbRobRibRgRiRebsbRcbRhb
LiLiRsbRebRiRgRebLeRsLsbLsbLsLsLsLsLimmmbLcbLoLsLcmbLibLcLsLsLsmmmbLcR
sbLibLiLsbLiLsRsLsbLcbLibLiRsbLiLgLsLsmbLgb

>ZF Recording 2016-03-18; tW: 300s; Start: 122307; End: 122807;
Recording: 3-1; Individual: 28; Drug: Control
bLeLsLsLeLcRsmbLibLsLsLsLsLgmmmbLoLcRsbRcRsRsmmbRsRsRsRsRemmmbReLebRsR
smbLebRhbRsRhRgbRsRebLeLgbLsbRoRgLebLoLobLiLibRhbRhRsmbRcbRcbRcLhbRcRi
bLebLiLeLjbLhRgRsLsmbsbLibLobRebRoLsbRjbReRsRgmbReRcbRcRsRsmmbLcbLcLhb
LhLsbLcReRsRsmmbRiRgbRobReRsmbRgLsLcbLcRebRebRsbRsRsRgmbRsbLoRibLebLsL
gbRibRebLebRibLebLebLebLibLgLgRsbRsLsbRcbRcbRcbReRsRombRsRsmbRcRebReRe
bRiRsLcRcmbRsbLoLsLimbLoLsmbLhLsbLcbLeLsLebRsReRcbRcLsbRoLhbLiLeRsRsmb
sbLcbLcbLibRebRcRsmbRcRcRsRsmmbReRsmbRhRsmbReRcLsbLibLibLhbLibLoRsLoRg
RsmbLcLeRsbLhLebLibRoLsbRcRsmbReRsmbReRebRcbRebRcRsmbRcbLobLeLsLsmbLib
LcbLcLsmbLcLsRsmbLebRcRsmbRhRsRiRsmmbLcRsbRcRhRsmbRgbRcRsmbRsRsRsmmb

>ZF Recording 2016-03-18; tW: 300s; Start: 122307; End: 122807;
Recording: 3-1; Individual: 29; Drug: Control
bLobLsLobRcRsmbRiRiLgRebLobLcLibLcbLgLsbLgLibRgLsbLsLebLoLoLcbLsLobLoL
smbLcLoRebRsbLoRsLsLsmbReLoRobLgbLebLebLgbLcbRoLsbRiRsmbRgRsmbRsRsmbLc
RsbLcRoRjbLsLsmbLgbLiRsbLcbLgbRobLobRgbRcRsmbLsRjbLibLcLeLsbLcbLcbLsbL
cLsmbLoLobLiLibLeRsbLcRhbRobRiRsmbLobLsLibRsbLhLobRebRjbLobRoLgLcbLeRc
RcRsRsmmbRobLgbLcbLobLcbLebLsLgLgLsbLebLebRgbRsRebRebReRsRsRiRemmbReRi
RgRsRsRsmmmb

>ZF Recording 2016-03-18; tW: 300s; Start: 122307; End: 122807;
Recording: 3-1; Individual: 30; Drug: Control
bLsLsmbLsRsLsLsmbLsLsmbRobRoLsbLobLcLoLcbRoRsmbRsLebLcLcLoLoLobRhbLobL
oLsLcmbLsLsLembLobRoLsLsLsLcRsmmbLhLsbLebLebRoRobRebRoLibLebLebLsLgbRe
bRcRiRsLsLcmbLebLeLsbLgbLebRcRcbLsLgLsLsLiLsmbLsLsmbRobRcbReRsmbRibRib
RgbRobRebLebLebLebLgRebRgLgbRibLcLcbLsLsLsLiLsmmbsbLobLcbLiRsLhLeLeLcR
ebLsbRiLsLsLsmmbRcLsbRcRiRsRhRsmmbRiLcLsLgmbLcbLhbLsbRsRiRhLsbLiLsbRiR
sRsmmbRibRoLsbRsLsbRcbRiRcLsbRjbRhRobLebLebLebLsbLebLeLhbLsbLsLsmbRobR
cRsmbLeLsbLoLsmbLsLsLsLsLsLsLsLsLsLsmmmmmmmmmbRoLsbLcLcbLcLcRsbLobLeLh
LeReRgbRcbRcRsLsmbLiLeLgLcRsLsLobLebRoRsmbRcbLgLsLgLeLsbLgLsLiLgbLsLsL
gLgmbRobLebLgLsLiLhLcLibRsbRcRcbRiLsbRcRsLsmbLgbRoRhbLeLsLeRsbLjRsbLsb

>ZF Recording 2016-03-18; tW: 300s; Start: 122307; End: 122807;
Recording: 3-1; Individual: 31; Drug: NDMC 1 µM
bRobLeLsLeLsbRhbRiLsbLebLeLsLsmbLibLsbRsLsbRgbLcLcLsRsmbRhbLoLgLgLsLsm
bRcRoLsbRobRiLsRsbRobRhLsLsLsmmbRcRsmbRcLgbRiLsbLobLcLsLeLsLembLhbLhLs
LsmbLiLsLhLiLeLsbLcLsLsmmbRcbRcbLeLsLsLcmbRiLoLgLeLsLsLsmmbRcbLiLobLeL
gbLcLsLsmmbRjLeLgLhLgbReRsmbRhLsRsbLeLhLebLibLoLsmbLoLsmbRhbRiLhbLeLeL
eRebRsRsmbRcRsmb

>ZF Recording 2016-03-18; tW: 300s; Start: 122307; End: 122807;
Recording: 3-1; Individual: 32; Drug: NDMC 1 µM
bLiLsLsmbLjLeLibLeLsLobRebRebRebRcbLobLiLobLiLobLebLebLhbLhbLebRhbRsLh
LsLsmbLebRsbRebRibReRsmbRgbRgbRsLsbRibRiReRsRsmmbRsRoLhbLcbRhLobLhLsLs
mbRgbLeLoLsmbRiRcbLiLsbLeLoLsRimbLjRgLsLsmbRcRjbRhLsbLibRebRjbRebLgbLe
bLcbLobRjbLjLcbLebLsbLobLcbLebLgLibLobLsLoLgb

>ZF Recording 2016-03-18; tW: 300s; Start: 122307; End: 122807;
Recording: 3-1; Individual: 33; Drug: NDMC 1 µM
bRcRsRcmbLiLsLhbRjRsmbRiRsmbLebLcbLoRsbLcRsRsRsmmbLgbRoLsbLobLoRsbLoLc
bLoLibRcbLibLoLibLcbLibLiRsbLoRsbLhbRcRsRsmmbLjbLoLibRcbLobLjLebLiRsbL
eRsLgbRjbLibRsbRgbRebLgbLhLhbRebLiRsbRhbLcRsbLgbLoLcbRsRobLibLgbRsRsRs
RsRsmmmmbLoRsLiRsbLsbLcbLoRsRsmbRsbLoLsmbLobRjbRsbRcRsmbRiRsRgRsmmbRib
LcLcbRhRsmbRcbLcLibRobLobLoRsRsmbLsbLsLsRsmbsbRcRsmbLjbLoRgbLcbLcbLsbR
cbRebLiRsbLsRsLsLibLobLcRsbLebLcbLeRsRsLombRsbRgRcLsbLsbRcbLeLsbRjbRoR
cbRcRsmbRhbLiLsLiLsbRobLoLgbLcbLibLcRsLibLebLebLiRsLcbLebLoLgbLsLsLsLg
mmbRsbRcLcLcb

>ZF Recording 2016-03-18; tW: 300s; Start: 122307; End: 122807;
Recording: 3-1; Individual: 34; Drug: NDMC 1 µM
bLcbLcbLcbLobLhbLcbLcbLoLsLeLhRsmbLsLsmbRobRobRoRoRcbRobRoRobLoLcbLeRg
RsmbLoRsbLoLobLsbLoLcbRibLebLebRcRobRgbLoLoRsRsRsRsmmmbRcRsRoLsmbRcbRo
bLoLcRgLebLcLsLsmmbRoLobRobRjbRobLcbRcbLeLsLgbLcbRoLeLsLsmbRobLcRsbRcR
sRcRsmmbRsLsRebLobLgbLobLhLsLibRsbLgLsLjbRiRsmbRcbRcbRebLgLsLcbLgbLcLs
mbRibRgbRsbRsRsmbRcbRcbLsbRibRobLgbLcbLobLsLsLsLcmmbLsbLoLebRcLibLcLsm
bLcRgbLobLcLobLcLcbLcLebLeLsLsmbLcbRsRebRgLsbRobLobLcLsRsLoRsRsmmbRcRs
RsmmbRibLeLsLsmbRcbRcbRcbLsbRcbRebRcRiLsbRcbRcLsLsmbLcLsmbRsLsbLsbRgLs
LsmbRcRobLgRoLsbRcLsLebLeLsLcbRibRhRsmbRibRiLgLsbLsRsbLgbLibLhLebLcLcR
sb

>ZF Recording 2016-03-18; tW: 300s; Start: 122307; End: 122807;
Recording: 3-1; Individual: 35; Drug: NDMC 1 µM
bLeRgLibLobLcbLobLobLcLebLhLcLsmbLcbRsbRhRsRsmmbLcLsmbLeLibLcLsRsmbRsb
RiRgRsmbLobLoLsmbRcRcbRcbRoRsmbReReRsRsRgmmbRcReRsmbRsRgbRgRsmbRcRsmbR
oRsmbRoRsReRsRsmmmbLibLsLsmbLobLobLcbLobLoLebLoRsLsLcLsmbLcLsmbLebLgLs
bLcLsmbLsbLhRsLiLsbRcRsRimbRoRsRsmmbLgLsLsLsLeLiRsmmbLiLgbLsLsmbRobLob
RsbRsbRoRobReLsbRgbLsbRebRgbRcRibRiLcbLebRsbRsbRibLobLobRcRsmbLgbLebRh
bRcRsmbLcRsbLobLgLcbLcbsbLsbLsLsmbLcbLcbLcbLcbLebLobLcbLoLobRebLcbLebL
gbLiLobRebRebRebLsbLibLobLoLsLcLeLsmbRcbLcRsbReb

>ZF Recording 2016-03-18; tW: 300s; Start: 122307; End: 122807;
Recording: 3-1; Individual: 36; Drug: NDMC 1 µM
bLcbLebRobRcbRobLcLiLsLebLobLebLeLsLgbReLsbLsbRoRobRsbRcbLobLoLoRsRsmb
RoRobRsLsLsLsmmbLcbLjLsRsRsRsmmmbRcLsLiLgLebLoRsRsRimbRsbLcbLobLcRsRsm
bRhRsRsRsmmmbLiLsLsRsmbLsbLcRsbLoLsLsLsLoLsLcmmmmbLcbLoRebRebRebRcbLhL
sbRsRsmbLsLsLsLsLsLsRsLsRsmmmmmbRsRgbRobRsLibLeRgbReLsbRgbRcLsbLeLeLeL
gbLoReRsmbLhb

>ZF Recording 2016-03-18; tW: 300s; Start: 122307; End: 122807;
Recording: 3-1; Individual: 37; Drug: NDMC 3 µM
bRcbLcbLiLsLebLgRsRsRsLsRsmmbLebLebRcLhbReRcbRebReRsmbLoLsLsLsRsmmmbRj
bRebLgbLgLsRsbRcLsbLcbLcRjbLobLebRiLsRsRsLsmb

>ZF Recording 2016-03-18; tW: 300s; Start: 122307; End: 122807;
Recording: 3-1; Individual: 38; Drug: NDMC 3 µM
bLcLsmbRcRsRcRsmmbRgRcbLcbRjRsRsmmbRsRsRsRsmmmbLebRcLibLsLebRsbRsRcbRc
RsLembLcLsmbLeRsRsmbRsRgRsRsRgmmbRiRsRsmmbRcLsLeRcbReRcbRgbRebRcRhLhRi
RsRiRiRcRsRsRsRsmmmmmbLsLsRsRsRommbRgRsmbRsbRcRgRsRcmbLcLsmbLeLsRsbRhb
RiRsmbRsRsmbRsRsRgLgmbLhbLsLsmbLgLsLsLcLsmmbLsLgLsbLgLsbLiLsbLgLeLsLsm
bLsLsRembReRiReRsmbRebsbLsRsbRsbRsRsmbRsRsRgmbRibRsRsmbRsRsRsRsmmmbLjL
smbRcRsmbRiRsRsmmbRsRsRembLsLsLsLgmmbLcLsLiRsRsmmbRgReRebRiRgRcbRibRsR
smbRiRcRsRcmbLcLcbLcbRcbRiRsRcRsmmbRsRsRsRsRsmmmmbLsbsbLsbReRsmbLsLsLs
LsLsLsLsmmmmmmbsbRebRoRgbRsRsRsmmbLsLsLoLoRiRsmmbRgRgRsRgmbRsRcbsbRcb

>ZF Recording 2016-03-18; tW: 300s; Start: 122307; End: 122807;
Recording: 3-1; Individual: 39; Drug: NDMC 3 µM
bLoLsRembRebRebRobRiRsRsRsRsRsmmmmmbRgbRgRsRsmmbLibRiRibRebRhbRsbRgbRi
LsbRgbLsLsLsmmbRsRsmbRibRgbLgbLcLsmbLcbRibRhbRsbRibRibsbLsbLiLsLsmbLeL
sbLhbLcLsLcmbLsbLsbRgbRiRsmbRiRsRcmbLsLsmbLsbLeLsbLeLsbRsbRgbRhLsRsbRg
bRoRsmbRsbRgbRcbRiRcRibRiRiRgRcb

>ZF Recording 2016-03-18; tW: 300s; Start: 122307; End: 122807;
Recording: 3-1; Individual: 40; Drug: NDMC 3 µM
bLoRebReLsLsmbRsbLgbLsbsbsbRsbRsbRsbRsRsmbRsbRgbRsRsRsmmbRsbLoLibRcbRe
bRebRsbLcbLgRsbLsRgRsRsmmbLoLgLiRsbLibLsLsmbRiRcbRcRcbRcRsmbRcbRsLcbLc
bRcbRsRsmbRcbLcbLsbLsLsLsLsLsLsmmmmmbLhRsRebRsRgbLobRcRsRsRsmmmbRebLeb
LsLsLhmbLobRcRsLgLcmbLeLgLeLsbLgLsLsLsLsLsLsLsLsLgLsLsLgLemmmmmmmmbRcR
smbRiRgbRcRsmbRsRsmbRcbRcbRgLcbRgRebRibRebRsbRsbReRsRgmbRebRsRsRsRsRsR
sRemmmmmbRhbLcReRhbLjbRcRcbRjLcLsLeLsLhmbLhbLgLsLgbLcbsbLgbLeRcbReRsRs
mmbRsRgRsRsmmbRebReRsmbRsbRsRsmb

>ZF Recording 2016-03-18; tW: 300s; Start: 122307; End: 122807;
Recording: 3-1; Individual: 41; Drug: NDMC 3 µM
bLoRsRsmbLibReRibRiRgRgRsRsmmbLobLobLobLoRgbRobLhLobLhbLobLoRsRcbRcRsR
sRsRsmmmmbRobLsLeRsRsmbLoRibRebLebLgbLcbRobRob

>ZF Recording 2016-03-18; tW: 300s; Start: 122307; End: 122807;
Recording: 3-1; Individual: 42; Drug: NDMC 3 µM
bLsLsLombLsLsLsLsLsRemmmmbRhbRsRsLsmbRebLebRhRiRsRsRsRsRsmmmmmbLobRoRe
bRjbLeRsbRcRsLeLsmbLgbLjLebLsbLsLsmbLsLsmbLsLsLeLombLsbRoLsLsmbRcLsLsR
eRsmmbRiRcbRsRsmbRsRobLgbLsLsLcmbRcbRebRsbLeLebRobsbRsLsRsbRsRsRembLsL
gLcLsmbRsRsmbRobLsLsLsLeLsmmbRsRgLcbLsLsLsmmbLsLibLsLgLsLiLsbLsLcRsLoL
sLsmmbRjbLsRgbLebLgLsbRjbLsLsLcmbLebLhLsbLhbRgbRebReRcbRebRebRsRsRgmbR
hbRgbRsRsRsRsRsmmmmbRsRsmbLcbLebRoRsRiRembLcRebRiLsbRebLiLeRsLsLsLsmmb
RcLobLebLebLsbLsLsLjmbRiRcbRcRsRsRommbLsLsRgmbRgRsRsRsmmmbRcbRebLebReb
RsRsRsRsRsmmmmbRsbRiRsmbRsRsRsRsRimmmbRcbRebRgRgRsRembLebLgLobLcbLsLcL
smbLebRgbLiLoLoLsmbLsLsLsmmbLgLsLsRimbReb

>ZF Recording 2016-03-18; tW: 300s; Start: 122307; End: 122807;
Recording: 3-1; Individual: 43; Drug: NDMC 10 µM
bLsLsLsLsLsLsmmmmmbLeRsLoLsmbLsbsbsbLgLsLsLcLoRoRsmmbLsbRsbLsbRgbRsbRs
bRsRsmbsbsbRsbRgLsbRebLsbLsLsLsLcRcRommbRsbLsbsbLsLsLsmmbLsLsmbLgRsReb
RobRebLoLsRgmbRhRsRhRsRsmmmbRgLsbLcLsLsLsmmmbRgbLsbsbRsbsbReRsRcmbLsbR
jbRcbLebRoRsmbRoRsRgRgmbRoRsLsLsRsRsRsmmmmbRsLsRoLcRsbRibRobRsbLcRsbLe
RibRgbLobLeLobLhbLsLsLsLsLsLsLsLsLsmmmmmmmmbLobLsRsRgbsbRsbRobLsLsLsmm
bLsLsmbLsLsLsLsLsLsmmmmmbLsLcLsLoRcRhRsRhRsRsRgmmmmbLsLsmbLsbsbLsLsmbR
sRsmbsbLgbsbRsRsmbRsLsRsbLsLsLsLsLsmmmmbLebRobRsRsLsLsLsmmmbRobRsbRsLs
bRsRsmbRsRgbRiLeLobLcLeLsLobLsbLsLibLibLsLsLsLsLsmmmmbReLeLgb

>ZF Recording 2016-03-18; tW: 300s; Start: 122307; End: 122807;
Recording: 3-1; Individual: 44; Drug: NDMC 10 µM
bLiLsbLcbLcLcLobLeLsLsLcmbRgLsbLcRsLobRgbRiLsbLsRsRsRsmmbLeRhbLebLebRs
bRiLsLsmbLibLjbLeLsLibLcbLiLsbLcbLebLiLsbLgbRibReRiRobRcRsRoRsmmbLcLsL
eLsLcLsmmbRcRsmbLcbLhbLiRcbRebLsRibLobLgLsLsLgmbLhLebRoRoRsRcRsmmbRgbR
sRsRcmbRcRibLcLsLsLeLsmmbLebRgRsLsLsmmbRcbRcbRcbLcLeLsLibLibLiRsbLsbRe
RsRsmmbLsbRsbLcbLebLhbLcRsRiRsRombRcbRgbLobLcLsmbLgbLibLcLebLsLsLgLsLs
LsLemmmbRoRcLsbLobLhLcbLebLsLgLsbRhbRebRcbRiLhLeb

>ZF Recording 2016-03-18; tW: 300s; Start: 122307; End: 122807;
Recording: 3-1; Individual: 45; Drug: NDMC 10 µM
bRoRiRsRsmmbLgLcLeLibLsRsLsLsmbLcbLhbLcRebReRiRsmbRgbRibLsbRsbLoRsbRoR
cbLobLcLgLsbLcRsbLibRebRgRhbRcbRebReLgbRsReRoLgLjbRhbRsbLobRebRhRgbLib
RjRiRiRsmbRebLibLebLoLiLsLcbLgLsLsmbLgLsLibRcbRgRsmbRcRsmbLcbLcLsmbLjb
LebRebLcbRsRsmbLcRsLobRobRebRcbRcbRsbRcRsmbRgRsLcmbLcbLoLiLhbLsLsmbLoL
sLhmbRsRsReRcRcmbLebLsbLjbLcRibLebLcbRcRcbRgbRiRgbLiRsLobLsLebLcbLsbLg
LsLcbReRcbLsbReRjbRcbRibLsbRsbLsbRjbRsRsRcRsRcmmbLsbLcbRsRsmbLoRsbLeLo
LsRsmbRcRcRcbRsRgRsRsRsmmmbRsRebRsRsmb

>ZF Recording 2016-03-18; tW: 300s; Start: 122307; End: 122807;
Recording: 3-1; Individual: 46; Drug: NDMC 10 µM
bRobRcRoLsLsmbLgbRoRsmbRcRsmbRhRsmbReRsRgRsRsmmmbRiReReRsmbsbReRebRcRs
RsmmbRsRsRsRsmmmbLcbLsbRgbLsLgbLebLcbRsRgLsLoLoRgRsLsmbLobLsbLgbLsbsbL
sLsmbRhbRjbRsRebRcbRgbRgLsbRcbRcRebRgbsbReRsmbRibRgRsRsmmbRibLhLcbLiLs
RsbLebRebRgbLebRsRcbRoRebLobLgbLobRobRgbLiLobRobRibRiRsRjmbRhbRhRjbRcb
LsRsbLsbLsRsbRjbRibRsReLsbRcbRobRcRsRsRsRsmmmmbRcRgbRebLsbRsRsmbRsRsRs
RsRsmmmmbLsbReRjbLeLcbLebRcbRcbsbsb

>ZF Recording 2016-03-18; tW: 300s; Start: 122307; End: 122807;
Recording: 3-1; Individual: 47; Drug: NDMC 10 µM
bRoLeRsbRgRgbRsbRsRgRsRgRsmmbRiRsRsRsRsmmmmbLsLsmbRcRobLoRgbLsLsLgLsLs
LsLsmmmmbLeLsbReLsbRsbRsbLsbLsbLsbLsbRsbReRsRsmmbLibLsLsmbLsRsRsmbRgbL
eRebLibLsRsbRgRgRsRsRsRsRsRsRsRsRgRsRgLsRsmmmmmmmmmbRsRsRsRoLemmbLsLsm
bLebRsRsRsmmb

>ZF Recording 2016-03-18; tW: 300s; Start: 122307; End: 122807;
Recording: 3-1; Individual: 48; Drug: NDMC 10 µM
bLebLsLsmbLiLsRgRoRcbLjbRoRoLeLcLcbLebLsLeRgRjbRgRsRsmmbLobLcbRobRoRsL
jmbLsRcbLebLcbLcbRgbLebRcLeLsRcRsmbRsLsbRibReLobLsLsmbLhbLebRobLsbLhbR
iLcLoRsLob

>ZF Recording 2016-03-18; tW: 300s; Start: 122809; End: 123309;
Recording: 4-1; Individual: 1; Drug: Control
bRsRcbLgRgRsmbLobLsbRjbLsRsbLebLgLsbLiLgbLgLgLsbLebLeRsbLsLsmbLiLsLgLs
bLeLsbLsLiRsbLsLcbLobLsLsmbLsLhbLsLgLibLibLsLsLsLsLsmmmmbLeLsbLsLsLhLs
mbLiLgbLsLibLcbRsbLcLibLsLsmbLgbLebLgbLgLsLsmbLgLsLsmbRgbLjbLsLgLsLibL
ibLgbLcbLgLgLsbLgLsLgbLgbRibLibLcbLeLgbLibLibLsbLcbLoLsmbLgLgbLebLhbLg
LibLiLsbLiLsb

>ZF Recording 2016-03-18; tW: 300s; Start: 122809; End: 123309;
Recording: 4-1; Individual: 2; Drug: Control
bLeLcRcRsmbRiRgRsRsRemmbLebRjLsbRsbLsLcbRebLjbLcLeLsLsLsLsLgmmmbLsLgbL
ibLoLsmbLeRcbRcRcRsmbRebRebLcLebLgLebLgLcLeRsLsbLeLcLsmbLgbLcLcbLeLcbL
eLcbLebLebLsRcbRsRsRsmmbRsRgRsRsRgmmbLebRsRsmbRiRsmbRgbRobRgRsmbReRsmb
RgRebLcbLcbLeLeLsbLsLsmbRebRhbReRsRsRsmmmbRcLsLebLeLeLebLgLiLsLiLsLsLs
LsLsLgRsmmmmbLcbLgLsbLibRebRebRcbReRgRsRsRiRcmmbRsRsRembLebRhbRebRcRsL
smbLgLcbLcRsRsmbLgLebLeLhbRgLsRiRsmbRiRsRhmbRcRsLsmbRiReRsRembRsbReLsL
smbLgRiRsRsmmbReb

>ZF Recording 2016-03-18; tW: 300s; Start: 122809; End: 123309;
Recording: 4-1; Individual: 3; Drug: Control
bLoRcLoLoLeLsbRsRsRsmmbRoRcReLebLjbLoLcbLobLcLiLsbLhLsbLcbLibLibLsRebR
sRsRgLsmbLsbRsRsmbRsRsRsRsmmmbsbRsbsbsbsbsbRebRgRsRiRsRsRsmmmmbLoLobLi
bLcLsmbLoRsbLjLcLsmbRcRcbRsbRoRsLcLsLsmmmbLsLsRsLsLgLsLgLsmbLebLobLebR
ibReLeLsLsLsmmbLoLsLombLibLhLsLsmbLiLsReRsmbRebRsRsRsRsLsmmmbRebRsRgLs
bLjbRgRsReLsmbLgLsbLcbRcRsRsmmbRsRsmbLcbLebRhbRsRcReRebReRebRebRib

>ZF Recording 2016-03-18; tW: 300s; Start: 122809; End: 123309;
Recording: 4-1; Individual: 4; Drug: Control
bLgLgLgReRsRsmmbRsRsRsRsRsRsRemmmmmbRcRsRgmbReLebLebLgLsLeLsbLcbLebRib
LsbLsbLsLsmbRsbReRcRsLsRsmbLsbLebRebRhbRiRsRimbRcRsmbLsLsLsmmbRsRsRsRg
mmbLsbRobRcbRjRobLeLsLsmbLsLsLembLhbLeRoRsmbReRsmbRsRsmbRiRsRcmbLsLsLs
LiRemmbRebLiRibRcbRebRgbLhbLeLsbLebLeLebRebLsLsmb

>ZF Recording 2016-03-18; tW: 300s; Start: 122809; End: 123309;
Recording: 4-1; Individual: 5; Drug: Control
bRcbRcbRebRebRcRsmbRcbLgbLsLsmbReLsbRgRsLeRembRsRsmbLiRcRcReLjbLsbRsbL
sLsmbLsLgLsbLsbRcLsbLebLgbRoRsmbLjbRhRsLeLsmbRsLebLsLeRsRsmbReLoLeLsbR
sbReLsbLgLsRsbRsbLgLsLsmbRebRcRsRsmmbReRcRsmbRiRsRsRemmbLsbRcbRgRcbLsb
RsRsmbRobReLcbLgLsLebLsbLobLiLebRcbRebReRibRhRgbLsLsmbLsLsmbLjbRebLebR
ibRgbRcbRebLgb

>ZF Recording 2016-03-18; tW: 300s; Start: 122809; End: 123309;
Recording: 4-1; Individual: 6; Drug: Control
bRiRsmbRhRhbLsbRjbRobLoLsLgLsLgRcLhLcmbRcRgbLobLebLibRiLgbLibLobLebReL
hLsLgLsbLeLhbLeLgLsbLsLgbRsbRcbRsb

>ZF Recording 2016-03-18; tW: 300s; Start: 122809; End: 123309;
Recording: 4-1; Individual: 7; Drug: NDMC 1 µM
bLsLibRcLsbLebRoRsmbRcbLjLcLsmbRsRgRsRsRsRsRsRsRsmmmmmmmbRiRsmbLebRobR
cbsbsbLobLobLobLoLsmbRcbLiLsbLcbsbLsLsLsLemmbLiRsLsbLgbLgLsbLoRsLsbRsR
oRsmbLhbRsRgbRoRiRsLsmbRobLobLcbRsbRsbRsRibLcbRobLsbLcRsbLiLsbLsLsmbsb
LsLsmbLobLoRsRibReRoRebRebLcbLebLeLsLsLsLimmbRobRcRsRcmbLgbRhRsRsmmbRc
RhbRhbRcbLobLsLsmbLsLsLsmmbLjLibLobRibLsRebRcRsRsmmbRgbRsRsRsRommbRgRs
mbRsbRsRsmbRibRsRsRsRsmmmbRsRsRjmbRhbRcbLcbLibLebRsbLsLsmbLcbLiLsLcbRc
RsmbLsLsmbLcbLcbRcbRebRoRibReRsRiLsmbRebRibLobLobLsbLsbLobLcbLcRsbLcbR
sLsbLibLjLhLcbLobRibLcLcbRcRcbRcRsRsRsmmmbRibRhRebRcLcLeLsLibLebLiLibL
cbLeLgLgbLsLeRsRsmbLob

>ZF Recording 2016-03-18; tW: 300s; Start: 122809; End: 123309;
Recording: 4-1; Individual: 8; Drug: NDMC 1 µM
bLsLsLsmmbLsLsmbRsbLsbRcLeLobLgLsLsmbLgbLsbLsLsLsLsmmmbRsLsbRsbLsbLsbL
sLsLsmmbRsbRsbLsLsmbLsbLgLsLsLsmmbLoLoLcbLoLoLoLsRsmbRsRiRgRsmbRsLgbRs
bLsbRsLsbLsLsmbLsbsbsbsbsbsbLgLgLsReLoRjRhbLsRsbLsRsbRebRebRiRobLsbLsL
smbLgLebLebLebLebLibLsLsLsLsmmmbLhbRiRcRsmbRiRsmbRoRobRsbLoLoLhLsLebRs
RgRebRebRebLcbLebRcbLobRsbRsRsmbRsbRobRebRebRebRibRsbLgRebLiLsLsRembLg
bLebLebLsRsbRibLjRsb

>ZF Recording 2016-03-18; tW: 300s; Start: 122809; End: 123309;
Recording: 4-1; Individual: 9; Drug: NDMC 1 µM
bRcRoRsmbRsRsRsRsRsmmmmbRsRsRsmmbRsbLeLsbLcLoLobRgRsReRcRoRsmmbRsLsLsL
jmbRoLsRcLgbRsLsLsLsmmbRsbsbsbsbsbLgbReLobLiLsLobRsRcbRcRcLcbRebLsbLsb
LgLcbRcbRjbRsbRjbLebLoRoRcbRgbRgRibRiRgRsmbLebLsLeLsbLsLsLsmmbRcbLcLob
RsbRobRgbRgbLcLsLembLsLsLsmmbLsbLeLgbLsLsLsLgLsLemmbRiReReRhLsLsmbLsLs
LsLsmmmbRsLsLiLsLgLeLsbLsLcLobLsbLcbReLoLsLsLsmmmbLebLgbRoRsRsRsRgmmmb
RsRsmbReRsRsRsRsmmmmbLeLsLsRoRsRemmb

>ZF Recording 2016-03-18; tW: 300s; Start: 122809; End: 123309;
Recording: 4-1; Individual: 10; Drug: NDMC 1 µM
bLiRgLsbRgLebLhbLeLsbLibRhbRsRiLsLgbLibLebLjbLsLeLgbLhLsbLeLhbRgRsmbRi
RsmbRsReLebLhLeLcbLgLgLeLsbLsLiLhLsbLsLsLiRembRhRcbRebRgRgbLeRsbLebLeb
LebLeLsbLebLeLsbLeRsbLibLsLebRsLsRsbLeRsbRcRsmbRgbLcRcbLeLsbLibLcbLibL
gbLsLibLhLsbLibReRsmbReLsbRebReRsmbLcbRsbRiLsLebLebLebLibReb

>ZF Recording 2016-03-18; tW: 300s; Start: 122809; End: 123309;
Recording: 4-1; Individual: 11; Drug: NDMC 1 µM
bRjLebRsRcbRjLebLoLeLsbLsLsRsLsLsmmbsbsbsbLebLcRgbLsLiRgRgbRebRcRoRoLc
LsLsLgLsLsmmmbLsbsbRiLebRjLsbLcLgLeLebLhLebLcLsLsLiLgLsLsLgLgLsLemmmbR
sRgbRcRcRobRsbRcRhLsbLeRebRhRsRsReRsLeLsRsRsmmmmbLcLoLobReRiRcbReLsLiR
sLsbRjbRsLebRgbLeRsRsRsRsRsRsRsmmmmmmbRcRobReLobLebRiRsRimbLgLsLsLsLeR
sLsmmbLsbRiRiReRsReRiRsRsReRiRemmmbRsRgRsmbRsRgRgLsReRsmbLcbReLcRjRsRs
LcmmbLeLsLhbReRcLcLiRcbRsRsmbRebLsRsbReRcbReRsmbsbRcLeLcRsLcbRcRsRombR
sRsRsRsRiRiRsRcmmmmbLsbRsRgbLjbReRsmbRibRoRcRiRsmbRsReRcRsmbLsb

>ZF Recording 2016-03-18; tW: 300s; Start: 122809; End: 123309;
Recording: 4-1; Individual: 12; Drug: NDMC 1 µM
bRsbRibLsLgbLgbRsbLsbLoRibRgbRiLebRebRsRsRsRsRsRimmmmbRsRsmbRsbsbsbRsb
LsbRsbRebLgbRsbLebLobRsRsmbRgRgbRsRsmbRebRgRsmbsbLsbRgbLsbLgbRiRsmbRsR
ebRoRsRsmmbLibRobRsRgRsRgmbRsRsRembRgRgRiRebsbLsRsRsRsRsmmmbRsbRebRsbL
eLsLsmbLjbRsbLgbRsbLsbLebLcbLebLsbLcbLcbRiLsbRebReRobLeLebLgbLhbLeLsbL
sLgLebLcbLcbLsLeLsbRibLebLibLsbRcbLsRcbRcbRebLcbReRsmbRibRebRgbsbRhbRs
RhbRcbRgbRgRsmbRebRsbLhLsbLeLcbLgbLsbLiLsbLcbsbRgbLsLcbLibRhbRgbRsRsmb
RgRgbLsRsbRibRsLsRsRsmbsbRibRiRsmbRgbReRsmbRsbRjbRiLebRoRobRobLebLiLeb
LgbLsLsLcLcRsRsmmbRgbRebRsRsReRembRebRcbRobRsRsRsRsRcLsmmmbRcRsmbLsLgL
sLgLsLcbLsLsLsLsLsLjmmmmbLebLeLebLibLgLebLsbLgbLsLebRsb

>ZF Recording 2016-03-18; tW: 300s; Start: 122809; End: 123309;
Recording: 4-1; Individual: 13; Drug: NDMC 3 µM
bLsbLcbRsbRcbRcbLsbLobLcRsbLobRoRsmbRsRsLgLsmbLsbRobReRsmbRsRiLsbReRcb
RsRsRsLsmmbLgbLcLiLsLiRsLsbLibRjRobsbRhbRoRsRiRcmbRgbRcLgbRebRsbRoRcbR
sRiRsRsmmbRsbRgLsRsbRsLoLoRsLsLsmbLibLobLcbLsbLsbRebRiRobRgbLebLebLcbR
ibRcRcbLgLsLsLsLsLiRsRsRsLcmmmmmbRebRgRcbRebLsbRhbLebRebLebRebRcbRgRsm
bRsRgbRsRsmbRcRcRhbLoLsLsmmbLsRsbLcLsLombRebReReLcbRobReRgRibRgbRgRsmb
RsRsRsRsmmmbRiRebLiLsbLsLsmbLsbRcLcbRiRsRjmbRobRebRgbRsbLsb

>ZF Recording 2016-03-18; tW: 300s; Start: 122809; End: 123309;
Recording: 4-1; Individual: 14; Drug: NDMC 3 µM
bLcLcbLeLsbLhLsLibLsLsmbRgbRoRhLsRsbRoRsmbRgbRgRsmbLsbsbRoRsmbRcLsbReb
LsLsLsmmbRsRhbRiRsmbRsRsRsmmbLebLhLsLcbLcbLiLsLgbRibRcRsRsmmbLoLsmbLoL
cbLoLsmbLcLsmbLcbRgbRcRhbRebRhReRsmbReReReRebRsRoLsLsmbRobRibRcRgRsRsm
mbReRsRsLsmmbRcRsRsRsmmmbReRsmbRcbRiRgRsmbRobLsbRoRcbRsRsmbRiReLsbLsbL
cLibLiLibLsbLcLsmbLsLsmbLcLsLsmmbLsReRsRgmbLoLsLsLsLgmmmbLsLsmbLcbLcLc
b

>ZF Recording 2016-03-18; tW: 300s; Start: 122809; End: 123309;
Recording: 4-1; Individual: 15; Drug: NDMC 3 µM
bLgbRiLsbLsbRsLsbRsLsbRsbRcbLeLsbLcRoRsmbLcRsbRsbLsbLsbLsbsbLsRsLsRsLs
bsbLsbLsRsbRsbRsbLsbLgbLsbRsbLsLsmbsbRsbRsbRsbLsbLsLobLsbLgLsbsbLsbLcb
RebReLsbLsRsbLhLsLgbRsLsLsLsReLiLsLgRsmmb

>ZF Recording 2016-03-18; tW: 300s; Start: 122809; End: 123309;
Recording: 4-1; Individual: 16; Drug: NDMC 3 µM
bLsRoRsLimbReRgLgbLeLsRcRgRsmbLoRsLobRcRsRoRcLimbLsbLsLsmbLoLoLeRgbRhb
RibLoRebRsRsmbRibLeLsLsmbRcLeRoRsmbReRoLiRsbRsbLcLobRsRoRcRcRsmbRgRsLs
mbRgLsbRgRcbLcLsLimbLcReLcbLsLsLsmmbRsbLobLhRibLebLiRebRebLoLsmbRibRsR
sRsRsmmmb

>ZF Recording 2016-03-18; tW: 300s; Start: 122809; End: 123309;
Recording: 4-1; Individual: 17; Drug: NDMC 3 µM
bReRsRsmmbRcRsRsRcmmbRcbRhbsbRcbLhLsLsmbLiLibRgLcbLeLgLgLobLsbLeLsLcbR
iRsRsmmbRcbsbLibLeLsLsRombRhbRcRsmbRcbReRebRsReLsbRgbRcbReRsRoLsLsmmbR
cbLeLsbLcbLhLsbLhLsbLeLsLsmbLgLsbLsLoLsLsmmbLsLsLsmmbLiLsbLhbLibLgLsbL
cLsLsmmbLibLhLsbLeLsbLiLsbLcLsLsmmbLiLcbReRsmbRiRcbRebRcRsmbRebRebRoLs
LsmbLcLsmbLebLsLsLsmmbLoLcLsmbLsLsmbRsbLcRobRebRoLibRcLsbRhbRcRcRsmbRi
RebLoLsLcLombReRcLsbRsReRhbRcbRhbReRsmbRiRsRsRcmmbRcRsRcRsRgRsmmmbReRc
bRsRsRsmmbsbRsLsbRiRsRoRcmbRgRgRcLsbLgbReRsmbRcRcbRcRsmbReLeLsLgLsLgLe
RsbLsLsLsLsLsLsLsLsLsLsLsLsLsLiLsmmmmmmmmmmmmbLgLsRsLsbLebLcbLcLsLombR
eRsLsRcLsmbRibLibLsbRhLcbLcbLebLhLsbLiLobLgLsbLsLsLsmmbRebRgRsmbRebRoR
smbRsRgReRsmbRsbRiRebReRsRcmbRsbRgReRsLcmbLsLsLsLgLsLsmmmbRibRcRcbLcbL
sLgbLib

>ZF Recording 2016-03-18; tW: 300s; Start: 122809; End: 123309;
Recording: 4-1; Individual: 18; Drug: NDMC 3 µM
bRebRebRebRgbRgbRsRsmbRsbLebLeLsbLeLsbLgLibLiLsLsmbLibLsLoRebRcbLcLobL
ebRibRsRebRgRibRcbLcLsmbLsLsLsmmbLebLcLobLsLsLsmmbLcLcLobLobLgbLcLsmbs
bLiLsReb

>ZF Recording 2016-03-18; tW: 300s; Start: 122809; End: 123309;
Recording: 4-1; Individual: 19; Drug: NDMC 10 µM
bLjbRsbRibRcbRcRsRgRsRsmmmbReLsLsmbLobRsLsbLcbLcRsbLgLsLcbLobRebLebLoL
cbLjbRobLsLcbRsbRob

>ZF Recording 2016-03-18; tW: 300s; Start: 122809; End: 123309;
Recording: 4-1; Individual: 20; Drug: NDMC 10 µM
bRsRsmbRsbRoRsmbRoRsRoRsmmbRobRgbRobLcRobsbRsbRgRsmbRibLcRsbLcbLobLgLo
bRgbRgbRhLgbLsLsReRsmmbRsbReRgbLcRsbLgLgbLebLebRebLiLsLsRgmbRebLgbLsbR
sLcLsmbRsLsbLsbLobLcLiRsRgbRgbRgbRiRsmbRibRebRiRiRsRsmmbRsLsbRgRsmbRgR
ibRsbRsbRsRsmbRgRsRsReReRsmmmbReRsmbLsRiRsmbRgbRhLgbRsbRoRebLhbRob

>ZF Recording 2016-03-18; tW: 300s; Start: 122809; End: 123309;
Recording: 4-1; Individual: 21; Drug: NDMC 10 µM
bLgRgbRoLoLsmbLebLsLsRsmbLeLgRcbRcb

>ZF Recording 2016-03-18; tW: 300s; Start: 122809; End: 123309;
Recording: 4-1; Individual: 22; Drug: NDMC 10 µM
bRcbReRcbLobRibLgLobLiLsRgRsmbRsbLsLsmbRebRoRcRsmbRibRiRsRsmmbRebLeRsb
LgbLhbRebRoLobLsLsmbRebRiRsmbLgbRgbLsbLcRcbRcbReRsLsmbRebsbRsbRgRsmbLe
bRgRsmbRhbRgbLeLsb

>ZF Recording 2016-03-18; tW: 300s; Start: 122809; End: 123309;
Recording: 4-1; Individual: 23; Drug: NDMC 10 µM
bRcbRcRsmbLsRsRgRsRsRsRemmmbRsRsmbLiLsRcRsmbRiRibRsRebLebLibLcLsmbLcbR
obRoRsRsmmbRsbRebRgbLcbLsLsLsLsmmmbRebRgbLgbLcbLsLgbLiLsLsLsLsLhmmmbLc
bRobRcbLsbReRsRsLimmbLsLgRsbLsLsLsLsLsRcmmmmbLebLgLsLsLsLeRemmbRebRebR
gbRcLibLiLcbRcbRcbRobReLiLsLsLsLsLsLsLsLhmmmmmmbLsLsmbLsLsLiLsLhLsRgmb
LgLibLcbLcbRebRebRebLeRsbLsLsLsLsLsLsLsLhLgmmmmmmbLgLcLcRsbRjRcRoRcbRe
bRsbRgbReLcbLsLcbLsLsLembLsbRoRsRsmmbReRsRsRommbRibLcRcRoRsRsmmbLjRebL
ibLgbLsLsLimbRebReRsmbRsRsRsRsRsRsRgRsReRsmmmmmmmbRsRsRsRgLsLgmmb

>ZF Recording 2016-03-18; tW: 300s; Start: 122809; End: 123309;
Recording: 4-1; Individual: 24; Drug: NDMC 10 µM
bLcbReRjbLsLebLiRgReRgReRebRsRsmbRsRsRgmbRoRsRsmmbRgRebLebLcLcbLeLsbLg
LgLsLsLembLebRibLsLcbsbLsbLsbLhbLebLsLgbLobRgbRobRgRsmbRebRoLgLgbRcbRs
RsmbReRsmbRebRiLsbRebRebLibLiLsLsmbRsbRibLcbLsLgbLjRsbRibRcbRsRsRcRsmm
bRgRsmbRsbLobRgbLcLsmbLsLoLsRsmbRcbRsbRgbRgRsmbRibRcbRsRsRgRsmmbRsRebL
cRsRoRebRcbRsbLoRsRsmbRiRebLeLgReRsmbReReRsmbRgRgRgbRsRsmb

>ZF Recording 2016-03-18; tW: 300s; Start: 122809; End: 123309;
Recording: 4-1; Individual: 25; Drug: Control
bRobRcRsRsmmbRcReRsRsmmbRsRsmbRcbLoLebRsRsmbLeLeLoRsbRiRsmbRsRsmbRcLcL
sLsLsLsRsmmmmbRoRsRsRsLcmmmbLcLeRebRsLoLsmbLgRsRsRsmmbLjbLcLsLcmbLcLsL
cmbLhLgbLebReLeLgLsLsmbLcRsbLcbLibLcbLcLsmbRiRsRsmmbRiRsmbLjbLebLgRsLo
LebLeRebRcbLsLsmbRebRoLsLsLimbLebRebRebRiRsmbRgbLcbLcbLebLibRsbLgbRsbR
ebsbReRibLiRsLsLgLsbLsLsLembRebRebLcbLiLjbLobLeLsbLcbLcLgbRebRgbRiRsRe
mbRebReRsmbRcbRobRgbReRibRcLcbLsbLcbLsbLjLsmbLebRebRgRebRcRjbRhbRsbRiR
sRsmmbRebRcbRgLsRgRsmbRcbLsLcLsLeRembRgRsRsmmbRebLebReRgLsbReLebLobLeb
LibLcbLibLsLeLibLiLsLsLsmmbLebLsLsRsmbLeLeLobRibLcLsmbLhbLsbLcbLcLeRsb
sbRsLeLsbLebLcbReRsRcmbRcLibRcbReRsmb

>ZF Recording 2016-03-18; tW: 300s; Start: 122809; End: 123309;
Recording: 4-1; Individual: 26; Drug: Control
bRebRcLsRsRiRcbRiRsLsmbRoRhLjbRsRsmbRebRebRiLoLoLcbLeLiLeRcbRsRsRgRsRs
RgmmmbLobLoRcLsbLibLsbLgLsRibRhbLibLoLobReReRobRiRsRembLebRcRgLebLebLe
bLebLebReRsReReRsmmbRsRsmbLobRhbRebRcbRebRsbLebLcbLebLebRsbLebRebLsbRe
bRebRibRcbRebRebRgbLcbLebLebLeLibLcRsbLcLobLeLebLcbLebRebRebLebLoLjRgb
LobLcbLgbLiRsRsRsRemmbRjbLiLebLcbLebRgbReRsRsRcLsmmbLibLoRsbRgb

>ZF Recording 2016-03-18; tW: 300s; Start: 122809; End: 123309;
Recording: 4-1; Individual: 27; Drug: Control
bLibLibLgLsbLcLsRembRgbRsRsRsmmbLcRgRsRsmmbRcRgbRsRsRsRsRsmmmmbRhRsRgR
cmbRsRsRsRsRsRsRsRsRsRsRsmmmmmmmmmmbRcbRcRiRsRsmmbRcRsmbRebRcRsmbRcbLc
LeLsLsLeRsmbLcbLcbLcbLcLsLsmmbLhbLobLcbLeLsbLobLiLsLsLembRjbLiLsLsLsLs
LsLemmmmbLeLgLgbLibRebRcRhbRsRsmbRcbRcbRiRsRcmbRgbLcLeLsLebLibRgbRebRe
bLebRibLibLsLebRebRcRsmbRhRiRsLsmbRcRsRsRsRsmmmmbRoRsmbRobRhRebLeLsLcb
LsbRsbLobRcRsLembLgLsRcRsmbLsLsLsLeLemmbRoLsRobLiLsbLcLsmbLsbLebLgbLgb
RiRebRiRgRebRcRebRibRebRsRsmbRsRsmbLsbRiRsmbRibRgLsRsbRcRgbRibLcLsLgLs
LsLsLcLoLsmmmmbRsbLebLebLcbLcLsmbLiLsbLhbLoRsRsmbLcLgbLibLcbRiRsmbLebL
gRsbLiRsRsLsLsRimmbLsbRebLsbRcRebLibLebLjbLhRsbLcRsbRhbRobLgLebRcbLiLe
bLebLebLgbLcbRsRsRsmmbRcbRcReRsRembRibRhRsReRsRsmmmbsbRhbRcbRsLsbRibLj
LsmbRiRsmbRsRsmbRgLsRsbRcRsRsRcmmbRcbRiRgRsmbRibRibLgbRsbReLsLsRsmbRhL
sLsmbsbsbRibRiRsRsmmbRcLsbRiLsbLibLoLsmbLcLsmbLcLsmb

>ZF Recording 2016-03-18; tW: 300s; Start: 122809; End: 123309;
Recording: 4-1; Individual: 28; Drug: Control
bLebRcbLcbRsbLcbLcRsbLeLhbLsLsmbRsRcbRhRsmbRoRobLcbLgRsbsbRgLiRsbLiLeb
LhLsbLiLoRsRsRsmmbLsbReRsmbRsbRebLsRsbRsRsmbRoRsRsmmbLeRhbRgLeLsLebRgb
LgbRsbRgbRobLibLobRcRsmbRebRsRgbReRsRembRebRebRebsbLsbRcRsRembLebLhbLo
RsbLcLcRsbReRsmbRibRhReRsReRcRsmmbRhRsmbReRgRsmbRgbRhRsmbRiRsmbRcRibRc
RsmbRcLsbRcRibRibRhbLebLcbRsRsRgLimbLobLiRibRibRebRjbLcbRsLjbLgRgbRcLs
bRsbLcLcbLobLsbRhLsRsbRebRoRebRcRsmbLcbLiLsRiRsmbRhbRsbRebRcbRcRebLcbL
gbLoRsLebLeLiLibLsbLebRobRobRsbRobRiRsRcmbLgbLsbRibLcLcRibRcbLcLobLcbL
sLsLembRiRsmbRobRhbRoLiRsb

>ZF Recording 2016-03-18; tW: 300s; Start: 122809; End: 123309;
Recording: 4-1; Individual: 29; Drug: Control
bLibRgbRgbLcRobLcLsmbLebLsLsLsLcmmbLsLsLsLeRemmbLobRcbReRcbLeLobLsLebL
sb

>ZF Recording 2016-03-18; tW: 300s; Start: 122809; End: 123309;
Recording: 4-1; Individual: 30; Drug: Control
bLiLsLiLcbLsLsmbRsbRcRsLeLsLsLimmbLebLcLsLsLsmmmbLibLsLibLsLsLsmmbLsLs
LsLsLsLsLgLsmmmmmbRoLebLsbLsLsLsLsLsLemmmmbLsLgLgLibLsLsLsLsLsLsLsLsLg
LgmmmmmmmbRsLsLsmbRiLgbLoLcReLjbLiLebLebLebLsLebLsbLcRgRjbRoLgLsbRcbRo
bLsRgbLeLsLsLcmbLebLsbLgbRoLsbLcLcbRiLsbRgRoRgReLsbRcReLsRsLcbLiLsbLcR
sbLiLsLsLiLiLeLcmbRiRsmbRcLsLsmbLsbLsLsmbLoLobRcRhLsbLibLcLsRsmbLcRsbL
ibLobLiLeLcLcLsmbLiLsLsmbLiRsLebRcRiRsRsmmbRsLsbRoRiRsmbRcbRiRsmbRibLg
RhLsbLeLgLiRsbLoLobLcbRcbRibRgbLebLebReLebLebLgLeLeLeRebRsRsmbRgRsLsRs
LsmbLebLiLoLcbLsLgLsb

>ZF Recording 2016-03-18; tW: 300s; Start: 122809; End: 123309;
Recording: 4-1; Individual: 31; Drug: NDMC 1 µM
bRcRsLsLimbLeLeLgbRgLsLiLsLgLsbLoLcLsLsLcmmbLsLsLsLgmmbLhLsLsLsLsLsmmm
mbLiLsLsLgmbLoLcbRibRcbLcbLoLiLcLeLeLgbLgLsLsmbLsLsLsmmbRebLeLebLsLsmb
LoRsbLcLgLsLeLeLgLsRoLsLsLsRsmmbLsLeLeLcbLeRsLsRsbRsRsRsLsRsLsmmbRsLsL
sRsmbRcLcLebLcLsmbLebLsLsLsLsmmmbLgLsLsLiLimbRsbLsLebRoRhbLcbLsLgLiLsL
sRsmbLsLsLsmmb

>ZF Recording 2016-03-18; tW: 300s; Start: 122809; End: 123309;
Recording: 4-1; Individual: 32; Drug: NDMC 1 µM
bReRsRcmbRsbLsRsLsbRsLsRsbLoLobRsbRjbRgReRsRcmbRobRgbRgRsmbLsRsRsmbRsb
RsRsmbLsReRobRcbRobRsRsRsRommbLsLcLcbRoLobLeLcbLebRgRsmbRsbRiRobLsLsmb
LebLsLgLoLsRsRsmmbLsLsLsLemmbReRibRsRsRgmbLobLebLcbRiRsmbRcRcLsbLsLgLs
bLhLsbRjbRcbRcbRcbRsRsmbRsRsRimbRebRsbRjbLsbRobLcLcbLcLebRebRsRsmbRgbR
gbRsbRsbRsbRgRsRgmbRgRgLiRsbReRsmbLibRoRsmbRoRsmbRgRsmbRibLibLebLebRsb
LcbLcLcRsbReLeLsbLebLebReRcbLsbRebRebLjLebLeRcbRcbRsRsmbLhbLsLgLsLsRem
b

>ZF Recording 2016-03-18; tW: 300s; Start: 122809; End: 123309;
Recording: 4-1; Individual: 33; Drug: NDMC 1 µM
bLiRsbLobLobLsbRoRsRombRcRgbLeLsLsmbLgLsbLcLibRcbRobRiRoRcbRgbRoLobLgb
RobLobRebRiLhbsbRgRsRcRsRcmmbRcRsmbReRcRsRcLsmbLcbLoRsbLhLeLcRsbLcLiLe
LcbLsLhLsLcLoLhbLgLobLiRsLiLiLoLhLhLsLsLsLgLgmmbLcLoLibLebLsLsmbLcLsLo
mbLebRjbRcbRcRgRsmbRsbRsbLsLsLjmbLcRsLsbRebRgbRcbRgRsRsmmbRebLebLsbRhL
jbLsLcbLiLsLhbLcbLcbRibLobRsbRgbLgLcLebLsLcLeLsbLhLcbReRobRiRsRsRsRgmm
mbRhRhRiRiRsmbRiRoRsLsmbRoRsRsRsmmmbReRhbLebRoLhLsLcbLcRsLcLobLoLiRsbR
cRsLgLeRsmbRsbRobRsRsmbRcRgLcbLiLsLgLgLoLgbLgbLgLcbRsbRsbRcRobLiLebLsb
RoRobRiRiRiReRiRcRobRsRsRsRsmmmbRsbRgbRoRoLcLcLcLcLsmbLcb

>ZF Recording 2016-03-18; tW: 300s; Start: 122809; End: 123309;
Recording: 4-1; Individual: 34; Drug: NDMC 1 µM
bRsbLcLsLombRebRgLsRsbRiRibLcbLebRcRgbLsbRgbRobLoLobRoRcbLcbRsbRcRcRsm
bsbLjLobsbRcRobLgLsRebRoRebRsRsRsLgmmbLcbLiRsRebRoLsLcbLibLcbRebRsbRcb
RcRjbRibLebLobRibsbRsRgRsmbRobLhLsRibLgLobRgRsRsRemmbLgLsbLsbLgbLcRsbR
cbLibRiRsReLsLembLcLsmbLobLgLsLoLobLgLcbRcbRjbLsbLoLcbRcbLobLoLoRsbRsR
iRsRsmmbRsLsbRgbRiRcbLeLobLobLibLeLobRcRcbRcbRcbRcbRgRoLjbLoRsRsmbRcbL
ebLebLiRsbRsLsRsRsmbLcLsLcmbLeLsbLcLsLimbReRiLgbLcLsLsmmbLgLgLsLsLembL
ebRibLcbRsbLsLsmbLebReRsmbRjbRebRsLsbRebLiRcbLobLobLoRsRebReRgRgbReLsb
Rcb

>ZF Recording 2016-03-18; tW: 300s; Start: 122809; End: 123309;
Recording: 4-1; Individual: 35; Drug: NDMC 1 µM
bRgbRcLiLebLsbRsbsbLsLsLsLsLsLsLsmmmmmmbRebRgbRobLebRcRoRsmbRcRiRsRhRi
RsmmbRsRsmbRcRsmbRebReRsRhRsmmbRsRsmbLcbLcLsLsmmbRsbLhLiLcbLcLsLcLsLgL
cmmbRsRsLsmbRsbLoLsmbLcbLcLcLibLjLsmbLcbLcbLcbRebRebRcbRebRjbRebRcbLeb
LebLgbLsLgLgLsLsmbLsLsLsRsmmbLibLobRobLebLobRcbLsLsmbLobLcLebLsLcbLebL
sbLsbRobRcbLcRsbLcbRcbRebRebRcRebRsRsLsmbLeLsbLsbLoLsLsmmbLibRsLebLcbL
obLcbLobRcbReRobLeRebRebRiRsRsRcmmbRsRsRsRsRgRsReRsmmmmmbRsRgRsRsReRcR
gmmbRibLcLibLjbLcLsRsRsRemmbLoLoRsbRsRcRoRsmbReRsmbRsRsRsLsRsLsmmbRoRs
mbLobLcRebRsLgbLcLgLhbReRgbRsbRsRsRsRsRsLsRsLsRsRsRgmmmmmbRgbLcbLsLsLe
LembLobRobRebRcRibLeLcbLsLhb

>ZF Recording 2016-03-18; tW: 300s; Start: 122809; End: 123309;
Recording: 4-1; Individual: 36; Drug: NDMC 1 µM
bRebRibLsLibRcbRiRsmbLhLeRgbRebRoLsbLobLcbLcRsRhRgbRiRebRcbRsbLibRsLsb
LoLsLcmbLcbReRsRoLeLsmbRebReRsmbRiRsmbRibLsLsRsmbLobLgbRcRebLsbLebLobR
sLgbLhRsLiRsbRebRsbRgbRiRcRhbRebRgbLsLsmbLsLsmbLcLsmbLgLeLsLsLsmmbLsLs
mbsb

>ZF Recording 2016-03-18; tW: 300s; Start: 122809; End: 123309;
Recording: 4-1; Individual: 37; Drug: NDMC 3 µM
bRebLcbLoLobRhLjbLcLebLiLsbLebLibLsLsLsLsLsLsLsLsLsLsLsLsLsLsLsmmmmmmm
mmmmmmmbLsbRsbLcLebLiLcbRhRsRsLsmmbLsLsmbRebLsLcbLsbRobLebLsbRcbRebLjb
LcbLeRcbLeLgLsRsbRibRibRebReRgbRebRebRcRhbReReRsRgmbRgReRhRsmbRsRsRsLs
LsRsRsLsRsLsRsLsmmmmbLibLhLsbLgLsLsLsmmbLsLsLsLsLsmmmmbLcb

>ZF Recording 2016-03-18; tW: 300s; Start: 122809; End: 123309;
Recording: 4-1; Individual: 38; Drug: NDMC 3 µM
bReRsReRoRsRiRgRsReRsmmmmbRebRsbRsRsRsRimmbRsRsmbLeRsRiRsReRembRsRsmbR
cRsmbRsbRsRsRsRsmmmbLeLsbLiLsLsmbRebRgbLjReRobRsbRjRsRsRcmmbRebRsReRsR
iReRiRsRemmbRiRibRsReRoRsRcmbLeLiRsbRsbRjbRgRsLsmbRgLsRebLeLsbLsLsmbLs
LgLsLsLsLeRsmmbLgbLsRsbLsLgLsRcRiRsRembRsRebRgRgbLcLgLsLibLsRsbLcRsbLe
bLgRcbLhRcbRcLsbRsbLsLsLsLcmmbRiRibRcbRiRsmbReRsmbRibReLsLsmbRjb

>ZF Recording 2016-03-18; tW: 300s; Start: 122809; End: 123309;
Recording: 4-1; Individual: 39; Drug: NDMC 3 µM
bLcbLoLsmbLsbLeLcRcbRsbRsRsRsLsmmbRsRsRsRsRsmmmmbRgLsbRiLsbLsLsLsmmbRo
RoReLsbLsbRobLebLsLsmbLsbLgLsLsmbLobLcbLsLsLgmbLcLsLhmbLeLsbLeLsLcbRiR
gbRiLsbRobRoRcbLgbLiLsLsmbLeLsLsmbReRsLiRsLcLembLibLoLsmbRsLsLobReLsbR
iRiRsmbRcbLeLeLsbLcLsLsmmbRebRcbRibReRhRgRcbRsRsRgRsmmbRibRcRcbRibLoLs
LembLsLsmbLsLsLcmbRebRcbRebRgRcbLsLgLsLebRebRcbRebRjbRgbRgbRsLgLcbLiLs
bLcbLeLeLebLeLsLebLebLcbLgLsLsmbLcLeLsbLsbLsbLiLibLebLhLsLibLcbRebRgbL
sbRcRebRgbRcbRsbLhLibRebLgLcbLcLibLcLgLsLsmbLiLgbReLsLgLsbRcbRcReRsmbR
gbRobRiRhbRsLoLibLeLsLsLcLsmmbLcLeLsLsmbLgLgLsbLcbLcbRiRsRcmbLsbLcbRcL
sbRcLsLsLsmmb

>ZF Recording 2016-03-18; tW: 300s; Start: 122809; End: 123309;
Recording: 4-1; Individual: 40; Drug: NDMC 3 µM
bReRsRembReLgRcRsRsRsRsRgmmmmbRgbRgLsbLcLsmbLsLgLsLhbRsbLoReRsRsmmbLgR
cRebLsbRhRsRsRiRsmmmbLcLsLombLcLiLsbLsLsLsLcmmbLiLcbLsLsLsLsmmmbLibLob
RsLiLeLgbLeLeLgbLsReRsmbRcbRsRsmbRcRcbLgbRebRsRsRsRsRsRsRsRsmmmmmmmbLs
LsmbLoLsmbLcRsbReRebRsReRsmbRsLcLsmbLsLsLsLsLsLsLiLoLgLsLcLemmmmmbLeLe
bLeLsbLgLsbLsLsLsLsLsLeLsmmmmbLiRsbLibRibLsLsLsLiRcmmbRsRsRsRsRsRsRsmm
mmmmbReRebLsLsLsmmbRcRsRsmmbLibReReRebRgRcbRebRebReRsmbReRsmbRebRgRsRe
ReReRsmmbRibRsRgbLcLibLcbRebLebLebReRsLembLoLcbLeLsLeLeRsLsbReLcLsLsmm
b

>ZF Recording 2016-03-18; tW: 300s; Start: 122809; End: 123309;
Recording: 4-1; Individual: 41; Drug: NDMC 3 µM
bReLebRgbsbLoRsbLeLgbLgbRgbRebRsbLgbLcLgbLibLsbLgbRgbRobLcLeLsbLebLiRs
RsRgmbRiLsLsmb

>ZF Recording 2016-03-18; tW: 300s; Start: 122809; End: 123309;
Recording: 4-1; Individual: 42; Drug: NDMC 3 µM
bLsLgLsbLsbLsLsmbLsLsLembLcLsmbLeRsbLsLsLsLsmmmbRcRgbLcLoLcbRiRgRgRebL
ebLsLgLgLsLgLcbLsLsLgLsLsLsLsmmmmbLsLsLsLsLsLsLgLsLsLsLsLsmmmmmmmmmbRc
RobRsRsRgReRsmmbRiLsLgbRgLsbLsLcLsLembLeLsLgbLoLebRhLjRsbLobRcRcRcRcRs
RembLsbLsbReRsmbRcbRsbRgRsRsRgReRsmmmbRsRsRsRsRsRsRgmmmmmbLsbLebLeLsbL
ibRgbLeLebRebLebLsLeLsLsLgmbLsLsLsLsmmmbLcLeLsbRgbRibRebRgbLcLiLgLgbLs
LsLsmmbRcbLebLiLcbLebLibRebLibLibLibLebLebRsRgRsmbRgRsRsRgRsRsRsmmmmmb
RebLebRebRebLcbLibLhbRcLcbLiLsbLiLsLsLsLsLsmmmmbLsLsReLgmbLsLsLsLsLiLg
mmmbLeLsLsLsmmbLgLsbsbLsLgLeLgLebLebLsLsLsLsLsLsLsLsLsLsmmmmmmmmmbRoRo
RibRibRibRsLsb

>ZF Recording 2016-03-18; tW: 300s; Start: 122809; End: 123309;
Recording: 4-1; Individual: 43; Drug: NDMC 10 µM
bReRsRsmmbReRsmbRsLcbRsLeLiRsbLoLcLebLeLgbLebLsLsLeLcLoLsmmbLsLsLsLsLs
LsLsmmmmmmbRiLsbLeLsbRibRhbRsRsRgmbLoLobRobRsRsmbRsRsRsmmbRsRsRsRsmmmb
RhLeRobRcbReRsRsmmbRsbRsbRsRsLsRsLgmbLhLiLsLcLsmbLiLibLebLcLsmbLeLgLeR
sLeLsLiLsLebLeLsbLgbLsLsmbsbLsLcLcbReRsmbLsLgLsRsRcbRoRcRiRiRsmbRsRsRs
mmbLsRsbRsRsmbRsRsRsmmbRgRsRsRsRsmmmmbRsRsRsRsRsmmmmbLgRsbLjbLsbReRoRs
mbLsRsLsLsmbRsbRhRobRoLsRobRsbRgRobLobLjbLjbRhRobLebLsLsLiLsLsLsmmmbLs
LsLsLsmmmbLobRebRsbRgbLsbLsLsLembLcbLeReLsbRiLoRobLgbLsLibLcRhbLiLsbLs
LsLembRebRsRgLibLsLsLsLsLsLsLsLsmmmmmmmbLobLibLsLsmbLsLsLsLsLsLgmmmmbL
sLgLibLobLhLsbLeLgLsbRsRsmbReRgLsLsmbLsLiLcbLsbRsbRgLcLcbLeLibLeLobRgb
RsbLiLsRsRsmbLsLsLsLsLsLsmmmmmbLcRcbRhRsRsmmbRsbRsRsmbLsRsbLsbsbLsb

>ZF Recording 2016-03-18; tW: 300s; Start: 122809; End: 123309;
Recording: 4-1; Individual: 44; Drug: NDMC 10 µM
bRcLeLobRcLebLiLsLcLeLibLsLebRsRsmbRcRsRiRcmbRsLsbRcRcbLcRsLcRebRsRsRg
RgRsmmbRhLebLebLhReRcRsmbRsbLcbLsbRgbLcLeLeLeLeLeLeLgbLeLebLeLeLcLsLsm
mbLgLsbLsRsbRebLebRcRsRsRiRsmmmbRgRsRsRsRcmmmbLebLiLeLhbLgLsLsmbLsLsmb
ReLsbRgRsRsRsRsmmmmbRgRsRsmmbRhRcbRiLsbLeLebRcLebLgLgbLiLgLsLebLcLsmbR
cRsmbReRcRsmbRsRgRsLsmbRhbRcbReRsLcmbLebRsbLcbRsbLobLeLcbLeLsbLibLebLg
LiRsbLcbLgRhRiRcbRiRsmbRiLsbRcRsRcRimbRgRcbRsbReRsmbRibRgRgbRgRiRsRcmb
RiRsmbRsRsmbRsbRsRsRsmmb

>ZF Recording 2016-03-18; tW: 300s; Start: 122809; End: 123309;
Recording: 4-1; Individual: 45; Drug: NDMC 10 µM
bLcbRsLebLcLibLgLcLsmbRsLgLsLsmbLoRsbLhLsLiLsLiLibLgLcbLebLeLgbLiLibLg
LsLcbRcbRsRgbLhLsLsmbLeLiLeReRiRsRsRhRhRcmmbRsRsRimbLcbRebRcbLgbRebLjb
RjReRobRcRebRibLibReRibRsReRgbRsbRjLeLobLeRobRobRsRsmbRhRgbLsLcLsLcLcm
bRsbRobRcRobLgLhLobLsLcbLsbRsRsRsRsmmmbLoLcbRiReRebLebLcLibLeRsbLgLsLs
LcmbRibRcbRobRiRebRebRibRsRsmbLgbRsbLgbLsbRiRcRebLcLsmbLjLebLebLiLgLsb
LgLiLcLiLibRsLsLiLsLsLembRsbLebRcbRibRcbRibRsbRibLcbLcLjbRibRiRcbRgbLe
bLebLgLsbRebsbLjbRibLcbLgbLebRsbLeb

>ZF Recording 2016-03-18; tW: 300s; Start: 122809; End: 123309;
Recording: 4-1; Individual: 46; Drug: NDMC 10 µM
bLhRobRibRoLiLsLsmbLsLobLsLgbReRsRjmbLibLebLibRiLgbRebRobLcbLoRsbRhRsR
eLsRcmbLgLsRsbRiLsLibLsLsmbLgbRcbLcbRebRebRsbLgbRjbLibLsbLebLebRgLebRc
bLjbRjbRsRsmb

>ZF Recording 2016-03-18; tW: 300s; Start: 122809; End: 123309;
Recording: 4-1; Individual: 47; Drug: NDMC 10 µM
bLsRsRsRsmmbLsLsmbRsbLcRsRsmbRsbRgRsRsRcmmbLgLebRoRsmbRsRsmbRsRsRsmmbR
sRsmbRsRsLsmbRgRcbRebRebRiLsbLgbRgbLgbLsbRcRobReRsmbLebRcReReReRibRgLc
bLib

>ZF Recording 2016-03-18; tW: 300s; Start: 122809; End: 123309;
Recording: 4-1; Individual: 48; Drug: NDMC 10 µM
bRibRcbRobLobLsbLsLsLsRsmmbRsRsRsRsRsmmmmbLjLsmbRsRgRgRgRoLobRgbRcRoLg
LsbReLsLsReLimbLiLcbRsRsmbReRgRsmbRsbLibRebRiLcLcbRjbRgRcbRsbRsbRiRhbL
cbLjbLiRebRcbLeLebLgRcbLiLoRsLgbRsbRsLsLsRsLsRgLcmbLebLgLebLoLsmbRcRgb
LeRsbLsRibLcbLebLebLgRcRcbLgbRhbRcbLib

>ZF Recording 2016-03-18; tW: 300s; Start: 123311; End: 123811;
Recording: 5-1; Individual: 1; Drug: Control
bLcbRcRsRsmmbRcbRibRiRsmbLsbRsLsRsbRibRjLsbRiRgRsmbLsRsRebLiLsbLhbLebL
sLgLsLiLsbLgLsbLsLsLsLsmmmbLeLsbLebLibLgLiLsbLiLcbLsRsbRgbLsbRsbLibRsb
RiRobLsLsmbRsbLsRcRsmbRebLgbLeLsRsbLebLebLibLebLsLgbLebLebLiLsbLebLsLe
bLeLsLsmbLeRsbLgbRsLsbLebLeLsLsLgmbRcRsRsLemmbLgbLebLeLsbLsbLsbLsLsLsm
mbLiLiLebLsLibLgLsbLsRsbLsLgb

>ZF Recording 2016-03-18; tW: 300s; Start: 123311; End: 123811;
Recording: 5-1; Individual: 2; Drug: Control
bRjbLeLcbRebLeLebLebsbLcbLsRcbRibLeLobRebRgbsbRcbReRsRsmmbRgRsmbLeLsLg
bRsLeLcbLcbLebRebReLsbRhReRsLimbLebRjRgRsRsmmbLeLcRsbLebLebLeRiRsmbRib
RiRsmbLeLhbLsbLcLcbLebRibLoLcbRoRgbRgRsmbRebReRsmbReRsmbRebRcRibLibLeb
LcbLebRebRcLibReb

>ZF Recording 2016-03-18; tW: 300s; Start: 123311; End: 123811;
Recording: 5-1; Individual: 3; Drug: Control
bsbLebReRcbLiLoRsLcbRcLcLsmbLeLgReLcbLcLsmbLsbLsLsLsLsmmmbsbRoRcRsmbRs
RsRsmmbRcRsLembLsLsLiRgmbRcbRgRcbLsRcReRsmbRibRsRsRsmmbRsRsmbRoLsbRobL
cbLeLsLhLsbLeLgLeLsbLibLhLobRcRebReRsLsmbLsbRsRsRsmmbRoLsbLiLsLsLsLsLs
RsmmmmbLsbLhLebLobLeLgbLgRgLsbLobLhbLcLebLsRsbLgbLiLsbLiLiLsbLiReRobRs
bRcbRoRiReLsbLeLsbLsbLsLsLeLsmbLsRsbLgbLoRoLibLsLsLsmmbLsLsmbRsRgLiLsL
oLcbLsb

>ZF Recording 2016-03-18; tW: 300s; Start: 123311; End: 123811;
Recording: 5-1; Individual: 4; Drug: Control
bLsLeRebRsRcbRebRgReRcRsmbRebRsRsmbLsLsRsmbRiRsRsRsRsRsRcmmmmmbRcRgbLh
bLhLebRcbRiRobLebRebRcbLsbLcbLebLebLgLsbLebRgbRgRsmbLsRsRgRsRhmbRgbLeb
LebLgbLebLebLebLiLsbLebLgbLibLebRoRsRsmmbRsbRibLhLsbLgLcbLsbRsRsmbLebR
oRsRsRcmmbLibsbRcRcbLcbLsLgLsLsLsmmbLebRsRiRibReLsbRebLiLsRcbRcbRcLsbL
eLsbRiRoRsRsmmbRiRcbLsLsmb

>ZF Recording 2016-03-18; tW: 300s; Start: 123311; End: 123811;
Recording: 5-1; Individual: 5; Drug: Control
bRcRgbLebRhRgbRcbLsLeLsLeLsLsLsmmbRcbRsRoReRsmbRsbLsLsLsmmbRebRcbRgReR
smbReRsmbLsbRgLobRcRsmbRebRebRebRebRgbLcLiLsbRcbRsbReRcLhbRebReRhbRebR
eRsmbRjbRgRsmbRebRcbRsbLsRsbLibLgbLgbRsRsmbLsbLsbRjbRgbRcbRhbRsLsRgbRg
RsmbReRebRcbLebLsbLebLhbRcbRobsbRgRsRgmbRiLcbLebLiLebRgbsbRebRebRebRsb
LibLsLsLgRsRembRsbReRsmbLsLsLsmmb

>ZF Recording 2016-03-18; tW: 300s; Start: 123311; End: 123811;
Recording: 5-1; Individual: 6; Drug: Control
bLcbLcbLeLebLcRsbLebLeLsLeLgLsLgLgbRsLsLsLgLsmbLsbLiLsLsLsLgLsmmbLgbLg
b

>ZF Recording 2016-03-18; tW: 300s; Start: 123311; End: 123811;
Recording: 5-1; Individual: 7; Drug: NDMC 1 µM
bLsLhLgLgbRsRsRgRcmbRgRgRsRgmbLeLobReLsbLobLobRjRsmbLoLsmbReRiRsRsRcRs
LsRgRgRsLsmmmmbLeLgLsLsmbLobLcbLsLsmbLiRgbLcLsmbLsLsmbLsLsLsLgLgmmbLgR
sRgbRoRebLcbLebLebLobLebLebRoRebRibRsbRgRhbRsLsbRsbRgbRgbRebRsbLsbRjbR
obLsbRjbRsbLsbLsbRobRobRsbLobRsRsRsmmbLsbRsbRsbLsbLsbRsbLsbRsLsbRsbLsb
RsbRsbLsbLjbLsbRsLsbRsbLsLsmbRsLsbRjbLsbLsbLebLjbRob

>ZF Recording 2016-03-18; tW: 300s; Start: 123311; End: 123811;
Recording: 5-1; Individual: 8; Drug: NDMC 1 µM
bLibLeLgLsbLeLsbLsLgLebLsLsLsLsmmmbLsb

>ZF Recording 2016-03-18; tW: 300s; Start: 123311; End: 123811;
Recording: 5-1; Individual: 9; Drug: NDMC 1 µM
bRcLeLsbLcLsmbLgLsReLsbLjbLcbLsLsLeLsLsLgmmbLsbLjLjbRgRebRsRgRsRsRiRsR
sRsRgRsLcmmmmmmbRjRcRebReRgbRsRsRsmmbRsRsmbLeLoLobReRsRsRsmmmbRsRgRebL
cRsLsbRhLsLsmbLjLebRebRjRobRobsbRebLsLsLsLcLgmmbLsLsLsLsmmmbLebLeLeLsL
cbLsLsLsmmbLsLsmbLsLsmbRcRsmbRebRebReRsRcmbRsRsRsLsRsmmbRsRsRsRsReLgmm
mbLsbLsLsLsLimmbLsLsLsmmbLoLsmbLsbLiLeRebRgRsLgmbReRgbRsRsmbRsRsRsmmbR
sRsRsRommbLsbLcLsLsmmbLeLoRsbLiLhLsbsbLoLsmbLsLsmbLebLibLiLsbRoRsRcLsm
bLsRgRsmb

>ZF Recording 2016-03-18; tW: 300s; Start: 123311; End: 123811;
Recording: 5-1; Individual: 10; Drug: NDMC 1 µM
bRgRiRobLiRsbLeLcbLebLebLebLeLeLebLebLeLsbLebLsbLcRebRebLibLjbRgbRcbLs
bLsbRjbRebLsLiLsbLsLgbRcbLjbLebRgbLobRebLeLcbLebLsRsbLeLsRobLcbRiRhRsR
gmbRhbRebRebRsbRgRgbRcbRgRcRhbLgRhbRsLsLsmbRcbRsLgbRcRsRsmmbRsb

>ZF Recording 2016-03-18; tW: 300s; Start: 123311; End: 123811;
Recording: 5-1; Individual: 11; Drug: NDMC 1 µM
bsbsbLjbLibLcbRibLibRgRsRembRebRsLsbRgbLgLsbLibLeRjbLgbRsbLebRcbReRcRc
LsbLsbRgRsRsmmbReRcRhLcbLiLsbRjRjbLcbRcbLgbLsLsRgmbLgLobRebRcRibRjbLjb
LcbLsbRebRcbRcbRcbLsRsRsRcmbLsbRsbLebLcbLobReRgLsbRgRsmbReRoLeLcbLcbLe
LcbRsRoRcbRsReRcRgRcRsmbReReRebLsLgRsLsReReRgRsmbReReRsRsmmbsbRhRsRiRs
RsRsRsRsReRsmmmmmmmbRsReRsRsmmbRsReRsmbRiRebRsbRsRsRsmmbRgbLgLiLgbsbRj
bRsRgRsRsLemmbLgLsLebLeRsbLsbLjbLcLobLgbRcRsmbLcLsmbRebRcbRiReRcRcbLcb
RsRsmbLibLiLcLcLobLgRcRcRsmbRsRcRcbLcbLsLsmb

>ZF Recording 2016-03-18; tW: 300s; Start: 123311; End: 123811;
Recording: 5-1; Individual: 12; Drug: NDMC 1 µM
bRebRcRcRsmbsbRebRsRebRgbRoRsmbRebReRsReRsmmbReLsbRebRebRoLcbLiLsbLcbL
ebLoLsRsmbLsRsbLsLgLgbLsLsmbsbLsbRgbRiLsbLgbLibLebLgLibLebLebRsLsbLeLs
LsLeLsmbLsLsLsLemmbLebLsbRcRsmbRgReRcbReRsmbRcbRsRsmbRebRsRsmbReLcLsLs
mmbLeRsbLebLebLebLebLebLebLgbRsLgLsbLgbLsLsmbLibLsLibLebLobRcRsmbLsbRs
bRsbLsRsLsLsRsRsmmbLsLsRsmbsbsbLebsbReRsRsmmbRsRsRembLsbRsLsLsmbLcbLsL
smbRgbLebRjbLebLsbReRgbLsbRsLsbRsLsLsmbLsLsmbRsbLebReRsmbLsbRiLiLsbLsL
sLsLsmmmbLjbLsbLsLgbLgLebRcRsmbRsRsRsRsmmmbRsbLgbRebRebLebLobReRsRembR
gbRsReRsmbRgbsbRgbRiLoLcLsmbLgLsLsLgLembLsLsLsLsLsLimmmmbLsLgbRgLsbRsb
LsbLobLsbRsRsRsRsmmmbReRsReLombRebRcRiLsbRcRsRsmmbRgRsRsmmbRcbLebLgLib
LgLgbLsLgRiReLsbRsRsRsReRcmmbRsRsRsRsmmmbLeRsbRgRgRibRsRsRsRsRsRemmmmb
RsRgRsRsRemmbRsRsRsRgRgRsRemmmbReLgb

>ZF Recording 2016-03-18; tW: 300s; Start: 123311; End: 123811;
Recording: 5-1; Individual: 13; Drug: NDMC 3 µM
bLsLhbLcRsbRoRsmbLebLoLcLobLjRsbRoRsRsmmbRcbLjbRsRebRobLeLsbLhbRcbRsbL
cbLebRebReLsbLcReReRsmbRebRgRsmbRcRcRsRembLebLoRsLsRibRhRcbRgLcbLsRsbL
iLobRgRsmbReRsRsRgmmbLobLsbLgLiLoRsbLiLsRsbLcLsmbRcRgRsRcRcReLeRjmbRsb
LsbLoLebRsRebRsRsmbRiLsbsb

>ZF Recording 2016-03-18; tW: 300s; Start: 123311; End: 123811;
Recording: 5-1; Individual: 14; Drug: NDMC 3 µM
bRobLgLsbRsRiLobRcRibRgbLeLsbReRsmbRhLeLcRebRebReLcLsLoRsmbRgRgRsRsmmb

>ZF Recording 2016-03-18; tW: 300s; Start: 123311; End: 123811;
Recording: 5-1; Individual: 15; Drug: NDMC 3 µM
bRoLsLsLsmmbRsbLsLjbRebRobLsRoReRsmbLeLsbLsLsmbsbsbRebRebLobRgbLjbLgbR
ebRebLebRibsbsbRebRcbRebRobLebRcbLcbRgbRebLsLsmbLsLsLgLsLsLsmmmbLsbLcL
gbLobRcbRcRsmbRsbRgbLsRsbRiRsRsmmbRiRsmbReRsmbRibLsbLeLiLsbRsbRebsbsbL
sbRsRsmbRsbsbRsbsbsbsbsbsbLsbLsbsbsbLsbsbsbsbRsbRsbLjbRcbRebLcbLsLsLsm
mbLsLsmbsbLgLeLsbLgbLgbLeLsRcRsmbLsb

>ZF Recording 2016-03-18; tW: 300s; Start: 123311; End: 123811;
Recording: 5-1; Individual: 16; Drug: NDMC 3 µM
bRiRsLcLcLcLsLsRemmmbRsRsmbRcLeLcbRebRsRsmbLebRcbRebReRebLsRebRsRsRsmm
bRcRoRsLgmbLsLgRsbRsLsRsRgRsmbLcRcRebLeLgLsLgbRgbLsRsbLeLsLoLoLsmbLebL
sLcLsLsRsLsmmbLebLsLsmbRcbRoRsRcmbRsRgRsRsmmbLebRcbReLibsbsb

>ZF Recording 2016-03-18; tW: 300s; Start: 123311; End: 123811;
Recording: 5-1; Individual: 17; Drug: NDMC 3 µM
bRiRsRoLsLsmmbRcReRcRcbLebLobLobLebLebLgLeLsLsLiLeLsLsLimmbLeLgLgLgLsL
iLsRsbLgLsLsLsLsmmmbLgLsLsmbLebRsRsLgLsLeLsmbsbRsLsRsRsRsRsRsLsLsLgLsm
mmmmbLebRcRsLsRcmbRiRsmbRibRiLsRobRjbLsLsLgRsmbLobsbRsbsbsbLsbLsbsbsbs
bsbsbsbRsbsbRsbRsbsbLsbLsRsLsLsLsLsRsmmmbLsLebLebLsLsmbLcRcbRiRsRcLsmb
RgRsRoLsmbRgbRcbRcLsRsbRcbRcLsbRiLsbLsLsLembLoLcbLgbLsbLsLsLsReLsLsRsm
mmbRcLsbRobRcRcbLcLeLoLsLgRcmbRcLsRibRsRebRobRiLsbLcRcRcbRiRcbReRcRsRs
mmbRgRsRcmbReRsRsmmbRsRsRsRsRsLsmmmmbRsb

>ZF Recording 2016-03-18; tW: 300s; Start: 123311; End: 123811;
Recording: 5-1; Individual: 18; Drug: NDMC 3 µM
bRsRiRsmbReRsmbRiRgRibRgbLsbLgbRsRsRsmmbRsRsRsRsRsLsmmmmbRibRgbRsbRiLs
LcbLsLcRsbLebLsLsmbLebRiRcbLcbRgLsbLsbLiLsLsmbRsLsLsLsmmbLsRsLsLsLsLsL
smmmmbRsbLcbLcbLeLeLsbLsLsLsLsLsLsLsLsLgLsLimmmmmmmbRgRsmbRsRsRgRsmmbR
sbRibLebRgbRebRebRebLobLebLgLebLhLgLeLeLiLsLsLsmmbLgLsbLsLsLsmmbLgLsLs
LsLsmmmbLsb

>ZF Recording 2016-03-18; tW: 300s; Start: 123311; End: 123811;
Recording: 5-1; Individual: 19; Drug: NDMC 10 µM
bReRgLsLsLiLsRcReRombReRsRsRimmbRsRsRsRsmmmbRcRsmbLcRobLibRsRsRsReRsmm
mbRebLcbRebRoRsmbRiRobLebRgbRsReLcLsRsmbLcbReRsRcmbRcbLeLsbLsLgLgbLsLh
LoRgbLeRsbLcbLhLebLib

>ZF Recording 2016-03-18; tW: 300s; Start: 123311; End: 123811;
Recording: 5-1; Individual: 20; Drug: NDMC 10 µM
bLeLebRjRsmbRsLsbLiLeLsLsLsmmbLgbRsbLibLeLsbLgLebLiRsbRsbLebLgbLcRgbRe
RsRsRsmmmbRsRsmbRgRebRsbRgbLsLsLsLgmmbLiLsLcRebRgbLsbRcRgbRsLeLeLsbLgL
sbLsLsmbRebLibLiLsLobRobLgLgRsbLcbLebRcbLcbRgbRsbLobLcbRoLoLoLsmbLsbRg
bLgbLebLsRgRsLombReLcbRoLsLsmbRsbReRsRcRsmmbLeLsbLeLebLebLcLsmbLebLcbL
sLibLebLsLebLiLobLibLsbLsLsLsmmbLcRsLobRcRgbLsbLsRsbLsLsmbRsRgLsbRsbRo
bReLsbRsRsRsmmbRgRiRsmbLeLsLsmbLgLgLsLsLsLcLsmmmbLsLsLembLgbLiLgLobLoL
smbLcRobRibLjbLiLeLsbLebLeLsbLgLsRsbLsLsmb

>ZF Recording 2016-03-18; tW: 300s; Start: 123311; End: 123811;
Recording: 5-1; Individual: 21; Drug: NDMC 10 µM
bRgRsmbLgbLgbRiRsRsmmbRsRsLsRsmbsbsbLsLsLsLsmmmbRobRgbLeRsbLcb

>ZF Recording 2016-03-18; tW: 300s; Start: 123311; End: 123811;
Recording: 5-1; Individual: 22; Drug: NDMC 10 µM
bLcRoLcbLgbLebRibRsbRsRsmbRsbsbLsbLebRcbRgbLcbLsbRcbLhLgbLeLcbLebRsbLe
RoRgLibRcbReRsmbLsbLsRsbLjbsbLibLgRebsbsbsbLsbsbLiRcLoRsRoRsLcmbRsbRsR
smbRebRgbRobsbRsRibRcRiRsRsmmbRiLcbRiRcLsRibLsLcbRjbRsRjbLcRsbLcbRcb

>ZF Recording 2016-03-18; tW: 300s; Start: 123311; End: 123811;
Recording: 5-1; Individual: 23; Drug: NDMC 10 µM
bReLsbLsLsmbLiRobRgbRgRebRebReLhbRiRsmbRsbRcRobRsRiRobLsLsmbLeLsbLsbRh
RcReRsmbRsRsRsRsRsRsmmmmmbLoRcbsbRsRsRsLsmmbRebRsbRgbLcLsLimbRoRcbLsLs
RsmbLeLcbRoRsmbRoRobLsLsmbLiRsRcRsRcLsRembRcbRebReRsmbRsRsmbLeReReLjbL
ebLibRsLsbLeLsbLgbRsbRibRiRsRsRimmbRgLsLsLsmmbRgbLeLsLhRsRcRsmbRsLjbRc
bRebLhbLgLsLgLsLcbLebLoRsbRsRsRsRsRsRsRsRsLsRsmmmmmmmbRebRsLsbsbsbRsbR
sbRebLsLsmbLeLoRsbLcRsLobRsbLcbLsbLeRsbRcRhbRsRsRsRoRhmmbRibLcbRebLsbR
sbRebRgRsmbRebLgbLsbLobRsbLcLcLcbLiLcbLsbLeLsbRebLgbRebRcbRsRebLeReb

>ZF Recording 2016-03-18; tW: 300s; Start: 123311; End: 123811;
Recording: 5-1; Individual: 24; Drug: NDMC 10 µM
bsbsbLoRsbRsbRgbRebLibLebLebLcbLeLcbLebLsLeLeLsbLgLebLsLsmbLsLsmbLsLsL
sLsLsmmmmbLebRoRcbLoLsmbLsLsLimbLgbLcLgLsbLcLgbLoLgLgLiLibLebLiLsbLgbL
cbLiLobLcbLgLgbLib

>ZF Recording 2016-03-18; tW: 300s; Start: 123311; End: 123811;
Recording: 5-1; Individual: 25; Drug: Control
bLcbRobLsRcbRcLcbLeLsbLcLebLcLoRsRsmbLcLhbLcLiLsbLebRcbRsRsRsmmbRcRsLs
mbLebLoLsmbLgLcbLcLsmbLeReRsmbLgLobRsLsLsLsLcmmbRebReReRsRgRsmmbRsRsRs
RsRsRsmmmmmbLgLsLsmbRcbLoLcbLiLsLeLsbLhLcRsbRcbRcRsmbLcbLoRcbReRsRsmmb
RsbRcLgbLcbRibLgLsbRoLcLcLsmbRebLsbRebRsRiReRsRembReRibLebLsLsLsLsLsLs
LsmmmmmmbLebLjLsLembRsRsmbLsLsmbRsRsRsRsRsRsLsReRimmmmmbRsbReLsbRgbRgb
ReRcRsRsmmbLhLiLsLcLsmbLhbLgLibLgbLhLibLibLgLsLsLsLcLsmmmbLsLsLsLsLsLe
mmmmbLiLsLcbLebLebLibLgbLebLebLibLebLibLsbLgbLeLsRsbLibLebRgbRebLcRsLc
LsmbLebRsb

>ZF Recording 2016-03-18; tW: 300s; Start: 123311; End: 123811;
Recording: 5-1; Individual: 26; Drug: Control
bRjRibLcbRcReRcRsRsmmbReRsRsLsmmbRgLcRsbRsRebRcbLobLeLeLebLhbLeLsbLsLi
LsbRebLoLsmbLcLsmbLcbRhbRebLibLgLsbLgLsLgbLsLsmbRobRebRibReLsbLgLgRsbs
bLibRobLcLiLsLoRgbRgLobLeRsbRoLebLeLcLsmbLoLcbLebLebLobReb

>ZF Recording 2016-03-18; tW: 300s; Start: 123311; End: 123811;
Recording: 5-1; Individual: 27; Drug: Control
bLsLsLsLsLsLcmmmmbRoLsbLsLsLsLgLsLsmmmbLcLsmbLobLeLcbLhbLiLsbRebLcbRcb
RcbRcRsRsRsmmmbRiLsRsbRcRiRsRsRcmmbRjRiRsmbRibRcbRibReRgRsmbRibRebRhbL
iLsbRoRsRsmmbRhRsRcLembRiRsmbLobLobLcbLjbLcRsLobLcbLhbReRsRembRhRcLebL
cbRsRsRsmmbRobRgRgRsmbRcbRebLsLsLsLsmmmbLgbLibLcbLsbLsbRebLsbRiRsRgRem
bRsLsLsmbRhRebRgbLebLcLsmbLgLsLsmbLsLsRsLsLsmmbLoRsbRsbRsRgbRsRsRsRsmm
mbRgbRcRsRsmmbLcbLebRsRgbLcbRiLsLgLsLsLsLsmmmbRobRcRsmbRgbRiLsLsLimbLe
bLebLcbLsLsLsLsLsLsLiLsLsLsLeLsmmmmmmmbRebLeLgbRhRcbLcbLebLebLhbLcbLib
LhbLcRsbLobRcbLsbRibRobRebRcRcbRjbRcLsbLiRsLsLsmbLeLsbLsLsLsLsLsLgLimm
mmbLcbLsLgLsbLcbLcbLsbLcbRebRebRcbRcbRjbRoRsLsmbRcReRsRoLsmbLiLsbRjbRc
bRebLiLebLiLsLsLsLhmmbLobLeRsRsRsmmbLcbLcLsLsLsmmmbRgbReRsRsRsRimmmbRi
bRcRsmbRcbRibLhLsLsmbLcbLcLsmbLcLsmbLcbRebRcbRiRsRsRemmbRhRsRembLoLsRe
mbRiLgbRsRsRsRsRsRsmmmmmbReRsmbLeLcb

>ZF Recording 2016-03-18; tW: 300s; Start: 123311; End: 123811;
Recording: 5-1; Individual: 28; Drug: Control
bRjbLcRsRsmbLgRsbRcLobLebLeLsbLebRsLsLsLgmbLsLsRsmbLobReLsbRgRhbRsRsmb
LobRhbReRsmbRgRsRimbRcLsbRsbRsRsRsRsRsRemmmmbLhbLsbRjRsmbRsRsRsRsmmmbR
gbRebLoRebRoRsmbRiRgbLeLsbRiRiRsmbRsRsmbReRoRsmbLcLsLsReRsRsmmmmbRsRiR
eRsmbRsRiReRebReRcbLiLibLsbLcbReRsRsRemmbRsRsmbRsLibLsLsLsLsmmmbLsbLsL
ibRsLsbLiRcLebLobLibLsLsmb

>ZF Recording 2016-03-18; tW: 300s; Start: 123311; End: 123811;
Recording: 5-1; Individual: 29; Drug: Control
bLeRcbRebRebRobLcbLsbRgbRsReLcLsLsLimmbLsLeLcRsLsLgbLsLobRebRsRcLsbReR
smbRebRcRcLsbLiLgbReRsRhLsmbLobRibLeLsbRobLoLsLsLsLsmmmmbRsbLibLiLebLe
bLebLebRgRsRembRebRebRgRsmbLeLebLcLsLsLsmmmbLcbLgRsbLcbRebRsRgbRsbRiLg
LobLgLebRsbLibRsbLobLeRcbLcRobRebLobLobLhbLsbLobLobLcbLcbLgbRgRsmbRebR
sRsReRcLsmbReRcRcLsbLebRebRobRgbReReRsRsRsmmmbRgbLsRsRibRsbReRsRsRgmmb

>ZF Recording 2016-03-18; tW: 300s; Start: 123311; End: 123811;
Recording: 5-1; Individual: 30; Drug: Control
bRsLeLsbLcbLgLeLcRsbLeLsLcbRsbRoLsLcbLsRebRoRsmbLhLoLsmbLsbLgLsLsLeLcL
sLcRsmmbLsRsbRgbLeLeRobRsLsbLsLsLcmbLcbLsLsLsmmbLcbLcbLsLiRsbLcbRgRcbL
sLgbRcbRiLsLcLobLgLsLsLembRjbLiLgbLcbLsbRoLibLebLibLebsbLebLibLiLibRgb
RoLsRcRhbReLsLsRsmbRoLsLsRsmbLsLibLoLsmbLhLobLebLiLobRsbRcRibLiLgbLobR
cRibRebReLsbLiLsLcLcLsmbLcLcLhbLhLibLsbLcbLgLsbLsLoLsmbLcLcbRsbRoRsmbR
hbRsRsmbRiLsbLibRebRebLeLgbLgbRcRebLgLsLsmbRsbRjbLhbLibLcbRsLsbLcbsbLh
bLobLcbRgLsLsmbsbLebRebRcbRebRsRgbLcbRobLiLeLgLsbLhLsbLsbLoLcbLeLsbLeb
Lgb

>ZF Recording 2016-03-18; tW: 300s; Start: 123311; End: 123811;
Recording: 5-1; Individual: 31; Drug: NDMC 1 µM
bLiLiLeLsbLoLsLgLimbRhbRibLcLsmbLgLgLgLsbLgLsbLsLgLsLsLembRgRsRsRsmmmb
RiLsLeLsbLhbLiLibLsLeLgbLibRsLibLibLibRgLgLsLsLsLsLsLsLsLsmmmmmmmbLsLg
LsLsLsmmbLsLsLsLsLiLgLsLsmmmmbLsLsLsLgLsmmbLobLsLgLsbLsLsmbLsLsLsmmbLo
LcLsmbLgbLsRsLcLeLsLsLombRsLsLsLsLsLimmmbLsLsLsmmbReLsbRoRgRgRsLgmbRsL
sLjbLjLgLeLeLgLhLeLiRsbLeLibLgRsbLsLsmbLsLsLsLsmmmbLsLsLgLgLsLcmbLsLsL
sLgLsLsLsmmmmbRiLsLsLgLsLiLgLsmb

>ZF Recording 2016-03-18; tW: 300s; Start: 123311; End: 123811;
Recording: 5-1; Individual: 32; Drug: NDMC 1 µM
bLcRcbRsRcRibLjLebReReRibRsbLebLeLebLsLgbLebLgLcbLsLsLsLsLcLhmmmbRgbLe
bLgbRcbRebLoLiLsbRebRsRgRsRembLsbRgReLsbReRsmbRiRgRsmbRebReRsmbReRsmbR
ebRgRsmbRgbRgbRgRsmbRebRcRsRembRcbRhbLibLhLgbRiLibLebRebLjLsLsmmbLeLsL
smbLeLcbLgLgbLeLcbRsbLcLcRsbLcLsLombLsLsLsLemmbLgLgLebRgRsmbRebRcRgbLe
LsLsLsmmbLsLsLsLsLsLsLsmmmmmmbLsLeb

>ZF Recording 2016-03-18; tW: 300s; Start: 123311; End: 123811;
Recording: 5-1; Individual: 33; Drug: NDMC 1 µM
bRcRsRcLcLembLcLobReLiRebRsRsRsRsRsmmmmbRgLcbRoRsmbRsRhbReRsmbLeLsRebR
gbLoRsRcRoRsLcmbRsRsLcmbLeRsRobLsbLcbLiRsLoRsbLsbLcLcbRibRcbRcRcLsbRob
LgbLcLibLcbLsbLeLsbReLcbLsLsLsLsLsLsLsLsLsLsLsmmmmmmmmmmbLgRgbLsLsmbRo
RobLcLoRsbRiLoLsmbLibLiLsbLiRsLsbLgbLcbRsRobLoReRobRoRcRebLiLsbLeLeLeb
LeLsLhbLeLibLsbRsLsLsLsLsmmmbRoRcbRhRsRsRgRommbRcb

>ZF Recording 2016-03-18; tW: 300s; Start: 123311; End: 123811;
Recording: 5-1; Individual: 34; Drug: NDMC 1 µM
bsbLcRsbLeRsbLjbLiLgbRcbRoRsmbRebRoRsRgmbLibLoLsmbLiLebRibLcRsbLcbLcLc
bRcbRebRibRobRhbLgRibRgbLebLebLoRsbRibRcRsRsRcRsReLemmmbRsLgbRcbLcLsmb
LgbReRhRoLgbRsbRiLgLibRsRsmbLoLhbRobLcbRsRsRsRsRsRsmmmmmbRobLobLebLebL
ibLibLsLsLsLsmmmbLeLgbRebLgbLoLobLgbRebRebRibRhRsRsmmbLobLhLsLsmbLebRe
LhLsLsLsLsmmmbLiLcbLsLebLgbRoRibReRoRsmbReRsmbRebLgbLoLsLsmmbLibLebLcb
LgbRobRobRgbRsbRobLhbLcbRsLsLgb

>ZF Recording 2016-03-18; tW: 300s; Start: 123311; End: 123811;
Recording: 5-1; Individual: 35; Drug: NDMC 1 µM
bReRsmbRsRgbRsbLsRsbLsLebReReRsmbLcLcbRiRsRsmmbRobLcbLcLsmbLsbLhLcRsbL
cReRsmbRiRsRsRgRsmmmbRebLhbLcbLsLsRsmbRcRsRsmmbReRsRsmmbLsbLcRgbRebRob
RgbsbLcbLgLsLebLsLebRcbRebRebRebRiRsmbRgRsRgmbRgRsRgRhmbRiRsmbRsRibLcR
sRebsbsbRcLeLsbLebReRsmbLsbRgbRsRgbLsRiReRgRsmbLeRsbLgLcLsLsmmbLobRebR
sRebLoLcbLcLsLsmmbLebLebRiRsRembLgRhbRsRsRsRgmmbRgRsRembRibRsRsRgRiRcR
smmbRiRsRsRemmb

>ZF Recording 2016-03-18; tW: 300s; Start: 123311; End: 123811;
Recording: 5-1; Individual: 36; Drug: NDMC 1 µM
bRcRsmbLgLsLsLsmmbRebRhLsLsLsLhLsmmbRcRsRsmmbRgRgRgRhLebLhRsRsRsRsRgmm
mbRgRibLcLsLsmmbRsRsRsReRimmbRcRsRsmmbRcLsbLcLsLsmmbRibReRibRjRcLobReb
ReRsmbLgbLoRsbLgLsRsRsRsRsmmmbLcbLsLsmb

>ZF Recording 2016-03-18; tW: 300s; Start: 123311; End: 123811;
Recording: 5-1; Individual: 37; Drug: NDMC 3 µM
bRsbLobRsbRsRsmbRsRsRsRsRsRsmmmmmbRsLsRsRsmbRsbsbRsRsRsRsRsLsmmmmbRsLs
RsbLjbLsb

>ZF Recording 2016-03-18; tW: 300s; Start: 123311; End: 123811;
Recording: 5-1; Individual: 38; Drug: NDMC 3 µM
bRiRsLcLembLebLebRcRsRsRsmmmbReReLsbLgbReRcRsRsRsmmmbRsRsRembRhRsmbRsR
ebRcLsLsRcmbRsRsRoLeRsRsRsmmmbLoLsLsmmbLsLsLiLsLgmbLsLsLsmmbRcRgbRebRg
bRibReRsReRsLemmbLsbRebRiRiLoReRsRsmmbRsReRsmbReLsbRgRsRsmmbRgbRjbLiRg
bRsRsmbLoLcbLibRebRebRebRebRjRsmbRcbRcbLoLsmbLebLsLgLebRsbLgRsRjbLobLo
LsmbReRsRimbRgRsRsmmbRsLsReReRgb

>ZF Recording 2016-03-18; tW: 300s; Start: 123311; End: 123811;
Recording: 5-1; Individual: 39; Drug: NDMC 3 µM
bLcLiLcbLebLcbRgLsbRsRsRsmmbRhRsmbLibLibRcbRsRsmbRcRiRgReRcRcLcLsmbLcR
eRsmbRgbRgLsbLoLcLcLsLembLeLcLsmbLeLebLsbReLsbRobRhReRibRhRebLcbLcbLcL
cbLibRebRcbLcbRsbLcbLebLgRebRsRcbRebRebRebRebRiRsmbRcLsbLebLebLebLgLjb
LsLsmbLebLebLcLjbLebRebRibRcbRgbRebRsRsRsRsmmmbRibsbRsbLcbLgLebLgbLebL
ibLibRcbReRibRsbRhLsLsLjmbLcbLgLsLsLsmmbLgLiLjbRsRcbLsbLebLgLsLsmbLeLh
bLebLgbLgLiLsbLsLgLgbLeLcbLeLsLsmbLiLgbRgbRgbRsReRebRsReRcbLcLcLgLsLcR
eLsRibRsRiRsRsReReLsLsmmmbLiLsLcLcbRsLsLsmbLiReRsmbRcRobReLcbLsLsLsLsL
sLsmmmmmbLsLsLsmmbLsLsLiLeLeLsmbLgbLcLsmbLsLsLsLiLgmmbRibRsRsRsRsmmmbR
eRsmbLsLsLsLcLeRgLommbLsLsLsLcLsmmmb

>ZF Recording 2016-03-18; tW: 300s; Start: 123311; End: 123811;
Recording: 5-1; Individual: 40; Drug: NDMC 3 µM
bRebRcbLebLoLsmbLgLsbLsbRsbLsLsmbLeLgLgLebLebReLsbRiLsLsRcLsmbLsbLibLg
bLcbLoLsLsLcmmbRiRsRsRcLcmmbRobRgbLsbRsLhbLsLsLsRimmbRcLcRcbRsRiRsmbRi
RsmbRibReRiRcbRgb

>ZF Recording 2016-03-18; tW: 300s; Start: 123311; End: 123811;
Recording: 5-1; Individual: 41; Drug: NDMC 3 µM
bLiLsRsbRhbLibRcbRsRibRobLeLsbRobLhLsbLiRsbLcbRcRsmbLcLeLsbRoRcRsmbLcb
LiLsLgLsbLebLsbLoLsLombLebLibRsRsLsRsmbLebRcbRebRibRgbRsRsmbRsbLebRcbR
ebRebRebRsRiRiRsmbRsRgb

>ZF Recording 2016-03-18; tW: 300s; Start: 123311; End: 123811;
Recording: 5-1; Individual: 42; Drug: NDMC 3 µM
bRiLibLoLsmbLeLsLebLgbLebLsLsLsmmbLsLcLcbLeLsLsLombRsbRsLsbLsLsmbsbRsb
LsbRsbsbLsbLgLsLsReRiRimbLebLsLsLsmmbLsLsLsLsLemmmbLebRebRebRebRgbLcLs
mbLsbLsbLebLsLebRsbsbLsbLsbLsLsLsLimmbLcbLsLsLsLgLsLcmmbLgbLebRibLcbLh
LgbLsLebLibLoLsmbLeRoLsbLgbRjbRebRiRhRcRsmbRsRsmbRgLsRsbLebLebLobLgbLe
LhbLgbLobLcbLibRobLcbRsbLebLebLiLobRcRsmbRsRsRgRsmmbRsbRcbLsbLobRebLeb
LsLsLsmmbRsRsLsLembReRsRgRsRimmbLebRsbRebLcLeLibLgLsLsmbLcbLeb

>ZF Recording 2016-03-18; tW: 300s; Start: 123311; End: 123811;
Recording: 5-1; Individual: 43; Drug: NDMC 10 µM
bLiLsLiLcRgRoRsmbsbsbsbRsLsbLsbRsbRsbRsbLsbLsbRsLsRsbLsbLsbRsbRsLsbLsb
RsLsbRsbsbLsbsbsbLsLsmbsbRoLebLsRcLebLiLsLoRsbLoLsRsLhmbLhLobRiRsLombR
eLoLsmbLhLsbLeLsbLsLsmbLgLsLsLsmmbLobRcbRgLsbRsRsmbsbRsbsbRebLgLsLgLgb
LobLebLsbLcRcbRoRebRsRsLsmbLebRjRcbRebRsRsRsRemmbLebLcbLibLiLsLgLgbRcR
cbRsRsRsRsmmmbRgRsRsLsmmbRgLcbLoLsLiLsLoLsLsLcmmmbLcLgLsLeRsbRsRsRsRsR
smmmmbRobLsRsbRsRsmbRjbRebsbRsLsLcLeLgLeLcbLsLsLsLcmmbLsRsLsbLgbLsbLsL
sLsmmbLeLcLsLcLoLiRsmbRsRsmbLsbLgLgLsbRjbLiReRsmbRebRsRsRsmmbRiRsRiLsR
embRsbRsRsRembLeLiLiLiLobRsRsRsmmbRsbRcRcRsmbRsRsRsRsRcLemmmbLeLhLsbLe
bLsbLsLsLsLsmmmbLsLsLsLsLsLsLsmmmmmmbLsRsLsbRsbsbLsRsbLiLcRoRcbRsRsRsR
sLsmmmbRgRsRsRsRsmmmmbRsRsRsReLcRgmmbRsbLsLsmb

>ZF Recording 2016-03-18; tW: 300s; Start: 123311; End: 123811;
Recording: 5-1; Individual: 44; Drug: NDMC 10 µM
bRcLsLsLcmbLeLcLoLsmbLeLsLsLsmmbLsRsRsmbsbRiRgRsRsmmbRcRsmbRsbRgLsLsLs
mmbLeLsbLeLeLcLcLgbLgbLcLgbRiRobRcRsmbRcRobReRsRsReLcLcLsmmmbLsLgLhLcL
cbLeLsLobRcRsRsRsmmmbLsRsbRgbLeLeRibReLcbLiLcbRibLsbRgbRsbRhRsRsmmbLeb
LhbRebReRsmbRebLsRsbLebLibLhbRibLjbLgbLgbRiRgRoLgbLgLeLcLebRcRsRsRommb
LsLcbRebLebRsRsRsRemmbLgbLgbRebLcbLcbLebRgbReRsRjmbRhRcbLsbRsRsLsRsmbL
sRsRsRsLsRsRsRsmmmmbRiRsRsLsLcmmbLebLhLcbLebLsLsLsLgLsmmbLsLsLsLsLsLsm
mmmmbLiReRcbLsLsmbLsLsmbLgLsbRcbRiRsmbLcbLsbLcbReRcbRsbRibRsRsmbRgbRcR
obLebLcbLcbLgb

>ZF Recording 2016-03-18; tW: 300s; Start: 123311; End: 123811;
Recording: 5-1; Individual: 45; Drug: NDMC 10 µM
bLeRgbRoRebLcbRgbRobRgRsRsRsRgRsmmmmbRsRobRsRgRiLoRsLsbLsLoLoRebRsRsmb
RcLcbLgbRsbRcbLcbLibLcbLsLgbLsLsRcRcmbLjbRgbRebRibRobLebLsbRsLgRhbRsbR
cbRiLsbLcbLgbLeLebRiRebLsbReLgbLcbLcbLebLoRiRsmbRibLcLiLsbLsLsRsRcRsmm
bRgRcRsRsmmbRgbRjbRsbRjbRsbRsbLsbRsbRsbLsbRsbLobReRsRhLoLsmmbLgLsLsmbL
sLgRsLobRgbRoRobRebRsRsmbRsRsmbLcLhRebRebRgbRebLgLcLebRsLgbLsLsLsLsLsm
mmmbRsRsmbLhLebLcLgLobLsLsLsRsLcmmbRsLsbLgbLiRsRcRcRcb

>ZF Recording 2016-03-18; tW: 300s; Start: 123311; End: 123811;
Recording: 5-1; Individual: 46; Drug: NDMC 10 µM
bLsbRjRgRsmbRgbLeLsLsmbLibLgLsLgRjbLoLoRsbRsbRgbRsbLiRebLoLsmbRsbReLgL
ebRsRsRsmmbRsRgRiRobLoRsRjbLhRsbRcReRsmbRebsbsbReRobReRsmbsbReLcbLsbLs
bLiLsLgLebLsLibLeLiRobRiRgbRcbRgRsRcmbRoLsLsLoLsRsmmbLsbLgLsLsLsLsRcmm
mbRgRcbRgLcbRebLebLebRebRcRsRembRgRgRsmbRgRgb

>ZF Recording 2016-03-18; tW: 300s; Start: 123311; End: 123811;
Recording: 5-1; Individual: 47; Drug: NDMC 10 µM
bRobReRsRgRcmbRsRsmbRiRsRsRsmmmbRsRsRimb

>ZF Recording 2016-03-18; tW: 300s; Start: 123311; End: 123811;
Recording: 5-1; Individual: 48; Drug: NDMC 10 µM
bLcLsmbLgbRsbLebReReReRcbLhRcbLsLjbLgLgbRsLsbLoLoLoLsmbReLsRobReRcRsmb
RcRhLsRsRsmbRobRoLsLsmb

>ZF Recording 2016-03-18; tW: 300s; Start: 123812; End: 124312;
Recording: 6-1; Individual: 1; Drug: Control
bRebRoRcbRsRsRsRsRsLsmmmmbRoLcbRibRsRsRiRsmmbRibRsRebLgLsLsLsmmbLgbLsL
sRsRombRibLgLsbLibLgLsbLibLsbLcbRhRsRsRsmmmbLjbLebLibRgbLebLibLsbLibLe
LsbLgbLebLibLgLebLibLsLgLsbLgbRcRsRsRsRgRsRsmmmmmbRibLcRsbLebLgLcbRibR
cbRcLsbLsLsLgLsmb

>ZF Recording 2016-03-18; tW: 300s; Start: 123812; End: 124312;
Recording: 6-1; Individual: 2; Drug: Control
bLeLgLsLsmbLebRebRsRibLhbLebLsLsmbLsLeLsbLeLsbLebLeRsRsmbRiRsRsmmbRsbR
eLsbRcRgRsmbLeLsbLeLeLcLsLsLsmmmbLibLebLibRjbReLsbRsRgbRiRgRsRcmbLeLsb
LeLcbLcbLeLsbLgbLcLsmbLeLsbLgLcbRsLebRiRsmbRcRcbLsRsbLcbLcLsmbLebLebLs
bLcbRgRgbRcbLeLsLsmbLcbRhbRhReRsmbRibLeLsbLeLsbRebLcLebLsLebLebRebLgbL
cbLibLebRebLsbRsbRcbLiLsLsmbLebLebLcbLebLcbLgbLcbRjbLibLhbLebReRsmbReb
LebRcLsbLcbLebLibRsbRebRibRcbLebLcbLobLcLcbLeRgbRebLebRoRsRembRgRebRib

>ZF Recording 2016-03-18; tW: 300s; Start: 123812; End: 124312;
Recording: 6-1; Individual: 3; Drug: Control
bRebLgbLebLebLgLsbLsRsLsbLgRsbLsLsmbRebLebLcRgbLgbLebLebLgbLebLgLsLsLh
mbLhbLsbLcbLoLobLobLibLsbRgbRcbRebRebLgbLgbLsLsmbLcbReRcRsRcmbRiRiRebL
eLeLebRsbRcRcbRcbReLeLcbRoLsbLcbRsLsbLebLgLsbRsLsRsRsmbRjbRjbRoLsbLsLs
LcmbLiLsLsRsmbLiRgLcRsbLsbLiRjbRhbLoLcLobLiLsbRsbLcLsLsLgmmbReRcbRcRcb
RgRsRsmmbRsbLsLsRsRsmmbRsRsRsmmbRgRsRgRsmmbRsLeb

>ZF Recording 2016-03-18; tW: 300s; Start: 123812; End: 124312;
Recording: 6-1; Individual: 4; Drug: Control
bLsbLjbRcRcRsmbRsRsRsRhRimmbRgRgReRsRcmbReLsLsLsmmbLcLsmbLeLcbRebRebLe
bLiLsbLgbLibLibLeLsLsmbLgbLgbLebLsLsmbLsLsmbRgRibLsLsLsRsmmbLgbRcRsRcR
cmbReRsRgRsmmbRgRcbRsRsRgRombRiReRgbRiLsbRsRsLsmbLgLsLsmbLsLsmbLsLsLsL
gLsLommbLgRsLoLsmbLoRsbLeb

>ZF Recording 2016-03-18; tW: 300s; Start: 123812; End: 124312;
Recording: 6-1; Individual: 5; Drug: Control
bRgbRebRobRgRsRsLsmmbLiLsbRsRsmbRsbRsRcLeRibRsbLsbLsbLsbLsbRsbLebReLgL
sbsbLsbLgbLsbLgbLcbLiLsRcbRsbRsRsmbRsLsRsLsbRsLsbLsLsLsmmbLsbRsbsbLsLs
mbsbRsbsbRcbLebLiLeLgbRebReRebReLsbRebsbRsbsbLsbsbRsbLsbRsbsbsbsbLoLcL
ebLebLsLiLebLgbRebReRsmbsbRiRsReRgLsmbLeReRsReRsmmbRsbLsLsLsmmbRsbRsbR
sbLsbLsbRjbRsbLsbRsbRcbRiRsmbRebReLcbLcLeLgbLsLebRgRsLsmbRsbRcbLibLsLs
RsmbLgLsbLiLebRcbRcLsRsbRebRobLsbRebRobRsb

>ZF Recording 2016-03-18; tW: 300s; Start: 123812; End: 124312;
Recording: 6-1; Individual: 6; Drug: Control
bLobLebLobLeLsLsLeLeLgLimbLgbLebLibLsbLgLsbLhbLsLgLsbLsLsmbRsLibLsRsRs
mbLeLsbRsbLgLsbLgbLsbRsLsLgbLsLsLsmmbLebLiRebRibRebRcbRcReLcLeLjbLgLsL
sLembLebLsbRcbRgbLcbLebLibLhbLcbLcbLcbLcLebLibRibLsbRgbRsRgb

>ZF Recording 2016-03-18; tW: 300s; Start: 123812; End: 124312;
Recording: 6-1; Individual: 7; Drug: NDMC 1 µM
bLjbRsbLjbRsbLsbRsbLjbRsbRsbLsbLsbRsbLsLjbRsLsbLsbLsbRsbLsbLjbRsbRsbLs
bLsbLsbRsbRsLsbLsbRsbLsbRsbLsRobRoReRebReRsmbRiRsReRsmmbRsRsRsRsRsmmmm
bRsRsRgRsmmbRsRsmbRsRsmbRsbRgLsRsRsRsRsmmmbRsRsRsRsmmmbRiReRoRsmbRgRsR
sRsRsmmmmbRebRgbRsbRibRgbLgbRgRsRsmmbLobLebLcLsLcmb

>ZF Recording 2016-03-18; tW: 300s; Start: 123812; End: 124312;
Recording: 6-1; Individual: 8; Drug: NDMC 1 µM
bRsLebRgbRebReRsmbRhbRebRebLsRebRgLsbRsLsLsmbRsbRebRcbsbLiRcbLebLebRhR
sLsRsmbRiRsmb

>ZF Recording 2016-03-18; tW: 300s; Start: 123812; End: 124312;
Recording: 6-1; Individual: 9; Drug: NDMC 1 µM
bReRsmbRsRebRsRgRsRgmbLsRsRsRsRsRsRsmmmmmbRoRiRsRsRsRsRsRsRsRsmmmmmmmm
bReLsbReRsmbLeLsbLebLsLsLembLcLsLsmmbLobRgbRsRsLsLsLsmmmbLsLsLsLgLsLsL
cmmmbsbLcLsLimbLsLeRsbReRsmbRebRebRsRsRsRsmmmbRebRoRcRsReLsLsLsmmmbLsL
sLsLeLsLsmmmbLsLsmbLcRsRsmbLgbRcLeLebLsLsLimbRcLcLsmbLgLcbLsLsLembLsLs
LsLsLgLsmmmbLobRcLeRsRsRgReRgRgRsmmbRsRsLsmbRobLsbLibLibRhbRcRsmbLcbLc
LcLsmbLiRsLsbLgLsLsLgLsmbLobRcbRsRsRsRsRsRemmmmbRcbRebLebLebLsLsLsLgLs
LsmmmbRgbRcbRhRsRembReRsRgRembRebRhRibRgRsmbRiRsRsRsRsRsRsRsRgmmmmmmmb
ReRsmbRsbReRgRiRsmbRobLeLsbLsLsRsmbRjRiRsmbLjLebRebRiRebLeLeLebRcbRgRs
mbRsbLsbRcLcLsmbLeLsbLgbLsLsRsmbRcRsLeLsmbLsLsLsLcmmbRgRsLsmb

>ZF Recording 2016-03-18; tW: 300s; Start: 123812; End: 124312;
Recording: 6-1; Individual: 10; Drug: NDMC 1 µM
bRgbLeLsbLeLebLgLibLeRsLsbLeRsbLsbLeLibLsLgRoLsbLgbRsLsLibLgbLibLiLoRs
bRgRsmbLibLiLgbLsLgRgbRebRsbLcbLebLebRebLsbLebLebLsbLeLsbLeLgbLgLeLeLs
bLeLsLsLhmbRobRhbRgRsmbLebRibRsbLebLebLeLeRsbRebRhRsLsmbRiRsmbRiReRsmb
RsbRebRebLsbReRgbRibRiRsmb

>ZF Recording 2016-03-18; tW: 300s; Start: 123812; End: 124312;
Recording: 6-1; Individual: 11; Drug: NDMC 1 µM
bReLsLsmbLcRcbRhReLeRsbRgbLeRobReRsmbRgRsRsRsLeLsReLeReRgRgReRgRsRgRhR
sLommmmmbLsLsLsRsLsmmbLgbRebLsbRcbRsRsmbRcbLgLhLsLsLsmmbRsRsmbRjRgbLeb
RcbRgRebRoRsmbRebRcbRsbRcbRgbLibLsRsLsRsbLeLsbLgbRibRgLobRgbLsbLebLsRi
bRgbLebRcbRebRcbReLoRjbLeLsLsLgLeLsRembRibRebRsRsRsRemmbRoRebLcLsLsLcm
mbRsLsbLsbRsbRgRebLebRgRsReLgmbLsRgReRibRsRsRembRsRsRgRembLeLsLsmbLsLe
LsLsmbLsLcLgLsLoLeLsbLeLsbLsLsLeLeLsmbLsRsLcbLoLibLebReRsmbsbReLiLsLsm
bRjbLiLsRebRebReRsRsRgmmbRsRsRsRsRsRsRsReRsmmmmmmmbRsRsRsRsmmmbRob

>ZF Recording 2016-03-18; tW: 300s; Start: 123812; End: 124312;
Recording: 6-1; Individual: 12; Drug: NDMC 1 µM
bLsLsLembLibsbRgbRsRebRgRsRsRsmmmbRebRcRoRgbRcRsmbRibRiRsmbLjbRgbLjbRc
bsbLsbRsbRsbLsLsmbLsbLebLebLiLsRsbLiLebRsbLeLsbLjbLgbLcbRsRsRsLsmmbRsb
RsRebRebRhbRebRcLsbLsRsbRebRgbLsbLebLsbRobRgbRiRsLeLsmbLcbLiLsLibLebLg
LeRsbLsLsmbRebRgLsbRebRsRsmbRiRsmbLsRsbsbRsLiRsRcbReRsmbRsbLsbRsRsmbRe
bReLsbLiRiRsmbRsbRgRsmbRhRsmbRhbRiRcbLebRebRcbRobLebLsbLhbRcLibRsbRebR
ebRiLsbsbLsbLobRsLsbLsLsmbRiRsmbRsReRsRsRsLhmmmbRgRgReRsRsRsRsmmmmbRsb
RgRgbRcbLeLeLsbsbLgLeLsbLebLcbRcRsmbReRsRembRebRsLsbRgRsmbRsRebRgRibRg
bRsbRebRebRsRsRsRsRemmmbRsRgRsRsmmbRsbRsRsmbRsbRebRiReRsmbRsRsmbRsbLiR
cLeLsbLebsbLgLsLgbLeLsbLgLgb

>ZF Recording 2016-03-18; tW: 300s; Start: 123812; End: 124312;
Recording: 6-1; Individual: 13; Drug: NDMC 3 µM
bLsbRoRebRiRsRsmmbRgRsRsmmbsbLoRsRobLgbRibRoLebLeLsbLeLsLsmbRsLhRsRsRs
RsmmmbReLobLgLiLobRjbRjReRsmbRhRobReRsLsmbRebRebRcRsRsRsmmmbRsRsRsLsRs
RsRsRsRsRiRsmmmmmmmbRsRsRembRibLgLsLsmbLgRsRsmbLobRsbRsbLcbLoRibRsRsmb
LeLeRsLcbLobRsRsRsRsmmmbLobLsLsRsmbLsLsLsRsLemmbRgRsRsRcRemmbLgbRebReb
RhLibLebLcLsmbLsLsmbRsRebRebRebRebLibLsbRcRcbRoReLsRjbRsbRjRsRsRcmmbRe
RebRebRibRgbRsRsmbRcbLeLsbLoRjbRcbRoRsRsmmbRiRsRgmbRgRibRgRsmbRsLsLsmb
RebLsbRcbLiLsbLsRgRsRsmmb

>ZF Recording 2016-03-18; tW: 300s; Start: 123812; End: 124312;
Recording: 6-1; Individual: 14; Drug: NDMC 3 µM
bRebRcRsmbLsbRsLeRsLcbLsbRhRsmbRcbRebRiRsLgRsRsRsmmmbRsRsRsmmbRgb

>ZF Recording 2016-03-18; tW: 300s; Start: 123812; End: 124312;
Recording: 6-1; Individual: 15; Drug: NDMC 3 µM
bLcbLebLeRsLsLebLibLgRebLgLgbLiRobRcbLcbLsLsmbRobLcLeLsbLsLsLsLsLsLgLs
RjLsmmmmbReRoRcLsLcLsmbLsbsbRsbRsLobRsbLsbLsbLebRsbsbRsbsbsbsbsbLsRsbL
sLsmbLsbLsbsbLsbsbRsRsmbsbRsbRsbLsRsbLsRsbRsbLsLsmbLsbRsRsRsmmbLsbLsbL
sRsRsmbRsLsbRsbRsbLsbLsLsmbLebLgLsLsLsLsmmmbLsbLsLsLsRsmmbsbLsbLsRsRsL
sLsRsLsRsmmbRsbsbsbLsbLsbsbLsLsmbLsLsmbRgLebLebLsbLsRsLsLsLsRsmmbLgRjR
cLjbLcbLjbRebRcbRebRebLsLsRembLebLebRcbLhRsRobLsRcbRsbLiLsLsLembLebLeL
sbRsLsLsLsLsLsmmmmb

>ZF Recording 2016-03-18; tW: 300s; Start: 123812; End: 124312;
Recording: 6-1; Individual: 16; Drug: NDMC 3 µM
bLibRcbsbRsbRhbRsRsLsLsLsLsLcRcLeLsmmmmbRsLsLsLsLsLsRsLcmmmmbRcbRsRsmb
LsbRcbLibLcbLgbRoRiLsbRsbsbRsRsRsmmbLebRsbReRcbRibRhbLgbRebRiRsmbRhLsb
RgRsRsmmbRsRsRsRsmmmbsbLsRsbRoRoLgRcbLeLcLsLsmmbRoLebLiRjbRebLibLjbRob
RsRsmbRgbLsbRgRsRembLiRoLhLcbLsbRsRgRgRsRsRsRgRsLemmmmbRoLgLsbLhLebRsL
ibLsLsLiLhLiRembLsLsLsRcmmbRsRsRsRsRsRsLsLsLsmmmmmmmb

>ZF Recording 2016-03-18; tW: 300s; Start: 123812; End: 124312;
Recording: 6-1; Individual: 17; Drug: NDMC 3 µM
bReRsRombRcRsRsmmbRgRsLsLsmmbRobLsbLeRsbLsbRoRebReRibRcLsbRsbLgRsbRgbL
ibLsbLcLcbLcLsRsmbLsbLcbLebLsbRcRcbReRsmbRibRcbRgbLeLgbLgbLebRsLsbLebR
eLsRsbRhbRcRsmbRgbRsRsRcmbRsbLjbLeLsLsRombRcbRebLcbLgLsbLobReRoLsbLiLe
bReRsmbLoLcLibRcbRebRcbRcbReLsbLhbRiRsReRsmmbRgRiRhbRsRebRebRebLibLsLc
LsLcmbRiLhbLcLsmbLgLsbLoRhbRiRobLcRsbRebRibReRcbRebRiRebRhRcbReLsbRsRs
mbRgReRsmbRebRebRcRsmbRsRsmbRgbRiRoLsbRgLcLsmbLgbLebRsLeLcbLcbLsRsbLsL
cLoLcLsLsmmbLsbRsRsLemb

>ZF Recording 2016-03-18; tW: 300s; Start: 123812; End: 124312;
Recording: 6-1; Individual: 18; Drug: NDMC 3 µM
bLcLcLsmbLsLsmbLgbLsLsmbRsLgbRsRoRsmbLobRhbReRgRgRcbRebRibRibRobRebReb
RgbLsbRsbLsbLebLebLgLsbLsLsmbLcbLcbLiLebLcLsLembLsLsLembLiLsLgLsLgbLsL
gbRsLebRgRcbLoLcbLiReLsbRibRjbLgbLgRgbLeLeLeLhbRibLgLgLibLoRsRsLsmbRsR
eRsmbRebRebRsRsRsLsmmbLcRibRsbLeLsbLcLibLiLebLsbLebLebLgb

>ZF Recording 2016-03-18; tW: 300s; Start: 123812; End: 124312;
Recording: 6-1; Individual: 19; Drug: NDMC 10 µM
bRoLgbRibLeRsbLsLsLsmmbRebReRsmbRsRebRcRsmbLhbRsRcbLebRobRebRobRcbRebR
cbRsbRebLcbLsLsmbRsRebReRsRsRgmmbRebLcLebRoLsb

>ZF Recording 2016-03-18; tW: 300s; Start: 123812; End: 124312;
Recording: 6-1; Individual: 20; Drug: NDMC 10 µM
bRcbRiLsbLcLsmbLgLoLsmbRoRsRsmmbRsRsRsRsLeLsmmmbLhLebLeLebLsbLebRgRcRs
mbRsbRsbRsRsRsmmbRcLsbRjLgbLgbRcbLjLsRsmbLebLgLgLgRobRhRsmbRebRgbRgLsL
smbRcReLsbRobRcLebRebLoLsLsLsLsLsLimmmmmbLebLiRcbLgbLhLjbLsbLsLsLsLemm
bRoRobRobRsRsmbRgRsLsmbRibRobRhbRgbLeLsLsLgLombLibRcbRebReRsRsmmbRgRiR
sRgLgLgLsmbLsbLgbLhLsLsmbLgRobRebReRsRembRoLsbRcRsmbLeLsLsmbLgLsRsLsbL
iLsRjbRhb

>ZF Recording 2016-03-18; tW: 300s; Start: 123812; End: 124312;
Recording: 6-1; Individual: 21; Drug: NDMC 10 µM
bLsLsRimbRsbLsReLobRcRgRsmbRebLgLsbLgLsRsbLsLsmbLebLgLibLebLebLebRcbLs
bRsbRibRobRebRebRebLgbLibLhLsbRgbRgLgRoRsmbRcLsbLcLsmbLeLgbRcRsmbRgRgR
sRhLsmbLcbRoRobRibRcbLebLobLcbLobRsbLsbRibRebRebLsbRoLsbLoLoLobLgbReRs
mbRgbRsbRebRiRsmbRgRiRsmbsbRiRsmbLsLsRsRgmbRgRgRsmbRiRhbRebLebLibLiRsb

>ZF Recording 2016-03-18; tW: 300s; Start: 123812; End: 124312;
Recording: 6-1; Individual: 22; Drug: NDMC 10 µM
bRibRcRsmbRebRsLibLcbLebRoRhbRibRhbLgRsbRsRsRgmbLebRebRcRibRcbRebRsReb
RebRebLiLsbLsLsRsmbsbsbsbsbsbsbsbsbLsLsmbRsbsbLsbsbsbsbLsbsbRjbLibRebR
ebRsbRhbLhbRibRebRibLebLeLgbLsLsmbRsbLsbsbRjbRebReReRsmbRhbReLcbLobLsb
sbRsb

>ZF Recording 2016-03-18; tW: 300s; Start: 123812; End: 124312;
Recording: 6-1; Individual: 23; Drug: NDMC 10 µM
bRgLsbLsLeLcbLeRcbLsLsmbLsbLgbLgbRsbReRsmbRcbRsLcLibLsLebReRgRsRsRsmmm
bRsRsRgRsmmbRiRebLebRebLcLibLgbRcRobLsRsbLeLsRebLgLsLebLcbLibLsLsLsLsL
smmmmbLeLcbLiLcLgLcbLsLsmbRebLsLcbLsbLgbLsLsmbLsbLsbRibRoRsmbRsRsRsRgR
smmmbRcbRebRsRsRsmmbLsbLcLsLcLsmmbLsbLeRsLobLsLsmbLgLsbLsLgbsbReRoRcRi
LcbLsbRsbLcbRoRsRsRsmmmbRjbLcbRgbLsbRsRsmbLsRsbRiRebLcbLsRgbRsbRsRsRsm
mbReLebLsLgLebLsRebRebLebRcLobRebLgLsbLebReRobRsRsmbLobReRsLsmbsbsbReR
smbRsRgbRcLoLsmbLsbRiRgbRsRsmb

>ZF Recording 2016-03-18; tW: 300s; Start: 123812; End: 124312;
Recording: 6-1; Individual: 24; Drug: NDMC 10 µM
bLiRoRsmbLsLsmbLcbLsbReLgLobRiLsLsLembLiLsLhbLebLsLsmbLgLgbLobLhRsRsLg
RsmbRgLsbRsbRgLoLebRebLsLsLsmmbLsRsLjbLobLcbRoLsLsmbLsbRsRsRsRsRsmmmmb
RsbRjbRobLcbLcbLsbRcRsmbRcbLeLsbLgbLjLcbLgbLoLgbRhb

>ZF Recording 2016-03-18; tW: 300s; Start: 123812; End: 124312;
Recording: 6-1; Individual: 25; Drug: Control
bLcbReRsmbRgLeReRsmbRiLiLcLebLgbLebLcLoReLsRsbRsbLgRsRebLsLjRiRsRgRsmm
bLsRgRgbRhReRcRsRsmmbRebLcRsbRsRsRsRsmmmbRsRsRsRsRsmmmmbLgbLeLcLsmbLsL
sLsLemmbLcRcRhbLsbReRoLcbRiReRsmbRgbLoLcbLsLsLsLsLsLsmmmmmbLcRsbReRsmb
ReRcbRiRebRcRsmbRiLebRebRgReLebRgReReLsbLsbLeRibRgLsbLebLebLiLsbLebReb
LgLebLeLebLeLcbRsbReLsbLeRebRebRsRsmbRcbRsbRiRgLgLsbRhRsRsRsRsRsmmmmmb
LsbRsRsLsmbLebLjbLhLebLgLsLsmbLsLsmbLsLsLsLsLsLsLsmmmmmmb

>ZF Recording 2016-03-18; tW: 300s; Start: 123812; End: 124312;
Recording: 6-1; Individual: 26; Drug: Control
bRhRsRsRcLsRommbLeLsbLebLgLoLsmbLsLsmbLgbLeLcbRgRgRsmbLcbLeLcbLeLgbLsL
sLsLeLsmmbLiRcRebRcbRebRebRgbRebRebRiLsbLsLsLsLsmmmbRebLcbRgReRobLeLeb
LebLebRebRsbLebRsbLeLhbReRiRsmbLhbLsbLebRgbRsRsRembRoLgbLebLcbLebRobRs
bRsbLsbRoLoLoReRsmbRgLsLeLebLebLebLebLebLgbRgLebLibRgbLeb

>ZF Recording 2016-03-18; tW: 300s; Start: 123812; End: 124312;
Recording: 6-1; Individual: 27; Drug: Control
bReRsmbLsRgRsRsRsRsRsRsRsRsRsRsRsmmmmmmmmmmmbRobRoRsmbRiRsRimbLebLcbLs
LsRsmbLsLsLsLsRsmmmbLsbLeLebLiLgbLebRibRiRebRiLgLebRiLsbLsLsmbRsLsLsmb
LiLsLiLcbRsLgbLsLsmbRcbRsRebLsRebRsRsmbLebLeLibLcRsbLcLsmbLeLeLsLsLgLe
mbLebLgbRsRsLiLsLgmbLsLsLsLsLgLsRsLgLgRgRsmmmmbRebLsbRsRgRsRsRsRimmmbR
ebRgbRgRsLsmbRcbLiLibLjbLcRsbReRsmbRiRcbRcbLsLsLsmmbLiLsLsmbLjbLiLsbRj
bRcRgRsmbRibRibRibRgRsRgmbLeLsbLcRsRsRsRsmmmbLcLeLeLsbLiLsbLcLgLsbLhLs
LsmbLcbLcbLsbLoRsbLjbRebRiRebRhbRsRebRoLsbLcbLgbLcRcbRiRcRsReRembLcLsm
bReRebRgRsRgmbRcbLgbRebLeLsLsmbLsLibRsbRebLiLsLsReRembRebRsbLsLsLsRsmm
b

>ZF Recording 2016-03-18; tW: 300s; Start: 123812; End: 124312;
Recording: 6-1; Individual: 28; Drug: Control
bLcbRsLsLgbLcRsLsLcbLcbRoRsRsmmbRgRibRcbRjLsbLcbLebRsbRsRsmbRsRsRsRsmm
mbRjReLebRsRsmbLeLeRsbRsRsReRsmmbRibLiRsbLsbsbRsbRsbRgbRoRoRsmbRsRsRsR
cmmbsbRsbLsbsbsbsbsbLsbLsbRsbsbsbsbLsbLsbRsbLsbRcRsmbRiRebRobRsRsRsmmb

>ZF Recording 2016-03-18; tW: 300s; Start: 123812; End: 124312;
Recording: 6-1; Individual: 29; Drug: Control
bReRsRoRsRsmmmbRsRsRembLsbLsbLsRsLsLsLsLemmbRibRoRcbLeLsLebRgbLcbLebLi
LcbLsLsLsmmbLiRgRsmbRcLsLsmbRjbLgbLobLcbLgRsbLebLcbLhLsLsLsLsmmmbLcbsb
RsRsRsLsmmbLobLgbLobLebLeLsbLsLsLgmbLebLsLsRsmbRebLiRobReLsbRiRoRebLsL
gLsLsLembRgRsRsRgLsmmbLeLcLsmb

>ZF Recording 2016-03-18; tW: 300s; Start: 123812; End: 124312;
Recording: 6-1; Individual: 30; Drug: Control
bReLeLibLcLsmbLeLsbLeLcLcbLiLsbLsLgLiLsLsLsmmbLsLeRsbLsLsLiLsLiLcmbLsb
sbRsbLebLcbRibLsLsRsmbLebLeLiLsLoRsLcLhLgbLibLsbLebLcbLsbLcbRgbRebLsRg
bLebLebLibLgLsLobLiLibLgLsbLsLsLsLsLgmmmbLcLcLiLebLsLsLsLgLeLcLsmmmbLs
LsLsLsmmmbLeRebRsRoLcbLeLsbLeLsLeLebLebLsbLiLgLsLgbLeLsbLeLcbLcLsmbLsL
ebLgRgbRoLeLcbLsLgLsLsLsLsLsmmmmbRsRhLjLcLcbLgLsLeRsbLsLhLeLsbLebLiLsL
cbLsbRibLoLsmbLsLsLiLgLembRcLsbRoRsLcLcLhmbRsbLebRsLsbLsLsLgLsmbLsLsmb
RjbRoLgbLcbLeRsbLcLsLsmmbLebLsbsb

>ZF Recording 2016-03-18; tW: 300s; Start: 123812; End: 124312;
Recording: 6-1; Individual: 31; Drug: NDMC 1 µM
bLsLsLsLsLsmmmmbReLsbRsRsmbLsLsLiLsLgLeLsmbLsLsLsLsLsLsmmmmmbLsbLgLebL
gLcbLebLcLsLeLsmbLsLgLebLeRsbLeLeLsbLiLsbLsLgLgbLsLsLsLsLsLsmmmmmbLsLs
LsLgLsLsLsmmmmbLsLsLsLsLsLsLsLsmmmmmmmbLsLsLsLsLsLsLsmmmmmmbRsLsLsLsLs
LsLsLsLsLsmmmmmmmmbLsLsLsLsLgmmmbLsLsLsmmbLsLibLgbLgbLsLsLsLsLsLgmmmmb
LsLsLsLsLsmmmmbLsLsLsLsmmmbLsLgLsLsmbReRcLsbLoLsLsLcmmbLiLeLhbLeLsLsmb
LhbLsbLgbLgbLsLsmbLsbLsLsLsmmb

>ZF Recording 2016-03-18; tW: 300s; Start: 123812; End: 124312;
Recording: 6-1; Individual: 32; Drug: NDMC 1 µM
bRhbLcbLiRsbRsbLcbLobRoLcLgLsLeLoLebLebLeRsbLgLebLiLsbLsbLsRibRebRgbLo
bLcbLsbRjbRoLsbLsLsmbLgLsbLiLsLsLsmmbRgLcbLsLsmbLgRsLsbLiRsbLsbRgLgLsL
smbLgLebLgbRgRsmbRoRgLeLcbRiRoLsLsmbRibRcbRjRebLiLebRsLsbReReRsmbRgRsR
sRsRsRsRsReRsmmmmmmmbRiRhbLcbRsbLgbReRgRebRcRsLsLsmmbRgLsbLiRsbRgbRsRs
mbRgRsReLgmbLebLeRsbLebLhLcRsReRcbRiRsRsRimmbRhbRiLsLsmbRebRhRiRsRsmmb
RsbRhbRgbLsbLhRsbRhRsRcmb

>ZF Recording 2016-03-18; tW: 300s; Start: 123812; End: 124312;
Recording: 6-1; Individual: 33; Drug: NDMC 1 µM
bLcLsRcRsmmbRgRsmbRobLiLeLibLgLibLoLobLhLgbLgbLsbRcLcbLcRsbLsLsLsRsmmb
LcLcbLebRibRib

>ZF Recording 2016-03-18; tW: 300s; Start: 123812; End: 124312;
Recording: 6-1; Individual: 34; Drug: NDMC 1 µM
bLeLsLsLiRcmbLebLcRsRsmbRebLobLsLeLsLsLsLsLcmmmbRgRsmbRsbLgbReRgbLebLe
bLebLebRebReRgbLsbLoLjbRcRgbLeLebLebLiLcbLeLsLgbLgLsbLhbLsbReLcLsmbLsb
LobLebLgbLsLsLsmmbRsbReRsRsmmbRcRcbLgLsLsmbRgbRebRsbReRgRiRcbRsReLgbRe
bLcbLebLiRsRsmbLcbLjbLebRcLhbLcLsLeRcLsmbRoRcRsmbRebRgReReRsmbReRgRsRs
RiRsmmmbRsRsmbRoLcRcRoLsbLcb

>ZF Recording 2016-03-18; tW: 300s; Start: 123812; End: 124312;
Recording: 6-1; Individual: 35; Drug: NDMC 1 µM
bLoLoLibLsRsbLobRibRcRsmbLcLobRcbRebRsReRsRsmmbRebLsLsLsLemmbLsbLiLebR
oRobLobLebLsLsLembLoLoLcbLcbLobRcbLcbRibRcbLebLobReRsmbReRebLobRsLgbLi
Lcb

>ZF Recording 2016-03-18; tW: 300s; Start: 123812; End: 124312;
Recording: 6-1; Individual: 36; Drug: NDMC 1 µM
bRsRsRsRsLsmmmbLcbLobReRsRsmmbRiLgLsLibRcRiLsbRgbLoRobLsLsLsmmbRoRsmbR
sRsmbLoLsRsRsRsmmmbRcRoLsbLsLsLsLsLsLsLsLsmmmmmmmbLsLsmbRoRsRsRsRsmmmm
bRoRobReLsbLsbLgRsLsLsLsLsLsmmmmbRsLgbRcbLoRsbRcbLoLsLsLiLsmmbLiLgRebR
ebRebRcbLcLsLsmmbLcbRebRebLgLobRjbLjbReLsLsmbRcbLsLsmbRebLcLoRsbRhLsLo
bRgLgbRcRiRsmb

>ZF Recording 2016-03-18; tW: 300s; Start: 123812; End: 124312;
Recording: 6-1; Individual: 37; Drug: NDMC 3 µM
bReReRsRoRsmmbLcLsmbLsLgLoLebLibLebsbLsLibRsRsRsmmbRsbRsRsRsRsmmmbRgRs
LsmbLsLsmbLsRsLsbRsRsRsLsmmbLsb

>ZF Recording 2016-03-18; tW: 300s; Start: 123812; End: 124312;
Recording: 6-1; Individual: 38; Drug: NDMC 3 µM
bLsLcRcLcLsLeLsmbLebLsLsmbLcRsReRiLeLgLsLgbLsLsLsLgmmbLsbRebLsbLcRsbRo
RcRsmbRsRsmbRsRsmbRcRgRcbReRsmbRsRsRsRgmmbRsRsRembLeLsbLebLobReRsRsRiL
jmmbRiRsRsLiRcmmbRsRsRsRsReLcLsLgmmmmbLebLsLsLsLsLemmmbLeRebRebRiRsRsL
iLhmmbLsLsLsLgLsLsLsLsmmmmmbLsReRsRsmmb

>ZF Recording 2016-03-18; tW: 300s; Start: 123812; End: 124312;
Recording: 6-1; Individual: 39; Drug: NDMC 3 µM
bLgbLsLsmbLcLsLsLsLsmmmmbLeLsbLcLsmbLhRcbRsRgRsRsRsmmmbRsRsRsLsRsRsRsR
sRsRgRgRiReLommmmmmbLcbLeLsLiRcLcLsLsmmbLeLsLsmbLcLgbReLsbRebRiRiRsmbR
sRsmbRsRsmbRoRiRobRiRebLcLsmbLoLsmbLgLhLsLobLhLsLsLembRhRsRsmmbRiReRiL
sbLeLsLsmbRcRsRgRsmmbRibRcRsLimbLiLsbLcLgbLsRebRoLsLsLombLeLobLibLeLsL
smbRebRsRsRsRsReReRcLsmmmbRgbRcLsbLcLsLsLsLhReLcmmmbLcLsLeLsLsmmbLgLeb
LsLsmbLcLibLebLiLsRsbReRsRombRcRsRgRsRhRemmbRgbRoLsLsmbRcRsLsmbRsRsRsR
sRsRsRsRsRsRsRsmmmmmmmmmmbRiRsmbRcReRoRjbLcbLhLsbLcbLebLcbLiLsbRebRibL
eLsLcbRjRsLcLcmbLcLcbReLsLsLsLsmmmbReRibLgLgLeRobRcRsmbRsRsRsRsRemmmbL
ebLcLeLebLeLsLeLebRsbRcLsbLebLeLsbLsLsLgLgLsLembReLsbRcRsRsRsmmmbRgLsL
sLeLsmbLcbLcLiLsLsmbLcLebLebReRsmbLgLib

>ZF Recording 2016-03-18; tW: 300s; Start: 123812; End: 124312;
Recording: 6-1; Individual: 40; Drug: NDMC 3 µM
bRhRobReRcbLebLoRsbRgbRsRsmbRsbLsbReRsmbRibRsRsRgmbRsbReRebRsbReLiLsbL
eLeRsRsmbLebRiLsbRsRsReRsLoLsLsmmmmbLsLoLsLimbLsLsLsLsmmmbLgLsbLoLsLsL
cLsmmmbLeLsbLcbRcbLeb

>ZF Recording 2016-03-18; tW: 300s; Start: 123812; End: 124312;
Recording: 6-1; Individual: 41; Drug: NDMC 3 µM
bRcbRsbLhLeLsbLgRhbRobRsbLsLsmbLsLsLsmmb

>ZF Recording 2016-03-18; tW: 300s; Start: 123812; End: 124312;
Recording: 6-1; Individual: 42; Drug: NDMC 3 µM
bRgRsmbRgRsRsmmbLsLebLcbLgbLsLgLebReRibLgRjbRebRebLebLcLsmbRebRsbRgbRe
bRebRcbLgbLebLgbRebRobLgbRsRebLsbLgbRgbLcbLiRibRgLcLebRgRsRsmmbRiLsLcb
LsbLgbLsLsLsLsLsLeLsRsmmmmbLsLsLsLsmmmbLsLsLsLsmmmbLsLeLsRobLsbLcbLobL
iLsLsLembLcbRsRgRiLeRsbLebLgbLobRsRsRsRgRgmmbRsRsRsRsRsRsRsLsRsRsRsRsm
mmmmmmmmbRebReRsReRsLsmmbRgbRsbLebLgLeRsLsbLsLsmbRgRsmbLobLcbRhRcbRsRs
mbRsRsRsmmbLobLsLsmbLsLibLebLgbLsb

>ZF Recording 2016-03-18; tW: 300s; Start: 123812; End: 124312;
Recording: 6-1; Individual: 43; Drug: NDMC 10 µM
bLjbLebRoLsbLebLsbLjbRcRiLsLsLsLsmmmbRsbRcLhbLcLsLoLsRsmmbLsLsmbLeLsbR
sLsbsbsbLgLsLsLsReLgmmbLjLgLhLsbLsLgRibLobLobLsLsLsLcmmbReRcLsLobLoLsm
bLgbLgbLcLcbLeLsbRgRsRsRsmmmbReRsmbRsbRebRsRsRsmmbRcLcbLiLsLiLgRsRcLsR
sbRiRsRgRgmbRobLsRsLsbsbReLcLsmbLcLiLcLcLsLsmmbLeRsbLcLibLgLsbReLsRiLs
RsRibRsbRsbRsRsRsRsmmmbLeLoLcbLgLebRiRsLsmbRcRsRsLeRcmmbRgRsRiRsmmbRgR
sRsmmbRsbLeLsLsLsLsmmmbRsbReRsRcRombRiRsmbRsRsLsmbLiLiLeRsbLsbLsbLsRsb
LsbsbsbsbsbsbRsbsbLeRcbRiRsmbRgLsRsbLsLsmbLibLsLgLgLsLsLsLsmmmbRsbLsLs
LsLgmmbRsbLsRcbReRsmbRibReRoRsmbRsRsRsRsLsmmmbRsLsbRcbRhLsLsmbLsbLsbLs
RsbRsRsRsRemmbRobRsRsRsLsmmbLeRcRcLobRgbLeLsLsLsLsLgmmmbLsLsLsLsLommmb
LibRsLsbLsLsmbsbLsLsLsmmbRjRjRsmbsbRcRcbRsRsRsRsLsmmmbsbRsbsbsbRebRoLs
bRsLsbRcbReRgbRcbRgRsmbRsLsRsRsmbRsb

>ZF Recording 2016-03-18; tW: 300s; Start: 123812; End: 124312;
Recording: 6-1; Individual: 44; Drug: NDMC 10 µM
bsbRebLcLcLsmbLoRgbRebRgRsmbRgbLeLebLgLeLebLeLsLebLebRebLcbLcbLsbLgbLc
bRgRibRiLsbRibRiLibLcLcRibRsRebRebRgRsmbLibReLsbRsRsmbRjbLiRcbRsRgbRgR
smbLcLsLhRombRebLeRsbLeLgbLsLsmbLsbLiLcbLsLsRimbLgbLcbLebLgbLsRsbLiLsR
sLobLsLibLcbRcbRjbLebRcbRcbRgRsRsmmbLcLsLsLsLsLsLsmmmmmmbLiLcbLgbLsRsb

>ZF Recording 2016-03-18; tW: 300s; Start: 123812; End: 124312;
Recording: 6-1; Individual: 45; Drug: NDMC 10 µM
bLgbRhRsmbRsbRebLcbLsLsLsLiLcRsmmbRsRsReLoLsmmbRsLebRgRsRsRsmmmbRjbRgR
cbRebRoLibLsLsLsLsLgLsmmmbLgRsRebLgLsRsLebLjLsLsLsRsRiLcRsmmmbLeLiLsLe
LcRsbRsbReLebLcbRsRobLebRebRibLsbRgbLibRiLsLsmbLsbLebLebLiLeLoLoLsmbLs
LiRjbRebLgbRgReRsRsRsmmmbRgbRcRebRcbRibRgLgbLiLhLjbRsbLsbLebLoRebLoLcL
ibRiRsmbRgbRgRsmbLcbLobLoLobLcbLhbLsRsLsLsLsmmbLsLsLsmmbLsLsmbLsRsbReb
RcbRsRsmbRoLebLcLsmbLiRcbRsRgbRebRibLoRsReRebLcLsmbLeLobLebLobLsLebRsR
sLsmbRsLhReLiRsbRgbLoLeLhRsbLeLcLeLsbLsbLsbRsRsRsRgRsmmmbLgRsRcRsRcRsR
eRsmmmbReReRsmb

>ZF Recording 2016-03-18; tW: 300s; Start: 123812; End: 124312;
Recording: 6-1; Individual: 46; Drug: NDMC 10 µM
bLcbRcbLeLoRibLsbRsLsbLjLsLgmbLibLobRcRgRsRsRgRemmbRiRebRsbRsbLsRcRsmb
RsRsRsRsLeRcmmmbRebLebLsLiLsLsmb

>ZF Recording 2016-03-18; tW: 300s; Start: 123812; End: 124312;
Recording: 6-1; Individual: 47; Drug: NDMC 10 µM
bRsRsLsRsRsLsLsmmmbLcbRcbRjbLsbRcLsLgbLgLsLibRsbRsbLsbLsbLsRsbLsbLsbLs
bRsbRsbLsbLsbLsbLsbLsLsmbLgLsRsRoLsbLeLebRgRgRgRsRsRsmmmbRsbRsRsRsRemm
bLoLebLeLsbLeLiLebLgLsLsRsmbLsLsLsLsLsmmmmbLsb

>ZF Recording 2016-03-18; tW: 300s; Start: 123812; End: 124312;
Recording: 6-1; Individual: 48; Drug: NDMC 10 µM
bLsLiLcbLsbLcLgLoLobRsRcbReLibLcbReLibLgbLsLsLsmmbLsLibLoRjbLhbLebLcbR
oLibLebLebLcRsLsbLobLsLsmbLoLoLobLebRibLoRcRibLebRgbReRsmbRebReLgLsbLh
bLsLsLsLsLsLemmmmbLsLeLoRsbRiRebRcRsRhmbReReRsRembRgRsRsRsmmmbRsRsLsLi
mbLcLoLcLhbLhLsbLsLeRgbRsRobLhRsLcbRgRsmbRsbLeRebRiRsmbRiRebLcbLebLoLs
mbLebRgLsbLebRibRcbRcbLsbLiLsbRsRsmbRjReLcbLcbRsbLoLebLsbLebRgRgReLeLs
LhLgRsbRgbRjbLcbLebLcRsLoLebLsRiRiRcRsmbRebRobLibLgb

>ZF Recording 2016-03-18; tW: 300s; Start: 124314; End: 124814;
Recording: 7-1; Individual: 1; Drug: Control
bLiLebLsLebLgLsLsLsmmbLiLgLsbLhRsbLgLebRgbRhLgLsLgbLgLsLsLeLsmbLebLgbR
iRsmbRgbLebLeLsbLebLcbLhbLsLsLsLimmbLgLsbLibLcbRebRiRgbRibRcLgLgLgbLeb
LibLiLsbLgbLibLgLobRebRcbRcbRhbLibRgRsmbRsbLebRsbLsLgbLiLsbLebLgbLgbRi
RsRsmmbRebRsbRcbLebLsLgLcbRibRsRgbLobLeb

>ZF Recording 2016-03-18; tW: 300s; Start: 124314; End: 124814;
Recording: 7-1; Individual: 2; Drug: Control
bRiRsRembRsRsmbLcbLsbLgbLcbRebLobLebLebRebLcbLcbRcbLcbRebRcbLsLgLcbLsL
eLsbRibLgbLgLcbLeRsbRebRgbRcRebRcRgRsRsRsRsmmmmbLeRhbRebLgRsbLsLsLsLem
mbLeLcbLgbLcbRibLsbLebLeLsLsmbLebLebLgbLebLebLcbRebRiRebRibRebRebRebRo
bRcbRebRgbRebRebRsRsmbRibRibLcbRcbLcbLgRsbRebLebLebLebLebLebLeLsLebReb
LeLsbLcbRsbLeLsbLebLebRcbRcbRcbLebLeb

>ZF Recording 2016-03-18; tW: 300s; Start: 124314; End: 124814;
Recording: 7-1; Individual: 3; Drug: Control
bRgbLeLsLcLgLsbLhLsLsmbLgLeRsRcbRsbRobRcbRebRebRgbLebLcbRcRsLsmbRgbLjb
RebRebRebLebLibLcbLebLebRgbLsLsmbLebLiLsLibRsLcbLebLcLsmbLsLsLsmmbLebL
ebLebLgLsbLhLhbRibLgbRgbLcbRgbLcbLebLcRibRebLebLsLsLsLsLgLsLsLgmmmmbRs
RsLsRsmbRiRebLgLebLsLsLsLgRgmmbRobLgRsLgLsbLsLsLsmmbRsbLeLebLgLsLsLgLg
LgLeLsmbRjb

>ZF Recording 2016-03-18; tW: 300s; Start: 124314; End: 124814;
Recording: 7-1; Individual: 4; Drug: Control
bRoLsLsmbLebLsbLcbRibLobLcLsmbLcbRgbRoLibRobRoLcbLebLgLsLcLsmbLsbRcLcL
iLsbLobRcLsLsLsmmbLsRsLsbRebRiRsmbRgLsLsLsRsmmbRsRsmbLoRsRcbRebReRsmbL
ebLiLsbLgLsLibLiLgbLgbLibRcbRebRebLgbLcbLsLibLibLcbRsRcbRebLobRiLsbRhb
RebRebRgbRiRhbRebRebRgbLobLebRgbLiLgbLcbRcRcReb

>ZF Recording 2016-03-18; tW: 300s; Start: 124314; End: 124814;
Recording: 7-1; Individual: 5; Drug: Control
bRcbLsRsRsRsRsRemmmbRebRsbRcLgLsbLcRebRebRsbRsRsRembLsLeLiLsbLsReRsmbR
sRgRcbRcbRcRsmbReRibLjLhbRsLiLiLsLsmbReRsmbRcRcbLgLsbRebLgLsbRibRsbRib
RiRoLsbLsLgbRebLeRsRebRiLsbRsbReRsmbRsReRsLsmbRjRsRsRemmbRgRebReRobsbL
jbReReRebRibReRsmbLsRsRebLgbLiRsbRsLsbRsbLhLibRcbLgLebLgLsRsbLsLhbRcbR
hbRgbLsRsRsmbRgLebLebLgLeLsbLiLsLsRsmbLsRsRsmbReRoRiRebRcRebRibLeLsLsm
bLebLeLsb

>ZF Recording 2016-03-18; tW: 300s; Start: 124314; End: 124814;
Recording: 7-1; Individual: 6; Drug: Control
bRcbRebRibLobLebLebLebLebRibLeLsbLiLsbLibLsLsLsLsmmmbRsLsLsLgLsmbRsbLs
LsLsLsRsmmmbLcRsbReRsLeLgLembLgbLsLgbLeLeLsLsLsmmbLhLgbLeLgLgbLiLsLgLe
bLsbLibLgbRsbRsbLhLgLsbLeRsbRhbLeLsLsmbLibLgbLsbLcbRcbLsbRibRebRcbRgbR
ebRsRebReRhbRebRcbRebLcbLebLgLsbLebLcLcbLeLsbLgRsbRebLoLsmbLebRiLcbReb
RsRgbRobLgbRsbRsRsmbRgLebLsLebLebRebReRcbRiRgRiRsRsRsmmmbRgRgRob

>ZF Recording 2016-03-18; tW: 300s; Start: 124314; End: 124814;
Recording: 7-1; Individual: 7; Drug: NDMC 1 µM
bLcRebLcReRsmbRcRebRebLsLsRsmbRgbLebRebRsbRibRibLgbLoLcbLcLsmbLebLgLsb
LsLsmbLgbLsRsLsLsmbLebRsbRcRobRsRsmbRoRsmbRcRsmbLoLhLhbLsbLsbLsbLeLsLg
bLcbLcbRgRsmbReRsmbRsLeLsLsmbLsLsLeLsLsRjmmbRebRsbRebReRibRobRcRhLsLsm
bLhLebLobRjbRgbRcRsmbRibRibRsRsmbLsRsRsRsLemmbLsbRgbRebRgbRiRsRsRhmmbR
ebRgRebRibRebReRgbRebReRsRsRgmmbRebRhbRsRiRiRgbRsRsmbRgbRibLjbLsLsmbLg
LeLsbLjbLgbLcbLibLgbRjbLcLsmbLebLhLeLsbLebLebLebLeLsLeLeLgbLgLhbLsbLgR
sbLobLoLsmbRebRebRiRsRsmmbReRsmbRiRsmbRcRcRsmb

>ZF Recording 2016-03-18; tW: 300s; Start: 124314; End: 124814;
Recording: 7-1; Individual: 8; Drug: NDMC 1 µM
bRsRsLsLsmmbsbRebReRebRcLsLcRsbLsbRiLsRsLsbRcbRobLobRibRobLgbRsRsmbRgR
smbRjRsRsRemmbRgRcbRsbRebLcbLebLsbRcRsmbRsbLibRsbsbsbLsbRiRoRcRoRsmbRg
RsRembRgRcbLibRebRobRsRibLsbLebLgbLeLsbLsbLebLebLoRsbRcRcReRsmbReRsmbR
eRsmbRsLebLebLsLeLsLsmbLeLiRsRebRobRcRsmbRiLeLiLeRcbRebRcbLcbLeLeLeLhR
sbRebsbReRsmbReLsbLibRoRsmbRsRsRsRsRgRsRsmmmmmbRebLiLiLsbLebRsbLcLsmbL
gLebRibRebRebRebRsRsRembRsbRsRgLsRsbLsRsbLiLgb

>ZF Recording 2016-03-18; tW: 300s; Start: 124314; End: 124814;
Recording: 7-1; Individual: 9; Drug: NDMC 1 µM
bLcRcbRgRsRsRsRsmmmmbRcLsbLgLeLsbLgLsLgLgbLebLsLsLgmbLsLsLsLsmmmbLobRs
RsRsRsReRsRsRsRgRsmmmmmmmbRsRsRsRsRemmmbRsRsRsLsmmbRsRsRsRsRsRsmmmmmbL
iLgbLsLsLsLsLsLgLsmmmmbRcRcRgRsmbRsRebLebRsRsRsmmbLgLsLoRsbRsRsRsmmbLe
RsReRiRsLsRhRgRsRsRsRsReRsmmmmmmbRsRsRimbRebRsRsRsmmbsbReRsmbRsLsbLcbR
ebRsbRsbRsbLhLeLsbRsLsLsmbRsLgRsLsbRibLeLsbRcRcbRgRsRsRiRcmmbRsbRebLeb
LcbRebRobLsLsmbLcReRsRgRgReLsmbLsbLsLeLsbLgbLsLgLsbLgRsbRcLsLcbLobRcLe
bLiLsLsmbLgbLoRsbRsRiLsb

>ZF Recording 2016-03-18; tW: 300s; Start: 124314; End: 124814;
Recording: 7-1; Individual: 10; Drug: NDMC 1 µM
bLebLiLsbRebRgbRsbRhRsmbRibRebRgRsRgmbRsLsRiRebLebLibLiLgbLebRjbRcbRcb
RobLeLsbLebLibRgbLsbLcLsmbLsRsbRcbLiLsbLcbLeLsbLiLcLsmbLsbLsbReLobLiRc
LjbRcbLsbReRcbLsRgbRcbRebLsbReLsbRcbRcRsmbRibReLsbLibLgbLsRsbLgRsLsRsb
LebLebLsbLebLebsbRcRsmbRhbLgRsReLsRsLsbRsbRcbLgbLebRiRgbRebRgRsmbRebLg
RcbRcRsmbRebLgLsbLeb

>ZF Recording 2016-03-18; tW: 300s; Start: 124314; End: 124814;
Recording: 7-1; Individual: 11; Drug: NDMC 1 µM
bLeLobLeLsLebRsRsmbRebRsLsbRgRsmbRjbRebRcLsbLsRsbLhLebLeRsRhRgLjbRsbLh
bReRsmbReReReReLcLsLiReReRiRembReRsRsLsRsmmbRsRsRsRgRsmmmbRsRebRsRsRsm
mbRsRsRembRgRsmbRgbRjLibRgLobRebLgLsbRiRsRsRsLeRsRemmmbRgRsRsRsRsmmmmb
RsRsRsReReLoLsLsmmmmbRsLsLsmbLsLsLsLeRiRsmmmbRsRsRsLgmmbRsbsbsbRebLibR
ebRcRcbLsRsRjbsbRsRsmbRsRsmbRgRgRebLiLcbRgReLcbRgRcbLebLibRsbLsLsRsLsm
bRcbRebLobLcbLebLcbRibRhbLebLobLcbLsbRsbRjRebLebLcbLibRebRebRsbRhRsmbL
jbLgbLcbLcLsLsmmbLsbLiLgLibRcbRcbReRsmbLsLsLsmmbRiRcRsRhmbRsRsRsRsmmmb
Reb

>ZF Recording 2016-03-18; tW: 300s; Start: 124314; End: 124814;
Recording: 7-1; Individual: 12; Drug: NDMC 1 µM
bLgLsLsLsmmbRibLeLsLcLsLsLsmmmbLebLsbLgbLhbLhbLgbLsLsmbLgbsbLgbLeLsbLg
LeLsbLgLibRobRsRsRsmmbLibRgRsReLsmbLsRsRsmbLebLsbLebLgbLeLsbLeLsbLhRsb
LgbLgbRsRsRgRembLgLsLsLembLgbLgbLjbRsbLsLsmbLebLgLgLsbLsbLsLsLsLimmbLs
bLsbRiRhRsmbRsbRebRgbLgbLeLcbLsbLeRsbLsLgbLiLsbLgbLebLebRcbRoRsmbRsbRs
bLsLsmbLebLebLibLibReRcbRebLebRsLsLebRsLsLgbsbLgbLiLsLsLsmmbLgbRobRhbR
ibRiRsmbRjbLebLebRsbLcRsLsbLgLibLebRsbLebLebLgLebLibLebLgLsbLgbRebRsLs
bRebRebRebRibRcbRcbRsbRhbLibRcRsmbRgbRgRsmbRibRsbLebRgRsLsmbRsbLcbLgLs
bLgLebLebLibLsLsmbLsbLsLcbLsLgRcbLsbRcbRebLgLsRsbLsLcLsmbLgbLebLiLsRsb
LhLsbLsLsmbLsbRsLibLiLcLsmbLeLsRsbLgbLcbLiLsbLsLiLsbLsLgRebRgbRsRcRsmb
RgRsRembRsbRjbRebLobRiRsmbRsRsRsmmb

>ZF Recording 2016-03-18; tW: 300s; Start: 124314; End: 124814;
Recording: 7-1; Individual: 13; Drug: NDMC 3 µM
bLcLeRcRcLsbLebRobRcbRiRoRcRebRebLgbLeRobRebRebRebRsRgRsRsmmbLgbRiRsRs
mmbRcbRsRsRgmbRiRgRebRgRsmbRsRsmbRsRsRembRgRsRsmmbRcRebRgbRsRsRsRsRsRs
mmmmmbRoRsRsLommbLsbLsRsbRiRgbRobLiRsLsRsLiLobRoLsLiLhReRsRcmbReRsReRi
RsRemmbRsRebRgbRgbRhRcRsRcmbRoReLsbReRsmbLobRgbRgRsmbRcLsbReRiLeLsbLcR
ibLobRsbRsRsRgRembLsLsRsRsmmbRsRsLembRgbRsRsmbRsRsRsRsmmmb

>ZF Recording 2016-03-18; tW: 300s; Start: 124314; End: 124814;
Recording: 7-1; Individual: 14; Drug: NDMC 3 µM
bsbRobLobLgRsLsLeRoRsmbLoLsmbRgbLebLgbLcbRcbLsbReLsbRsRsRsReRcmmbLeRsR
smbReRsReLgmbRiRsmbRgbLjbRiRibRibRobRiRebLebLsLgLobReReReRebReRcRsRgRe
ReRhRsRemmbReLsbRiRebReRsRsRiRemmbRhbRsRsmbLgbLhRsbRsbRsbLsbLsLsmbLsbs
bRsbLsbLeRsbRcbRgb

>ZF Recording 2016-03-18; tW: 300s; Start: 124314; End: 124814;
Recording: 7-1; Individual: 15; Drug: NDMC 3 µM
bRcLsLsmbLebRsLsbRgbLebLeLhbLeLsbLsLebLeLsbLsLsLgLsLsLsmmmbRsRcReRcRsm
bLebLsbLjbLsRsbLsbLjbLsbRjLsbLsbLsbRiReRsmbRgbRsRsRsLemmbLgRsLsbRibReb
RsbLobLgbLibRebRcbLcbLeLsbLiRobLcLgLcReRsmbRebLiLsLsLsLimmbRsLsbsb

>ZF Recording 2016-03-18; tW: 300s; Start: 124314; End: 124814;
Recording: 7-1; Individual: 16; Drug: NDMC 3 µM
bLeReLsbLsRsRgbRcbRebRebRsLsRsLsRsLsbLjbReLcLcbLeLsLsLeLeRsmbLsLsLsmmb
LsLsLsLsmmmbRebLhRsLsbRsRsmbReLsLebRebRgbLoLsLsmmbLeLcbLeLcLsmbLsLsmbL
ebLsLibLsLsLsLsLsmmmmbLebLsbRebRsbLcRcRebLiLobRebRobLsRsb

>ZF Recording 2016-03-18; tW: 300s; Start: 124314; End: 124814;
Recording: 7-1; Individual: 17; Drug: NDMC 3 µM
bLeLsbLcLsLombRhRsRsRoLsLsmmmbLcLcLsmbLoLcbLsLgLiLsbLgLoRsbLoLgLsbLeLe
LebLibLebReLsbReRhbReRsmbRcbRibLebLgLsLgRcbReRobLcRsbLsLsLsLsLgmmmbLcb
LebRiRsRcmbRebRebRibLebLebLebLeLsbLsLibLcLsmbLsLgLsLsmbLebRcRebRiRsRsR
emmbReRhbReRsmbLebLcbLebRgLcbLebLebLobLsbLobLcRiLsbRcLsbReRcbRcbRebRob
ReRsmbReLsLsmbRsbRiRcLgbRebRiRebRebRcbRsbsb

>ZF Recording 2016-03-18; tW: 300s; Start: 124314; End: 124814;
Recording: 7-1; Individual: 18; Drug: NDMC 3 µM
bLcbsbLiLsbLebRcRsmbRhbRebLgbRebRebRebLcReRiRsmbRiRsRsRemmbLsbRhbRiRsm
bLsRsbRgbLcbRebRsRsmbRebRebLebLeLsbLcLebLgbRsbLobRsbLebLhbLebLcLsLsLeL
smmbLebLiLgbLsbLsbRgRsLsmbLcLsmbRebRhbLeRebReRsRombRsRsReRsmmbLgbLeLib
LgRgbRebRjbLobLgbRsLcbLgLeLibRsbRgLsbRcbRibLcbLjbLebLobReLsLsmbLsbLeb

>ZF Recording 2016-03-18; tW: 300s; Start: 124314; End: 124814;
Recording: 7-1; Individual: 19; Drug: NDMC 10 µM
bRsbReReReRiLsLsmbRebLsbReRcRcRsRsmmbRsRgRsRsReLsmmbLsRsRebLsLsRcmbRgb
RsRsLsmbReLobLgbRjbLeRcRsmbReLcLsLcLgmbLeLoLiLsbLoLsmbLsLsLsLsLhRsRgmm
mbRsRsRsRsRcmmmbRsRgRgRoLeRsRcRsRsmmbRsRsRgRsRemmbRsRsReRembReRebReRgR
smbRsRsRimbRsRsRsRgmmbLobLsLsLsRemmbRsRsRimbRobRgbLsbRcRhbLgRsLcbLsbLe
bLebRsbLeRebReb

>ZF Recording 2016-03-18; tW: 300s; Start: 124314; End: 124814;
Recording: 7-1; Individual: 20; Drug: NDMC 10 µM
bLsLjbRcbRgbLcbLgLiLsbLsLsLsmmbLoLiRgLsLoLcbLhLsLsRsmbLgLgbLsLsRcRsRom
mbLsbReRsmbRgbRjbRgLjbLgbLiLsLsmbLiLsbRjbRebLcbLiLeLsbLcLsmbLsbLsLsmbR
sRsLcLeLsmbRgRsRimbRsRsRsLsRsLsmmbLeLsLsmbLsLgLcbRgbRiRsmbRcbLeLsbLeLs
bLcbReLebLsLgLibLgLsbRjbLcbLsbRsLeRsRhbLeRcbRsRsmbLcLsLsmmbReRgLebLgLs
bLeLsRoRsRgmbReRgbReReRiRebReRsmbRiRiRsRembRcRsmbRgRcLsbLsLsLimbLgLsLs
RsRsmmbRobRsbRgbLhLcbLebRebRgLibLgRebRibRcbLsLsmbLebLiLsbLcLsmbLebLsLs
LsLsLsLsmmmmmbLsLsmbRcRiLibLobRcbReRoRibLsbRebRsbLcbLgLsLgLsb

>ZF Recording 2016-03-18; tW: 300s; Start: 124314; End: 124814;
Recording: 7-1; Individual: 21; Drug: NDMC 10 µM
bLebRsbRsRcRebRobRobLeRsbRjbRgRhbReRsmbRsbLiLobLcbLgbRgRobLcbLiLobLgbL
obLobLcLibLgLibLsLsLsLgRsmmbRibRoRobLobRebRobRgbRsbLsbRsRsmbRsRgRibRgR
smbLcLgbLsLgLcRsbRgRsRsmmbRsLhbLcRsbLhLebsbLsRcRgbRcbRibRebsbRcLobLhbL
ebLibLgbLebLgLgbRibLebLhLsLsmbLibLeRsbLeLebLeb

>ZF Recording 2016-03-18; tW: 300s; Start: 124314; End: 124814;
Recording: 7-1; Individual: 22; Drug: NDMC 10 µM
bLsbsbRiLoReRgbRebRiRsmbLsLsmbLsbLsbLsbRsbRsbsbLsbsbRsbRebRcbReRsmbLib
LibLebRgbLjbRibRebRcbRsLeLsLsmbLsRebRebLcbLcLsmbLsbLsbRsbLsbRsRsmbRsbR
sRsmbRsLsRsRsmbRsLsbsbLsRsbsbRibReLsbReRsmbLsbLsbRebRgLsRcRsmbRgbLcLsm
bLsRebRebRebLcRsbRgbLiRsbReLebLsbReLsbRcRcbRsRibRsbLgLsbLgRsRjbLhbLcbL
gbRebReRsRsmmbLeLsb

>ZF Recording 2016-03-18; tW: 300s; Start: 124314; End: 124814;
Recording: 7-1; Individual: 23; Drug: NDMC 10 µM
bRiRiRoRsmbRcbRsRsRsmmbLsbRsLiLgRgRoLsbRsRsRgRgReLsmbLibRsbLiReLobLgbL
cLsLsmmbLeRsLoLsRsLsmbRsbLcbLsRsRsmbLcLsLembLiReRsReRsmmbRsRsmbRebLgLc
bLgbLeLsLsLembRgbLobLcbLsRsbLcbRsRsmbLibLgLgbRobReRhbRgRebRsbRsRcbRsRs
mbRebRcbRgRibRsRsmbLsbLsLsLsmmbLcbLcbLsLsmbLgRsLsLcLcbLsbLiLcbLsLsmbLc
bRsLcbReRoRsLjmbRsLsbLhbRebLcbLiLebRebRobLibRcbRsbRcLebLsbLibLsLsLembL
ebLsRsLsbLebRebRjbRgbRcbRsRcbRgbRsRgRsRsRsmmmbRiLsbRebLebRsLobRhRsmbRg
RsmbRsRsRimbLeLjbRebRcLsRsRsRsmmbReLsbLsbLebRgbRebRsRgRebReRsmbRsRebRe
bRibRsRsRsmmbLcbRgbRebLibRcRsmbRgbLjRebRhbLcRcbRsRsRgRsmmbRsRgRsRcLgLg
mbLiLeRobRsRsRsRsmmmbRsRsRsmmbRsbRebRsRsmbLcRsbLeLibLgLsLsRsmbLsLsmbRc
RcbReRsmbLiLsbLsLsLhLsLsmmbLsbLeRsbReRcLiLsLjbRgbRcbLsLsLembRsbRsLsbRc
RibRsLsbLgbLsLsLsmmbLgbLebRcbLsLsLhmbLsLsLsmmbRebRsRebReLgRcRsmbRiLeRj
bRobRiRobRebRgRsmbReRsmb

>ZF Recording 2016-03-18; tW: 300s; Start: 124314; End: 124814;
Recording: 7-1; Individual: 24; Drug: NDMC 10 µM
bLjbLcRsbRebLsRsRsRsRsmmmbLebRebRgRjbLhbLibRibRoLcbLibRebLgbRebLsRsbRh
bLebLeLgLsbLibLibLeLsbLsLebLgbLsbLsRsLsbRoRebLeLobRiLsbLebLgbLiLsLsmbL
oRsLiRib

>ZF Recording 2016-03-18; tW: 300s; Start: 124314; End: 124814;
Recording: 7-1; Individual: 25; Drug: Control
bReRsRsmmbRgRsmbRsRsRembRsRsmbRebRgRsRsmmbRcbRcbLjRcbRgbRebRhbRiLgbLeb
LeRsbLsLsmbLcLsmbLcbLibLebLgbLgbLebLebLobLcbRcbRgRsRembRgRsRcRsRsmmmbR
sbReRcRgbRsLsLsmbsbRsRsmbRjbRebReRsmbLeLsbLsLgLebsbRsRsRsmmbRgRgbRsbRs
RibReLsbRebRgbRebLebLsLgbLibLeLgbLgLibLiLgbLebRebRebLsbLeLcbLibLeRcbRe
bRgbRgbLsbRcRgbLcLobLebLcRgRsmbLeLebRgbRcbLcbRcRsmbRebLoRebLoLgLsbLebL
eRsLsbLsLsLsLgLeLiLsmmbLsLeLebLcLcbLcLobLcbRebLiLeRsRgReRcbRebLebLjbLo
bRebRgRgRsReRsmmbRhbRgRgRebLgbLebLebReRebRgRsmbLibLob

>ZF Recording 2016-03-18; tW: 300s; Start: 124314; End: 124814;
Recording: 7-1; Individual: 26; Drug: Control
bLcRobRebRcRsmbReReRsmbReLcLsmbLsbLsLsmbLsLsmbRobLcbRgRsmbRhRsmbRcbLob
RsbLebLsbLgRebRsbLibRgRsRembRsRsRimbLsRoRcRobLgbLcRjbRcRsmbRebLebLibLi
bLsbRsbRobLobLeReLsbLgbLebLibLebLhLsbLgLobReRibRgRsmbRgbLiRgbRcbLsbLeb
LebLebLcbLobLgbLsbRjbRebRebReLibRjReRsRsmmbReRsLembLgbLebRebLsLebRgbLs
b

>ZF Recording 2016-03-18; tW: 300s; Start: 124314; End: 124814;
Recording: 7-1; Individual: 27; Drug: Control
bLiLiLebLebLhLgbLibLeRebReRebRcRcbRsRcbLebLebLeLibLgRsbLjbReRobReRgRsR
sRsmmmbRgbRcLsRcbLebLcbLiLgbLsLsLsLsLsmmmmbLsLsRsLsLsLcLommbRsRgRsRemb
RgRiRsRcRsmmbRsRsRsRsRsRsRsmmmmmmbRcbLgbLsLsLsLsLsLsmmmmmbLcRibLcReReb
RgRsmbLcbLhbRsLiLsLsmbLiLsLibRebLsbLcLsLembLsLsLsRsLsLsRsLsLsLsLeLgmmm
mmbLiRsLeRsLsbRibRebRebLsLebLgLsLsLsLsLsLemmmmbRcLsLeLiLgbLsLsLsLsLgLe
mmmbLeLsLsmbLeLcLsmbLsLgLsLebLiLgbLgLebLgLsbLeLsbLsLsLgLsLsLsLgmmmbLeL
sLsmbLsLgLiLcbReRsmbRiRebRebRcbRgReRsReRiRgmbRsRgReRsmbReRgbRgbReLgbRo
b

>ZF Recording 2016-03-18; tW: 300s; Start: 124314; End: 124814;
Recording: 7-1; Individual: 28; Drug: Control
bReRsmbReRsmbLebLsbLsbLsbLeLsbLhLibLiLebRsbLsbRjbLebRjbRcLsbReRsmbRibR
gRsmbRgbLebLcbLcbRhbRebRhbRcbRebRiLibLcbLibLsLsLsmmbLcbLsbLhLgLjbRobRj
RsRsRsRsmmmmbRcbLebLcbLoRsbLsLsLsLsLsmmmmbLcbLobRsbRebRcRcbRibLibLgbLs
LsmbLcbLobLsLsLsLgLimmbReRsmbRcbRiRcRebRgbRsRsRsRsRsRsRsRsRsRsRsRiLsmm
mmmmmmmmbLibLcbLhLcbLeLhbLebRebLcbRcRhbRhbRibRsRhbRgbRjRsRombLebLobLsb
LgLcLcbLsbLsLsLsLsLsLsLsLsLsLemmmmmmmmbLiLgLsLsLgLsmbLsbLsLebRsRsmbRoR
obLebLiRsbLeLsbLiLgLsbLeRsbRebReRsmbLhLsLibLsLgbRiLibRiRsRoRsmmbRcRsmb
RsbRiLsLebRebRob

>ZF Recording 2016-03-18; tW: 300s; Start: 124314; End: 124814;
Recording: 7-1; Individual: 29; Drug: Control
bReLjbLeLobLcbRcReRsmbLeRsLcLsLembLeLebLebLebRsbLcRebLgLsReRsmbRsRsRsR
smmmbLobLsLsLcReRgRgRsmmbRsRsRembRjbLibLcbRebRcbLcLcRsRsLsmbLgbLeLcLcL
hbLeLibRsRsmbRgbLcLebReRsReReRgmbRsRsRsRgmmbRebRcbRgRsmbReRiLsbLjbLsLs
mbLoRgRsRsmmbLsbRcRcbReLcbRobLiLcb

>ZF Recording 2016-03-18; tW: 300s; Start: 124314; End: 124814;
Recording: 7-1; Individual: 30; Drug: Control
bLoLjbLebRgLsRobLsbLeLeLsLgRsbLebLeLgbLebLgLsLsmbLiLsLcbLsRsbRoLsLsLsm
mbLebLeLsbLsLhbsbLeLsLsmbRebLebLebLgLgbLsLgRgbLcLcbRsbLeRsbLeLcRsbLcbL
gbLcLeLcLsLgmbLeLibLcLgLsLsLsLsLgLsLsLsLemmmmmbRsLsbLiLsLsLeLgmbLgLsLs
mbLsLsmbLsLsmbLsbRoRsRsRsmmmbRgbLjLibLiLoLcbLebLsbLsLsLimbLeRsLsLsmbRg
bRjbLcbLibLsLebLcbRgbLsbRobLebLcbLebsbRebLebLebLebLebLsLhbLibLeLsRsLsb
LsLebLsLcRsLibLcLeLsLsmbLsLeLsbRsLsbRsLsLsLsLemmbRsbRjbRoLsbLiLebLeLcL
smbLgLeLcbLeLcRsbRcRsmbRgRsRsLsmmbReLsbLsbRoRiRsRsRsRcRimmmbLgRoRgLsbL
gLeLsbLeLsbLsLhLgLebLebLsbLeLsbRoLsLcbLobLeRsbLsbLsbLsLsLeLsmbLiLcRobL
gbRoLebLcbLsLsLgmbLebLgb

>ZF Recording 2016-03-18; tW: 300s; Start: 124314; End: 124814;
Recording: 7-1; Individual: 31; Drug: NDMC 1 µM
bLsLsLsLsLsLsLgmmmmmbLsLgLsbRsRsLsLsmmbLsLgLsLsmbLsLsLsLsmmmbLsLgLsLsm
bLsLsLsLsmmmbLsLsLsLsLgLsLsmmmmbLsLsLsLsLsmmmmbLgbLsLsmbRgLsbLsLsLgLsm
bLsLsLsLsLsmmmmbLsLsLsmmbLgLsLsmbLsLgLgbLgbLsLsLsLsLsLgLsLsmmmmmbLgLsb
LsLsLsLsmmmbLsLsLsLsLsmmmmbLsbRoLsbLibRjRsmbLgRsbRsRsmbLsbRgRsLeLembLe
LsbLgLibLgLsLsLimbLsLgLsbLgLgLhbLgb

>ZF Recording 2016-03-18; tW: 300s; Start: 124314; End: 124814;
Recording: 7-1; Individual: 32; Drug: NDMC 1 µM
bLeRsbLiLcbLsLebLeLcLcbLiLgbLeRsbLcLibLgbLsbLsLsLsLemmbRjbRobLobsbLsLg
LgRibRiLgLiLgbLsLsLgmbLebRsRsmbRhLsLsLjmbLebRsbLjbLoLgbRsLsLsLembRcRoL
sLebRsbRgRsRembLsLsLsmmbLsLsLsLsLsLsLsLsLsLsLsLgLimmmmmmmmmmbLebLsbLsL
smbLgbLhLsbLsbRobRebRiRebLcLgbLcLhbLsLcbLebLsbLsLsmbLebLebLcLcbLgRebRc
LsbRebRgRgRsRsmmbLebLebLcLgbRsLsLsLsLemmbLeLgbLiLsLgLibLcRgbRhRsRsRsRs
LsRsmmmmbLebLeRsLoRsbRsLgLebLiLgbLebRgbRibLgbReRcbLiLsLsmbReRcbReLsbLe
bLebLeRsRobRsRsRsRsReLommmbReb

>ZF Recording 2016-03-18; tW: 300s; Start: 124314; End: 124814;
Recording: 7-1; Individual: 33; Drug: NDMC 1 µM
bRibLebRcLhLcbRebRebLeLeLsLsLsmmbLebLeLiRsbLoLobLcLobRcReLcLsmbLcLeLsb
LibRobLjLsmbLebLcLsLgmbLsLsLembLcLiRsRsmbLeLsRcbLsbRsRsRsmmbLjbLcLobRh
bRcRsmbRsRsmbLgRcRsRsRommbReRsReReReRsmmbRgRsRcRsRemmbRgRsRsmmb

>ZF Recording 2016-03-18; tW: 300s; Start: 124314; End: 124814;
Recording: 7-1; Individual: 34; Drug: NDMC 1 µM
bLoLibRsbLebLjLsmbLcbLcRsbRgRebLcLcbLcLiLhLsLsLsLeLsmmbRebRibRcbRgbRob
RhLebRobRcbRgbRgRsLhRsmbRebRsRsReRcmbLsLeRsbLcbLsbReRgLsbLgbLsLcbRgbLi
LcbLgLsbLsLsLgmbRjbLobRgbLcLsRjmbLebRebLebLebRobReRcRsRsReRsmmmbReReRg
bRoRhRoLcLsRsmbRgRebRebReLibRcbLeLsbLobRobRcRcRhRsmbRoRcRsRombLcLgRobL
oLcbRgRsLsmbLobLeLsbRoLsbLiLeb

>ZF Recording 2016-03-18; tW: 300s; Start: 124314; End: 124814;
Recording: 7-1; Individual: 35; Drug: NDMC 1 µM
bReRsRombRgRiRhbLeLibRsLeLgLsLebLgLebLeLgbLiLsbLoLobLobLcLebRcbReRsmbR
ebRiRsLombLobLobRsRcLeLsLsmbLibLgbLeRoReRsRsLemmbLebLebLsLgLiLsLsLsLcL
iLsLsLsmmmmbLgLebLoLobLobLsLsmbLebLgbLiLsLeLgb

>ZF Recording 2016-03-18; tW: 300s; Start: 124314; End: 124814;
Recording: 7-1; Individual: 36; Drug: NDMC 1 µM
bRcRsLsLsmmbLoLsLsmmbLoRsRsRsmmbRoRsRoRcRembRgRsmbRiRsmbRibRiLobRebRsR
cbRebRsbRoLsLobRiLsLgbLgLsbLsLsLsLgmmbLsLsLsLsmmmbLsbLsLsmbLiRsRsmbLcR
eRsRsRhmmbRsRsRsRsRsRsRsmmmmmmbRsRsRsmmbRsRsRsLsLsLsmmmmbLcb

>ZF Recording 2016-03-18; tW: 300s; Start: 124314; End: 124814;
Recording: 7-1; Individual: 37; Drug: NDMC 3 µM
bRsRsmbLhLobRiRsRgRsRsRsRsLsLsmmmmmmbRsRsRsRgmmbLebLsbLebLebLeRsLcbLcb
Leb

>ZF Recording 2016-03-18; tW: 300s; Start: 124314; End: 124814;
Recording: 7-1; Individual: 38; Drug: NDMC 3 µM
bLcRcRsmbLeLsRsLeLsLsmbLhLsLsLgmbLsLsLsReReRsmmmbReRsRiRsRsmmmbReRsRim
bRhLsbReRiReRsRsReRemmbRsReRsLembLsLgbLsReRibReRsmbRiRsLeLcLimbReRibLs
LebLsLiRsbRsRsLsRsmbReRsmbRgRgLebLsLsmbLebLhLsbLiLgbLebLebLsLsLeLsLsmm
bLsLebLsbRsRsRsmmbRsRebReRcbReRsRcmbLsLsRsmbReRcbLgRiRiRsmbRebLsLsLsLg
LsLsLsLemmmmbLsLeLebLsLeLibLsLsLgLeLgLgLsLsmmbLeRsbLebLeLsbLeLsbLebLeb
ReRsRsRiRsmmmbRgLsbRsLsbRsRgbLoLcbLsb

>ZF Recording 2016-03-18; tW: 300s; Start: 124314; End: 124814;
Recording: 7-1; Individual: 39; Drug: NDMC 3 µM
bLeLoLsmbLsLsLsLsLcmmmbLsbRgbLiLsLsLsLsLgLsLhRcRimmmbsbRcLsLsLcRoRcmbR
ebRgbLcLsLsmmbLebRsRsRsRsmmmbRjRsRsRsRgRcRsmmmmbReLebLsbLebLeLibLsLsmb
LebLebLsLcbRsbLibRiRsLsLombLcbLobRsbLgbLgLebLeLsbLebLgbLebLcbLeLsbReLs
LsmbRebRebRgbRsRgRsRsmmbRebLsRsbLsbLcbRebLebRoLeLcbLcReRsLeRsReReRsReR
sRsRsmmmmmbRsRsRsmmbRsRsmb

>ZF Recording 2016-03-18; tW: 300s; Start: 124314; End: 124814;
Recording: 7-1; Individual: 40; Drug: NDMC 3 µM
bRsbRcbRoRibLebLgbRoLsbLeRsbRebRgbRebRhbLhbLsRebLiRgRsmbLcbRgRgbReRibL
gLebRgbLebLebLebLebLhbLsLeLsbLgbRibReRgbRgbLgbRcbLiRcbRcbRebReRgbRebRi
bRebRebLiLsLsLsLhLsLsLemmmbLiLsLibLcbRebRebRcbLcLgLsLsLsLimmbLeLsbLsbL
gLeLgbLsLsLsLsLiLsmmmbLiLsLeLgLebLhLeLsLeLsbLeLsLsLsLemmbLgbLebLebReLs
RsRebReRsRsRsmmmbReRsmbLgLeLsLeLsLsLsLsLgLsmmmbLeLeLgRebRhRgLsbRebRibL
cbRcbLcbLobLebLebLiLgLgbLsLgbLhbLsbRobLeLiLsLsmbLeLeLsLiLsLgLsLgLsLsmb
LgbLebLiLsLcLgLsbLgLebLeb

>ZF Recording 2016-03-18; tW: 300s; Start: 124314; End: 124814;
Recording: 7-1; Individual: 41; Drug: NDMC 3 µM
bLcRsbLcbLgLgbRsLgbLeLgbLsRsbLsLsLsLsLsmmmmbRsLsLsmbLcRsRsmbLeLebReRob
RibRgbRsRsRoReRembRebLsLsmbRebRgbRgbRsRsRsRsRsmmmmbRsbRsRsmb

>ZF Recording 2016-03-18; tW: 300s; Start: 124314; End: 124814;
Recording: 7-1; Individual: 42; Drug: NDMC 3 µM
bLiRobLoLgbLgbLeLoLsmbLebRcbLebLcbLhLsbLsLgbLebLebRcbLibRebLeLsLsmbLgb
LgbRgRsRiRimbRibLobLebLebLgbRgLsLsmbRsbRcbLibLebLcbLibRsRsmbRgbRcbLobL
sRcbLgLsbLsLsRsmbRgRsRiRgRembLebLsbLsbLsLsmbRsRsRsRsRsRsmmmmmbRsRsRsLe
mmbReRsRsRhmmbRsRsRsRgmmbReRsRembRgRgbRebRgRsRsmmbRiRgbRebReRiRsmbRebL
obLgLebRcRcbReRsmbLebLsRsRsmbRsbRsb

>ZF Recording 2016-03-18; tW: 300s; Start: 124314; End: 124814;
Recording: 7-1; Individual: 43; Drug: NDMC 10 µM
bLjLoLoLibRcLsLsmbRsRoLsRoRobLsRhbsbRsRsRsmmbLeRsbLcbLsLgLibLsLgLobLib
LiRcbRhRsRgmbRsRsRsRsRsmmmmbRiRgRgReLcLcbLsLgLgLgLsLeRsbLsbRsRsLsmbLeR
eRsmbRsRsRsLeLsmmbLiLgRoRsRsRsmmmbRgLsbRoLsRebLebLsbRhRsRsmmbRsbRcLsbL
obLsLiLsRsLiRobLsbRiLsRsRsRsRsRsmmmmbReLsbRsRsmbLebLcRsRsRembRsbLgLobL
oLobLgLiLsLsmbLsLgLcRcbRebRgRsRsRsReRoLsLsRsLeLemmmmbLeLgbLebLsRsbLeLo
LibLeLeLcLobLgLsLsRsmbRgLcRebLsbRsRsRimbRsRgRgRsmbRgLsRgbRebRhRgLoLiLc
LcLgLgLgLsbLgLsLsLsLsmmmbReRsRsmmbReLebRoLsLsRembsbRebLhLhLsbLcbRibLhL
sbLgLsLsLsLsmmmbLgLsLeLsRebRiLcbLobLeLsLsmbLgLhLeRsRobLsbLsbRsbLsLiLsL
smbLibLsLsmbLebLsLsmbLsLsLsLcmmbRgReLsbsbRsLsb

>ZF Recording 2016-03-18; tW: 300s; Start: 124314; End: 124814;
Recording: 7-1; Individual: 44; Drug: NDMC 10 µM
bRcbRiRsmbRebLeLsbLebLebLsLgLgLebLsLgLsLeLcbLsLsLsLgLsLsLsmmmmbLsLsLsm
mbLgbLgLsbRiRsRsmmbRgRsmbRcRoRsmbRebRsbLgbLiLsLsLsmmbLsLsLsLsRsLsmmmbL
cLoLcLsLsmmbLgLsLsLsLsLsmmmmbRsbRgbLjbRcRebReLcbLhbLgLsLiLeRsbRgRsmbLe
LsbRgbRiRgbLcLsLsLsmmmbLobLsbLgLeLsbRgLsLsmbRiRiLebLibLhbRhbRsbRobLebL
eLjbReLjbRgRsRsmmbRgbReRsmbLiRsRsLsmbsbLcbLobLebRgbRiRebReRsmbLebLibLc
bLgbLhbLgbRsLsbRsbRcRjbRcbLobLsLsmbLcbRjbLeLsRsLibRsbLcbLibLebLgLibReR
sRsRsmmmbRgbRsbRebLebLcLgLsLebLgbLibLsLsLembLgLsbLgLsbLsLsLsLemmbLsLgL
eLebLsRsbRiRsRsRsmmmbRgbReRhbLgbReLsbRsRsmbRgRsRsLsmmbRsRsRsRsmmmbRgRh
bLebLsb

>ZF Recording 2016-03-18; tW: 300s; Start: 124314; End: 124814;
Recording: 7-1; Individual: 45; Drug: NDMC 10 µM
bRsbLebRgLsbLgbLcLoRobReLsRcRsmbRebRcReLsRebRsRsRsRsRsmmmmbLcbRcRiLsRs
RoLsbRsLsLgLeRibLebRcRiLsbRsbRcLibRsRgRgbLsRsbRgbRcRsRcmbRsRsRembLebLs
bLgRcRcRebRebRibRgLeLiRsLobRsbReRcbReRoRcRibLcLcRsbLsLoRgbLcbLsLsmbLsL
smbLgLgLsbRgbLeRsRcLsbLsLsmbRjbRgRsmbRsRsmbLcbRcbRsLiLoLeLsLsmbLeRibRe
RcRsRsmmbReRebRcRsmb

>ZF Recording 2016-03-18; tW: 300s; Start: 124314; End: 124814;
Recording: 7-1; Individual: 46; Drug: NDMC 10 µM
bLsLsLsmmbLsLsLsLsLsmmmmbLsLgLibRibLsbLsbRsRsLsmbLcbLcLeLsbLebLcbRebRg
RsmbLebLcb

>ZF Recording 2016-03-18; tW: 300s; Start: 124314; End: 124814;
Recording: 7-1; Individual: 47; Drug: NDMC 10 µM
bRgbRobLeLsLsLimbRjbRsbLgbLsbsbRsbLgLsLobRcRobRsbRobLgbLebLsRsbRgbLcLo
b

>ZF Recording 2016-03-18; tW: 300s; Start: 124314; End: 124814;
Recording: 7-1; Individual: 48; Drug: NDMC 10 µM
bLiLcRsbLeLsbLibLsLsLsmmbRsbReLebLsRsbRsRhLsbRgLebReLcLsLcLembRgLsbRsb
RibRoRebRebRcbRsRcRsRcRgmbRebRjbLjbRgRsRsRiRgmmbRgbRgLebLebReLcbLebLsb
RcRhbLsbRcbLsLcbLiRhLsbLgLebLeRsbLeRiRsmbLcbLgbLcbLeLcbLjbLebRcbReRhbR
cRsRhReRsmmbRgReLhbLibLgbRcbLjbRgbLobLgLeRsbRsbLcbLoLobLeLgLsbLgRsbRcR
smbRsRsReRhRhmbRiRsmbLsRoLeLcRsbLsLcbRibLgLcbLgbLeLsLoLcbLeRebRcRgbLsb
RjbLibLcbLeLebLeLoLobReRsmbRgbReLcbRcbLeLsbLeLsLsmb

>ZF Recording 2016-03-18; tW: 300s; Start: 124816; End: 125316;
Recording: 8-1; Individual: 1; Drug: Control
bRebLibLsbLiLsbLgbRsRsLgmbLebLiLebRibRsbLcbLcbRobLgbRobRgRobLgLsbLibLg
bLeRsbLgbLiLgbLgLsLsLsLsLsLsmmmmmbRebRsbLgLibLsLsLgmbLgLibLsLhbRcRsRem
bRsRibRsRebRcbRcbLgLebLibLibLiLhbLsLcRgbRgbRhbRsbRsbRsbLhbLgLibRcReb

>ZF Recording 2016-03-18; tW: 300s; Start: 124816; End: 125316;
Recording: 8-1; Individual: 2; Drug: Control
bRcRsmbRebRcbReRsmbLcbRcRsRsRsRgmmmbRebRiRsmbLsbLgbLeLsbRiReRcbLebLebR
sbLjbRgRgRibLebLibRsbsbRgbRsRsmbLcbLibLebRebRsLsbLjbLhbRjbLebLsLsLgmbR
eRcbLgbLgRsbLsLebLeRsbLcbRgbLsbLsbRgbRiRsRsRsmmmbReRebRebRsbLebRebLiLi
LgLiLsbLcbLsRgbLjbLcbLobLebLebLebLebLibLebLcbLgbRcbRcRsmbRgRsRsmmbRcbL
cbRebReb

>ZF Recording 2016-03-18; tW: 300s; Start: 124816; End: 125316;
Recording: 8-1; Individual: 3; Drug: Control
bLoRebReRobLcLsmbLsLsLsmmbLsLiLeLsLsmbLsLsLsLsRsLsLsLsLsLeLemmmmmmbRsb
RoRoLhbRiRobRhRcRsmbRgRgRgLsRcRebRebLsbRjbLeLsbLibLcLcbLobLcLgbLgLsLsL
smmbLsLsmbRoRsRcRsmmbRsbLjbLsLsmbRsRsmbLiLgLebLcbLcbLcLsLcmbLebLeRibRs
RsRoRsRsmmmbRcRebLeLgLgRsbLgLsLsLsmmbLsLsLgLsLimbLsLhLgLiLsbLsRjbLibLs
LsLeLsmbLgbRsLsLiLebRcbLcLsLiLeLsLcmbLsLsLgmbLsb

>ZF Recording 2016-03-18; tW: 300s; Start: 124816; End: 125316;
Recording: 8-1; Individual: 4; Drug: Control
bRebLsbLgLgLsbLsbLgLsLsLcmbLcLsmbLeLcbRcLebRsbLiLsbLcRsRsmbRhRsRsmmbLs
LobLcLcbRcRsRgRembLcLebRgRiRsmbLiLsbLhLsLeLsbLiLsbLhLsLsmbLgbLsLsLsLgL
sRsmmbRobRibRebRsbRiRsmbRsRgRsRsmmbRsRsRimbRiLsbLsbRcbRobLhRsLsbReRcRs
mbRhbRsRsRsmmbRiRgbLeLsbLcbLeLcLoLsmbLhLsRsLeLsbLcLsLcmbLcLcbReLib

>ZF Recording 2016-03-18; tW: 300s; Start: 124816; End: 125316;
Recording: 8-1; Individual: 5; Drug: Control
bRebRcbRcbReRsmbLhRsbLgRsbRoLibRebRcRsmbRsRgRebLebRcbRsReRsmbLebRcbsbL
sbRsbLeLsbLebLebLsRsbLgRsbRgbRoRsmbLsbsbsbRcbLiLsRsRcbRgbRebRjbLgbLibL
ebLebLobRgbReRgLeLibLsRsLsLsRsmbLgbReRcRcbRiReRsmbReRsmbRsRiRsRimbRgRe
RsmbRebLgLsLsLcLeLsmbLgLsRsRcRebRcb

>ZF Recording 2016-03-18; tW: 300s; Start: 124816; End: 125316;
Recording: 8-1; Individual: 6; Drug: Control
bRobLobRibLsRsbLeRoReRsmbRsReRsmbRebReReLsbLgRgbRebRebLeLebLebLebLhbLi
LsbLiLsbLiLsLsLsLsmmmbLibLeLsLsmbLobLoRsbReLebLebLibLeLibLeLeLsLgLsbLe
LebLebLgLsLebLeLsbLibRebLibRebLobLeLhbRsbLgbLebLsbLgbLsLsmbLebLjbLsbLg
LsbLibLgbLeLsLgbLjbRcbRsRsmbRibLeLsbLibLeLgLsLgbRjbRebLgLsbLgLgLsbLibL
sLsLsmmbLsbLgbLibLibLibRebReLgbLiLsLsLsLemmbLgbLsLgLebLsLiLgLsLsmbLobL
sbLcLsRsmbLcbLcLsmbRsbLebLeLgLibLibLgbLiLsbLibLobRsbLsbLiLsLeLgLsbLebL
iLsbLgbLgbLeb

>ZF Recording 2016-03-18; tW: 300s; Start: 124816; End: 125316;
Recording: 8-1; Individual: 7; Drug: NDMC 1 µM
bRcLeRobLiReRgRcbRsRsRgRgRgRgRombRgRsRsRsRsRsRsRemmmmmmbRgRsmbRiLgRgbR
ebRgRcRsmbLsLsmbRsbLcbLcbLhLsbLiLsbLebLebReRhbRibRsbRsRsRembRgRsReRsmm
bRiRgRsmbRsRsRsRsRsRsRsRgmmmmmmbRobRgbLcReRsmbRsLebLsRsLsLeRsbLsbRjLoR
obLsRcbRgRsmb

>ZF Recording 2016-03-18; tW: 300s; Start: 124816; End: 125316;
Recording: 8-1; Individual: 8; Drug: NDMC 1 µM
bLobLsLsLeLsmbLgLcbRgRcReRsmbReRsmbReRcRsLsmbLeLgLsbLcLebLebLeLeLsLsmb
LeLcbLiLeLsLsmbLebRgbLiRcRsmbRsRsRiRsRsRsmmmmbReLsbLsbLobRobRoRobLsbRs
RhbReReRsmbRgb

>ZF Recording 2016-03-18; tW: 300s; Start: 124816; End: 125316;
Recording: 8-1; Individual: 9; Drug: NDMC 1 µM
bRsLsbLsLsLgLsLembReRsLeLcLsmmbLsbLgLgbLsLcbRiRsLcmbLsLsLsLsLsLsmmmmmb
LeLsbLsLsLsLemmbLsLsmbLebLgRcReRsReRsmmbReRsmbRgRhReRibRhRcLsLsmbRsRsR
eReReRsmmbRsRsRsRsReRgRsRsmmmmmbRsReRsRsRsRgRgRsmmmmbLsRgRgRsReRsRemmb
LsRsRgRgbRsRsmbReLeLsLsmbLebLcLsmbLsLsLsLsLsmmmmbLjLoRcbReRsmbReRsmbRs
ReRebReRsmbRgRsRsmmbRsbRgRgRsmbLgbRiLsRsbLebRcRsRsRsRsmmmmbRsRsRcLsmbR
iRgReRsRgmbsbRsbRsbRsRsmbRsbRsRsRcRcLsRsRcmbRsRsRsRsRsRsRiRgmmmmmbRiRs
ReLsmbRebReRcbRsRsRsRsRsRsRgRcmmmmmbLcLsmbLsLgLsLgLsLsLsLsLsmmmmbLsbLc
bLcLsLsLsmmmbLibLebRcRsmbRgReLsbLgLebLsLsmb

>ZF Recording 2016-03-18; tW: 300s; Start: 124816; End: 125316;
Recording: 8-1; Individual: 10; Drug: NDMC 1 µM
bRebReLsbLibLebRhbLebLebLebLibLebLsLiLsbLebLgLebLgbLsLebRsbRcbReRcRsmb
LeRsbLcLsLsmmbLebRgbLcbLgbRebRsbLebRgbRgRibLgLeLsLsmbRsLibLibLgbLsLgLg
bLiLsLsmbLsLiLsbLeLcbLebLiLhLhbReLebLgLibLebLsbRebRebRhbRsbRcbLcbLcLib
LibLibLgbLgLsbLsLsLsLsLimmmbLoLebLiLebLgbLiLebRsbLcbLebLebLcb

>ZF Recording 2016-03-18; tW: 300s; Start: 124816; End: 125316;
Recording: 8-1; Individual: 11; Drug: NDMC 1 µM
bRcbRgRsLsRsLsLsmmbLsRsLsbReLebLcLibLibRebRcLsLiLsLsmbLsLsLeLhmbRjRcbR
jRcbRgRcRsRcReRsmmbRsRsReRsRcmmbReRcbRiRgRsmbRsReLgReRsLcmbLcLcLsLsmmb
LgLgbLjReRcRcRsmbReRsRembReRiRcRcRsmbRsRsRsRsRsmmmmbRsRsRgReRgmbRsRsmb
sbRcLcLcLsLeLgRsLsmbLsRgRsLoRembRsbRjRsRcRcRcmbLsRsbLeLcbRobLibRgbRebR
cbRcRiRibRcbRoRcbRcLiLsLsLcRsLembLebLibRjbLiRsbRsbRgLsRgRiRsmbReRsmbRi
RcbRobRgRsmbRsLsb

>ZF Recording 2016-03-18; tW: 300s; Start: 124816; End: 125316;
Recording: 8-1; Individual: 12; Drug: NDMC 1 µM
bReReRsmbRgbRcbLcLsmbLsLgbRsLsLsmbReRsmbRebRgbRsbLsbReRsmbRebRsbLsbLsb
LjbLiLsbLebRjbRsbsbRsbLebLgbRgbLebRebReRgbRcbLeLsbLgbLoLsmbRsbLsbLgLhb
RobRebRgbRgbRgbRebRebRgbRsbRgRsRsmmbRgbRibRsbRsRibRibRiLsRsbRebRsbRebL
cbLeLsLsmbLebLebLgbLhLebLsLebLgLebRsLsbLebLsbRgbReLsRsbRgbLsbRsbRgbRiR
sRsmmbRsbRsRsRsmmbRebRsRsRsRsRsmmmmbRibRiRsReRsmmbRsbRgbReRsmbReRsLsmb
LsbLcbLsbLsbLsbRjbLeLeLgbLsbRsRsmbsbLsLcRsbReLsbRgRsmbsbRsReRcbsbLebLs
LsmbLsLsLsLsmmmbLsLsmbReLsbLebLhbLgbLebLebLeLsbLebLebRgbRoRsmbRgbRgReL
sbLsLiLhbLsLgLebLsLsmbLsLsmbRcbLebLebRgbRebRgRsmbRsRgbRgRsmbRsbRebRiRo
RsRgmbRibLcLsLimbRsbLgbLeLsLsmbLgLgbLcLsmbLebLeLsbLsLgLebLeRsLsbLgLsbR
oRsLsmbRcRsmbRsRsmbRsbLsRsRsRgmbRcLsbRiRsmbRsLsbRebRsRgbRebLeb

>ZF Recording 2016-03-18; tW: 300s; Start: 124816; End: 125316;
Recording: 8-1; Individual: 13; Drug: NDMC 3 µM
bLcReRobRobRgRsRsRsRsRsReLoLsmmmmmmbRgLsbLsRcbLgLsLsLsmmbLeLiRsLsbRhRg
bRsbRcRcLsRsLcRgRsmbRiRoRoRcbLsbRobRsbLoLsmbRcRsRcmbRobRsbLoLibLsbsbRe
bRsRsRsRsRsRsLommmmmbRgRsmbRcRsRsmmbLcLibLcLiRibLgRibRoLsbLjLgRcRcRcRs
mbRcRibLgLsbLsLsmbLsRsRsLsLsmmbLcLsLombRcbLsbRibRsRsmbRsRsRembLsbRcbRg
bRebRebRibRebLsbReRibRcRsRgmbRebRebReRsRsmmbRsRsRsRsRsmmmmbLobReLoRsLi
bRiRgRsRcmbRoRgbRcbLgbRoRebRsbLiLsLiRsbReRsmbRgRsRgRsRsmmmbRsRiReRsmbR
oRibLeLsLsmbLsLsRsmbLoRiRsmbRebRiRsmbRhRgLsRsbRgRsRsRgLsmmbLcbRjbRoRsR
smmbRiReReReRsmbRiRsRgRsReRcmmbRoLcLsLsRommbRebRebRiRsmbRsRsRsmmbRsRcL
sbRgRcbRsRsRiRcmbRgRsRsRsRsRemmmmbReRebRsRsRsRsRsRemmmmbReRsmbRsReRcLc
bLgLsbLcLhLsLsmbLib

>ZF Recording 2016-03-18; tW: 300s; Start: 124816; End: 125316;
Recording: 8-1; Individual: 14; Drug: NDMC 3 µM
bRcLobRgReRebRibLhbLeLgLsLoRgRgRsRsmmbRsRibLoLoRcRobRcbLsLiLcLoReRgbLi
LobRgbLsLobLgbReLsbRsLcbRcbRebRiRebRsbReRsRiReRsmmbRhRsmbRiRcbRebRcLsL
smbLebLiLsbLeLsbLiLoLsmbLsLsLsmmbLsRsbRjb

>ZF Recording 2016-03-18; tW: 300s; Start: 124816; End: 125316;
Recording: 8-1; Individual: 15; Drug: NDMC 3 µM
bRgRgbLsLsmbRcRcLebLsbLsbLsbLsbsbRsbLebLsLsRgmbRhRsLsLsmmbLsbsbLjbRsbR
sbRsRsmbRsbRiLebLsLsmbRebRsLsLsRhmbRiRsRcRcRsLsmmbLgbLsbLsbRcbLebRsLsb
LsLhbLeLhRsLsbRgbRsRsRembRhRsmbRsRsmbRsReLeLsLsmbLgbLsLsLsLgLsRjmmbRsb
RsbsbsbRsbLsLsLsLsLsmmmmbsbLibLebLiLebLhLsLsLcmbRobRebRsRsmbRgReRobRsR
smbLcbRiRgbRsLcLsmbLsb

>ZF Recording 2016-03-18; tW: 300s; Start: 124816; End: 125316;
Recording: 8-1; Individual: 16; Drug: NDMC 3 µM
bLeLcbLebRobRsLcbRsbRiLebLeLsLsLsmmbLsLsmbRsbRebRoRhbLsbLeLsLsLsmmbLsR
sbLebRcLcbLeRsLcbLcRobLcbRibRhbRgRsmbRsRsRsRsmmmbRibRhbRcbLgRsbRcbRebL
iLcbLibRgbRcbRcbRebRcRebRgRsRsRgmmbRgbRebRcbLebLebLebLsRsLsRsRsmbLgLsb
LsLsmbLebReRebLoRsbLjbLcbLsLsLsmmb

>ZF Recording 2016-03-18; tW: 300s; Start: 124816; End: 125316;
Recording: 8-1; Individual: 17; Drug: NDMC 3 µM
bRsLsLcLsLcmbReLsLsRcRcRsRhRsmmmbReLsRebRebRgRsmbRiRoRiLsbLsbRsbLebReL
jbLsbLsbRgRcbRgbLebLsLgRjbRebLgbLeLobLsLsLsLhmmbLcRsbRcbReRsmbRcRsmbRs
bLgbLsLsLsLsmmmbLsRsRsmbLsLsLgLsLombLhbLobLhLsbLgLsbLebLgLsbLiLsbLeLoL
smbLgbRobRhbLsbRcLeRcRsmbRsRsLsmbLcLcLeLsLoRsbLiLsbLsLsLsmmbLeLoRcbRhR
sRcmbLeLsbLebLiLsbLgbRsbRobLsb

>ZF Recording 2016-03-18; tW: 300s; Start: 124816; End: 125316;
Recording: 8-1; Individual: 18; Drug: NDMC 3 µM
bLsLebRgbRgbRgRsmbRsRsmbRgLsbLsbRsRiRsLoLgLsLsmmbLgLsLsmbRgRsmbRsRsmbL
cbLsbLeLcbLebLeLsbLeLsbLsLeLsbLeRoRsmbRsbRgLsRgbLcLsLcmbLebLeRsbRgRsmb
RebRcRsRsRsRsRsRgRsRsmmmmmmmbRgRsmbRiRsRcmbRsRgRgReRcRsmbRsRsRgmbLebLe
LibLebRgbRcRibRgbLebLebLeLsLibRgbRibRibLsRsRsRgmbLcbLsbRsbLsbLsbLgbLsb
LiLibLgbLgbRebLeLsbLiLsLsmbLgLsLsLsLgmmbLsbLoLoLsmbRebLcbLibRebRgRsmbL
ibReRsRsmmbRebRebRjbLoRobRhbRebReRgbRgbLgbRiRsRsRgmmbRsbRjbLebLgbLsbLg
bLeLsbRgbLiLsbLgbRibReRcLsbsbRhLebLeLgbRsbRsRsRsLsmmbRsbRsbRibLeRsLsbR
gb

>ZF Recording 2016-03-18; tW: 300s; Start: 124816; End: 125316;
Recording: 8-1; Individual: 19; Drug: NDMC 10 µM
bRoLobReRsRsmmbRsReLsbLgRsbRgRcbLcRgLjbRcbLsbLgbRhbRcLgbLibLoRsbRgbRsR
sRcRembLsbLsbRibRcbLgLsLebReLobRcbLibRcbRiLcbLgLsLsLsLimmbRsLibReReRsm
bRebLcLebLibLsLiRsbRoLsLgRsRebRhRsRsmmbRsRsReLsmb

>ZF Recording 2016-03-18; tW: 300s; Start: 124816; End: 125316;
Recording: 8-1; Individual: 20; Drug: NDMC 10 µM
bLgLsbLsLeLsLiLgbRsLsLgLebRebLjbRjbRgRebReLsbRebLjbLiRebLcbLgLsLsLsLsL
sLsLsRsRsLeLsmmmmmmmbLgLsLsLgmbLsLsmbRhRsLembLgLeLibRsRgRsmbLcbLebLeLo
bLsbLjbLeRcRsmbRsRsRsRemmbReRsRsRsRsRsRemmmmmbRibRiRebRhbRsRgRgbRgRiRs
mbRiRsRsRgReRemmbRgbLeLsbLebRsbLcbRobRibLeLsLibLebLsLgRsbLsLsmbLeRcbRe
bRhbRcRsmbRsRsLsmbRebLebLcLcbLcbLgLsLebLgLgbLiRsbLebLebLebLebLsLgRsLsL
sLsmmbRsRgRsmbLebLhLibLebLsLsLsLemmbLebLebLebLgbLsLebLgLsLibLsbRcbLibL
iLebReRgbRhbRebLeRsRsmbsbRsRsRiReRimbRgReRsmbReRsRsRsReLsmmmbRiReRsmbR
gb

>ZF Recording 2016-03-18; tW: 300s; Start: 124816; End: 125316;
Recording: 8-1; Individual: 21; Drug: NDMC 10 µM
bRibLsRsRgbRebRoLsbLsbRjRibRibLebLhbRsLebRibRebRgbRiRsmbRebRcRgbLebRsR
gbRebLeRobRsbRsbsbRsbRsbLibLeLebLoLsLoRsmbLoLsLoRsmbLsbReRgRgRsmbRgRsL
gLsmbRgbRgRsRsRsRsRgmmmmbRibRhRsRsmmbRhbRgRsmbReRsmbLcbLgbLgLsLsLsLsLs
mmmmb

>ZF Recording 2016-03-18; tW: 300s; Start: 124816; End: 125316;
Recording: 8-1; Individual: 22; Drug: NDMC 10 µM
bLsRsbRsbReRsRsmmbRebRebRjReLcRjbLiLsLgbReRsmbRgRsRiRsmmbRgRcbLsbRgLsb
RibLeLsbRebRebRebLjRebLsbRibRebRiRgRobLcbLgbRebRcbLgbLcbLebLeLgLsbRebR
gRcbRebLcbRcbRgbRsRsRiRsmmbLebLebLebRsbRebRcbRsRsRsmmbRhRebRiRobRgLsbR
ebLgbLcbRgbRcRgRsRgmbLjbRhRobLcbRjLeLeLiLsbLsbLoRsLiRsbLcLsmbLsbLeb

>ZF Recording 2016-03-18; tW: 300s; Start: 124816; End: 125316;
Recording: 8-1; Individual: 23; Drug: NDMC 10 µM
bLsbLsbRsRsRsRsRsmmmmbRgLeLgLgbRcbRsbLjRebLcbLeLsbLsLsmbRsbLebLgbLeLcR
hbLsbRgLgbLoRobRcRsLsRcmbRsRsRembLeLiReRsmbRgRcRsmbRsRsRiRsmmbLsRsbRhL
cbRcbRsbLhReRsmbRsRsLsmbRebRsRsRsmmbLebRsRsmbRsbLsRsbLebLebLhbRebRibRs
RhRsRsRsRemmmbRiRebRcbRoLsbRebLebLebLebLcbReLsLsmbRsLsbLebRebRgRjbLgRg
bRcbLsRibRsbRsbRiRibLebRebRsRibLhLcLcbRebRoRcbRsRsmbLeLsbLsLsLsLsLsmmm
mbReRoRsLjmbRgbRsRsRsRsRhLommmbLebRebRgbLsbLcbRsRsLimbRoRsmbLgLoLcbRhb
sbLebRgbRhRsmbLcbRcRsRsmmbLhLebLibRebLsLsmbLobLiLgbsbRebRgRebLeLsRcRcb
RcLeLebLebLiLcLcbRsbLcLhRsbRsLgRsbLsb

>ZF Recording 2016-03-18; tW: 300s; Start: 124816; End: 125316;
Recording: 8-1; Individual: 24; Drug: NDMC 10 µM
bLoLsmbLoLsLembRhbLsbRiRjbRcRebRebRobRebReRsRgmbReRsRsmmbRibReRebRebRs
ReRsmbLsRgbLcbLsRsRsmbLeLoRebRsLsbLgbLibRjbRob

>ZF Recording 2016-03-18; tW: 300s; Start: 124816; End: 125316;
Recording: 8-1; Individual: 25; Drug: Control
bLgLsRsLcbLsRsRgRibLibReRsRsRemmbReRsRsmmbRgRsRsRiRsRgmmmbRsRsRsmmbReb
LsRcbLeLcLsmbLgLsLsmbLsLsLsLemmbLiLsLebLsbLgReRsLsRcRiRsmmbRebLebLebRs
bReLibLgbRsRsRsRgmmbLcbRebRsbRsRgLsbRsReRsmbLsbReRsmbReRhbLsRsRsmbRgRs
RsmmbRcbLebLiLsbRsReRebRsbRgRsmbReRsmbReReRsmbRiRsRsRsmmmbLjLsmbLcbLgb
LeLgRsbLhLiLsbLgbRsReLgbLsLhbLeLgbLeRsRsmbLsLsmbRjbReRebRcbRsRgRsmbRgR
smbLcbLhLibLibLebRcRsmbRiRjbRobLhbLebRsLsbRhRsRembLcbLcbRibRebLsbRebRs
RsRsRsRsRsmmmmmbRgRsmbRsRebRgRsmbRsRsmbRibRebRebRebRgbRcbLcbLgbLgbLebL
cbLcLsmbLebLgbLsbLiLsb

>ZF Recording 2016-03-18; tW: 300s; Start: 124816; End: 125316;
Recording: 8-1; Individual: 26; Drug: Control
bLobLebRcRsRombLgRebRebLebLgbLebLsRebLobRcbLsb

>ZF Recording 2016-03-18; tW: 300s; Start: 124816; End: 125316;
Recording: 8-1; Individual: 27; Drug: Control
bLebReRebRsRibRebReReLebLebLebLsbRsbRebRcbRsRsRsRsRsRgRsRsRsRsmmmmmmmm
bRsRgRsRsmmbRsRsRsRsRsmmmmbLgbRhLsbLebLiLebLhbLsRsRsRgmbReRgRsmbLjbLeL
sbRebRebLeLebLibLsRsbLebRcbRgRgRgbRcbRsRsRsRiRgRcLiLsmmbLeLgLgbLsLgb

>ZF Recording 2016-03-18; tW: 300s; Start: 124816; End: 125316;
Recording: 8-1; Individual: 28; Drug: Control
bRebLebLcLgLsbRebRebRgRsRembLgbRsRsRsRsRsRsRsLsLeLgmmmmmmbRiRsmbRebLeL
ibLebLebLibLiLgLsbLibLiRsbLgbRsbLsbLgbLcLsRgReLsmbRcRsmbRcbLobRibRiRsR
cmbLeLgLsbLcRsbLsLebRjbRsRsmbRebRcbLhbRsLsLsLsRsmmbLebRsbRcbLgRsRsmbRs
RsmbLsLcLsLsLemmbLsLsLsLimmbLsbRsRsmbsbLcLsLcmbLhRebRobRgbRgbReLobRsRs
mbLcRsbsbRebRhRgReRsmbLsRsRsRsRsRcmmmbRgbRgRsmbRgbRcRobRobRobLiLebLsbL
eLebRoRsRsRsmmmbRsRsRsRemmbRsRsmbLcbLcLgLcLibLsbRiRsmbRgRsRsmmbReLsRsb
ReRsmbRoRibLebLcLsLsLcRsmmbLiLebRebRiRsRembReRsmbRcbRhbLcLcLsmbLcLebLc
LcbLcLhRsReRgbRoRsmbRcRsRsLsmmbRiRibLeLsbLiRsbLiLcRsRgbLhLcLebRebRsReR
sRsmmbRebReRsReRsRsRemmmb

>ZF Recording 2016-03-18; tW: 300s; Start: 124816; End: 125316;
Recording: 8-1; Individual: 29; Drug: Control
bLebReRjbLcReLsbRcbsbsbLcbLeReLsRobRebRebRebRjRebRebRiRsRsRemmbRebRebL
ebLgLsbLgbReLsbRcbLebLiLsLsmbLsRebRebRgbRebLsRsbLcbRoRebLgbLgbLgbRhbLo
RgbRobReRhbLgbLcbLhbLeLsRobLebLsRsLsbRcbRebLcbLgLsLsLsLsLgmmmbLcLsmbLs
RsLsbLcbLiLgLgLcLeLcLgRsbLsLsmbLsLsLsmmbLobRebRobReLebLhbLsLsLsmmbLsLs
Lsmmb

>ZF Recording 2016-03-18; tW: 300s; Start: 124816; End: 125316;
Recording: 8-1; Individual: 30; Drug: Control
bRoLiLeLhbLeRsbLeRsbRebLgLsbLebLebLebLebLebRsRsmbRsLsRsRsRsRgLcmmbLcLs
mbRcbRebLcbLobLebLgbLcLcbLsLsLgLsLiLcmbLsLsLsLsLsLsLsLsLsLimmmmmmmmbLs
bRcRsRsLcmmbLebLebLebLsLgbLebRsLgbLobRhbRebRibLcbLsbLsLsLeLsmbLeLsLsmb
LeLebLsLsmbsbRebLcbLiLsLcbLeLobLebLiLsbLgbRjbRgbRgLsbLebLhbRsLebRcbLcb
LcbLgbLcbLsbLiLsbLgLebLcbRsLgbRebRebLgLsLsLcLsmmbLeLsLcbLsLsmbLebLgbLs
bLsLebLeLsbLgbLebLibLeLibRoLibLcbLcbLebLibLeLgbLobLcLsmbLjbRgbLcLeb

>ZF Recording 2016-03-18; tW: 300s; Start: 124816; End: 125316;
Recording: 8-1; Individual: 31; Drug: NDMC 1 µM
bLsLgLgLsLsLsLsLemmmbLhbLsbLiLgLsLsLsmmbLsbLiLsbLsLgbLibLsLsLgRsmbRibR
gbRsRsRsmmbRsRsRsRsmmmbRsRsRsmmbLsLsLiLsLsmmbLsLsLoLimbLgLsLsLsLgLeLgm
mbLsLsmbLsLsLimbLiLgLgbLebLgLiLsRgRsRsRsmmmbLgbLsbLeLsLsmbLebLsLsLsLsL
sLsmmmmmbLibLsLsmbLsLhbLsLsLsLsLsLsLemmmmmbLiLsLiLsbLsLsLsLiLeLcRsmmbR
sLsbsbLsbRsbRsRsmbLsLsmbRsbLsLsmbLsLgLiLgbLebLgbLsLeLsbLiLgLsbLibLsLeb
LiLsbLsLsLsLsLsLsLgLgmmmmmbLsLsLsmmbLgLgLebLebLgLsbLebLibLsLsLsReRiLsm
mbRsb

>ZF Recording 2016-03-18; tW: 300s; Start: 124816; End: 125316;
Recording: 8-1; Individual: 32; Drug: NDMC 1 µM
bRgRgbRibLsRsRsmbRhRsRombRcbRgRgRsmbRgLsbLebRcRsRsmmbReRsmbRgbRsRsRsRs
RsRsRcmmmmmbsbRsRsmbLebReRcbRsRsLsRsmbRsRsRsmmbRgRsRhmbRgRsmbRsbRiRsmb
RsRsRsmmbRiRsRsmmbRsRsRsRsmmmbLsRsbRsbRsbLsLiLsLsmbLebLsLsLsLsmmmbLgRs
LcRsbRebRsbRsbRibLsLcLebLsLeLebLsLebLeLsbLsLgLebLsLsmbRgLsRsRsmbRsbLcL
sLsmmbLeRsRsmbLibLsRsbRgbRiRgbRgRsRsmmbLsLobRcRsmbRiLjbReRhRsmbRsbLebL
cbLsLsLsLsmmmbLgbRsbRsRsLgmbLcbRebLgLgLsLsmbLsLgbRcbRsRoRsmbRjbReRsRsm
mbRsRsRsmmbRgRsmbRibLsLgbLebLsLsLimbLibLebLsbLgbLsLhbLsbLgLsLcbRsbRsbL
gLgLsbLsLsLsmmbLgLebLgb

>ZF Recording 2016-03-18; tW: 300s; Start: 124816; End: 125316;
Recording: 8-1; Individual: 33; Drug: NDMC 1 µM
bLeRcRibReReReReRsReRembLhbLebLiLgLgLsLsmbRsLsbLjbReLibLgbRhbLobLcbLeb
LcbLeLsbLibLeLgbLebRjLebLiRsbLhLsLsmbLgLsbLobLobRobLebLsLsmbLobLhLsbLh
bLibLobLebRibLgbRcbLsRiRibRcbRebRebRiRebReRgRsmbRibRgRsRsRgRemmbLsbLgb
LebRcbRobRcReRsmbLjbLhbLsLsmbRjbRoRibLcbLcbLeLsLibLeLsLcLibLeLcLsLsmmb
LeRsReReReLcLoRsRsmbLeRsRsmbLiLebLeLsbLeLibLsRsb

>ZF Recording 2016-03-18; tW: 300s; Start: 124816; End: 125316;
Recording: 8-1; Individual: 34; Drug: NDMC 1 µM
bLebRcbLebRgLsbRibLgbLobRgbRcRsmbRhLsbLebRgbLebRebLiLsbLebLgLgbLebRoRj
bRcLsbLgLsLsRsmbLsLsLeLsmbRobRebRsRsRgRcmbRgbRobRoRcbRibRcbLsbLeRsRsmb
LsRsbRoLsRobLcRsLoLgLobLcRibLcbLsLsmbRhbRcbRibRhbRebRsbRibRgLsbLsLsmbL
sbLeRsbLibLsRsLsLsLsLsLsLeLsmmmmbLobRobLebRobLcbLsLsmb

>ZF Recording 2016-03-18; tW: 300s; Start: 124816; End: 125316;
Recording: 8-1; Individual: 35; Drug: NDMC 1 µM
bLebLeRcbLebLgLsLebRcbRoRsRsRsRgmmmbRebRsbRgRiRsLsReRsRsmmmbRebRgRebRs
RgbLoLcbLsRsRsmbLcbLcbLsbLobRcbRgRebLebLsLcbLsbLeLsLsmbLebLoLsRsmbLcbL
sbRoRsRgRsmmbReRoRcLsbRsLsbRobLoLcbReLcLsRcmbReRebRebReRsRsRsRsRiLsRsm
mmmbRhRsRsmmb

>ZF Recording 2016-03-18; tW: 300s; Start: 124816; End: 125316;
Recording: 8-1; Individual: 36; Drug: NDMC 1 µM
bReLsbLcbRsLsbRebLebLibLebRoLsbLhReRibLgRsbLcbRjbRebRebRebRebRgLsbRsRs
RsRsRsmmmmbLhbLhRsbLoReRcLoLebRibRsRsRsmmbRsRsRsLsRsRsmmmbRsRsRsRsLsmm
mbLsRsLsRsRsmbsbLcbReLoLsLsLsLgmmmbRebRoRoReRcbLsb

>ZF Recording 2016-03-18; tW: 300s; Start: 124816; End: 125316;
Recording: 8-1; Individual: 37; Drug: NDMC 3 µM
bLoRobRebReRiLcbLebRjbRgLsbLsbLebRobLsbLibLiRgbLhbLeb

>ZF Recording 2016-03-18; tW: 300s; Start: 124816; End: 125316;
Recording: 8-1; Individual: 38; Drug: NDMC 3 µM
bRjbRiReLsRsbRgRsLembLgLsbLsLsLsLsmmmbLhLcLsmbReLsRgbRsRsRembRsRsRsRsR
sLsLsmmmmmbRcRsRsRiLgmmbRiRcLjbRiRsmbRsRiRsmbRgRsRgmbLiLcbLsbLsLcLcReb
RsbReRsRsRsmmmbRsRsRsReRsmmmbLsbRgRcbRebLcbLsLeLsbLsRebRgRcbRjbRsRsRsR
eRgRemmbRsRsRsRsRsmmmmbLeLebRebLsRsRsReRsmmbRsRsRsRsReRsLsmmmmbRgbRiRc
LgLsLsLsLsLsmmmmbLsLsmbRgbRcRhLeLsLeLsbLsLiLeLsbLeLsbLsLsLsLgmmbLcbLoR
cRsmbRiRiRcLsbLcbLebRsRhRebRgbRgLeRcRsmbReRsmbLsRsRgRgRsRembRgRgRsRgRe
mb

>ZF Recording 2016-03-18; tW: 300s; Start: 124816; End: 125316;
Recording: 8-1; Individual: 39; Drug: NDMC 3 µM
bLeRoLsLsmbLsbRcLeLeLsLebLsLebLebLsLsLgmbReRebRoLsLsLsmmbLsLsmbRibLebL
iLoLsLsmmbLeLcRsbLgLsbLsLsmbLcRsLsbRcRcbRiRcRsmbReRcbRgbRoRobRibRsLibL
oLcbLeLsbLsLgLobReRsmbRsRsRgRgmbReRgRcbRibLibLhLsRgLcLsRsmbLsLebLibLsL
iRiRsmbRgRsRgmbRsRsRsReLeLeLcLemmbLeLiLebRsLsLsmbReLsLibLsLiLsbLsLgLiL
ebLsbLgLsbRibRiLsbLobLebLcLcbLeLcbRebRebRebRebRebRsRgbRsbRgRgbRebLeLcb
LebLebLgbLiRjLsRebLcLcLsmbLibLebRibLeLsLsmbLebLibLebRibRgRsRsRsmmmbRgR
smbRsLsbRsLobLsbRgbRjRcbRobLsLsLsmmbLebLoLsLsmmbLiLgbLeLgbLiLsbRsLsbRc
RsRcLgRsLoLcRembLeLeLeLgLsbLeLeLcbLsLsLgLeLsLsRsmmbLsLsLsLemmbRsb

>ZF Recording 2016-03-18; tW: 300s; Start: 124816; End: 125316;
Recording: 8-1; Individual: 40; Drug: NDMC 3 µM
bRjRcReRsRsmmbLeRsbRgRgLgbRebLcbLibLeLeLeLeLebLibLeLebLgbLgbLebLeLhbLj
LgbLebRiLeLgLsbLebRgLcbLsLeLebReRsmbRsbRgRcbLeRsRsmbLcbRcRsRsRsmmmbReb
LeLsLsmbRebRgRebRibRcLeLcbLeLobLjbRcbLibLcLebLibLcbLobLebLcbLcbLebLiLg
LsLibLiLsReLeLeLeLsbLebLgLhLsbLsLgLeLsLiLsLgLeb

>ZF Recording 2016-03-18; tW: 300s; Start: 124816; End: 125316;
Recording: 8-1; Individual: 41; Drug: NDMC 3 µM
b

>ZF Recording 2016-03-18; tW: 300s; Start: 124816; End: 125316;
Recording: 8-1; Individual: 42; Drug: NDMC 3 µM
bLsLsLsmmbLsLsLgmbLebRcLsRcRoRsmbRsRgbRsRsRsRsRsRsRsRgmmmmmmbLsRsRoLsb
LsRsbLebLcbLobLgLsLsmbLsLiLsbLgLgLsbLebLsbLsLsRsmbLsLsLsLiLeLommbRebRs
LsbRsbLsLsmbLcbLgLcLeLsbLiLsLsmbLgLsLsLsLsmmmbLsLsLsLsLsLsLhmmmmmbLsLg
LsbLgLsLsLsLsmmmbRsLgLsbLsLsLsmmbLsLsLsLgLsmmbRsLsLgLsLsLsmmbRsbsbsbLs
bsbRsbLsLsmbRsLsLsLsLsLimmmbRsbRsbReReRobRjRsRsmmbLcLoRsbLsbLsLsLsLsmm
mbLeLibLsbRcReLsRsbLgbLibLebLebLeLsLebLebLsLebLsLsLgmbLebReRcbRsLsbReR
cLcLeLsLebLeLsLsmbRgbRsRsRsRsRsRsRsReRsmmmmmmmbRebLcb

>ZF Recording 2016-03-18; tW: 300s; Start: 124816; End: 125316;
Recording: 8-1; Individual: 43; Drug: NDMC 10 µM
bRcLoLoRsbsbReLsRebLsLsmbLsLsLsLsLsLsmmmmmbLgLsLsLsmmbRebRsbLgbRcRcLsL
oLsmbLsbLoLsmbLeLeRgLsbRiRhbReRsRgReLcLcLsmmbRsbRiLsbLsbLgLoRcbRsbLsRs
RsmbsbRgRsmbRcRsRhLgLoLoLombLcLsLombLeRsbLsLsLsRsLsLsLsLgLoLsmmmmmbRgb
RgLsbLjbRhRsmbRsbRsRsLsmbLhbLgRgbRibLeRcbRsbRebLcLcbLgLobRebRoLsbRibLs
LsmbLeRsbRebRcbLsbRcbRsRsmbRcbRsbRibLsbLebLsRsbRsLsbLhLsReRsLsRsmbRiRg
RgLeLsLsmbLebLsbLsLsLsmmbLcRsbReRcbRibLjLibRsLsLiLsLgRoRcRsRsRsRsmmmmb
RsRsRsmmbLeLsLsLombRcRsRoLsmbReRiLsbRiRsmbRsRsLsmbRsRsmbLsbLsRsbRsRsRs
RsRsRsRsmmmmmmbLsRsbLsbLsbRsRsLsLsLsmmmbReRsmbLiLsRsbsbLgLsLsLiLcmbReR
smbRgReRoRsRcmbRgRsmbRsbsbRsRsRgRgRsmmbLjLoRsbRsLsbLsLoRgbRsbRhLeLsLcb
LsLsRgmbLoLsmbLeRsLoRsRsmbLsbRcLsb

>ZF Recording 2016-03-18; tW: 300s; Start: 124816; End: 125316;
Recording: 8-1; Individual: 44; Drug: NDMC 10 µM
bRibReRsmbLgbRgbLeLcbLgLsbLgLsLsLsmmbLiRsRsmbRsbRiRhbLcLebLcRsbLgbLhLe
bRebRgbRebRebRgLgbRiRsRsmmbLsLsmbLebLobLibLgbLgLcRebLsbRiRsmbRsRsRsmmb
RgRgRsRsRgmmbRsbRgbRsLsLsLgmbLcbRsLebLsLsLsLsmmmbLsLsmbLsLgbLiLebLebRc
RsmbRibRebRoRsRembRebRsbRgRsRsRsRsRsmmmmmbRsRsmbRgRsmbLgbRgRsLsmbLeRsb
LsRcLcLsmbRsbRiLsLeLsbLiLsbLjbLcbLcbLsbRebLeLibLsbLeLebLsbRiRsRsmmbRsR
sRsRsLsLsmmmmbRgRsmbRsbLebLsbRcLsbRgRgbLjbRibRibRibLobLgbLgLhLcbLobLcb
LebRsbRgRibRibRhbRsbRebLcbRsRsRsmmbRjLgRebRsbRsRoRsmbRibLebLcLcb

>ZF Recording 2016-03-18; tW: 300s; Start: 124816; End: 125316;
Recording: 8-1; Individual: 45; Drug: NDMC 10 µM
bRsReRoRsLsRiRombRcbLhbRcbLebLibRoLsRobRgbRgRcRiLcLsmbLcbLsLobLsRgbRsb
LjbLhLcbRsRoLsbRsbLsbLsbsbsbRsbLsRsbLsLsmbsbLsbRebLobLeRebRibReRhbReLc
bLebLibLoLibReRsRsLsmmbLebReRsmbLebRobRobRsRibLsbRjbRcLeReRsmbLibLebLo
bRobLsbLebLebLebRjbLebReRsmbRiRoLeLeLebLibLiLebLeLcLsLcmbLsLsLsLgmmbLg
LsbReReRsmbReLeLcbRebLobRcRcbRebReRsmbLhbRoRebRgbLsbRcRcbReLhbRgbLsbLs
b

>ZF Recording 2016-03-18; tW: 300s; Start: 124816; End: 125316;
Recording: 8-1; Individual: 46; Drug: NDMC 10 µM
bRsbLiRiRgbLibLgLeLgbLsLsLsLsLsLgmmmmbRsLsLiRsbRsbRiRiLjbLebRcLcbLebRo
bRcRibLibLgbRsbRsbRsbLsbLeRgbLeLsRsbLibLsRcbRcbRgRsRsReRcLgmmbLcRsRsRe
RsmmbReRsLsmbRsRgb

>ZF Recording 2016-03-18; tW: 300s; Start: 124816; End: 125316;
Recording: 8-1; Individual: 47; Drug: NDMC 10 µM
bLgRoRsRsmmbReRsLimbRebRebRebReRsRimbLsbRiRsReRsmmbRebRobLcbReRsmbLcbL
ebRhbRjbLsLsLsRsmmbLsLsLsLcmmbRgRobRebRcbRcbRgbRebLsRibReLgRsLsLsLsRsm
mbRjLsbRsbRiRsRsRsRemmmbLcRsbRsRsRsRsRsRsRsRsRimmmmmmmbRobRsRsRsRsRsRg
mmmmbRsRebReLgbRsbRsbLgLsbLcbRgbRcbRcbLcLeLeLeLeLiLsLeLhLeLeLsLeLebLhL
sLsLiRsmbLsLeb

>ZF Recording 2016-03-18; tW: 300s; Start: 124816; End: 125316;
Recording: 8-1; Individual: 48; Drug: NDMC 10 µM
bRsRiRobLobReLoLebLgbLeRcLsLcLgLsbLebRcLebLebLebRibLeLobRhRcRsLiLsLsRe
mmbRebRgbRebRsbLebRgLobLcbLsLsmbLsLibLsLsLsmmbRsbLgbLcbLebLeLsLsmbRsLo
bRiRsLsRsmbRsRsmbRgbLjbLgbRoRgRoLsLsLhmbRobRhbRoLsLibRebRsRebLebLebLeb
LsbLsRsLsbLebRcbReRsmbRsRsRsRsRsmmmmbRsRgRsRembRjbRcRsRsRsmmmbRebRgbRi
bRjbRcbReLsLcbLhLobLcLsmbLeLsbLebRgRsmbLebLeLsLcbReLjbRsRsmbLeLobLebRe
bRhLsbRebLgbRcRsRcmbRgbRsRibRgbLcbLebLeRsbLcbLebLebLibLcbLcLcRsbLsLsLs
LsLsmmmmbLjbRsbLcbLcbLibLebLebRsRsmbLcbRcbRsbRgbLsbLcbRgbLeLcLgbRsRcRi
bRiRgRobRcRgLsbRsRsmbRibRsRsRgRcmbRsRibRiReLsbLcbLcLsLgLeLcLcLimbLeb

>ZF Recording 2016-03-18; tW: 300s; Start: 125318; End: 125818;
Recording: 9-1; Individual: 1; Drug: Control
bLsRebRcRsmbRebLiLsbLibLiLebLibLibLiRsbLgbLiLsLsmbLsLiLgbLiLgLebLcbLib
LsLebLibLhbLcRsbLsRsbLibLcbLeRcbRsRsLsmbLjbRibRgbRgbLibLibLebLgbLgLsbL
eLsbLibLgbLibLebLebRsbLib

>ZF Recording 2016-03-18; tW: 300s; Start: 125318; End: 125818;
Recording: 9-1; Individual: 2; Drug: Control
bLhbRcbRebRebRsbRgReRibRsRsRembRgbRibRibRgbRibRibRgbRibRgbRsRsmbRgbLsb
RibRibRibRibLibLsbRgRsmbRsbLibLiLiLsbLiLsLsmbLgbRgbLibLebLiLsbRibRhbRi
bRibRibRiRsRsmmbRsRsRimbLhLsbLebLeLsLeb

>ZF Recording 2016-03-18; tW: 300s; Start: 125318; End: 125818;
Recording: 9-1; Individual: 3; Drug: Control
bLcbReLsbLebRgbRsRsmbRsbRcbRcbRobRcbLsRsRsmbRgbRebRebRobRsLsbLeLsbLsLs
mbLgLeLsRebRebRebRcbLgLebLgbLsLsLeLimbLcbLibRsRsmbRebRcbLcbLsLsLsLsRcR
gRemmmbLebRcRsmbLobRoRebRhbLcbLobLeLjbLebLsLibLcLsmbLgLgbLhRsbsbLjbLcL
sLcmbLobRcbRebLiLgLgbLgbLsLebRibRiLeLeLgbLgbRsLsLsmb

>ZF Recording 2016-03-18; tW: 300s; Start: 125318; End: 125818;
Recording: 9-1; Individual: 4; Drug: Control
bRiLibRoRsRcmbLiLsLsRiRsRsRemmmbRgRhbRobLeRibLebLeLgbLgLsLgLsLsLgmbLeb
LebLibLsLiLsbRsLsbRebRsbRhRsmbLgbLcLcbLebLebRebLibRoLgbLgbLsbRgbLgLgbL
ebRoLsLsmbLsRsbRoLsRsbLgRsbRgLsbRobLebRebRgbRgbRibRobRiLsbRoLsbRiRsRcm
bRoRgLsbLiLhbLgLsbLcLsmbLcLsRsRimbLcLcLcRsbLcLsLgRembLhLsLgLsbLhbLebLe
bRiRcRgbLgbLhbLeLebReRsmbRsRebLsRebRiRsmbLeRebRebLebsbRgbRebRgRsRimbLo
LsmbLgLsbLsb

>ZF Recording 2016-03-18; tW: 300s; Start: 125318; End: 125818;
Recording: 9-1; Individual: 5; Drug: Control
bRcRgbLgbReLeLeLsbLgbLobRoRsmbReReReReReRhbRebRibRebRiRsmbRibRgbLebLib
LebLsbLgLebLiLsLgbLibLibLgbReRcbRsbLebLgbLcbRcbRsbRcbLibLebLebLebLsLiL
sbLobRcbRebRebRebRebRhRsmbRebRebRjbRgRsmbLebLeLebLeLsLgLgLgLsLgLgLsLsL
gmbLeLsbLsLgLhRsb

>ZF Recording 2016-03-18; tW: 300s; Start: 125318; End: 125818;
Recording: 9-1; Individual: 6; Drug: Control
bLebLeLibRobReRsmbLsLsReLeRhRsmmbLibLibLhbLebRibRsbRgbLcbLgbRgbRobRebR
eRsmbRebRgRsmbRgRsRsmmbRsLgLoRsbLsRsRsRgRsRsRemmmbLsbLsbRebLeLsbLsLeRe
RsReRsReRoRgRsLimmmbLoRgRsRembRgRsRsRsRsRsmmmmmbRsRsmbRsRsmbRgRsmbLsbL
sbRsbsbsbLsbsbRgLoLsRoRsmmbRsRoRobReb

>ZF Recording 2016-03-18; tW: 300s; Start: 125318; End: 125818;
Recording: 9-1; Individual: 7; Drug: NDMC 1 µM
bsbReLsLhbLsbLobLebRcRsRsmmbRebReRhbReRibRsbLsLsmbReRsmbRgbRsRsmbRsbRi
bRibRgRsmbRsRsRsRsmmmbRsLsLsLsmmbLhRebLgbsb

>ZF Recording 2016-03-18; tW: 300s; Start: 125318; End: 125818;
Recording: 9-1; Individual: 8; Drug: NDMC 1 µM
bRobLebLeLsLsLgLsLsLsmmmbLeLiLsbLeLhLsLsmbLibLeLgLsbLeLiLsLibLiLeLsLsm
bLebLebLiLsbLebRsbRsRebLeLsbLsLsLsRemmbLsRsLsbRsRsmbRcLhbReRsRsmmbLcbR
ob

>ZF Recording 2016-03-18; tW: 300s; Start: 125318; End: 125818;
Recording: 9-1; Individual: 9; Drug: NDMC 1 µM
bRebLebLgLsbRebRsRsRsmmbRebLsLcLsmbLsLsmbLsLgLsReReLeLgbLeLsLgLgLiLsLe
LsbLsLsmbLiLgbLgbLgbLsRsbLsLgLsRsLsLeLsbRgLsLsmbLeLibLiLsReRsmbReLsbLh
RsbLsLsLsRcLsmmbRsbLiRebRsRsRgRsRcmmbRsRiRgRsmbRsRoRgRsmbReRebReRgRsmb
RiRsRgmbRsRgRsRgRsmmbRsRsmbRsRobRsRsRsRsRsmmmmbRiRebRcbLibLsLsLcmbLgRs
RsmbRcLsbRsRebRebLobLsLgRsLsLsmbRjbLgLsLsmbLsLsReRsmmbLeLsbRjbLebRoRsm
bRsbRsRgbRsRsmbRsbLsRsRsRsRsmmmbRsRsmbLeLcbLebRebLgbLsLsLsmmbLsRebRsRs
RsRsRcmmmbLebRcbRsRgRgRsRsRsmmmbReLeLsbLiLebLeReRsmbRsRsRsRgReLsmmbLsL
sLsLgLsLgLgmmb

>ZF Recording 2016-03-18; tW: 300s; Start: 125318; End: 125818;
Recording: 9-1; Individual: 10; Drug: NDMC 1 µM
bRgbRebLcbRgbLcbRcbRgRebRsRgbRsRibLibLgbRebRcbRobRjbLgbLjbLcbLcbRsRsRi
mbRebLebLibRcLsLebLebRiRobReLebLgbRhbRsRsRhmbRebReReRhbRgbRebRebRibReb
RibRhbRibLsRgRgRibLebLebRebRsbRcbRgbLebLebRebRgRebLeb

>ZF Recording 2016-03-18; tW: 300s; Start: 125318; End: 125818;
Recording: 9-1; Individual: 11; Drug: NDMC 1 µM
bRsbRsbLebRgRsRsmmbRgbRgRsmbRebRiRsmbRhRsmbRsRgRsmbRebsbLiLsbLebLebLsL
smbRgLsRhbsbRsRsRsmmbRsRsmbRgRsmbRgRsRsmmbRgRsmbRgRsRsmmbRiRsmbReRsmbR
gRgRsmbLsLsRsRsmmbRsbRgbRgRsmbRsbRsRsRsmmbRgbLgbLcLsmbLebLgbLsbRsRsRsR
immbRsRsRsRsRsmmmmbsbRsRsmbRsbRsbRgRsmbRgbRgbRiRsmbRsRsmbRgbRgbLibLgbL
jbRjRgbRiRiRsmbReRsRsmmbLgLgbLjLibLcRgbLcbLsbLiLsLsmbLibsbsbRhRhbLibLg
bLjLsLsmmbLebLeLsbLhbLiLsbLgLiLsbLgLebLibLiLsbLebLgbLibLgbLgbLgLsLsmbL
gbLeLsLgLsbLsbLebLibLgLsLgbLhbRsbRsbLjbLeLsbLibRiRsmbRibLgbLjLcbLebLeL
sbLibLgLsLsLsmmbLsLsmbLibLiLcLsmbLibLjbLebLibLjbLiLsbLeLsbLsLsRsmbLibL
iLsLsmbLgbLgLsbLiLsbLibRsbRgRsmbRibRebRebRebRcbRhbRgRsmbRibRiRsmbRiRsm
bRibRiRebLsbRibRhRiRsRsRhmmbReRsmbRcRobRsbRsRgRsmbRsRsRsmmbRgRsmbRgRsR
gRsmmbReRsmbRiRiRsmbRgRsmbRgRsmbRgRsmbRgRsRsRsRiRsmmmmbRibLsbRgRsRsmmb
RiRsRsRsReRsReReRsLsmmmmmbRiRsmbRgbLgbLgbLiLsLcbLsbLsRsbLgLsbLiLsbLjLs
LsmmbLibLgLsbLgbLiLsbLeLsLeLsbLgLsbLgLsbLjLsmbLebLhLcbLsLsmbLjbLhbLeLs
bLgLsLsRcRiLsmbRiRsRgmbRsRsRsRsRsRcmmmmbReRsmbLiLsbLebRiRsRsmmbRiRsmbL
gbReRgRsRsRsRcRsRcRcmmmmbRhb

>ZF Recording 2016-03-18; tW: 300s; Start: 125318; End: 125818;
Recording: 9-1; Individual: 12; Drug: NDMC 1 µM
bRiRsLsLsmmbRiRgbLcLhLsbLebLebLgLgbLibLebLgbRiRobLcLsLsmmbLebLebLgLsbL
sLgLsLsmbLsbLsLsmbRgbLeRsbLibLsLgbLeLsbLebRsLsbRcbLsbLebLibLsbLebLsLsL
sLsLgmmmbRobRibRgbRsbReLsRsbLgbRsbLsbLsLsmbRjbRhbLcLsLsmmbRsLsLsLsLsLs
LcLsmmmmmbLsbLsLsLeRsmbLsLsmbLsbLsLeLsbRebLjbLsbLebLsLsmbReRjbRebRsRsm
bRgRhbLoLgRsbReRjbRsbRcLsRsLsLsmbsbRsRsRsRsmmmbLibLsbLsbRobRgRgRsmbRgb
RsRsRsmmbRgbRebRibRebRobRsbRsbRibLcbRcbRgbReRsmbRibRebRgbRibRibRsRgRsm
bRebReRsRsmmbRcbRgRsmbRebRhRsmbRgbRsRsmbRhbLsLsLembLcReRsmbLeLsbLsLebL
sLsLeRsmbRsbRibLsRsbLsbRsbLiLsbLgLebLeLsbsbsbLgbLgbLebRjbLeReRsRsmmbRi
bReRsmbRgRsRsRsRcmmmbRsbRcbRsRebRgbLsRsbLgbLeLsLsmbLcbLebLsbLsbLgRsbRg
RebRsReRsmbRgRcbRgRsRembRsRgRsmbRebRsbRsRsmbsbReLsbRsLsbRsLsLsLgLsmbLs
LsLiLsmbRsLgLsLsmbLeLsb

>ZF Recording 2016-03-18; tW: 300s; Start: 125318; End: 125818;
Recording: 9-1; Individual: 13; Drug: NDMC 3 µM
bRcbLgLsbRsReRebLcbLsRsRsLsLgLsRsLembRoRebRgbRsRsRsReRsmmmbRgRsLsmbRob
RhLsbReLsbReLgLsbRjbRcbLcRcbRebLibReRsmbLgbRibRgRebRgbRsRsmbRsRebRcRsm
bRibRebRobLgLsLsLimbLebLibLsLsmbLebRcbRebRebReRibLgLgLsLsLsRsmmbLgLsRs
LcbRebRsRibRibRebRsRsLsmbLgLsbLsbRibLsLsLsLsLgRsmmmbLsLsLsmmbRsRsmbRsb
LiReRsRcReRimbRgRsmbRebRjRsmbReRsRsRsmmmbRgRsmbRoRcbRibRiRiRcbLgLcRobR
cLobLsLsLsmmbRcRsLsmbRgRebLsLeLsbLsLeLebLeLsRsLeLebRsbRiRcRsLoLgmbLebL
gb

>ZF Recording 2016-03-18; tW: 300s; Start: 125318; End: 125818;
Recording: 9-1; Individual: 14; Drug: NDMC 3 µM
b

>ZF Recording 2016-03-18; tW: 300s; Start: 125318; End: 125818;
Recording: 9-1; Individual: 15; Drug: NDMC 3 µM
bReRsmbLcbLgbRebsbReLsbRcLsRhbRgbRsRsRimbLgReRcRcbLeLcbLsbRsbRsLsbRebR
ebRsbRcbRhbRebRobReRebReRsmbReRibRgRcReRsRsmmbRiRsReReReRsmmbRgbLsbRsL
sbRjbRcRjbRoLsb

>ZF Recording 2016-03-18; tW: 300s; Start: 125318; End: 125818;
Recording: 9-1; Individual: 16; Drug: NDMC 3 µM
bLgRsRoLsbLsRsbLsRebReLcbRebLsbLsbReRsmbRsRsRsRgmmbRoReReReRsmbRiRibRg
RsmbRiLcLeLeLeLeLgbLgLsLsLeRsLsmbLsbLeLgbLgReRgbLgbReLiLibLcRjbRebRibL
oLsLeLgLeLsLeLembLsLsLsLgLsLsLsmmmmbRcbRsRgRebRobRsbLgbLgbLebLhbLsLsLs
LsRsRsmmmmbRjbLibLebRcRcbLjbRcbLeLiLebLsbLeLeLebLgb

>ZF Recording 2016-03-18; tW: 300s; Start: 125318; End: 125818;
Recording: 9-1; Individual: 17; Drug: NDMC 3 µM
bRiRsRhRcmbRebRcLcbRebReRsmbRjbRebRgbRebRsbRiRsmbLibLgLsbLeLsLsmbLsRsb
LebLhLcbLgLsbLcbLcLhbLebLcLsLsmmbLsLcbLcbRoReRsmbReRsmbReRhbLebRebRibR
ebRebRebRebLebLebLeLgLsLsLsLsLsmmmmbLgLsLgbLsbLobLcbLibRebRoLsRobRhbRe
bLcRsbRebLsbLebLcbLsLgbLsbRibRgbRobRcLsbRcRsReRsmmbRebReb

>ZF Recording 2016-03-18; tW: 300s; Start: 125318; End: 125818;
Recording: 9-1; Individual: 18; Drug: NDMC 3 µM
bLebLebLeLgRebRoLsLiLhbRobLgbLobsbsbLsbsbsbLebLiLsbRsLiLsbLsLsLsmmbRsb
LsbRgbReRibReRsmbRgRgRsmbLibRsbRebLeLcLsmbLebLebLgbLebLcbLebLebRsbLhbL
iLsLsLimbRoLsLcbLsLsmbLiLsbRebLcbLcbLibLsLsLcmbLcbLobLgLgbRcbRsRcbRiLs
RsbLsbLsRsRgbRiRsRembReRgRiRsmbRsbLcRibLiLebLsb

>ZF Recording 2016-03-18; tW: 300s; Start: 125318; End: 125818;
Recording: 9-1; Individual: 19; Drug: NDMC 10 µM
bsbRoRebRcbRebRcbLcbRcbRgbLebLgRsbLsLsLsLsLsmmmmbLsLsLsmmb

>ZF Recording 2016-03-18; tW: 300s; Start: 125318; End: 125818;
Recording: 9-1; Individual: 20; Drug: NDMC 10 µM
bRiRhRsmbLcRsbRcRhLoLgLsbLsLsLsLsRsmmmbRobLhLsbLeLeLsbRobRsRsRsRemmbLs
LgLsLiLsbLsLebLsLsRsmbLsLsLsLsLsmmmmbLsLsLsLsLsLsLgLemmmmmbLjLsmbLgLgL
gLhLgbLgLebLsRsRsmbRgbLebLcLsmbLgLibLsLsmbLsRsbRoRsmbRiRebReRsRsReLsmm
bRgRsmbRebLoLsRsReLsmbReRsLembLcbLjbLebLcbRcbLcbLsbLsbRsRsmbLcbLebLsLe
bLsLgbRsbLsRsbRcbLibRebLibRcbLeLgLcbLsbLeRiLibRiRsmbLsRsRsRsRhRsmmmbRe
bRsbRsRsmbReRsRcmbRebLgLsLsLsRsmmbRebRgbRsRebRobLcLsLcmbLiLoRsbRjbRebL
obReRsRgLsmbRgRsmbRobRsRsRsmmbRgbRiRsmbRsbRhRsmbRsRsmbRebRebRebRebRcRc
LsbReb

>ZF Recording 2016-03-18; tW: 300s; Start: 125318; End: 125818;
Recording: 9-1; Individual: 21; Drug: NDMC 10 µM
bLsRebLibLoRsbLoLsmbLcbLgLsLoRsbLgbRgRsmbRsbRgbRsRsRsRsRsmmmmbLhLsbLhb
LebRsbLibReRsmbRsbLeRsbRebLebLcbRsLsbLiLibLsLoLsmbLebRcRsLombsbsbsbsbs
bLebLeRsbLeLsbsbLgbRsbLiLsbRgbLhLibLibRsLiLsbLhLoRgbLiLgRsbLsLgLeLsbLh
RsbLjLiLsbRcRsmbRgbLsRsRsRsmmbRsRsmbRsRiRsRsRsmmmbLcbLgLsLsLimbLsLibLs
RoLsbRobLsLobLoRsRsRimbLeLsRibLsbRgLsbLsRgbRgRsmbRgRsRhmbRobRgb

>ZF Recording 2016-03-18; tW: 300s; Start: 125318; End: 125818;
Recording: 9-1; Individual: 22; Drug: NDMC 10 µM
bRebRebRibLhLcbReRcbRgbLsbLsbsbsbRsbsbReLjRebsbsbLsbRsbLsLsmbRsLsRsLsb
sbsbLcbRiLeLsbRjRebRgbLjbRgbRebRebRgbLebRcRiRsmbRsLsbLebLsbLgbLcbLibRe
bReRsmbRebRebRebRgbRgbLobRgbLiLhbLsRsbRsbRebRsbsbLsbLsbRsbsbReRsRsmmbR
ebLgbsbLebRgbRobRiRcbRsbRiRebRobLsbRsbLcbRibRcbRibLsbRjbRcbRgLcbLebReb
LsRsRsLeLembLsRgRsLsLeRiLcLsLimmbLgRcRcbRgb

>ZF Recording 2016-03-18; tW: 300s; Start: 125318; End: 125818;
Recording: 9-1; Individual: 23; Drug: NDMC 10 µM
bRcRebRibLsLsLeLcLsLimmbLsLsLsLsmmmbsbLsLsmbsbRcRobRgRsRembLibRcRsRsLi
mmbLebRebRebRibRsRsmbLjbLsbRibRebRobRsbReRsmbRjbLebLsbLcbRibRebLebLebR
ebRebRsbLcLcbRsLhbLhLcbLebRgbRoRobLgRibLsRsRgRebRsRsRsRsmmmbRsLsRsRsRs
RiLemmbRsbReRsmbRjbLebLcbLsReRsLsLcRsRsRsRsRsRsmmmmmmbRibLsbLsLsmbLsbL
cbRebRebLcLsLsmmbLsLsLsLsLsLsLemmmmmbLgbLsLsmbReLibLsLsLsLgRsmmbLgLiLs
bLgbLiLsLsReRcLsRsmbRsRsmbRebReLebLsLeLiRsbRsRsRsRsRgmmmbRsRsmbRiRsLem
bRgRsmbLsbRcLsbRcbLebRcbRebRoRcbRsRsRsmmbRsbLcbLsLiLcbLiLiLsbLebLiLsbL
ibLsLibLsLsLsLsmmmbRibRgbLsLcRsbRsLsLsmbLjbRgbRgbRobRsRiReLsbLhbLsLsmb
LsLsmbLgLsRiRsmbLiLsLsmbLsLsLsLsLsmmmmbLgLiRsLgLcLsmbRcbRsbLjLsLembLhR
cRsmbRsbRebLgLsLsmbRebRgbLcbLsLsLsmmbRcbRoRsmbReRibRsRsReRombRcLebLsLs
LsmmbLsLsmbLiReRsmbLgbLcLgLsbRhbLebReRsRoRsmmbRsRsRsRemmbRibRsbRgLsLsm
bLibLebLeLsbRsLsLsLsmmbLsLsLembLsLsLsLsLsmmmmbLgLeLsLgbRibLiLsLsmbRsLg
RsbLiLsLiLiRsRsmbLsbLcLiRobRsRsRcRcmbRsRebRgRiRsRsmmbRsRsRsmmb

>ZF Recording 2016-03-18; tW: 300s; Start: 125318; End: 125818;
Recording: 9-1; Individual: 24; Drug: NDMC 10 µM
bsbRsbRgRoRcLsbLebLsLsmbLsLsmbLibLebRebRibLobLhbLebLeLgLebLiRsbLiLeLsL
sLsRoRsRsmmmmbRsRsRsmmbRsRsmbRsRsmbRsbRsbRsRebRhbRobRebRcRebRhRiRgRsmb
ReRgRcbRsRsRsRsRsRgRgRsmmmmmbRsRsmbRsRsmb

>ZF Recording 2016-03-18; tW: 300s; Start: 125318; End: 125818;
Recording: 9-1; Individual: 25; Drug: Control
bRsReLgbLgbRcbRiRsmbRsRsRsmmbLeLcLsmbRiRsRsmmbLsRebLebLsLsLsLemmbLsRsb
LsLsmbReRgLsLsLsLommbLsLeLcbLsbRsRgRsRgRsRsRgLsmmmbRsRsRsmmbRhRsRcRgmb
RgRsRsmmbLibLeLsLgLcReRsmbLgbLgbRsbRiRsRsRsRsRsRgmmmmmbRsLsbLcbLeLsLsL
sLeRsmmbLgLsLibRsbRsRsRsRsRsRsmmmmmbReRgLsbLsLsLsLsmmmbLsLebLcbReReReR
smbRsbRiRebLcLsmbLcbLeRebLsLeRibRebRcRcbRebLibLcbRebRebLcbLoLhbLgLsLsL
smmbLsLebLsbRsRgRsRsRsRgLjmmmbLsLebLeLsbLhLsLebLgRsLsbLibRsbRgbRsRgReb
LebLsLsLsLsLsmmmmbLsLsLsLsmmmbRjbRgbLsLeRcbRsbLeLibLibLjbLibLsLgbLcbLe
LsbLeb

>ZF Recording 2016-03-18; tW: 300s; Start: 125318; End: 125818;
Recording: 9-1; Individual: 26; Drug: Control
bRibReRebLcLsRgLsmbReRgRhbRgRsRsmmbRgRebLeLoLcbLsbLoLeLeLeLsLeLebRsReb
LebLoLebRgLeLsRsbLibRcbLebLebLeLibLebLgbLoLsmbRiLsLsmbLsLsLsmmbLcbLobL
ebRibLebLebLgbLebRsRsmbRhLsbRibLeLobRjbRcLsbLcbLgbRoLcbRgb

>ZF Recording 2016-03-18; tW: 300s; Start: 125318; End: 125818;
Recording: 9-1; Individual: 27; Drug: Control
bReRhbRgbRebLebLgbReLeLsbLsLsLgLeLcmbLeLgbLiLsLsLsLemmbLsbLibRcbRcbRsR
sLsLsRsmmbLcRhbLjbLcLsRembLiLebLiLebLgLgLeLcbLsLgLsLsRsmbLgLgLeLsLsmbL
gLsLsLiLgmbRoRebRiRiRcLsbLcbLiLsLsLgmbLcLhLsbLgLsLsLsLgmmbLcLgLgLgbRcR
smbRiRsLsmbLjLiLsLsmbLgLgLsbRcbRcbRcRsmbRgRcbRiLsLsmbRcRsRcRsmmbRiRebR
iRcRsmbRgRiRcLsReRsmbRiRsmbRiLsLsRsmbLjbLiLsLebLcLsLhmbLiLibsbLcLgLeLh
LsLsmbLsLsLiLgmbLcLeLsLgbRebRebRebLsbLcbLeLeLibLsLsLsmmb

>ZF Recording 2016-03-18; tW: 300s; Start: 125318; End: 125818;
Recording: 9-1; Individual: 28; Drug: Control
bLebLgLeReRsLsmbsbRcbLcLgbLebRobRebRsbRjbLcbLcbLcbLiLsLsRimbLhbRobRcbR
cRgbRobLgbLcbLibRebRoRsmbLjbLobLeLsbLsLsLsLgmmbLsLsmbRiRsRsmmbLsRgRsRs
RimmbLgLhbRsRsRembLebRcbRcbRibLibLgRcbRsbRebLobLebLeLsLcbLiLsLsmbLob

>ZF Recording 2016-03-18; tW: 300s; Start: 125318; End: 125818;
Recording: 9-1; Individual: 29; Drug: Control
bLobLcbRcRsmbLiLsbLgLgLgLgbLsLsReLembLsRsbLobRoLsbLgLebLebRgRsRsmmbReb
RhRcbLgLsLgbLsLsLsLsmmmbLcbLgbLsbRcRsmbLsRebLeLsbLebLibRebLebLsLsLgmbL
sLsmbRsbRgbLcLsRcmbLcbLoRebRebLsRsbRgbLcbRgRcbRsReReRebReRebRebReReRsm
bRibLibLebLgLsbLcbRebLcbLgLibLcbLsLsRimbRebsbRsRcbRcbRcRebRsRsRsRemmbR
ebRcbRobLebLebLgbLebLibLiLibLibLsbLgRsbRobLcbLgbLeb

>ZF Recording 2016-03-18; tW: 300s; Start: 125318; End: 125818;
Recording: 9-1; Individual: 30; Drug: Control
bLsbLgbRoRsRcLsmbRsRiRcLsRcbRebReRsmbRcbLcLcbRsLsLsmbLebLibLgbRsLsLcLs
LcLsLsmmmbLgLsbsbRsbLebRebRebLcbLhbLhbLeLcbLebLebLibLcLsmbLeLsbLeLeRhb
LeLgbLsLsmbLebRgbLebLsLsLgmbRoRsmbLcRsbLoLsLgmbLsbLcbRsLcLsmbLibLhLebR
ebRcRibRcRebReRsRsmmbRiRhRsRoLsLeLsmbLiRgbsbLsRsRsRsmmbRsbLsbRsLjbRgbL
iLebLebsbRebLhLcbLebRebLsLsmbRsRsmbLebRsRiLsbsbLgbLibRebRhRsmbLcLsLeLe
LiRsmbLhLsLsLimbLsLsmbLsLgLsbLsLebRibLobRhbsbRcbRcbRcbRcLebLebLsLsLeLg
LeRombLeLcbLcbRcbRsRsmbRgRsmbRsbLcbLibLiLebLgLsLsmbLeLsbLeLsbLsLeLsbRc
LiLebRhbLhLiLsLsmbLcLcbLgbLeLsbLgbLibRibRsRcRsmbRibLcbRgRgRsRgLembLebL
ibLgLsRoLsLgbLcLebRebRcbRcRgRsmbRoLsLgbLoRebLgbLebLgbLebLibLgLsLsmbLeb
RsbLiLiLhLsbLsbRoLsLsmbRcb

>ZF Recording 2016-03-18; tW: 300s; Start: 125318; End: 125818;
Recording: 9-1; Individual: 31; Drug: NDMC 1 µM
bRsRsRsRsRsmmmmbRiRsRsRsLsmmmbRsLsbLsLiLgLeLsbLibLeLgbLibLsLsLembLibRg
LsLsmbLsbLsLsRsRsRsRsRsRgRsRsRsRsRsRgRsmmmmmmmmmmmbLsRsRsRsRsRgRimmmbR
ibRhRsLsLsLsmmmbLsLsLsmmbRiLeLsbLebLeLebLeLsbLeLeLeLsbLeLsRsbLsLsLgLsm
bLsLsLsLsLsLsRsmmmmmb

>ZF Recording 2016-03-18; tW: 300s; Start: 125318; End: 125818;
Recording: 9-1; Individual: 32; Drug: NDMC 1 µM
bLgLsbRjReRsmbLcLsmbLsLsmbLgLsLebLebRiRiRsRsmmbLsRebLsLiLsLsLsmmbLsLgb
LsLgLsLsmbRsLgLsbRibRcRsRombLoRsRsmbRhbRsbReReLiLgbLsLsLsLsLsmmmmbLeRs
bLiLsLsLgLembLebLeLsbLebLgLsLsLsLsmmmbLebLsLgbRcbRoRsLsLsmmbRebRibRcRs
mbRiRsmbLibLsLebLiLebLsLsLsLsLsLcmmmmbRibRibRsRsmbRsRsmbRcRsmbReRiRgbR
eRsmbRebLebLebLebRsbsbLebLebLebRsbLebLebLebLebLgbLgbLobRjRsmbRsRsRembR
ebRibLgbLiLcbLcbRebRibRebLgLgbLoRsbRsRgRsRsRgmmbLeLcRsbRebLhLebLeRsb

>ZF Recording 2016-03-18; tW: 300s; Start: 125318; End: 125818;
Recording: 9-1; Individual: 33; Drug: NDMC 1 µM
bRcLebLcLiLcRsbLcbLcLoLsmbLgLeLsLcLsLembRebRebLoRsRibRsbRibLoLgbRcRoLo
LoRsRjbLeLeLsLgbLcbLcLcbRebRgbRoRsLsRsmbRcRgbLebLgbLcRsbRcRsmbRcRsmbLo
RsLsbLcLsmbRsbLeLcLsmb

>ZF Recording 2016-03-18; tW: 300s; Start: 125318; End: 125818;
Recording: 9-1; Individual: 34; Drug: NDMC 1 µM
bLcbLobLebRcbRsReRiRcbRsRsRembRhRiRsmbRsRhbRebRhbRibRgbLobLebLobLiLsLh
bLebLebLebLcbLcLcbReRsRgRsRommbLsLsmbRjbLebLebRcLsbReRgRhbRcLeLsbLebRs
RsLgmbLcbLebLgLcbLibLobLobLobLcbLgRiLsbRgRsmbRcbLgLsbLiLsbLobLcbRiRcbR
cbLebRiLsbLiRcRsmbRsRgRgRgbRsRobRobRcRiRsmbRgRsReRsmmbRobRsRsRsmmbRgRs
RsRiRsmmmbRcRobRcbLeLsbLeb

>ZF Recording 2016-03-18; tW: 300s; Start: 125318; End: 125818;
Recording: 9-1; Individual: 35; Drug: NDMC 1 µM
bRiRcRsRcmbLcLsmbLcLsmbLsLebLebLebLebRgRsmbRsRsRsRgLcLiLsLsLoLsLiLsLsm
mmmmbLibRebRgbLgbRsLebLcLsmbLebLeLeLebLsLsLsLeLsLsLgLsLsmmmmbReRcRsmbR
sRsRgLsLsRoRcmmbLgbLcLsRsmbLgLsbLcbRebLhLsRebRebRcRsRsRsRgRgRsmmmmbLsb
RsRiRsRsmmbRsLsLsmbLsRsbRsRsmbRsRsmbRebRsb

>ZF Recording 2016-03-18; tW: 300s; Start: 125318; End: 125818;
Recording: 9-1; Individual: 36; Drug: NDMC 1 µM
bRgLsLsmbsbRsbLgLsbRhRsLimbLsbRcLsLsLsLsmmmbLsLsLsmmbRsbsbRcLsbLgbLsLs
LsmmbLsLsmbLsLsLsLsLsmmmmbsb

>ZF Recording 2016-03-18; tW: 300s; Start: 125318; End: 125818;
Recording: 9-1; Individual: 37; Drug: NDMC 3 µM
bLeLsRsRoLsRobLebLgbRebRsbReRcReLebLgbRebLobRebReRsmbReRebRgRiRsRsmmbR
gb

>ZF Recording 2016-03-18; tW: 300s; Start: 125318; End: 125818;
Recording: 9-1; Individual: 38; Drug: NDMC 3 µM
bLebLeLeLebLeLgbLsLgLgLhLsLibLgLsbLsReRiRibRcReLebRebRjRcRcLsRsbRsRsRs
RgmmbRsRcRhRsRsmmbRsRiRibRsRgRsRgRsReRemmbRsRgRebRsRiRsRsReRimmbRsRsRg
RhRsRsRsLjLgLiLimmmmbReReRibRobReRiRsRsmmbRsRsmbRgReRhRcLsbRcRsRsmmbRe
bRsRsmbRsRsReRcmbRebLcLsReRcmbRcLcbRebReRgRsmbRgRsRimbLsRgRsmbRebReRsm
bRgbsbRsRsRsRemmbLibReReLcLsmbLobLcLeRsLcbLeRsbLebReRsRhmbReRibRsRsRsR
eRhmmbRsRsRsReRgmmbLsbLeLcLiLsLsLhRembRebRebRsRsRembRsbRsReRhbRsReRib

>ZF Recording 2016-03-18; tW: 300s; Start: 125318; End: 125818;
Recording: 9-1; Individual: 39; Drug: NDMC 3 µM
bLebRiLiLsLsmbLiRcbRgbRiReLcRsRsLsmbLsLsLsLeRcmmbRiRsRgRsRemmbReRgbRcb
LeLebLeLsLhbLsRsbLebLobRhRsRsmmbRebRgbRgbRgbRiLibLobRcLsLebLhLhRsbRsRs
LsRembReRgbReLeLsbLiLsLgLeLsbRoLgReRcRiRsRgRhRembReRebRgbLiRebLsbRhLsR
gbLcLeRgbRiLjLsmbRsRsRsReRommbRsLsLsmbRiLebLsLcLcbLebLeLiLsbLgLsLsmbLe
bLsLsmbLsLsLsLgLemmbLgbRjRcRiRcRiRcbRsRsRgRsRsmmmbRhRibRsRsRsRgRhRemmb
RsRgRsRgRsLsmmbRobRgRsLsmbRsbRiLsbLebRcRcRibRsRsRiReLsLsmmbLsLsLiLsmbL
eLcLsmbLeLcLsmbLsLgLgLeb

>ZF Recording 2016-03-18; tW: 300s; Start: 125318; End: 125818;
Recording: 9-1; Individual: 40; Drug: NDMC 3 µM
bLiLeLcRsbLgLeLiLsLsLeLsmbLebLsbRebRsbLcReReRsmbLebLsLsmbLeLebLeLsbLeL
iLsLiLsLsLiLiLsLsmmbLiLsLgbLgLsbLibLgbLsbLebLebLoLgbLeLebLeLsLsLsLsmmm
bRsRsRsRsLsRsmmmbLeLgbRsRgbRebLcbLebLgLsLsLembLebRsbLebLibLebLgbRsbLgb
LebLgbLebRebRebRiRsRsLimmbRgRsmbReReRgRsRsmmbReRsRsRsRiLgmmmbRsbRgbRgR
sRsRsRsRgRsRsRsmmmmmmmbsbRebLsLeLiRsbLgLsLsmbLsLsLsLsmmmbLgLebLhLobsbs
bLeb

>ZF Recording 2016-03-18; tW: 300s; Start: 125318; End: 125818;
Recording: 9-1; Individual: 41; Drug: NDMC 3 µM
bRsRsmbRobLsLobRsLiLgLgbLgLsLgLsLsLsLsLsmmmmbLsbsbsbsbsbsbRsLsRsbsbsbs
bLsbsbsbRsRsmbLsbLsLsmbsb

>ZF Recording 2016-03-18; tW: 300s; Start: 125318; End: 125818;
Recording: 9-1; Individual: 42; Drug: NDMC 3 µM
bReRsRsRcLcmmbRibRsRsRsRemmbLcLsmbLgbRgRgRiRsRgLsmbRcbRsRsmbLsRsRsmbRi
RsRsmmbLsLsLsLgLsLeLeLgLgmmbLsLsLgmbLsLsLsLsLsLsLsLsLgmmmmmmmbRsLsLsmb
LsLsLsLgLsLsLgLsmmmbRibRobLcbLobRebLgbsbReReReLibLgbLsLsLsLimmbRcRgRcb
RebRebRgRgbReRsRgRgmbRiRibRsRsRsRsRgmmmbRsLjbLiLgbLgbLcbLebLobLebLebLe
bLsbRebRcbRsLsbRjLibLcbLgbLebLebRebRcbRgbRsRsRsLsmmbRsLgbRsRgRsLembRcb
LsbLsLsLsLsmmmbLgLsRcbRebLsRgRgbLcLgRiLgRiLsbRgRsRsRgmmbLeLcbLgRgbRgRs
RsRsRemmmb

>ZF Recording 2016-03-18; tW: 300s; Start: 125318; End: 125818;
Recording: 9-1; Individual: 43; Drug: NDMC 10 µM
bLeLsbRjRiRsRsLsmmbRcRsRcRhLsRcLsRiLsLsmmbLjLsLgLsLsLsLsmmmmbRsRsLsLsL
sLsmmmmbRoRsRsRsmmmbLsRsRsRgRsmmbReRsmbRgRsRsRsLsmmmbRsRhRsmbRhReRsLsR
smbLsRsRsmbLobLibLiRebRsbRsbRsbLsbRiRgRsRcLoLsmmbLsLsLsLgmmbLgLgLsLsLs
LsmmmbLebLsLsRgmbLsbLsLsLsLgmmbsbLebRiRgRsRsLsRsmmbRsRibLsRiRgLsbLsbLe
LobLcRsbRsRsRsRiRsmmmbLjbLebLsLsLsLgLiLsLommbLhLsLsLgLembRcReRibRsRebL
gLebLebLiRsbLsbLjLgLsLsLsmmbRoRcbRebRiLsbRgRsRsLgRsmmbReLsLsRsmbRsRsmb
RsRsRiRcRsLgLommbLiLsbLsLsLgmbLsLsLgLiLsLombLsLsLsRsmmbLcbLeRsRsRsmmbL
sbLoLsRsmbLhLgLsbLsLeRsbRsbRsRsmbRsbsbReRobRcRsRsRsmmmbsbRsbRsRsRsmmbs
bRsRsmbRsbRebRiLsbRsRsRsmmbRsRgRsmbRsLsbsbsbsbLsbLsbRibLebLeRsRoRcReRh
RobRsRsRsRsmmmbRsLsRsRsLsRsRsmmbRsRsLsRgRsmmbRsRsmbsbLcLcLobLoRsbLcbLs
LsLsLsmmmbLgLeLoRsRsRsmmbLsRsbLsbLgLgLjbRgLsbRcRebLsLsmbRobRsbLsbLsbLs
bRgbRsRsmbRsRsmbsbRsbRsbsbsbRsRsmbsbRsbRsbRsRsmbsbsbRsRsRsmmb

>ZF Recording 2016-03-18; tW: 300s; Start: 125318; End: 125818;
Recording: 9-1; Individual: 44; Drug: NDMC 10 µM
bLebLsbRcbRebLsbRebLoLebRebRgRebRebRibRgbRebRsbLsRsbLebLsLgLgbLgLgLeLg
LsbLsLebRsbRibRebLsbRiRsRembRhLcRsbLgbRgRgRibRsbRgRsRsmmbRcLsbRsbRiLsb
RhRsRsmmbLgLcLsmbLeLsbLeRsbRjRsRsmmbLjbLibLebLebLcbLibLobRibRebLebLgLe
bLebLibLeLcbLgbRcRsmbRsRsRsmmbRibLcLsmbLsLebLsLsmbRjbRibRgRsRsmmbRsRsR
sRsRsmmmmbRjRsRgRsmmbRiRsRcRsRcRsmmmbRgRsRsmmbRhbRsLsRsbRsbLeLsRsbRobR
ibRsbRgbRsbRiRgbRgRsmbRgRsmbLeLsbRsLsLebLgLsLgLiLobLebRebRebRiRgbLcbRg
bRcRgLsLebLeLsbLgLeLsbLebRcbLiLsLsRembLsb

>ZF Recording 2016-03-18; tW: 300s; Start: 125318; End: 125818;
Recording: 9-1; Individual: 45; Drug: NDMC 10 µM
bRcLsbRhbLcbRoLsbLeLeLsbLsbLcbLsLgbRobRsbRgRsRgLjmbReLsbRebLsbLsbRsbLs
bLsbRjbRsbLjbRsbLsbRobLjbLjbLjbRsbRebLsbRebLsbLjbLebReRgbRebRgbRhRcRsm
bLgbLcbLibLhbLjbRgbLcbRsRibRiRsmbLeRsLcLsmbReLeLsLsmbRgbRsRsRembLobRcR
gbRgbLcbLiRcbRiRsmbRebLebRoLoLcbLsbRoRcLgLsbRsbRcRsRsmmbReLebLcbRgbRhb
RibLiRsbLebLeb

>ZF Recording 2016-03-18; tW: 300s; Start: 125318; End: 125818;
Recording: 9-1; Individual: 46; Drug: NDMC 10 µM
bRsRsLembLeLsbLebLebLgbLiLsLgbRsbReLeLcbRibRgbLebLeLhLsLgbRcReRibRcbRg
bRsRgbRsLsRsLsRsRsReRcRsRsmmmbRgbRcbRsRsmbRgReRsmbRsRsRsmmbReRsmbRsRsL
cmbLhbLsbLgLgLsRhbRebRsRsmbRsRcbRcbRebRgb

>ZF Recording 2016-03-18; tW: 300s; Start: 125318; End: 125818;
Recording: 9-1; Individual: 47; Drug: NDMC 10 µM
bLebLobReLsbRhbLebLgLobLebRjbLgLebReLibLgLsbLsRsbLgbRgbRsbLsLsmbLsbRsb
RsbRebRebLeRoLcLgbLeRcbRebReLsbRebReRibLsLsmbLebRcbRcLsbRcLsbRsRsmbRsR
ebRjbRob

>ZF Recording 2016-03-18; tW: 300s; Start: 125318; End: 125818;
Recording: 9-1; Individual: 48; Drug: NDMC 10 µM
bReRebRgLsbLiRoLsRcbRgLsbLoLeLcbRoLsbLeLsbLiLsLsLsLjmmbLhbLsLsLsmmbLsL
sLsLsLsLsmmmmmbLcbLebRcRsRsRcmmbRebRcbRsRebRebRebLsLcLeLoRjbLgLcbLibLe
bLebLebLebReRsRcmbLsRgRcbRebRebRsRsRsmmbRsRcbLebLgLhRgLcbRoLibLebLhRsb
RhbLsRgRsmbRsRgRsRsRsRsRsmmmmmbRsRsRembLoRgbLsbReRibRibLsbLiLobRebRsRs
mbRgRiRsmbLsLiLoRibLsbLeLsbLgbLobRgbRoRobRsbRgRcLsLcRsRsmbRgbRgReRsmbR
sRsRcmbReRhRsRsmmbRibReLcLsLsmmbLiRjbRhbRgRsmbLibLcbLsLsLcmbLgbRobRoLs
RsRsmbRoRsLsmbRgRgRgbRiRsLsmbRgRoRhbRibRgbRhbRsRsRsmmbRgRgbLebLcLsLcmb
LcbLgLsbLgLcbRcbLcbRgRsmbLhRsRibLiLobLebRiRcbRgLsbRebLcLcRsRcbRebRibRh
RsRsRsRsmmmmbRgRsLsmbRebRoRsmbRebRgRsRsRsRsRsRsmmmmmmbRiRsmbReLsbReRhL
eLcLsmb

>ZF Recording 2016-03-18; tW: 300s; Start: 125820; End: 130320;
Recording: 10-1; Individual: 1; Drug: Control
bLibRibRiRebReRsmbRsRibRibRibLibLibLibLgLsLgbLibLhbRsbLiLsbRsbRjbLibLi
bLhbLhRgRsRgRembRhbRiRibRgbLibLibLibLibLebLibLgLibLibLebLebLeb

>ZF Recording 2016-03-18; tW: 300s; Start: 125820; End: 130320;
Recording: 10-1; Individual: 2; Drug: Control
bLebLeLebLebLebLebLebLebLebLebLebRsLebLebLebLebLeLsbLhLsbLeLsLebLhbLeL
sbLebLebLebLebLebLebLebLebLebLeLsbLhbLebLebLebLhLsLsmbLhLsbLebLebRibRi
RsRsRsmmmbRiRsmbLhLsbLebLcbLebLeLcLsLsmmbLeLsbLebLeLsbLebLebLhbLeLsbLe
bLiLsbLebLebLhLsbLebLeLsLsLsmmbLebLiLsLsmbLeLsbLebLebLeLgbLebLebLebLeb
LebLebLeLsbLeLhLsbLcLsmbLhbLiLsbLebLebLeLsbLebLebLiLsbLibLiRsRsmbLhbLe
LsbLeLsLsmbLebLebLeLgLsbLeLsbRcRgbRiRsmbLhbLebLebLeLsbLeLsLebLebLeLsbL
gbLcLsmbLebLebLebLeLsbLebLibRebRiReRsmbRebRcRsRsmmbRhReRcRsmbRsRsmbLcL
sLsmmbLeLsbLsLsLsmmbLeLgbLebLebLgbLsRsbLcLeLgLsbLeRsbRcbLeLgbLcLsmbLsb
RsLsbLcbRebReb

>ZF Recording 2016-03-18; tW: 300s; Start: 125820; End: 130320;
Recording: 10-1; Individual: 3; Drug: Control
bLcbReRsmbReRsmbLiLeLeLsbLsLeRoLgLeLgLiLeLiLsbLeLsLgLgbLsLgLiLgbLgbLsR
sbLsRebRebRibLhLsbRsLgLiLibReRsRsRsmmmbsbsbRjbRcLobLebLebLebLcbLsLgLeb
LsLsLsLiLeLhmmbLgLeLeLsbLsLeLgLcLsmbLhLiLsLsmbLiLiLsLsmbRoRsLsmbRibLcL
sLsmmbRsbRgbRsRibLebRebRebRibRcRibLeLsbLobLsLeRgbLiLcbLsLsLcLhLgmbLeLe
bLeLobsbRjRsLembLsLeLsbRgLsbReRsRsmmbRsLsb

>ZF Recording 2016-03-18; tW: 300s; Start: 125820; End: 130320;
Recording: 10-1; Individual: 4; Drug: Control
bLgLebLgbRsRsRsmmbRgbRebRhbRhRjbRgbRebRebRjbRgLsRsRsRsRsRsmmmmbRebRobR
cRgbLebLgbRsRcbLsbsbLebLsbLebRsbRgbRiRgRgbRibRibRsRsmbRcbRgRsRsRgmmbRs
RgbRgRsmbRgRsRgRiRgmbLibReRiRsRcLsLcLsmmbLeLsLsmbLiLsLeLgbLsLeLsLsmbRi
RsmbRsRsmb

>ZF Recording 2016-03-18; tW: 300s; Start: 125820; End: 130320;
Recording: 10-1; Individual: 5; Drug: Control
bsbsbRcLcLeLgbLsLgLebRsReRcbReReRsmbRgLebLcLgbLhLsLsmbLebRgbLeLebLeLob
LcLeLeLsbLgLiLeLgLsbLcLsLsmmbLebLgbLsbReRcRcbRebRebLibRsbLcbLhLcLgLsbL
ebLeRsbLhLsLsLsmmbLgbRjRsLgLembLsLeLeLsbLgLgbLebLebLeLsLsmbLebLsLsLeLi
LsmbLeLsbLsLgRgLsbRcbLeLebRebRcRcb

>ZF Recording 2016-03-18; tW: 300s; Start: 125820; End: 130320;
Recording: 10-1; Individual: 6; Drug: Control
bRsRsmbRgRsmbRsRsmbRcbRcbLcLcbRcbReReReRhbRiLsbLibLgLsRsbLiLeRsbReLcLe
bRgRgbLeLgLsbRsReRebRiRiRiRsmbRsLcbRsLobRsRsRhRembLgbRjbRgbReReReRebLo
bLhbLebLcLsmbLebLeLsLcLsLcLsLsLsmmmmbLeRebLebLibLjbLebLgLiLebLgLcbLebL
gLsbLgbLsLsLsmmbLsbLsbLiLsLgbLgbLibRsLhbLibLgbLibRsLsLsmbLgbLeLebRcb

>ZF Recording 2016-03-18; tW: 300s; Start: 125820; End: 130320;
Recording: 10-1; Individual: 7; Drug: NDMC 1 µM
bLebLgbReReLobRebLibLcbLhLeRgReRsRsRiRiRsmmmbRiRsRoLsmbLebLebLebLsLcbR
obLgbLebRsbRobLgbRcbLsbRsRcRsmbRhbRgRhRsmbRsbLobRebRebRcbLeLsbLsbLgLgL
sLsLsLsLsLgLemmmmbRsLsbLsLsLeRsmb

>ZF Recording 2016-03-18; tW: 300s; Start: 125820; End: 130320;
Recording: 10-1; Individual: 8; Drug: NDMC 1 µM
bRgbRgRobRcRsmbLgLsLibLebLebLebRsbLgbLeRsbLsLgLebRcbLiLsLsmbRobRsRgRgR
smbRebRcbRibReRsmbRcbLeLiLsLiLsLsmbRebLjbRoLsbRgLeLsbLsbLcLsLsmmbLeLeL
sbLsLsLeLimbLsLsLsLsLemmmbRebReRibRsRsmbRiRsRsmmbRobRcbRcbLebRebRebReb
RgbLobLebLebLebReRsmbRiRsRsLsRsRiRsmmmbRsbRgRiRhRsmbRgRsRsLjmmbRebLsbR
ebRebRcbLebLsLsmbLsbLebLebLcbRsRsmbRsbRsbLgbRcbRobRsbRoRiRcRsmbReRsmbR
eRsmbRcLsbLebRcbRebRebReRsmbRsRgRsRsReRsmmmbRgRsmbLoLsmbLebLiLiRcb

>ZF Recording 2016-03-18; tW: 300s; Start: 125820; End: 130320;
Recording: 10-1; Individual: 9; Drug: NDMC 1 µM
bLsLsLsmmbReRsRsmmbLiLcLsmbLebLebLebReRsmbReRsRsRsRsRsRiRsRsLsRsRsRgRs
RsRsmmmmmmmmmmmbRsbRsRebRsbRcbLeLcbRebLebLebLcbRebRebRsRgLcbLgLsLcLsmb
LsLsLiLhmbLeLsbLsLsLsmmbRobRsRsRsRsRsRsRgLsmmmmmbLeRsbRsReRsmbRsRsRsRe
mmbRsReRsmbRiRgRsRcmbLhLsLsLsLsReRsmmmmbRsRsRsRsRsmmmmbReRsmbRsRsRsRiR
sRsmmmmbRsRebRsRsRgLsmbLjbLgLsbLebsbReRcbRsRsRsRsRiRiRemmmbRgRsRsReRcm
mbReLsRsLsbRsRsRsRemmbLiLsLsLsLsLsLiLsmmmmbLebLsLibLiRebRsbRebRiRgRsmb
RsbRsRsLsmbRebRhRsmbRsRsRsRsRsRgRsRgmmmmmbRgRsmbReRgRgRsmbLgRsLsbRsRsR
embLgLeLsLebLebLsLgLgLiLsbLsLibLgLeLsLsmbLsLsRembRiLsbRcRsmbRsLsRsRsRg
RiRsmmbReLeLsLeLiLsLsLsmmbLebLobLgLeLsbLiLsLsLgLgLsRsLhLsmbLibRibLsLsL
sLsLsmmmmbLsbRjRsRsmmbRcRsmb

>ZF Recording 2016-03-18; tW: 300s; Start: 125820; End: 130320;
Recording: 10-1; Individual: 10; Drug: NDMC 1 µM
bRebLgbRcbLebLebRibRsbLebLebLebLebLgLgLsLsLiLsLimbLiLebLebLiRsLsbRsReb
RibRiLsLeLebLebLgLsbLsLsLsmmbRcbLobRcLsbLebLeLsbLebLgLhbLiLgLgbLcRebRs
RsmbLebLibLibRcbLgLsbLebRgbRebRobLiLcbLcLsmbLgbLiLsbLgbLsLgbLsLgb

>ZF Recording 2016-03-18; tW: 300s; Start: 125820; End: 130320;
Recording: 10-1; Individual: 11; Drug: NDMC 1 µM
bRsbLsLsmbRsbLgbLebLgbLiLeLhbLcbLsbRjRgbLsRsReRsRsmmbLsLgLsLsmbLcbRsbL
ebLiLebRgbLibRiRsmbRgRgReRgbRcRsRsRiRsReRsmmmmbRsbReRsRsRsmmmbReRsRsmm
bRiRsRsRsRcmmmbRsbRiRjReRcRcbRsbReReRsRcRsmmbLgLsbLebLebRgbRibRhReRcLe
RsbRcLsRsRcRsRcRsmmbRgRsRsmmbRgbReLsbLjbLsbLcbRibRsRsmbRgReRsRoRsmmbRg
RgRebRsbRcRsRsRsmmmbReRsRsmmbLcbLeLsbLsbRsReRcRoRsRsmmbRsRsRsRsRsRsRsR
smmmmmmmb

>ZF Recording 2016-03-18; tW: 300s; Start: 125820; End: 130320;
Recording: 10-1; Individual: 12; Drug: NDMC 1 µM
bRsRsLsRsmbLsbLiLsbLebLeLsbLsLcRobRebRgRebRsRgRgRsRsRiRemmbRsRgRebRcRc
RsmbRcRsRsmmbLoLsmbLsLsLembRhbLebLgbLibReRgbLeLsbLcbRsbRjbRgbRcbRebLgb
RebRgRsRsmmbReRsmbRibRsbRibRgRebRebLibLsLgbLibLgbLgbLgbLsLsmbsbLsLsLsL
sLgmmmbLibLiLsbLsLsLsLeLsmmbLgbLebRebLcbLgbRebLeLibRobRcRsRsmmbRgRsmbR
sbRsRsmbRsbLcbLebLibLebLibLebLibLsRsbLsLsmbLcbRebLsLebLebLhbRsLgbRcRsm
bRebRcbRebRcbRgbRsbLsbRsRsRsmmbRhbRebRsRgbRiRsmbRsRsmbRsRsmbRgbRebRsLh
bRebRebRsbRsRebRcLsbRgRsRsmmbRjbLgLsbRebReRsmbRgRsmbReLsbLiLibLsLsmbLe
LsRsbLsLsmbLcbLgLeLsRsbLsLsLcmbLgLebRcbLsRsbLsbRibRgRcRsmbRsRiRsmbRgbR
cbRsReRsmbRsRgRsmbRsRsRsRsRsRsRsmmmmmmbRsRsRsRgRemmbRiRsRsmmbRsRsRsmmb
RsRsRsmmbRgRebRsRsRgLsmbRebRgRsmbRcLcbLebRsbRebRiRgbRebRsRsRemb

>ZF Recording 2016-03-18; tW: 300s; Start: 125820; End: 130320;
Recording: 10-1; Individual: 13; Drug: NDMC 3 µM
bRebRcbRsRsRembRibRsbRgRsRcLombReRcbLibRobRoRsLoRiLeLcmbLiLeLsLhRsbRsR
gbLoRcLsbRoRsmbRsbRsRsmbRsRsRembLiLobLeRgbRsRsRsLsRsLsmmbRsLiRsbRgbLsb
LebLgbLgRibRhbRsRgbLeRgLebLeLsbLgLebLiLsRsLgLiLoLsLeLsLsmmbLsbLeLsLsmb
LgLsbRoLcLsmbLsLsmbLsLsRsRembRgbLjbRhbReLoLiLcLsmbLgLsRebRsbRgbLgRibLg
bRcRsLombRgRsRembRcRgbRgRgbLsLsRsRsmmbLsLhLsLsLsLsmmmbLsLsRsRsmmbLobLc
RgbLgLsbLeRsb

>ZF Recording 2016-03-18; tW: 300s; Start: 125820; End: 130320;
Recording: 10-1; Individual: 14; Drug: NDMC 3 µM
bRobLebLgbRobRoLsbLcbRibLsRgRsLeLeLsmbRobRebReLebLebLeRsbLeb

>ZF Recording 2016-03-18; tW: 300s; Start: 125820; End: 130320;
Recording: 10-1; Individual: 15; Drug: NDMC 3 µM
bRcRcbRgRjbLoLsmbLgLsLsLsLsmmmbLsLsmbLebLiLsbLhbLgLsLeLhLsLsmbLeLsbLsL
gRsbLsRebRebRgRgbRsRsmbRjbLebRebRibRsRsRgmbReRcRibLsLsLgLsmbLsbLeLebRe
bRebRebRsbReRiRibRebRibLjbRjRsmbRibLebLebLoLsmbLebLiLsRjbLgLsLeLsbLgbR
eLsbRiLgbLcb

>ZF Recording 2016-03-18; tW: 300s; Start: 125820; End: 130320;
Recording: 10-1; Individual: 16; Drug: NDMC 3 µM
bRgbLeRsbRcbRcbLebLebLsbLsLsmbLeLsRjbLcbRsbRcbRsbRsbLsbLobLsLibLjbRebR
sbReRjbRibLibLcbLsLsLgmbLcbLebLsLsmbRsRsmbRgbLebRibRgbLcbRebLgbLeLgLjb
RebLebLsbLgLsbRjbLcbRcbRibRebRcbLebLsLcbLhRcbLibRebRoRebLsLsmbLjbLcbRj
bRgbLgbRhbLeLsLsmbLsLsLsmmbReLoRsLcbLgLiLcbRsbLsbRsLsb

>ZF Recording 2016-03-18; tW: 300s; Start: 125820; End: 130320;
Recording: 10-1; Individual: 17; Drug: NDMC 3 µM
bLcbLcLgbLgbLsLsLsLemmbLhbLsbLgLsbLsLiLibLcbLebLsbLeRsbLeLgbReRobLsLhL
sbRebRiLobLoRsLsbRiRsmbRsLeLgbLeLsLsmbLgLsbLgLcbRsbLsRhRhLsbRcRcbRebRe
RsmbRgbRsRebReRibLsRiRsmbRiRsmbRebLebRebRiRibLobRcbLcbLcLsmbLeLsbLgLsR
sLsbLeReRsRsmmbRebReRsmbRebReRcbReb

>ZF Recording 2016-03-18; tW: 300s; Start: 125820; End: 130320;
Recording: 10-1; Individual: 18; Drug: NDMC 3 µM
bLcRsRsLombRsbLebRsbRgbLsbLibRibLgbLibLibLsbLgLsbLgbLebLebLeRsRsmbLsLs
mbLiRsbLsLsmbRcRsmbLeLcbLobLebRebRiRsReRgmbRiRsmbRsRhbRsbRsbRsbRhRsmbR
gbRsbRebRebRebRibRgbRgbRiLsRsbRiLeLcbLebLebRsLsbRiRgRsRsmmbRcLsRobRiRg
RebReRsRgRsRsRgLcmmmbLgLsLsLsLsLsLsLgLemmmmmbLiLsLsmbLsLgLsLsLsLsLeLsm
mmbLeLsbLcRsbLsLsmbLebLgbLcLcLsmbLibLebRebRgbRebRcbLoRibLsbLcbLgLoLhbL
ebLebLebLsbLgbRsbLhbLsRsbLsbLsbLsbLgbLsbRsbLsbLgbLgbLebLsbsbLsLsLsmmbL
gbLsLhRsbRsbRsbLsbLeRgRsmbRibRgRgRsmbRgLsbRsbRsbRsRsmb

>ZF Recording 2016-03-18; tW: 300s; Start: 125820; End: 130320;
Recording: 10-1; Individual: 19; Drug: NDMC 10 µM
bLsLsmbLgRsbLsRiRebRsRcbRgbReb

>ZF Recording 2016-03-18; tW: 300s; Start: 125820; End: 130320;
Recording: 10-1; Individual: 20; Drug: NDMC 10 µM
bRebLobRsLsRcbRebLeLsLsLsLcLsmmmbLsLebLsLsLgLjmbLsbRibRsRgRhRebLebLgLg
LsRsbLsLebLgLebLgLsLsLembRgbRoRcbLcLgLgLobLgLebLsLsLsLsmmmbLhRsRibLebR
sbLsbRcbReRsRsmmbRgRibRhbRebRibRcbRgRgRgRsmbRsRsRsRsmmmbRobRhRebLsbReb
LgbRebRgRsRcmbRgbRibRsRcbRobRjbLgbLiLcbLcLgLsbLgLsLsLsLemmbLibLebRebLe
bLsLsmbLsLsLgLsLsmmbRgbLebLhbLebLibLeLibRebLibLhLsbLibLcLsmbLebLeLsbLe
LgLhbLibLobLgLibReRebRgbRiReRsmbRgRebRsRsRsRsRcRsRsLsmmmmmbRhReLsbReRi
bLebLibLebRcRsmbRgRsmbRsRsRsRsReLgLsmmmb

>ZF Recording 2016-03-18; tW: 300s; Start: 125820; End: 130320;
Recording: 10-1; Individual: 21; Drug: NDMC 10 µM
bRgLsLsmbRcRsRsRgLeRgLsmmbRcRsmbRgRgbRoLsbReRsmbRgRsmbRsRsRgmbLsRsbLgb
LibLhLsbLgbLibLcbLibLebLsLeLsLsLsmmbRgbLhRsLiRsbLgRsbRjbRcLsbRsbRobLsb
RebRgbLeLsbRobRobRoLsbRcbRsRgRsRsmmbLsLoRsbRcbLcbRoRsmbRsRsRgRsRsmmmbR
ebRsRiRsmbLebRsbLeRiRsRsmmbRsRsRgmbLeLsRcbRsRibRsRsRsmmbReRsRsmmbsbLsR
sRsRsRsRsRsRimmmmmbLoRsbLhbRsLibLsLsLembRebLeLcbLebLebLsLsLsLimmbLgbRs
RsmbRsbLsbLebLgbRsbLgLsLsmbLcbRebRibLhbLsbRibLcbReRsRhmbReRebRiRsmb

>ZF Recording 2016-03-18; tW: 300s; Start: 125820; End: 130320;
Recording: 10-1; Individual: 22; Drug: NDMC 10 µM
bLcbReLsbLeLsbRsbLhbReRsmbRiRsRcReRsRsmmmbRiLhLsbLgLgbRgRgbLgRsLcbLgLs
LsmbLiLsbReRsmbRsRsRembReLebLhbLiLcbRiRsmbRgLebLeLcbRsbRebLcLsRsmbLcbL
cbRiRsRgLembRsRsLsmbRgLsbRcbLebRebRgbLsLobRhLcbLebLcbRebRjbLebLcRjbRjb
LcbRhRsmbRobRiRebLibLsRsLsbRcbLcbLcbLeRsbRibLcLsLgLsLsmmbLgLsRebLjLibR
ebRcLcLsmbLsbRebLeRcbLsRsRcbLcLeLebLsbLoRebLcLsmbReRsmbLgRsbRiRibRgLsR
sb

>ZF Recording 2016-03-18; tW: 300s; Start: 125820; End: 130320;
Recording: 10-1; Individual: 23; Drug: NDMC 10 µM
bLsLsmbLsLsLsLsLsmmmmbLgbRsRsRsRsmmmbRebRsRsRsRcmmbRsRsRsRsmmmbRgRsRgR
smmbRibRcRcbRsbRgbRsbRebLcbRiRgbLsRsReRobRgRsRsRsRsmmmmbRsRsRembRsRsRe
mbRsRsRsLsmmbRiRsRimbLcbLsRsLeRsLcLsmbRsLsLsmbLsbLeRjbLebRcbRebRoRsmbR
sRsmbLhbLcbLsLsLsLsLeLommmbLsLsLsLcmmbLsLsLsLsLemmmbRcbLeLsbLgbRoRsmbR
sRsRsRsRgmmmbRsLsbLjLcLsRembRcbRsRsmbRsRsRsRsmmmbRgbReLsbRebRsRsmbRsbL
eRebLsRebRsRsmbRsRsRsRsRgmmmbLibRebRsRcbRsLsbRcbLeLsLsmbLsLsmbLiLsRebR
cRsLsRsmbRgRsRsmmbRiRsRsRcLeLimmbRsLsLsLsmmbRcRsmbRsbRsRiLeLsLibLsLsLs
mmbsbReRsmbRcRobRcRsmbRsRsRembLsLsLsmmbRsLsLsLsLsLsLsLimmmmmbLsLsmbLsb
LcRsbLjLsmbLibLsLsLcmbReRcRsmbRgRsRsRsRgRsRemmmmbRebRsRsRiRsmmbRsRsmbL
jLcbRiLcbLgLsLhbReRsRcReRsmmbReRsmbRsRgbLebLebLsLgLiLibRsRsmbLgLsbRobR
iRebRgbRiRsLsmbRebRgbRsLiLgbLeRsbRjRibLeLiLsbLgLsLebLgbRhRsRcmbRgRsmbR
cbRcRobLcReRsmbRsRsRsRsmmmbRsbRsLsLgLgbLsbsbRobLiLsLsLsmmbRcbRsbLebLsL
sLiLiLiLcLsmmbLgbLsLsLsLemmbLsLsLsLemmb

>ZF Recording 2016-03-18; tW: 300s; Start: 125820; End: 130320;
Recording: 10-1; Individual: 24; Drug: NDMC 10 µM
bRebLgLiRsbLsbReRsRsmmbRgRsRsmmbRsRsmbRsbLiLsbLgLebLebLebRjRsmbRsRsRsm
mbLcbLcLsRsmbRgRsmbLoRebLsbLsLebRgbLsbLebLcRebRebRebLsLsmbRebRsbLjbLob
RebRsbRsbRgRsmbRoLsLsmbRebLobRibLsRsLgbRebRebRebRiRsRhmbRebRebRebRjRiR
sRsRsmmmbLgbRebRsbRgbRgRhRiRsRsmmbRsLsbRsbRiLgRgbRsRsRsmmbLsRgRebLiLib
LeLsbLcLsmbLgbLgRsbLgbLebLgLgLcbLobRgRebRobRibReLsbRgbRibLibRgRgRsmbRg
bRsbRsLsRsLsLsmb

>ZF Recording 2016-03-18; tW: 300s; Start: 125820; End: 130320;
Recording: 10-1; Individual: 25; Drug: Control
bLeLsLsmbLiLsLsLembLebLebLgLeLsLgbLebLeRsbLsLsRiRsRcLsmmbLsbRcRsRsmmbR
iRsmbLibRiRsmbRgLoLsLsmmbLcRsLsbLebLsLsLsLsLsmmmmbLiLeLsbLsbLiLebRjRib
RebLsbLgLgLcbRsbLsbRgRsRsLsmmbRgRsmbRsRgRgRsLsRsmbRcbLgLhLsbLebLcbLgLs
LcbLiLsLsLembLcbLcbLebLgLsLsLsmmbLibLebLsbRhRsmbRebsbRsbRsRgRsRsRsLsmm
mbRsRsRsmmbRgRsmbRgbLebLgLgbLhbLcbLebLgbReLsbLiLcbLebRsRsmbLsbRsbLobRg
RsmbRiRibLiLsLsRsmbLcbLebLgbLsLsLsLgLsmmbLhLebRebReRcbRgbRgbLjLobLobRs
bReRcbReRsmbReb

>ZF Recording 2016-03-18; tW: 300s; Start: 125820; End: 130320;
Recording: 10-1; Individual: 26; Drug: Control
bLobReLobLebLeLebLjbLsbLebLebLgbLgbRibLgLcbRibRcbRgbRobLgbRcRebRsLsbLe
bLibLgbRsbRebRgbRjbRoLgbLjbRcbLebLcbLeLsbLebLebLebLiLgbLobLibLsLsmbLsL
smbLebLcLcbLgLsbLsLsRembRobLgRsb

>ZF Recording 2016-03-18; tW: 300s; Start: 125820; End: 130320;
Recording: 10-1; Individual: 27; Drug: Control
bLcbRcbRebRebRebRsbRcRsmbRgbRsbRsbLsLsLsLsLsLcLsLsLsmmmmmmmbRebRhbRebR
sRgbRebRebLiLebLgLiLcbLcbLebLcLsLsLsLsmmmmbLgbLibLsLibLsbRcbRebRibRebR
cLsbLsLsmbLgbLibLibLgbLhbLjbRebLibLebRebRiRcbRgRsLsRcRsRemmbLeLeRsbLeL
iLsLsmbLsLsLsLsmmmbLiLsLsmbLiLsLsLsLsmmmbRhRebRsbLiLsbLebLcLsmbLgLeLsb
LiLsLsLsmmbLsLsLiLembRsLsbRebRcbRcLebLsRsLibLgb

>ZF Recording 2016-03-18; tW: 300s; Start: 125820; End: 130320;
Recording: 10-1; Individual: 28; Drug: Control
bReRsRsmmbRgRsmbRcbRiRsmbRiReRsmbRiRsmbRiRsmbLcLcRsbLcLsLsmmbLebLcRsbR
eRhbLeLeLcbRsbLobLsRsbLgLsLsmbLeLsbRcLeLsRsbLiLeRobLhbRsRsRsmmbRsRsRsR
sRsRgRimmmmbRgRebLiLiLsLeRsbLsLsLsLsLsLemmmmbLsLsLsmmbRgbLgbRebLeLcbRs
bsbRcbRibLebRgbRhLgbRcLsbLeLebLebRiReLcLjbRebReRsmbRebRgRcRsmbLebLobLe
LebLebLeb

>ZF Recording 2016-03-18; tW: 300s; Start: 125820; End: 130320;
Recording: 10-1; Individual: 29; Drug: Control
bLcbRebRebRsRebRsRsmbLsLsLeRoRombLebLiLoRsRsRimbReLsbRebLoLcLebLebRoRs
RsmmbReRcbRsReReRsmbRgRsReRembLibLgLsLsmbLgRjbLebLcLeLsbLeLeLeLsLcbLhL
gbLebLgbRebRobRebRsbRsRgRsRsRsRgRsmmmmbRgbRiRsRgmbRgRebRgRsRembRsRsRsm
mbRsRsmbLobLebLebLgbLobLebLcbLcbLebLobLibLcbRobRobLobLcRebRsbLsRsLsRsR
sRsmmbReRsRhmbLsLsRiRombRoRsmbLsbLcbRibReb

>ZF Recording 2016-03-18; tW: 300s; Start: 125820; End: 130320;
Recording: 10-1; Individual: 30; Drug: Control
bRcLebLhLcLsLsmmbLebLgbLcLcLeLsLsmbLebLgRgLsRobLgLsbLibLgLsbLsbLoRoLsb
LebRgbLebLcbRcbRsRsmbRebLgbLebLgbLgLhbLsLsmbRcbLsLsmbLsbsbsbRcbLebLibL
hbRcLsLgbLebLiLsbLebLobRebRsbRcLobsbsbsbsbsbsbsbsbLebRobsbRsRobRcbRibR
sbRsbLibLgbLgbLebLgLeLcLgbLsLsmbLsLsmbRsLeLobRcbRsRgRsLombRebLsRiRibRe
bRebLiLeLsLsRsLsmbLeLeLsbLhbLiLsbLsbLhLebRcbRebLsbLcLgLsRsbLjRcbLcbLiR
sLebLebLibRsbLsRsbRebRgbLhbLgbRcbLebRebRibLeRsLebLgLebLebLebLeLsLsLgLg
mbRsbRcRsRsmmbLcLsmbLeLhLsbRsLeLsLeLibLebLsbRgbLcbLebsbLsLsmb

>ZF Recording 2016-03-18; tW: 300s; Start: 125820; End: 130320;
Recording: 10-1; Individual: 31; Drug: NDMC 1 µM
bLsLsLsLsLsLsLgLsmmmmmbLsbRsLsLsmbLgbLebRgRsLsmbRsbRgRsRsRsRsmmmmbLsLs
mbLiLgRebRgbRgbLsbRcRgRebRibRiRcRsmbLibLsLcbRiRsRgmbRgbLsbRsRsLsLsLsmm
mbRcbRsRgRsLsmb

>ZF Recording 2016-03-18; tW: 300s; Start: 125820; End: 130320;
Recording: 10-1; Individual: 32; Drug: NDMC 1 µM
bLebRsLeRsbRgbLibLiLebRsLsLgLebLsbLsbReRsRsmmbLsRiRsmbRgbRebsbLsRiRgbR
iLeRsbLebLebRebReRsmbRsbRsbRiRsRsRsRsmmmmbRsRibLeLsLsmbLsLsLsLemmbLiLc
bLsLsLsLsLsmmmmbLgLgbLsLsLeRsRsmmbRebRcRsRsmmbRsRsRcmbRiLsbRsRsmbRsbRg
bRgbRsbLsLsmbRcLgbLgLsLsmbLcLsmbLsLsLsmmbLobLebLebRobRebRsRebRhRsRsmmb
RsRsRsRcRsmmmbRcLsLsLoRsmbLebLebLsbRsbLebLcbLeLsbLeLeLgbLcbLebLebLeLeR
sbLsLgb

>ZF Recording 2016-03-18; tW: 300s; Start: 125820; End: 130320;
Recording: 10-1; Individual: 33; Drug: NDMC 1 µM
bRjRibRoLsbReRsmbRsLcRsbRebRsRsmbLeLcbLhLiRsLcLhbLeLibRcbRcbRsLsLsLcmb
LcRsLsbRsbRibLjLsmbLcbReLsbRebLebLsbLcRsLobLgbRcLcbRhbRsRsRimbLsbLhbLo
bRibLgbRsbRcRsRsmmbLebLsbLiLeLgLsLcLeLeLgLsLeRsbLiLsLsmbLgLsLsLsmmbRoL
sbLebLcLcLcbRhRsLombLsLsLsmmbsb

>ZF Recording 2016-03-18; tW: 300s; Start: 125820; End: 130320;
Recording: 10-1; Individual: 34; Drug: NDMC 1 µM
bLeLgbLeLhbLsLiLsLcRsRsmbReLsbLsLsmbRobRobLeRsLsbRoLsLsmbRoRsmbRsLsLsL
gmbRcRoRsmbRebLsbLgReRsRimbLsRcRsRsmmbReRcbReRgLiRoLsbLeRsbRsbLebLcbRc
bLibLgLsLibLobLcbReRsmbLcRsbRsRebRjRgbRcbLsbRebRcbRsRibLebLibLgbLcbLiL
sbLiLeLsbLcRsbLeRsbRcRibRibRgRsRsRsRsRemmmmbRebRgbRoRsmbReLcbLiLsbRgbL
ebLcbRebReRcbRsRsRsRsmmmb

>ZF Recording 2016-03-18; tW: 300s; Start: 125820; End: 130320;
Recording: 10-1; Individual: 35; Drug: NDMC 1 µM
bLoRsRsLsRsmbLeLsbLsLeLsLcbLgRsbLeLeLsLsmbRobRgRsmbRsRebReRsmbRebRsRsR
sRsRemmmbRsRgReRsmbReRsmbRgRsRcmbLobLebLoLsmbRjbLcLebRibRgLjbLebLebLeb
LsbLsLebLebLebLebLgRsbRebRoLebLhLgLsLsmbLcLcbLgbLiLsLebLeLibLeLgbLsLeb
LeLsLgLsbLebLsLgbLebRsbLgLsbRjbLebRebRsbLcbLebLeLsbLgLcbLibRgbLeLeLcbL
ebReLgLeRsbLobLcbLsLsLembReRsmbRebRsRsRsmmbRsRsRgRsRgmmbLeLsbLeLsbLeRs
bLsLibRcRsmbRsbRsRsRsmmbRobLcbLiLsbRsLebLsLebLsLsRsmbReRebRsReRibReRsR
iLsmbReRsmbLsRsReb

>ZF Recording 2016-03-18; tW: 300s; Start: 125820; End: 130320;
Recording: 10-1; Individual: 36; Drug: NDMC 1 µM
bRoLsbLoLsmbLcLsmbLobRjbLcRsLsRiLsbLhbLebRebRjRsmbRcbRcRsLsLgmbLoRsbLo
bLcbRcbRcbRebRgRiRsmbLcbRoLsLsmbLcLiLobRhRgbLobReRsRsRsRiRsLsmmmmbRoRs
RsRsmmmbLsLsLcRcmbRsRsRsLsLsLsLsLsRemmmmmmbRiRsmbRjbLibLoRcRhbRobLebLc
bRgbLsLeLhbLibRebLeReLsbRsRgLiLiLhbLobReReRsmbLcLsLsLsLsLsRsRgRsRsRsRs
RimmmmmmmmmbRgRsLsmbLsLsmbLoRsRcRsmb

>ZF Recording 2016-03-18; tW: 300s; Start: 125820; End: 130320;
Recording: 10-1; Individual: 37; Drug: NDMC 3 µM
bLobLsbLgLsRobRebLsLiLsLeLsbRgbRcbLgLsbLgbLsbLsLsLsLsmmmbLgLsbLgbLsLsL
smmbRhbLsbRcbRebRobLgbRebRgbRebLsbRhRsmbLsLgbLsLcRsRgLebLcRjbRcbLebRcb
RebRsRsmbRcbLsbRebReRgRgbRsRebRsbReRgbRebLibRiRebRebReb

>ZF Recording 2016-03-18; tW: 300s; Start: 125820; End: 130320;
Recording: 10-1; Individual: 38; Drug: NDMC 3 µM
bLcRebRsRsmbRsRsRembLsLgRsbRcbLcbRcbLsRsLcRiRsmbRsRgRsReRsRsmmmbReRcbR
hRsmbRiRsRsmmbRsReRsmbRgRebRsRsRiRsmmbReRcRiRibLsLsRsmbRhbRebRsReLebLe
LsbLgLsbLsLsRembLcbLeRsLgbRcLebRebRcRsmbRcbReRsmbRsRgRsmbRgLsLeLsbLgLe
RebRcLsbLebLebLebLhbLebRebLgRhRsRsmmbRiRgbLsbRsRsmbRsRsmbLgbRibRcRebRs
RebLgbRsRebLobLhbLgRsLsbLebRgRsmbLcbLgbRsRibRgRsmbRgRebRibLcbRsbRcbLsb
LsRsbRibLjRibLebReRibRhRsRsmmbLsb

>ZF Recording 2016-03-18; tW: 300s; Start: 125820; End: 130320;
Recording: 10-1; Individual: 39; Drug: NDMC 3 µM
bRoLebRcbRsbReRobLcLebLebLeLsbLsLsLsLsmmmbLiLsLsLsLsRgLcRcmmmbLcLsRsmb
LsLsLgLeRgmbRgReRiRiRiLsbRsRsRsRsRemmmbRgRsRgmbRsRsRsRsRhLgmmmbRgRsmbR
gRsmbRiRsRsmmbLhRsRibLcbLsbLgLsLebLebLsLhLcbLgbLebRiLsLsmbReRsmbRiLsRg
RsRembRcbLcbLcbLcLsmbLgLsbRcRebLgLsbRebRebRoRsRimbRoLjbLibLiLsbLcbLcbL
gbLebLsLsLsLsmmmbRcbRgRsmbLcbRcLsLsmbRgRsReRgmbRhbLsLebRjRgRsRsRemmbRe
bLgLsLsLgmbLeLcbLibLhbRhRsmbLgbLeLgLoRsbRhbReLobLebRsRsRsRsRsmmmmbRgRh
bsb

>ZF Recording 2016-03-18; tW: 300s; Start: 125820; End: 130320;
Recording: 10-1; Individual: 40; Drug: NDMC 3 µM
bRebRebRgLebRgbRiRgbLsbRgRcRsRsmmbLcbRsbLeLsbLcbLibLebLgLibLebRgbLebLs
LsmbLeLsLsmbLsLsLiLsLsLsLgLsmmmbLgbRebRiRsRsmmbRcRebLcbLsbLcbRsRsmbReb
RsbReLebLcbLiLsLebLsLsmbRebLcbLhbLiRcbRebsbLebLebLgLsLsLsLsLsLgLemmmmb
LgLsLgLsLsmbLiLsLsLsLsLsLsLgmmmmmbLebLgLsLgLsLsLsLsmmmbLebLebRiRcbRibR
sbRebLhRsRgRgbRebRebsbReRcbRgRsRiRsRsRsmmmmbRebLcLcbLsbLebLebLebLibLeb
RoLsRsRsLsmbLgLgLsbReRiRibRsbRjRebLeLcbLjbRibRsRcbLcLsmbLcLgLeLgbLgLsR
sbLgLsbLiLeLsbLhLsb

>ZF Recording 2016-03-18; tW: 300s; Start: 125820; End: 130320;
Recording: 10-1; Individual: 41; Drug: NDMC 3 µM
bRibLebLebRibRsRsRsRgRsRsRgmmmmbRgRgRsmbRobLcbLebLsLsmbLgLgLgbLobRsbRe
bRoRsRsRemmbLsbLebLhbRsLjbLibLsbLebLgbRebReRsRsmmbRsRebRgRsmbRsRsRsmmb
Rsbsb

>ZF Recording 2016-03-18; tW: 300s; Start: 125820; End: 130320;
Recording: 10-1; Individual: 42; Drug: NDMC 3 µM
bLeLgbLsLibLeRsLsbLebLcRoRcRsmbRsRsReRsReRsRimmmbRsRsRsRiRimmbLebRgRiR
sRgRembRsRsmbRsRsRsRsRgRiReReLhmmmbLibLeLsbLeLsLsmbRoLcbLcLsmbLgLeLsbL
gLgLsLsmbLibLoLgLgLebLebLibLhbLebLhLsbLgLiLsbLgbLsRebReLgLsbLiLsLsmbLe
LsbLgbLgbLeLsLsmbLsLeLhLeLgLcLsLgmbLjLeLsRsLsbRiRsRsRsRsRsRsRsRsRsLemm
mmmmmmmbRjRgReRoReRsRsRgmmbRoReReReRsmbReRsRsRgRgReRsmmmbRsRsRgRsmmbLc
bLcbLgbLebLgbLgLsLsRgLcmbLcbLebLebLebReRsRsRimmbRebLcbRgbLcbRgbLeb

>ZF Recording 2016-03-18; tW: 300s; Start: 125820; End: 130320;
Recording: 10-1; Individual: 43; Drug: NDMC 10 µM
bLebsbsbsbsbLsLsLsLsLsmmmmbLsLsLgRcRcRsRsRsmmmmbRsRiRsmbRsRsRsRsRsLsRs
mmmmbRiLgRsLcLoLsmbLobLsbLebLsLeLobLiLgbLiLcbLgbLsLhLebLsLsLembLsLsRsL
smbRobRsbRhLsbLsRsbLsbRiRsLsmbRsLsbRsbLsRsbLibLhLsLsmbLhLebLeRsbReRcbR
sbRsbRgReLcbLcLsLsLsmmmbLoLsmbLgLsLsReRsRsmmmbRsLsRsRsRsLsmmbRsRgbLsRs
LsbLsbRcLsRobRsbsbRiRgRsmbRgRsRsRsmmmbLsbLsLsmbLebLgbLgLeLsLcbReRsRcLs
mbRsRsRsmmbsbRsbsbRsbRsbLgRsbLhRsRjbRoRsmbRhRsmbLhLsLsmbLgbLiLcbRiRsLs
mbLsLsmbRsbRcRgbLcbLebRsRsmbRsbLgLjLgLsLsLsLsLsmmmmbLsLgLgLebRcRsmbRsb
RsbLeRsRcbRsLsbLgLsLsmbRsLsLsmbRgbRsbLsbRjbLsRsRsmbRsRsmbRsRsmbLsRsbRe
RsRcmbRoRobRiLsbReLcbLsbLsLsmbLsLsLiLombLsbsbLsbRsbLcLsmbRhbRcRcbRobRg
LsbRhbRsbsbLsbRsbLsbLiRoRsmbRsbLsbRiRsRsmmbRsbLsbRsbRsbsbRsbRsRsmbsbRs
bRsbRsbRsbRcbLebLebRsbLgLeLsbLobLibLsRsLsLsLsRsmmbLsLiLeRcRobRiRsRsmmb
RsRsmbRiRsmbRgRsmbLsRsbLjbLcRsRgbRcRcbRsRsmb

>ZF Recording 2016-03-18; tW: 300s; Start: 125820; End: 130320;
Recording: 10-1; Individual: 44; Drug: NDMC 10 µM
bReLcbLebLgbLeLebRgRsRsmmbRibRsLsbRcRhRhRebLsbRgbLiLsbLcRebRcbRiRsRsRs
mmmbRibRhRsRsmmbRebRgRsRgRgRsmmbRibLebLebLjbLebLeLsbLibLebReRsmbRibReb
RiRgRsRsRsRsRsmmmmmbRgRsmbReRcbRgRsmbRiRsRsmmbRsRsRsmmbRjRsmbLeLsbsbLo
LsmbLgbLgLsLgLebRsbRcbRiRsRsmmbLsbRcbLgLsRsLsLsmbLgLgLsLsmbLcLcbLsLsLs
LhLcmmbLgLsLgLsLsmbLgLgLgbLsbRsbRjbRiRsRsmmbLjbLibRcRibLsbRsbRsbLcRcRs
mbLgRsbRebRgbLsLibRsRsmbRebRsRsmbRgRiRibLgLgbLsLgbRcRsmbLcLobRibRsRsRe
mbLebLcRsbRsRsRsRsmmmbRiLsbRgbRobRgbRsbRgbRgRebRgbRgRsRembLebLebLsLsLs
LsmmmbLgLgLsbRebRgbLsbRibRsbRgbRebLobLibRebLoLhLeReb

>ZF Recording 2016-03-18; tW: 300s; Start: 125820; End: 130320;
Recording: 10-1; Individual: 45; Drug: NDMC 10 µM
bLhLebLeRsRsmbLcLcLcbRibLsLeLsRibRsLeLsbLebLsbLobLibReRibRiRobRibLoLob
RiLcbLsbLcbRebRhRhRhRgbLcbLiLobLebRcbRgRgLobLcRsbLgbRsbRsRgbRgbRsbRiRs
mbLgbLibLebLgbLiRhbReLgbRgbRiRebLebLsbLsbLcLebRjbRobRobRiRsLembLeLcbLe
LsbRcbRcbLjbLoRsb

>ZF Recording 2016-03-18; tW: 300s; Start: 125820; End: 130320;
Recording: 10-1; Individual: 46; Drug: NDMC 10 µM
bLcReLibLibLeRobReLsbLsbRiRsLjmbReLsLjbLgLsbRcbRcbRebRobRibRebLibRgRsL
smbRibRcbRebRiRgbReRebRgRibRsLjRcbRebReReRebReRibRsRiRgRsmbRsRsRsReRsR
gmmmbRcRsmbReRsmbRgRibRhb

>ZF Recording 2016-03-18; tW: 300s; Start: 125820; End: 130320;
Recording: 10-1; Individual: 47; Drug: NDMC 10 µM
bRobRcbReRsRembRsRebRsbRiLsbLeLeLeLebRsRsmbRsbRgbLhRobRebRgbLcbRgbRcbR
obRsRsRhRsmmbRsRsRsRsRemmmbRebLgLsbLcbLgbRiRobRcbRsRjbRgReRebReLobLsLg
LsRsbLsbLsLsmbLcRobLjbRebRibRsRsRgRiLgmbLcLsmbLeLobRgLsbRsbRsRsmbRiRcb
LgbLgLsRsLsb

>ZF Recording 2016-03-18; tW: 300s; Start: 125820; End: 130320;
Recording: 10-1; Individual: 48; Drug: NDMC 10 µM
bRibRsRgLgbLeLoLsmbLsLebLgbLeLibLgbLebLhLsLsRsmbRjRcbRibRibLeLsLsLsLsL
sLsLsLeLsmmmmmmbLsLsRimbLgRsRsmbLsRsbLsbRhRobLgLsRebLcRibRgRgReRhbLsLs
mbLebLsbRcbLeLiLeLsbLibRgRsmbRgRsRiRgRgmbRsbRiRgRsRsRsRemmmbRgbRebRibL
gbLcbRgRobLgRsbLobRhbRebRiLgbLsLsmbLiRsRgbRgRgRsRembLhbLsbRebRebRobLsR
gRsmbRsbRsRgbRiLgReLsbRgbRgbRobLeLsbRiRsmbRsLebRobReRjbRgbRcbLsLibLoRs
bRibRgbRjbRebRsRebLebLsLebRibRsRebRhRsmbRhbRgRgbRibRgLsRsbsbRiRhbRiLsL
oLsmbLebLiRsbLgbLeRsbRsRgLsRoRsmbsbRsRsmbRebLsRsbRgbLebLoLcbLgLsbLgLcb
LgLgLsbLsLsmbLeRebLgLibLibRoRsmbRgRsmbLsRsRsmbRsRgRsmbRgLsbRibRgRiLsRi
RsRsRommbRsbRcRebRsRsRiRsRsmmmbRsRsmbRsReLsLebLeLsbLeLjbLcbRoRsmbRgRsm
bRsbRcLsb

>ZF Recording 2016-03-18; tW: 300s; Start: 130322; End: 130822;
Recording: 11-1; Individual: 1; Drug: Control
bLgLgRsLsLebLhbLiLsbLebLhbLcRhRsmbRiRsRsRgmmbRibRcbLibLsLiLsbLgLsbLiLs
bLgLibLgLsLgbLibLgLsLiRsbLiLsbLgRsbRebRebRcRsmbRsLsLsmbRjbRsRsmbRsRebR
ibLsRgbRebLiLsLsmbLiLsb

>ZF Recording 2016-03-18; tW: 300s; Start: 130322; End: 130822;
Recording: 11-1; Individual: 2; Drug: Control
bReRsmbLeLsLsmbRsLsLsmbLebLgLcbLeLsbLgLsLsLsmmbLhLsbLsbLsbLgLsLsLsmmbL
iLiLsbLgLsbLgLsbLiLebLeLgLsbLeLsLsmbLeLsbLebLebLsbReRsmbLcbLebLgbLebLg
LsLsmbLeLsbLibLebLsbRcRsRsRsmmmbReRsmbRcRsmbRsRcbRsRsmbRsLcbLebLobLibL
eLsbLebLiLsbLsbLjbLgLcbLsbLsLsLsmmbRebLobReReRsmbRebRgRsmbRsRsmbRibReb
RgbRhbRcbLsLeLsbLebLebLibLhbLsbLcbLiLsbLebLebLebLcbLoRsbRebReRsRsmmbRc
bLcLsmbLeLsbLsLgLsbLgLcbRcRsRsRsRgmmmbRiRgRsmbRsRgRsRsRsmmmbRsRebRsRgb
RcRsmbRiLobRgbLoLsmbLcbLsLsLgLsmbLeLcbLeLsbRcbLsLsLsLsLsmmmmbLcLgbLebL
ebLeLsbLgLsLebRebRiRebReRsmbRib

>ZF Recording 2016-03-18; tW: 300s; Start: 130322; End: 130822;
Recording: 11-1; Individual: 3; Drug: Control
bRiLeLsLcLsmbLebLeLcbLibReRsLcmbLgLgLeLgLsLgbLsLgbRcbLsbLeLcLsmbRcbLeL
sRobRsRsRsRemmbLsLsmbLebLebLebLsLhbLiLebLgbLebLiLiLsRoRsRsmmbRgLsbRibL
eLsbLsLebRsbRsRsmbLsReRsRsmmbRiRgRobRcRobReRsmbReLsbRsRsRsRiRemmbReRiR
iRgbRgRsRgmbRsRsLsRimbRsbLcbLjLcLeLsbLsLsRsmbLsbRoRsmbLoRcbRcb

>ZF Recording 2016-03-18; tW: 300s; Start: 130322; End: 130822;
Recording: 11-1; Individual: 4; Drug: Control
bLgRgRgLgbLobRsRsRsRsRsRcRsmmmmmbRgRgRsmbRsRsRsRsRsRsRsmmmmmmbLiLsbRob
RcbLeLsbRcRhbRsRhLibLsLsLsLsmmmbLcbRcbRsRgRsmbRibReRsmbRsRsRembLsbLgbR
ibRiRsRsmmbRibRgbLcbLcRsLiRsbRebRsbRsRsmbLobLoLcbLhLhbReRsmbRiRiRsmbRi
RcRjbRobLcLsmbLebReRibLsLsmbLebLeLoRebRgReRhLsbRcRsRsRsRsmmmmbRcRebLeb
LsLeLsbLeRsLsRsLsbLgLgb

>ZF Recording 2016-03-18; tW: 300s; Start: 130322; End: 130822;
Recording: 11-1; Individual: 5; Drug: Control
bRebLebsbLgLeLgbLobReReRsmbReRsmbRhbReRsmbRobLcLeLgLeLeLebLeLsbLeLeLeb
LebLeLiLsbLeLebLeLgLeLsLebReRebLgRsRsmbLebLgLebLeLcbLibLsbLcbLsLiLsbRs
bReRsmbRgRsRsmmbRgRgbRebLjLjbRiLsbRebReRiRsmbRsbRiReLcLeLeLebLobLiLgbL
sLebLhLibLgLhLibLgbLgRsbLgb

>ZF Recording 2016-03-18; tW: 300s; Start: 130322; End: 130822;
Recording: 11-1; Individual: 6; Drug: Control
bLeRibLsbLoLobRibLobRcbLebLiLgRsbRobReRsmbReRsRiRombReRgRsmbRibRibRsRe
LsbLgbLcLsmbRebRcRsLsmbLsRsRebRebLiLsLeLsLsmbLgRsbLhLebLeLsbLiLhLsLsmb
LebLcbLsLeLcbLgbLebLebLebRib

>ZF Recording 2016-03-18; tW: 300s; Start: 130322; End: 130822;
Recording: 11-1; Individual: 7; Drug: NDMC 1 µM
bRgbRcRsmbReLsbLsRcbReRsmbLsLsLsLsmmmbLebLobLcbRobRgReRebRebRsRsRsRsmm
mbLcbRebRcbReRsRgmbRgRebLebRiLibReRsLsmbLsbReRsRsRsRgRsRsRhRsRgRsRgRsm
mmmmmmmbRsRsRsRsmmmbRsReRsmbRsRsRsmmbRgRsmbLebLgbRgbLsbLsLgbLcbLoRcbRe
bReRcbReReRsReRsRgRemmbReRgRsRsRsRiRsRsmmmmmbRsRgRsLsmbRibRgbRiRsmbRiR
smbRsRibRsRsRsRsRsRsmmmmmbsbRsRsmb

>ZF Recording 2016-03-18; tW: 300s; Start: 130322; End: 130822;
Recording: 11-1; Individual: 8; Drug: NDMC 1 µM
bsbRcbLeLsRsbRsReLgbRobLgLsRsLgbLibLsbRcbLgLsLsLsmmbLsRsLsLsmbLcbRebRe
bRcbRebRebRebRebRiRsRimbRebReRsmbRiLebRcRebLsLebLjbRcbRgLobLeLsbLobRob
LsbReRcbRoLsLsLsLemmbLeb

>ZF Recording 2016-03-18; tW: 300s; Start: 130322; End: 130822;
Recording: 11-1; Individual: 9; Drug: NDMC 1 µM
bRjLiLhLgLsbLsRsLsbRcbLebLcbLsLsLsLgLsmmbRobRsRgRsRembRgRsRsRsmmmbsbRs
LebLsLhLsbRsLsLsLembLeLsLsmbRsLsLsLsLemmbLsLsLsLgLgLsLemmbLgLsLsLsLsLs
RsRsRsLsLsmmmmmmmbLsbReRebRsRsRgRcRcRsmmbReReRsmbRsRsRsRsRsmmmmbRsRsRs
RsmmmbRebLeLsbLgLeRcRibLebLiLsbRsRsLsmbLsLsLeLsLgRsmbLsLiLsLsRsmbLiReb
RsRgRgRgRibRsRsRsLsRsmmbReRsLcRsmbRiLsbLgLsLsLsLsLsLsLsLsLsLsLsmmmmmmm
mmmbLsLgLsRsLsbReLgLsbLsLsLsmmbLsLsLsmmbLsLgLsLsLcmbLjLsmbLiRebRsRebRg
RsRgRsmmbRsRsRsRsmmmbsbLjbRebRgLsbRebRsRsRsRsRsRgRhmmmmbRsRsmbRsRcbRgR
gbRsRsRsRgRcmmbLsb

>ZF Recording 2016-03-18; tW: 300s; Start: 130322; End: 130822;
Recording: 11-1; Individual: 10; Drug: NDMC 1 µM
bLebLgbLebRiRibLsRsbRebLsbLsLeLcbRebRhbRebRebReLebLsbLsbLebLeRsbRgbReb
RsbRebRsbLsbLebRiLsRsbLjbRgbLibLcLgLjbLebLebLebLibLibLgLebLebLebLebLib
LgLgLsLgbRcbRcbLebLgLsbLcbLcbRgb

>ZF Recording 2016-03-18; tW: 300s; Start: 130322; End: 130822;
Recording: 11-1; Individual: 11; Drug: NDMC 1 µM
bRgbRgRcbRoLcLsLsLeLsmmbLgbRgbRjRobRgRsRsRommbRjbRgbRcbReRobLebRsLsbLs
LsLsLsLsmmmmbLsLsLsmmbRgbRebRiRgbRobRsRsReLsLsmmbRiRsRsmmbRcRobRebRhLo
ReRsmbRgRgRiRsmbRsRsRsRgmmbRsRgbRibRsRsRsRsRsRsRsRsRsRsRsRsRgmmmmmmmmm
mmbRsRgRsRsmmbRgRebRgRgReRibRhbRgRgLsbRsRsmbRsRgRgRsmbLcLebLebLjLcbLeL
sbLsLsRsmbLgLoLgbRjRgbLhRsLsLsmbReRsRsRcRommbRebLcbLgbLeLsbLoLeLcbLeLs
RiRsmbRsRebLsRsbLsbRsbRiRsRcLsmbRsbRsRcLsLsRcLsLsmmbRsbRsRgRiRgLgLsLoR
sRcRsRemb

>ZF Recording 2016-03-18; tW: 300s; Start: 130322; End: 130822;
Recording: 11-1; Individual: 12; Drug: NDMC 1 µM
bRebLeLcbLcLgbLsbLsbLsLsmbLhLsLsLsmmbLsbLsbRebLebLebLebLebLgbLobLebRsb
RcbRhbRgbRibRebRibLsbRjbLgbLcbLebReRsmbRgRibRebLebRobRgRsLsmbLjbLgRsbR
eLsbLgbLobRsbRsRsmbLeLsbRcbRebLsRgLcbReRsmbRebReLcbRsbRebRebReRsRsmmbR
ibRgRsRsRsmmmbRsbRsbRsbRebRcbLebRcbRsRsmbRebLebLcbLhbLeLsbRsLeLgbLgbLs
LsLiLembLsbLsbLgbLgbLebLhbLsLsmbLsbLsbLebLsLsLgmbLgLsLsmbLiLsLgbLsLsmb
LsLsmbLsLsLembRsRsmbRgbRebRcbRsbRebRhRsmbLeLsLsmbLgbLebLsbLsLsmbLeLsLs
mbLsbLsbLsbLebLgLsLsLsLeRsmmbLgLsLsmbReRsRsmmbRgRsmbRsRsmbReRsmbLsLsmb
RsbRsRsmbsbRhbLebRcbLgbLebLsbLeLsbLgbLsbLgbLsLsLembLgbLgLobLsbRebRiRsR
embRsbRsbRjLebLgbLgLsLsmbLsLsLgLsmbLobLebLeLebLsLsLsLsLgLsmmmbLsLgLsLs
LembLsLgLib

>ZF Recording 2016-03-18; tW: 300s; Start: 130322; End: 130822;
Recording: 11-1; Individual: 13; Drug: NDMC 3 µM
bRcbRsbRsRsRsReRgLsmmbLsbLeRiRsLoLsLsLsLsmmmmmbLebLsLsLsRsLemmbLeLsbLg
LsLsmbLsbLsbLsLebLgLgLebLsLsLsmmbRcLoLsmbLsRsLsRsbRsbRcReRgbLebLeLobRe
RiRgRsRsRsRsReRemmmmbLeLobRebReRjbRiLsbRjbLeRebRiRibRgbRcbRcLsRebRcLsb
LjLjLsLimbReRobRebRebRcRsmbRebRcbRhbLebRsLeLsLsmbLebLgbRgLsbLsLeLjbRjb
RcbRebRsRhRcbLebRgbLeLgLsbReRsRsRemmbRsRsRsRsRemmmbLgLibReRsmbRsRsRsRs
RsRsmmmmmbRebRsbRebLoLcLebLeLeLsbLibLebRcbRsbRsReRsRimbReRsRsRcRsmmmbR
sRsRsRsRsmmmmbRgbLgLiRgbLeLcbLebLgLebLsLsmbLeLhLobReb

>ZF Recording 2016-03-18; tW: 300s; Start: 130322; End: 130822;
Recording: 11-1; Individual: 14; Drug: NDMC 3 µM
bRjbLobRebRoRgbRebRiRsmbRsRsRgmbLebLebLcbRjRcLobLsLsmbLgbRgbRgRsmbRsRg
bRcbLsLsRombRibRgRsRsmmbRsRiRiLhbLeRsRsLsmbRcbRoRsLsmbLcLsLombLcbRobLo
LsmbRcbLhbLcbRiRsmbRhbLsLcbLobRcbRobLsbLcbRsbRjbLcbRibRebLeLgbLsLeLsLo
bLsbRebRhbRibRgRsLeLsmbLgLsLgLsbLebLcLsLsRsmmbRiRgLsRsRebRib

>ZF Recording 2016-03-18; tW: 300s; Start: 130322; End: 130822;
Recording: 11-1; Individual: 15; Drug: NDMC 3 µM
bReRcRebLsbReRgbReRsmbRiRibRgRgRebLsbRgRsRsmmbRibRhbLcRcbRjbLcbLeLsRsb
RebLgRsRsReRsRsmmmbRgbRsRsRsmmbLcbRsRsRembRcRcbLcRsRsRsmmbRcbRsRsmbRcR
eRgLsbReRcLcbLgbReRsmbRgRsmbRebLeb

>ZF Recording 2016-03-18; tW: 300s; Start: 130322; End: 130822;
Recording: 11-1; Individual: 16; Drug: NDMC 3 µM
bReLebRobLiLeLsbLgLsRobRcbLsLsRgLiRombLsbRobRiLgLjbRcLcbLgbLsbLgbRebRe
RsRgmbRibRgbLebLsLsmbLjbRsbRobRebRcRebReRsmbRsReLeLebLsbLsRiRcbLsLsRsm
bRcRcLsbRsRsRsRsRsmmmmbRsRebRsRgLsbRsRsRsRsRsmmmmbReReLsbRgRsRsRsmmmbL
cRoRcbRcbLcLeLsLiRsLsLsLsmmbLeRebLsRsbRsRsRsRsReLsmmmbRsLsLsRgmbRsRsRg
LcRgmbLibRgbLsbLjbRcRcbRebRsRsReRhLembRsb

>ZF Recording 2016-03-18; tW: 300s; Start: 130322; End: 130822;
Recording: 11-1; Individual: 17; Drug: NDMC 3 µM
bRebLebRcRsmbRsLsLcLeLobRsRebReRcbRsReRsReRsmmbRsRsRsLcRgmmbRebRsbLsbL
ebRsLiLsLgLgbRgLgbLsLeLcbLgLsLsmbLsLsLimbLsLsLsLsRsLsLsmmmmbRcbLhbLcbL
sLsRcmbLcbRsbLebLebLebLebLeRiRsmbReReRebLoRsRsmbRiRebRgLcLsReRsmmbRsRe
RsRsRcRemmbReLebLebLgbLsRiRsmbReRcRcLsbRobRhLsLsLcmbLgLsRcRsmbRibReLsb
LeLobLhbRgLibReRsmb

>ZF Recording 2016-03-18; tW: 300s; Start: 130322; End: 130822;
Recording: 11-1; Individual: 18; Drug: NDMC 3 µM
bLeLcbLgLsLgbLsLsLsLemmbReLsLsmbLgbLobLibLebRgRsRgmbRsReRibRgRgRhRsmbL
ibRcRsRsRimmbLsbReRgLsbRsRiRebReReLsbRsRiRgbRsRgbRgRsLsmbRebRhRsRsmmbR
iRsRsLommbRjRibRsbLobLcLsmbLsLsmbLsLebLobRebRsRgRsRsRsRemmmbRebRiRsmbR
eRcbLsRgbRibRiRsRsmmbRjbLoLjbLcbLebLiLsbLebsbLcbLeLhLobLsLsLgmbLsLgbLe
bLebLgbLebLsLgLsLebLgbRsbRebRsbRgRcbRebRsRgRsRgRgmbRcRsRimbLeLsLsmbLeR
jbLobRgRsRsmmbRsbRebRgRhbRgRgbRebReRsmbReb

>ZF Recording 2016-03-18; tW: 300s; Start: 130322; End: 130822;
Recording: 11-1; Individual: 19; Drug: NDMC 10 µM
bRsLgbRebLebLgbLebReLsLsmbLsLeLgLsLib

>ZF Recording 2016-03-18; tW: 300s; Start: 130322; End: 130822;
Recording: 11-1; Individual: 20; Drug: NDMC 10 µM
bLsRibRiRiLsbRoRcRsRsmmbRsRsReLsmbLhbReRsLoLcLcmbLeLhbLeLgLsLsLsmmbLeL
ebLeLsbLebRcRiRsRsmmbLiLsLcLsRoRgLombLebLeRcbRebRcLsbRebLgRsbRebRebReR
ibRebLeLebLgRsbRebRsRsRiRsLsLsmmmbLebLeLsbLjbLcbLcLsmbLibLebLebLhbRjbL
ebLibLiLsbLgLsbLeRcbRebRiLebRsbLiLibLsLgLsLsmbRcbRiRgRgbLibRhbRsbLebLi
RcRsRsmmbRsRsLcLsmmbRcbRebLgbRobRoRibLgbLeLsRgRibReRsmbReLcbRcRgLsLsmb
LsLgLsLsmbLgRcLebRgRsmbRcbLgLsLsmbLsLgLsRsbLiLsLsRsRombRebRgRhLobLsLsL
gLsmbLebLebLeb

>ZF Recording 2016-03-18; tW: 300s; Start: 130322; End: 130822;
Recording: 11-1; Individual: 21; Drug: NDMC 10 µM
bRgLcLsmbRgbRebLsbLsbRebLebLsRebLgRgbRiLsbLgbLeLsRgbRgLsbLsRsbLeRobReb
RsRsRimbRebRsRibReLcbLiRibLgbLeLsbLebLcbLebLiLobLgbLsLgRsbLjbLsbLebLeL
sRcbRsRsRhmbRsbRsbLsLoLcLsmbRoRibRibRiRiRgRsmbRebLsbLsbsbLibLsbLiRsbRe
LsbRjbRoRsRembLgbLgRibRgRsRsmmbRcbLebLcRsbRcbLcReRsmbLsbLiLibRsLibLeLs
LsmbRcRiRsRsmmbRsRsmbRiReLcbRgbLebLibLeRebRcLsbRgRsRsRgmmbRsbRsbRgRsmb
RebLgLsLsmbLibLsLoRsbRiRsRsmmbRgRsRgRgmbRsRsmbLebReRsmbRgRsmbLcbLhLiLs
bLiLebLsLsLsLsmmmbRsLibLsbLgLsRsbRcbRhbLeLsLsmbLgLsbLsbRsRsmb

>ZF Recording 2016-03-18; tW: 300s; Start: 130322; End: 130822;
Recording: 11-1; Individual: 22; Drug: NDMC 10 µM
bLjLobRsbLebLgbRebRiRsRsLgmmbRsbRgRcbRsbLebLsbLcRsRsmbsbRibLcbLibLsbLe
bRsbsbReRcRsmbReRsmbRgRsReRsReRcmmbRiRsRoRsmmbLebReRgbRgLobLiLeLsbLgLs
bRcbLeLcbLcbRsRhRsmbLebRcbLcLsmbsbRgReRoRcbRebLiLsbLgbRsLcLsReReRsmmbL
cRsbLcReRsmbLsbLebLsLsmbRebRebRebLobLsbReRsmbRebLobRgbRebRhbRoLsbReLcL
eLebLeb

>ZF Recording 2016-03-18; tW: 300s; Start: 130322; End: 130822;
Recording: 11-1; Individual: 23; Drug: NDMC 10 µM
bReRsmbRsRsRsRsRsRiRsmmmmmbRsRsRsRsReRsmmmmbLsRsbLsbLsLsmbLgLsLeRsbRsR
smbRsbRcRsmbRsRsRsRsmmmbReLcbLiLeRsbLgbLcbLsLsLembLgLcLhRsbRsRsRsmmbRe
bReRsmbRsRsRsmmbLgLcLsmbLibLsbLsLgbLiLsLhLebRebsbLgRcbRebLsLsmbReRsRcm
bReLsbRgRcbLcRjbRebRcRebReLcLiRsbRsbRcbRhLhbRsbLsbLiLsbLebRebRjbRsRsRs
mmbRebReRgbRhbRsRsRsRsRsmmmmbRebLebLebLsbLgbReRcRsmbRsbRhRobsbRcRsmbRs
bRebRsRsRsRsRsRsRsmmmmmmbLebLsLsLsLsmmmbRsLsbRsLgLsLsmbRebReLibLeLcbRs
LeLiLcRsbRsbLeLsLsLiLsmbLsbLebRebRobReRsRsmmbRsRsmbRsRsRsRsmmmbLeLsLsm
bReRsmbRsRsRsRsRsmmmmbRsRsRsRcRcRommbRsRsRsRemmbRsbLeLsReRcbLebLeLebLe
bLgLebLebLsLgbLgbLibLebRsLjbLhLgbLeLsLsmbLgLsLeRsbLsLsLsmmbLeLebLebReb
RebLebRebRiLebReRsmbRsRsRsRsRsRsmmmmmbLeReRsmbRsRsRsmmbLeRsLcRsbRsLsLs
LimbReb

>ZF Recording 2016-03-18; tW: 300s; Start: 130322; End: 130822;
Recording: 11-1; Individual: 24; Drug: NDMC 10 µM
bRsLcLsmbLcbLsLgLsLsmbLsLsLgmbLgbRebRsbRebLebRebRibLsbRibRsRsRgRsRiRsR
emmmbRsRsRsLsmmbRgRsmbRgRsRsmmbRsLsbRobRgRsmbRsRgbRsRsRsRsmmmbRgbLsbLs
bRsRsmbLsRsRsmbLsRsbLibLsRsbsbLsRsRsRsmmb

>ZF Recording 2016-03-18; tW: 300s; Start: 130322; End: 130822;
Recording: 11-1; Individual: 25; Drug: Control
bLjLcbLebLgLebRgRsmbLcLebRiRsmbLebLebRsRsmbRibLibRibRebLebLiLsbLebRibR
eLsLsmbLsLsLsmmbRgbLsLsLsLgLcmmbLsLebRcReReRgbRsbRgRsRgRsRhRsmmmbRsRgb
RsReRgbsbRiRsRsmmbRiRgbLcLcLibLibRiRgbRebRebRebReLebLobRobLebLebLobLeL
sbLsbLgLeLeLeLgLsLebLsRsbRsbRsbLsLsLsmmbLeLsbLhLsbLsRsRsRsLsLsLemmmbLe
RsbRsRsRsmmbReRebRibLsLsmbRiRiRsRsRemmbLjbLeLcRsbRgbRsReRebLhbLgRcbLeL
oRsRgbReLiLsLsmbLgLsLebLeLeLeRsbLeLsLeb

>ZF Recording 2016-03-18; tW: 300s; Start: 130322; End: 130822;
Recording: 11-1; Individual: 26; Drug: Control
bLgRebLebRhbRebLobLibLhbLiLsbLibLsLsRgLsmbRgbRsbRgRsmbRsRsmbLebRebLcLs
LgLembLgLgbLebLcbLeRgRhbLsbsbLebLsLsmbLebLiRcbLeLeLsbLeLsbLeRebRebRsbR
iRsmbRebRgRsmbRcbRsbRobRebLebRobReRgbRebRebLebLebLgbRebLobLeb

>ZF Recording 2016-03-18; tW: 300s; Start: 130322; End: 130822;
Recording: 11-1; Individual: 27; Drug: Control
bLgLcReRcbRebRebLiLsLgLsbLsLsRsLsRsLsmbLcLebLgLsLsmbLsLsLgRimbLgbLebLc
LobLebLcbLebLgbLobLgbLsLeLebLebLsLsLsLsLsLsLsmmmmmmbLsLibRsRsmbRsRsmbR
ebLibLsLgLgLhbLeLibLgLiLsbLiLsbRgLsLhbRsbRebRebRjbRebLobLjbRcRsmbRcbRc
bRsRsRsRgmmbRsRgbLcbLhRsbLcLsLsRgRsRsRemmmmbLsRgRebRsbRgRebRsRgLsRsRsR
sRgRsRgRemmmbLsLsRsRsRgRsmmmbRiRcRsmbLjLgLeLsLsLgLsLimbLsLsLsLhRemmbRe
bRcRsmbRsRgRebRgRsRsRsRsRsmmmmmbsbRgRebRsRgRebRiLsLsmbRgLebLeLsLsmbLeb
RgRsRsRemmbRib

>ZF Recording 2016-03-18; tW: 300s; Start: 130322; End: 130822;
Recording: 11-1; Individual: 28; Drug: Control
bLcbLgLebRsRsLimbLebLeLsbLhbRebRgRsmbRebLgLgLebLobLhbRibReRsmbRgbRibLg
bRebLebLgbRsbLebLebLcbLibLibRjbRcLgbRoRiLgLcbLsbRiRibReRsmbLcLhLebLgbL
cLibLibLeLsbLiLsLeLgbLebLibRcbRcbRibReRcLsbRhRsmbRcRcbLebLcLsLsmmbLsLs
LgLsLembLsbLcLcbLcLgLebRcRsLimbLobRcbLebRobReRiRsRgmbRgbReRsReRsRsRiRg
RsLsmmmmbRgbReb

>ZF Recording 2016-03-18; tW: 300s; Start: 130322; End: 130822;
Recording: 11-1; Individual: 29; Drug: Control
bRcbLcbRcRsmbRcbRebRebLobLebLebLeRibRebLcbRcRgbRsbLeLgLsRsbLsLgLsRsbLi
bLgbLobLcbRobRgbLebLcbLebLcLcbRebRiRgbRebLeLsLgLsbRebRiRcb

>ZF Recording 2016-03-18; tW: 300s; Start: 130322; End: 130822;
Recording: 11-1; Individual: 30; Drug: Control
bRjbLsLebRsRsmbRgRsmbRjLcLcbLebLeLeLcbLebRgRsLsRimbRcbRebLgLsLsmbLiRsR
sRsLgmmbLiRjbRsLgLsbLcbLcRsLsReRgbLsLsmbLoLeLsbLebLsLsmbLebLsLeLsLeRsb
RibRhRibRcbLsbLeRsLsbLeLgLsLsmbLgbLsLsmbRsLsLgbLgbLeLcbLibLibsbLsLsmbL
cbRgbRjbRcbRsbRgRiLsbRcbRibLjbLibLsbRjbRcRcbRsbRjbLcbLebRcbLobLhbLebLe
bLsLsLimbLsLebLeLebLgbLjbLgRsbRebLebLebLebLeLsbRsLibLsLgLgbRiRsmbRgbLe
RcbRcLebLgLebLsbLgLsLsmbLcLsmbLsLsLsLsmmmbLebLsLhRsbRcRhRibLebLeLsLgbL
iLsLsmbLsbLeLcRsbLgbLsLsLsmmbLsLebRsbRcLcbLsRhbLebLebLebLgLsbLeLgbLgbL
ibLibLeLsb

>ZF Recording 2016-03-18; tW: 300s; Start: 130322; End: 130822;
Recording: 11-1; Individual: 31; Drug: NDMC 1 µM
bRsRsRsRsRsRsLsmmmmmbRgRgRsRsRsmmmbRsRsRsmmbRsRsmbsbRsRsRsRsmmmbRsbLsL
jLgbLsLsLeLsLsLgmmbRcbRjRsmbLebLeLsLeLgRgbLoRsRsmbLsRsRsmbRsRsRsRsRsmm
mmbRsLsRsbRsLsRsb

>ZF Recording 2016-03-18; tW: 300s; Start: 130322; End: 130822;
Recording: 11-1; Individual: 32; Drug: NDMC 1 µM
bLibReRsmbRibRgbRgRibRibRsRiRsmbRiRsmbRsRhbRgRgLsbLgLsLsmbLhbLhbLiLsbL
cRsbLeRgbLebLgbLobLgLebRebRiRgbRsRsmbRebRiRsmbRibRsRiRsmbRebRibRgRgbRi
LgLcRsbLebLsLiLcbLebLebLhbLeLcLobLhLsbLebLibLebLjbRgbRhRsRsRsRsRsmmmmm
bRgbLcbRcbRsbLebRibRoRsmbLeLsLsmbRsLebLebLebLebLobRsLsLsLsmmbLebLsLsLs
LsLsLemmmmbRiReLgLiLsbRsbLcb

>ZF Recording 2016-03-18; tW: 300s; Start: 130322; End: 130822;
Recording: 11-1; Individual: 33; Drug: NDMC 1 µM
bLgLcbLebReRsmbRcRcLcLcLcbLebLeLsLsLsLgLeLsmmbLebLcLeLiLsRsLsLsmbLeRsb
LebLiLsLsLsmmbLiLgLebRiLeLebLjLsmbLsbRoLcbRcRsmbRsRsRsRsRsRsRsmmmmmmbR
sRsmbRsbLgbRsbReLgbLcbLsLeLeLsbLeLsLsLsLeLsmmbLsLhbLhbLgLsLeb

>ZF Recording 2016-03-18; tW: 300s; Start: 130322; End: 130822;
Recording: 11-1; Individual: 34; Drug: NDMC 1 µM
bRgbRebLoRsLcbLibReReRsmbReRebLsbRgRgRsRiRsRsmmmbReRebRibLoRobReRsRhRc
mbRsRsmbLoRsRsRembRoLgbReRiRsmbRibRibRebRcRsmbReRsmbReRibRsRsRsmmbLoLg
LoRsbLcbRebRsReRgbRebLibReRibLgLibRiRoLsbRsbRebRebLeLebReRsRgRsRimmbRe
bRgRsRsLemmbRsRsmbRhLcbRsRsRembRebRcbRoLoRibLjbReb

>ZF Recording 2016-03-18; tW: 300s; Start: 130322; End: 130822;
Recording: 11-1; Individual: 35; Drug: NDMC 1 µM
bLcLobRcLsbRsRebRsRsRgRsReRsmmmbRsRebLiLsLcbRobRsRsmbLebLeRcbRgRsRembR
gRsRgRsmmbLcRebRsRsLeLsmbLebLiLgLcLsLsRjmmbRcRiLsbRsReRibRgRsRembRgRsm
bLsRcRsRimbLsRebReRsmbRiLsbLibLoLsLsmmbRiReLjbLsbLebRibRsRcbReRsRsReRe
RsmmmbReRsRgmbRsReReRsmbRhRsRcmbRebReRsmbRebRsRsRsRiRsmmmbLoLebLsLsLcR
smbLoLsmbLibLsbLebLcLsLsLsmmmbRebRcReRsmb

>ZF Recording 2016-03-18; tW: 300s; Start: 130322; End: 130822;
Recording: 11-1; Individual: 36; Drug: NDMC 1 µM
bRjRebLgRiRcLgbLebLcLeLsbLgbLoRsRebRsRsRembRsbRsRsmbRiLgLsbRsRsRsRsLsR
sRsRsRsRsRgmmmmmmmbRoRebRiLsbLgLgLsLsLsLsmmmbLsLsLsLsLsLsmmmmmbRebRcbR
cbLoRebRsbLobLoRsRcb

>ZF Recording 2016-03-18; tW: 300s; Start: 130322; End: 130822;
Recording: 11-1; Individual: 37; Drug: NDMC 3 µM
bRgLcRsLcbRebRcbRgLsbLcRoLsbRebLobLgLsLeRsbReRcb

>ZF Recording 2016-03-18; tW: 300s; Start: 130322; End: 130822;
Recording: 11-1; Individual: 38; Drug: NDMC 3 µM
bLhbLiLsReReReRgbRsRsRsmmbRsLiRsRcRiLcLsmbLsLgbLeLiRgbRcbRgbLeReLeLsLs
LeLsmbLeLsLebLebLeLibRebRebRebRebRsbRsRsRsRgLiLemmbLgLsbLgbRsbRebReLob
LeRcReRsRsmmbReRsRsRhmmbRiRcRsmbRsRsRsRsRsmmmmbLcbReRsRsRgRsReLemmmbLg
bLibRcbRgReRsRgmbRsRsRsRemmbRsbRsRgRibLobReRiRsmbRiRsLcmbLeLebLgLsLsLe
mbLgbReLsbLgRhRibLcbLsLgbLsLsLsRsRemmb

>ZF Recording 2016-03-18; tW: 300s; Start: 130322; End: 130822;
Recording: 11-1; Individual: 39; Drug: NDMC 3 µM
bRhLsLsmbRsLsRsReLsbRebLcbLhbLeLoLhbLebLcbLeRgbRebRgRsReRimbRhReRsRsmm
bRsRgLsRgRibRcRhRsmbLsLcLebRsbRsRcbRsbRgRsmbRgbLeLsbLeLsLsmbLiLsLsmbLe
bLibLgLsLsLsmmbLsLsLsmmbRsRsRsmmbRgbLsRsbRhLsbRsRsReReRsmmbsbReRebRgRs
RsRsmmmbRcbRsRsRsRsRsRsmmmmmbRcRsRsmmbRsbRsRsRsRsRgReLimmmbRsLebLoLsmb
LebLoLiLsbLebRobLsRiRsmbRsRgReLjRcbRsRsReReRgmbRcRsmbLeLsbRobRibRiRsRe
mbRibRiRsLsmbLgRsLsbReRgbRiRgbLgbRhRsRsRsmmmbRsRsRsRsRiRimmmbLebLiLsLe
bRsRsmbRsbRsLeLsbLsbRcLsLsmbRiRsRgRcmbLhRsRgb

>ZF Recording 2016-03-18; tW: 300s; Start: 130322; End: 130822;
Recording: 11-1; Individual: 40; Drug: NDMC 3 µM
bRgbRcRebRgRsRsReRsRsRsRsmmmmmmbRiLebLeLgLcbLgbLeLsLiLeLiLsLgLeLsbLibL
eLcbRebReLeLsLsLsLsLeLemmmbLeLsLiLiLgLsbLsbLgLsLsLsRsLgLsmmbLgLsLgLsLs
LsRommbLgLeLsLibLgbLeLsLsmbLgbLsLsmbRsbLsbRiRsmbLgbLcbLibLobLebLjbLobL
sLsLsmmbLebLibLsLsLembLcbLjbLgbRibLebLcbRsLsRcRebLebRgbRebLsLsLgLgmbLh
bLeReRibRsRsmbRsRgbRiLiLibRiRsRsRsLsmmmbLsbReRsmbRebRsRsLsmbRsRsRsRgmm
bRsRsRgRsRsmmmb

>ZF Recording 2016-03-18; tW: 300s; Start: 130322; End: 130822;
Recording: 11-1; Individual: 41; Drug: NDMC 3 µM
bRsRsRsmmbRsRsmbRgbLoLsmbLiLsbLsRsbRsRgLsbRsRsmbRsbRsLsRsRsmbRgRsRsLoL
smmmbLcbLgLsbLiLib

>ZF Recording 2016-03-18; tW: 300s; Start: 130322; End: 130822;
Recording: 11-1; Individual: 42; Drug: NDMC 3 µM
bLeLcbRsbReLsLsmbRsLebLgLsbLiLebLcbLcLsLsLeLoRsmmbRsRsRsRsRgRimmmbRsRs
mbRsRsRgRsRgRsRsRgmmmmbRsRsRsRemmbRebLsLebLsbLoLebLsLgLsLgLgReRibRsRsm
bRsRsmbLsLcLsmbLiLsLsLgLsmbLeLsbRsbRoRsLgmbLsLsLsLsLsmmmmbLobLcLsmbsbR
sLjbLebLgbLcbRibRebRebLebLcRiLcbLsLsLsLsLsLsLemmmmmbRhLebLgLgLsLiLeLsL
smbLsLiLsLebLobRsbLsLsLembLsLiLsLebLsbReRebRebRebRsRsRsmmbRgbRgbLgbLeL
eLcRsbLsbRoRhbLcLhbLsLiLebLcbLebRiRiLgbLeRgRgRsRsmmbRsRgRibRsRgLebLeLe
bLgbLiLsbLcbLebLgbLsbRsbLsLgbLsbLebLgLsLsmbRsLgb

>ZF Recording 2016-03-18; tW: 300s; Start: 130322; End: 130822;
Recording: 11-1; Individual: 43; Drug: NDMC 10 µM
bRsRsRsRsRgReLsmmmbsbLeLsLsmbLsLsLsmmbLgLsLebLsbLgLgLsbRsRsRsRsRsRsmmm
mmbRsRgbLcRsbRebRiRsRsmmbRsbRsRsRsRgRgRsmmmbLgbLsRsbLgLsbLeRsbRgReReRi
RiRsmbRsbRsRsmbReRsRsLsLcLsLoRsmmmbLsLsLsLsmmmbLobLcLgbLsLsLsLsmmmbLsL
sLgLsLeRsmbRsbRgRsRiRsRsRsRsmmmmmbLsbRebRoRcRsRoRcRcRsmmbRiLsbLhbLgLsb
LhLgbRiRsmbLoLebLobLebLgbLcbLobLsbLsLsLsmmbLsLsmbReRiRcRsRcRembRsRsRsm
mbRsRsRsmmbLebRcRgLcbLhbLsLsLsLsLsLsmmmmmbLsLsLsLsLgLsmmmbLsLgLgLsLebL
eRsRcRcLsRsbRsRsmbLsbRgRgLsbRiRsRsmmbsbsbsbRhRsLgmbRsbRcbLgLsRsbRoRgbs
bRsRsmbReRcRsmbLsLsmbRsLsLsmbLsLsLsmmbLebLiLsLsmbLsLsLoReRcRcRsRsmmmbR
sRsRsmmbRsRsmbLsbRebRiRsmbRsRsRgRsmmbRsLsRsRsRsRsmmmbRsRsmbRsRsmbLsRsb
RsbLebReRsmbRsRgRgbRsbRobRsRsmbRgRsRsmmbRiRsRsRsRsRsRsmmmmmmbLcbLsLgRs
bLsLsmbRsbsbLsLsLsLiReRsRsReRcRsmmmmmbLsbReLsLsmbLsbRsLsbRsRsmb

>ZF Recording 2016-03-18; tW: 300s; Start: 130322; End: 130822;
Recording: 11-1; Individual: 44; Drug: NDMC 10 µM
bRoLiLsbLeLsbRiRsmbRsRsmbLeLsLcbLsbRibRcRsRsRimmbRsbRebRcbRgbLebRgLiLs
bLebLsbLjbLsLcbRsbRiRsLsmbRiRgRsmbLsbReRobRcbRsRsmbLeRsLebRebRgbRiRgRc
RcbRsbRgRsRsRsmmmbLcLgLsbLcbLebLibLsbLsbLsbRsbLebLsLgLsbLsbRsbRgbReLeb
LebLeLobRiRsRsRsmmmbRgbLeLsbLeLcbRebRsRsmbRsRsRsmmbRsbRsLsbRgRgRgRsmbR
sbsbsbLsbLsbLebRhRgRgLsbRcRsmbRibReRsRcmbRiRgRiRsmbRibRsbRsbRgbRgbRiRc
RobLeLcLsLcmbLiLgbLebLgLebLebRsbRhbRsbLsRgLcbLsbLgbLebLsbLsbReRibRsRgL
ibLebRsbRcbRsRsmbRgRsmbRgRsmbRiLsbLcbLebLebLsLsRsmbLgLgLsLsRcmbLibLgbR
cRsRiLcmbRsbRiRsmbLeLebLgLgbLeRiRsmbRsRsRsRsRsRgRsRsmmmmmmbRgRsLsmbRgb
LibReb

>ZF Recording 2016-03-18; tW: 300s; Start: 130322; End: 130822;
Recording: 11-1; Individual: 45; Drug: NDMC 10 µM
bLeRoRsRoRombRsbRebRibRgRsLcmbLgLeLsbRobReLsbRiRsmbRgRsmbRebRibLjbRsbR
cbRcRibRsRsmbsbsbLjbRobRibRiRsLjmbLebRsRebLsbLjLiLsbLgLiLeLsbLebLiRsRs
mbLgbLhbLsLsLcmbLsRcRcRcbRsbRsRiRhLeRgbRcbRsRsRsLsRsmmbReLcLcbRibsbsbR
iRjbLoRibLcbLibLibReRhbRibRcRcbLoLiLcLsmbRoRcRsmbRiRsmbRsReLebLeLsRsbR
sbRebRcLiLsbLobRcRobRjbRcbRgbRcLibLsLsmbLgLsbLgRgbRoLebRgbRibRsbRgbLsL
eLoLcbRobLsbLeRsbRsRgbRibRoLsLjbRobRsRibRgbLsbRiRsRiLcmbLgLebRcLsbLgRg
b

>ZF Recording 2016-03-18; tW: 300s; Start: 130322; End: 130822;
Recording: 11-1; Individual: 46; Drug: NDMC 10 µM
bLsbRebLibLcbReLsbLeRsRebRsLsbLsLgRsLgbLsRcRsmbRibLsbLgLsRcLcLsLombLob
RebRcbRebRebLsLsmbLebRebRebLeb

>ZF Recording 2016-03-18; tW: 300s; Start: 130322; End: 130822;
Recording: 11-1; Individual: 47; Drug: NDMC 10 µM
bLebRcRsRhRembLsRsbRiLcLeReLebLgbLcRsbLsbRgRibRgbRgbRiRsRjmbRebRgbRsRg
bRebLobLibLobLsbRebLobLeLjbLcbLibLcLsmbLebLsLebRcReRsmbRsRsRiRembLeRsR
sRsRsmmmbRsRsRiRsRimmbRsRsRiRsRsRsRsLcmmmmmbLiLsLsmbRobLibLsLsLsmmbLsb
LiLobReLeLsRibRebRhRgRsmbRgRsmbLsRebRobLsbLoRsRsRsmmbRsRsmbRoLjbLcLsmb
RsRcRobLcRsbRsRsRsRsRgRcmmmbReRsmbRgRgRebLeRobLsLsLsRsLsmmb

>ZF Recording 2016-03-18; tW: 300s; Start: 130322; End: 130822;
Recording: 11-1; Individual: 48; Drug: NDMC 10 µM
bLcRgRhLcLsLsmmbLibLsbRsRsmbRjbRsRibRoLsRobRgbRsRsRsmmbRebRcbLsbRiRjbL
sRebRgRsmbRsRsRgRcmbLebLiLcbRoRsmbRiLsLsRsReRoLsmbRiRibRsbRgRsmbRsRsmb
RsLsbRsRsmbRsRsRsmmbRsRsLembRsLsLcLsmbLeRsLcRjbRgbRhLsLsLsLgLsLommbLgL
sLcLsLjmbLgbLgbLgLsLsLiLsmbLsbRjRsLcRoLsmbRebLsbRsRjbRobRgRsRsmmbLeLsL
smbLebLcbLebLeRgLcRcbLhLsbLsLeLgbLeLsRsRiLsLsLjmbRhbLsRcRsmbRsRsRsRsmm
mbRsRsRsmmbLebLcbLgbLgLsLgLsLsRsLsLsmmbLgbLjbLeLcbLgbLsLsmbLsbRgbLcbRg
bRsbReLeRsLsbLiRsLsbLgbRsbRjbRcbLeLsbLsbLsLgLsbRsbLsbRsLsLsLsRsRsmmmbR
sRsRsmmbRsLsbLsLsmbLsRsLsLsRsRsmmbLsbLeLcLcLsmbLebLsbLhRcbLhbRgRsRsRsR
sRemmmmbRsRoRsmbRsRsRsRsmmmbLsbLeLebLcbLsRsbLgLsLsmbLsb

>ZF Recording 2016-03-18; tW: 300s; Start: 130824; End: 131324;
Recording: 12-1; Individual: 1; Drug: Control
bLhbLgLebLsLgLsbLsLibLsLgLgbLhLgbLgLiLgbLeLsbLiLsbLiLsbLsLibLgLgbLhbLs
LhLsbLibLibRobLoRgbRebRiRsRsRsmmmbRgbLebLibLhbLibLibLhbLeLgbLgLsLsmbLi
LsbLsLiLsbLgLsLsmbLebLeLgbLiLsb

>ZF Recording 2016-03-18; tW: 300s; Start: 130824; End: 131324;
Recording: 12-1; Individual: 2; Drug: Control
bReLsbLoLsmbLebLeLebLobLebReRgRsmbRsRibLsLsmbLebLebRebLcLsmbLcbLsbLsLg
bLcbLhLeLsLsmbLcbLcbLiLeLsbLcRsbReRsmbRcbLeLsRibRgRsmbLcbLcbRebRsReRcb
LebRcbRsbRobRebLiLsLsLsmmbLeLsLgLsbLebLeLgbLcbRgRsRembRiRgRsmbRibRgReb
LeLsbLibLebLcbLebLibLebLiLiLebRebRebRcbRiRebRgbRsRebRgRgRcbRsbLeLgbLjb
LeLsbRgLsbLeLsbLsLcbRiLsLsLsmmbLeLsbLebRebReRsRembLgLeLsLsLeLsLeLembLe
LsbLiLgLsbLsLgbLiLsbLibLgbReLsbLcbLgRcbRebLsRibRcRib

>ZF Recording 2016-03-18; tW: 300s; Start: 130824; End: 131324;
Recording: 12-1; Individual: 3; Drug: Control
bRoLebLcLhLsRebRcbLgLgLgLsLsLembRiRsRembRgLsbRgRsmbRsRsmbRgRobRjbRiRhb
RoLgbRsLhLcbLsbRsLsRsbLebReRibRsRsmbRebLebLeLgbLebLgLeLcLebLsLeLgLgbLs
LgLhbRsRibReRoLeLeLgLiLsLgLibLeLsbLsbRgReRsRgmbRsRsLsRsRsmmbsbRsRsmbRg
LsRsRsRsReLeLimmbLgLebLhLgRsbLebLsLsmbLebRgRiRhLsbLhbLsLsmbLebLcLcbLsL
ibLgRcRsmbRebRsRsRiRgmb

>ZF Recording 2016-03-18; tW: 300s; Start: 130824; End: 131324;
Recording: 12-1; Individual: 4; Drug: Control
bReRsRsmmbLsLgLsbLsLsLgLsRoRoRembRhbRsRsRgmbLsRsRsRsRsRsmmmmbRiReRsRsR
smmmbRsRsRsRsmmmbRsbLsRgbLgbRebLsLebLgLsLsmbLsLsLsRsmmbRsRsmbLhbRobRgR
cRebRgbRebRebRibRiLsbLeLsbLgLsLeLsbLiLoRsRgRsRsmmbRgRsmb

>ZF Recording 2016-03-18; tW: 300s; Start: 130824; End: 131324;
Recording: 12-1; Individual: 5; Drug: Control
bRsRebLcLsLgLsmbLibReRsLiLsmbLebRhbLeLiLgLsbLeLsLiLsbLhLcLiLcbRebLeLsb
ReRcbLsRcRobRcLcLsLsmmbLsLgLebLhbLeLsbLeLebLsbLsbLcbRcRcReReRiRebRsRsm
bLsbLsbReRsmbReRoRsRsmmbRibRgRoLsbLsLgLgbLiRsRgbRebLsb

>ZF Recording 2016-03-18; tW: 300s; Start: 130824; End: 131324;
Recording: 12-1; Individual: 6; Drug: Control
bRgLsbLebRebLebLobRgbLgbLibRsLhLsbLsbLgbLobRcbLcbLebRobRobRsLsbRobLgbL
ebRebRibReRsRembReRsRsReLemmbRibRgbLgbLiLsbRgRjbRebLobLgbRobRgbRgRobRi
bRsLsbLiLsLcbRgbLsLobRsbRgbRcbRebLgbLcbLeRebRobRgbRcbRobRobRebRebRsReb
RcbRhRgRsRsmmbRebLcLcbLcbLebLobRobLgbLsRsbRiRsmbReRgRsRsRgmmb

>ZF Recording 2016-03-18; tW: 300s; Start: 130824; End: 131324;
Recording: 12-1; Individual: 7; Drug: NDMC 1 µM
bRcbRcRsmbRcbRcRgRsRsmmbRebRsRgRebLobRcbLsLgbRsRsRsRemmbLebLobRcLsbRsR
eRjbRebRsbRibLgbLgbRsRsmbRebReReReReRsmbRsRgRgbRgRsRsLsmmbRgRibRgRsRgR
sRgmmbRiRiRiRibRgRsRsmmbRgRgRsRgRsmmbReRsmbRgRsRsRsRgmmmbRgbRcLsbLobRc
bRgbLeRsbRgbRsRsRgRsRsRemmmbRsRsRgRembReReRsRimbRsbRsRsRsRemmbRibRsRsR
sRsRsRsRgRsmmmmmmbRsRsmbRsRcbLgRhbRgbRebLgbLebLsLebLcRebLcRcbRebLcLsmb
LibLsLsLsLemmbReRebRsRiRsRsLsRsmmbRgLsRjbLobReRsRoRsReLsmmbRgRsmbRsbRe
bRcbRebRebRebReRebRebRebRsRsRimbRsRsRsRgmmb

>ZF Recording 2016-03-18; tW: 300s; Start: 130824; End: 131324;
Recording: 12-1; Individual: 8; Drug: NDMC 1 µM
bLsLsRsmbReRcbRgbLcbLcbLeLsLebLebLsLeLsbRgbRoLsbRcRsmbRcLsbLebLeLsbLsL
sLsLsLcmmmbReRcbRebLcLebLoLebLebLsbReRsRsRoRcReRhmmbRsRsmbRebLcLsmbLjb
LsbLsbLsLsLsLemmbRebRiRsRsmmbRebRiRsmbRebLeRsRsRgRsRsmmmbLoReRsRembReL
sbRebRgRsRsRsRsmmmmbLoLgbRebRebLebLeLsbLsLebLgLiRcbRebRebRiRgRsRsRsRoR
emmmb

>ZF Recording 2016-03-18; tW: 300s; Start: 130824; End: 131324;
Recording: 12-1; Individual: 9; Drug: NDMC 1 µM
bReRsRgRembRiRiRebRsRsRgRembRsLsbLebLibLsLsLsmmbRsLsLebLsLsmbRcbRcRsmb
RgRsmbRsRsRgRsmmbRsRsmbRcReRibReReRsLsmbReRsmbReRcRsRgRsRsmmmbRgRiReRs
RcReRgReRsRgRsmmmbReRsmbReRebRiRsmbRsRiRiRsmbRsRsRgRsRsmmmbsbRsbRiRsmb
RgReRsLsmbRiRsmbRsRsRsRgRsmmmbRsRsRgRsRsReLsmmmbsbRsLsbRsbReRsmbRsRebR
cbLeLebLgLsRebRsRsRgRsLsmmbLjbLsLcLgbLsbLebLsLsLgRsmbReReRcRsRsmmbsbRc
RsLsmbRjRsRsRsRsRsRsmmmmmmbRsRsmbsbRebLgLsbRebRsRsReRimbRgRsmbRsRsReRi
RsRsRgRiRsReRsmmmmmbLoLsReRcmbRsRsRsReRimmbRgRsRsRsRsRsRiRoRsmmmmmmbRs
RsRsRsRsRsRsRgmmmmmmbRobRsRsRsmmbRsRsmbRsbReRsmbRgRsRsRgRiRcLsRsmmbRsR
sRsRgRsRsmmmmbRebRsRsRsmmbRsRsmbRebLebLsLsLsLsLcLsmmmmbLgLsLsmbRebRsRs
mbLsRsbRsbRebRsbLebLsLhLsLsmbRsbLebLsLsRsmbRibLgRsbRsRsRgRgRsRgRsmmmbR
sRsRsRsRemmmbRiRebLeRsbRiRsRsmmb

>ZF Recording 2016-03-18; tW: 300s; Start: 130824; End: 131324;
Recording: 12-1; Individual: 10; Drug: NDMC 1 µM
bLcbLsLsLeRombLebLiLgbRebLebLcRsbRebRebLeLibLibLibLjbLebLgbLebLebLebLe
bLiRsbLgbLibRebLeLiLebLgLebLebLebLhbLiLsbLgLsbLgbRobRsbRhbRebLhLeLsb

>ZF Recording 2016-03-18; tW: 300s; Start: 130824; End: 131324;
Recording: 12-1; Individual: 11; Drug: NDMC 1 µM
bRebRsRsRsRsRsRgRcmmmmbRsbLjLcRsbRsbLcRsLsbLsLgbRsbRcbLgRebRcbRsbRsRsR
sRsRcmmmbLsbLcbReRgRsmbRsRebRsLsbLsLiRgbLsLsLsLsReRoLcmmmbLoLsLsmmbLeL
oRsLeLsLsRsLsmbLeLeRgRsReLsmbRebLsbLoRsbLgbRsLsLeLsbRgbReLgLsbLsRsLeLs
LeLsLiLeLsRsRsRsmmbLiLcLsmbRsLsRsbRiRcRcLsbRiRiLsbRsRsLsLoLsmmbRsbLcRe
bRsRsReLsRcRsRsRsRcLsLsLsRimmmmmmbRsRgLcLsLsLsmmmbRcLcbReRcRsRsmmbRsRs
RsRsReRsReLsLsLsReRcRsmmmmmmmbLeLeLgLeLgbLiLsLsmbLsLgbsbLiLsLsLiLsLgLs
mbLiLsRsLhLhLibLeLiLsbLgbLsLsLgLsmbLeLsRsbRsLsRsLsRsLsLgLcLsmbLgLsbLsL
sLsLsmmmbReRsRsmmbLibLiLsLcRsbRcbReRsRcmbReLsRsReRsReLsRsLsmbRgRcLibLs
RsbReLobLeRcLeLcbLsLsmbReLobLgLsbLjLiLsRsRsmbRsReRcRcRobReRcRcRsReRsmm
bRsRsRsRsReLsLsmmmmb

>ZF Recording 2016-03-18; tW: 300s; Start: 130824; End: 131324;
Recording: 12-1; Individual: 12; Drug: NDMC 1 µM
bRcbRcbRcbRoLsLsmbLgLebLibLsLebLebLhbLgLgLsbsbRsLebLiLsbLsLgLsLhLsbLsL
gLhLsbReRsmbRsRsRsRsRemmmbRsRsLsRsmbRsbRsRsmbRcbRebLsRsbRebRsRgRsmbRgR
gbRobRsRgbRebReRcRsmbRgbRibRcRsRsmmbReRsmbRsbLsbLsbsbRsbLsRsbRgRsRgmbR
eRsRsmmbRsRsRgmbRsRsmbReLsbLebLcbLsbRsRsmbLsLcbLsLebLcbLeLsLsmbLgbLsLs
mbLsLsLsLsLsLsLeLsmmmmmbLgbLiLgbLsbLsLsLembRobLcbRgbRibLsLgbLebLgLebLg
LeRsbLsbLsLsLsLsLemmmbLebLgbLiLsbRsbLebLebLjbRibRsbReRsRsRiRgRgmmbRebL
sbRgRsRiRsmmbRiRsmbRibLeLhLsbLsLgLiLibLibLsLsLsLsmmmbLsLibLebRcbLgLsLg
bLhbLsLsLsLsLgmmmbLsLgLgbLsLsLsmmbLsLsLimbLeLsLsmbLgLgbLsLsmbLsLsmbLeb
LsbLgRsLsRsbLsLiLsbLgLsbLsbLsLgLsLsLcmbRibRsLsbLebLiLgbRsLsLsLsmmbRsRs
mbRhRsmbsbRsLsbRsRsmbRsbRhbRsLsbRiRsmbRsRsRsmmbRsRsRsRsmmmbReRsmbLebLs
LsLsmmbLsLsRsmbRsLsLsmbRebLsbRsRsRsmmbRebRgRsmbRgbRebRsRiRsmbRsbLgLsbR
sLibLsbRsbLsLsLgLcmbLiLsbLgbLgLsbLsLibLgbLiLsbLgLsLsLsLgmmbLsLsLembLgL
sLeLsLsmbLsLsLsmmbLibLsbsbLsLsLsLsmmmbLeRsbRebRsRcbRgbLjbRibLhRsbRgRsR
imb

>ZF Recording 2016-03-18; tW: 300s; Start: 130824; End: 131324;
Recording: 12-1; Individual: 13; Drug: NDMC 3 µM
bRhRsmbRcbRcRsmbRsRebRsRgRsRsRsRsmmmmbRsRsLsLsmmbRcRcbRgRsRembRibLsLsL
smmbLebRsbLeLgLsbLsLsLeLsLsLsLsmmmmbRoRsmbRsRsmbReRsLoLsLiRsRsmmmbRsbR
sRoRsRsRcRjmmbLcLcbRgLcbLibLcbRgbRcRsRsRsmmmbRjbLebRcRsmbRibRibRobRsRs
mbRebLcLsRembRcbRebRcLsbRsLsbRobLcLgRibRebRsbLsRobRgbRgbRcRsRsmmbLgbsb
LebRebLsbReRsRsRsmmmbRebRebRebRgRsRgmbRobLsLsLsLsLsmmmmbLsbLsRsRsmbRsL
sLsmbLgLsLeLcbReLcbLjLiLsLiRiRsmbRgRsmbRiRsRoLcmb

>ZF Recording 2016-03-18; tW: 300s; Start: 130824; End: 131324;
Recording: 12-1; Individual: 14; Drug: NDMC 3 µM
bRebRibRebRgRgRsRsmmbRgbRebReRebLeLgbLcRsbLcRsRsmbLsLsLsLsLhmmmbRiLhbL
eLsbLebLebLsLeRgbLeLgbLgLebLeRsRibRgRgbLeLsbLeLsbLgLsLiLsLcLsmbLoLsmbR
ebRebRsRsRgRsRsReRoRgmmmbRsbRoRgLcLobLgLeRebRsbLeRsRsLcmbLgRsbRebLgbLs
LhLobLeLiRsLsbLeLsLgbLiLsLsLsLeRsmmbLgRjbRsb

>ZF Recording 2016-03-18; tW: 300s; Start: 130824; End: 131324;
Recording: 12-1; Individual: 15; Drug: NDMC 3 µM
bLeReRsmbRgRsmbLobRsLebRcLsbLcLgbRhRgbLebLebLsbRcRgbRgRibRsRsRsRsRsRsm
mmmmbLsRsRsmbRsRsLeRcRembReLiLsbRebReReRsmbReRsmbRsRsRsRsRhLommmbLibRc
bRcbRibLcbRsbLebLibLsLsRsLsmbLsLsLsmmbRsLsbRobLcbLsbRebLsbLgbsbLebLcbR
sbRcbRgbRebReLsbRoLsbRsLiRsbLgbRcbReLebLgLgb

>ZF Recording 2016-03-18; tW: 300s; Start: 130824; End: 131324;
Recording: 12-1; Individual: 16; Drug: NDMC 3 µM
bLeLcLhLoRgbLebLiLsbReRsmbRjbRoLsbRsbLcLsLsmmbLgRsLgbLsLsLsmmbLobRsLeb
RobLsLebRsbLobLsLsLsLsLiRsmmmbRebLhLibLebLsLsLsmmbLsbRobRebLcLsLsmmbLg
bLgRgbRcRsRsmmbRsRsRsRsRsRommmmbLiRcbLsbRgbRsbReLcbRcLcbLgReRsLimbRcbR
cbRhbRgRsRsmmbRsRsRgRcRcmbRibLibReRibRebRcbRsRibRebRsRsRsmmbLcLebLebRg
bRoLsLsmbLsLsLimbRibRiReRsmbLsLsmbRebLiLsbRgbLsRsbRsRsRsRsReRoRiLgmmmb
RebRcbLjbLiRoLgLcLsLsLemmbLeLgLsLgbLsbLsLgLeLsRsbReRsRsmmbRsRsReRsmmbL
iReLsLsLsmmbRsRebLiLsbLsLsmbLsLiLsLsRsmb

>ZF Recording 2016-03-18; tW: 300s; Start: 130824; End: 131324;
Recording: 12-1; Individual: 17; Drug: NDMC 3 µM
bLcLsmbRcbReRcRcbRhReRcReRgRsmbRiRiRsmbRhRsmbRhbRsRsRsmmbLeLcbLgRsRsmb
RebReRsRcmbRibRsRsRcRembRsbLeLcbLebLebRsLsLsRsRsmmbLobReRibLsLcbRcbReR
hLsbLcbRoRsmbRibRibRcLsbLsLcLcRsbLsLgbLsLsLsmmbLsLsRsmbLsLgLsLcRsLsLoR
sbReRibRgbRsbRiRsRgRsRiRgRsmmmbRgRgbRsRebRgRcbLgLsbLgLsbRjbLcRsbLebReb
LsLsLsRcRcRsmmmbRcRcRsmb

>ZF Recording 2016-03-18; tW: 300s; Start: 130824; End: 131324;
Recording: 12-1; Individual: 18; Drug: NDMC 3 µM
bLebLsRjbLebLsLebLebLgLeLsLgLebLgLhLsLgLsLsLsmmbRsRsmbLibLgbLsbRsbLsbL
sLsmbsbLebLcLsmbLeLsbRsbLoLcbRebLebLebLsLeRcbRcReRgReRsmbRgRsRsRsReRsR
gmmmmbReRgRiRhRsmbRiRsmbLibLcbLcbRgbRgbLcbLoLsLcmbLiLsLsmbLebRcbLibLsL
gLsbLebLcbLcbLhLgbLsbLebLebLcbLeLhbLiLsLebLsbLgLsbLsbLgbLsRsbRsbReRebR
obLebLeLsbLeLsbLiLeLgbLgbLeLcLsmbLibsbLibLgbLgLsbLibRsRsmbLsbLiLgLsbLi
LsbLsLsLsLgmmbLsbLsbLgbRsLsbLsLsRsLsLsRsLsLsRsmmmbRsbsbsbLgLsLsLsLsLsL
smmmmmbsbRsLsLsLembRibLsbRsbLgbLebLibLebLgRsbLgLsLsmbRsLsLhbLebLeLeRsb
LsLgLsbRobLcbLsLsLembRcRsLsmbRgRsRgRgRsLommb

>ZF Recording 2016-03-18; tW: 300s; Start: 130824; End: 131324;
Recording: 12-1; Individual: 19; Drug: NDMC 10 µM
bLibRebRebRoReLsbRebLjbLhLsRsbLsLebRebRibRcRgLsRsRgRsmbRcRsmbLsRsbRcRe
bLibLiReRiRsmbRgLsbRsbRsRsLgRcmbReLsbLibLsRcRibRebRibRebLoLgLebLeLsbLe
LsbLgLsLsLsmmbLobRibLcbRsbRiRsRsmmbRebLsLibRhbRgReRebRgb

>ZF Recording 2016-03-18; tW: 300s; Start: 130824; End: 131324;
Recording: 12-1; Individual: 20; Drug: NDMC 10 µM
bRiRsRiRsmmbRjReRsmbRiLcbLsRsbRgbRgbRcRsmbRgLsbLsLiLsbLsLsLcLsmmbLsLsL
smmbRoRsRsRhmmbRsRsmbLjbRcbRoRsRcmbLsbLcbLsLsRsmbLgRsbReRsRcmbRebRiRsm
bReLeLgbLebLsbRsbRhRsLsLsRsmmbLcLsmbLiLsbLeLsLcbLebRjbLiLiLsLebLiRjbRc
RsRsmmbLcRsRsLiLsLsmmbLsRsRsmbLgLsbRebLiLeRobLsRebRsLeLsbRoRsRsRsRsRsR
gRgRemmmmmbRcLeLibLsLibReLsbLsLsLembLsLgbRcbLcLjbLcbLibLcbLebLebLcLcbL
cRsbRebRgRsLcRembRebReRhbRcbRsbRcbsbRsRsmbRsRsmbRobReRibRsRsmbRibRebRc
RhbRcRsRsReRemmbRcLgbRcRgReLebLsLsmbLsLsLsmmbRobLcbRsbRsbLsbRoRsRiRemb
LebLobLgLeRsbLsLsRsLsLembRibRjb

>ZF Recording 2016-03-18; tW: 300s; Start: 130824; End: 131324;
Recording: 12-1; Individual: 21; Drug: NDMC 10 µM
bLhRibRsLsbLsbLgRgbLsLsLgLembReRsRsmmbLebLiLcLoLobLjbRiRsRsmmbLebRsLsb
LsbLsRsbLgLsLsLsLsLemmmbRiLsbLsbRhbRhbRsRsRsRsRsmmmmbLsbLcbRobsbLsbLgL
sLibLsLsLsLimmbLgLgLgbLgbRsbLgLsbLcRsbLhLsbRgRsmbRsRsRgRsmmbRgbRebRgRs
RsRsmmmbRiLsbLoLsLsmmbsbsbLsbLsLsmbLsLsLsmmbRibLebLgbLsLgLsbLgLiRsb

>ZF Recording 2016-03-18; tW: 300s; Start: 130824; End: 131324;
Recording: 12-1; Individual: 22; Drug: NDMC 10 µM
bReRsmbLjbLcLsRhRembLhRcRsmbReLsLhLsbLeLeLhRsbRiRgRsRsmmbLsbLcbLebLcLe
LcLsmbLsLsLcmbLiLsbLgLcLhbRcRcRebLeLsbLsLsmbLsRsbRsbLsLsRsmbLsbRebLiRe
bRgRsRsRsReRsmmmmbLcLsmbRebReRsRcmbLeLebLiLsLcbLcbLsbsbRebsbReReRsmbLh
LsbRebReRgbRgbRibLcLsmbLsRsRsmbLebLeLcbRsRsmbRcRsmbsbRcRsmbRebRhbRgRcR
cRgReRsmbRgRsRembRsbLgbReRsmbRsLsbLcLsmbRebLiLoLsLoRsmbReRcRebLeLibReb
Lsb

>ZF Recording 2016-03-18; tW: 300s; Start: 130824; End: 131324;
Recording: 12-1; Individual: 23; Drug: NDMC 10 µM
bRebRebRsbRibRiRcbRsLsLsRgRsmmbRsRsRgmbRsbRgRsmbRsRsmbRebLcLcbRgbRebRs
RsmbLcbRcbReRsmbRgRsmbLebRcbReRebRobRobRebRebRsRsRsmmbRsRsRsRsmmmbsbLe
bLcbRebRebLcbRcbReRsmbRgRsmbRsRsRiRsmmbLsbRsbLcbRebRebRobRsRgRsRimbLob
LgRobRgbRebRgRcbLobRebRebRsbRebReRsmbReRsmbReRsLembRjbReRsRgmbRgRsmbRs
bLsbLeLibRjRcRsmbRsRiRebRiLsbLebReRsmbLebLgbLiLebReRsLsmbRebRgbLhLhReR
ebRsRsmbRsRsmbRsbLsRebLeLsbRjbLgbLcbRgbLjbRcbLcbLsbLcbRebRcLsbRsRsmbRs
RsRsmmbLebRebRsbRsbLjbLeLibLsLsLsLsLsLgmmmmbsbLsLsmbLsRcbRcRsmbLeLsbRs
LebLsLsLsLeLemmbRsRsmbRhRsmbRsRsRsRsLcmmmbLsLsLsRsmmbsbRsRsmbLgLjbRebR
sRsRsRsmmmbLeLsRgbLibLjbLgLsLsmbLsLsLsLeLcLsLcmmmbLsLsLsLsLcmmmb

>ZF Recording 2016-03-18; tW: 300s; Start: 130824; End: 131324;
Recording: 12-1; Individual: 24; Drug: NDMC 10 µM
bLgRsbRgLobReLoLgLsLsLsLeLommbLsbLeRsRgbRibLebLjLgLsbLcReRcbReRsRsRemm
bLobLcbRebRcbRcbLhbRebRcbRgRgRgLsbRebRgRebRiLcbLgbRgbRsbRsReRgbLeLobRi
LobLiLsbLjLsLsRsRsmmmbLgLhbLiRebLeLsLsLsLsmmmbLgbLibLebLsbRcRobLcbRcbR
gbRgbRebRgbRgbLsbLcRiLsbLsLsmbReRibRebRgLjbLibRibRebRsbRsb

>ZF Recording 2016-03-18; tW: 300s; Start: 130824; End: 131324;
Recording: 12-1; Individual: 25; Drug: Control
bLgbLoLhLsLgLiLgLeLhLsbLsLsmbRsbsbRsLsbLsbLgLsbLgbLsbLsbLgbLiRsLsLsRsm
bLiRsLgLsbLsbLsLsmbLsbLsbLsbRsLsLeLsLsLsmmbLiLibLibLgLsLebRgRsRgRsmmbR
gLgbRgRsLsmbsbRgRgRsmbLsLsLsLsmmmbLjLhLsLgbLiLcbLcLsmbLsLsLsLsLsmmmmbL
sbRiRiRsRsLsmmbRjbLgLsbLgLsLgLsbLsRsLsLiRgReLeRsbLeLcbLhLsLgLsbLsLsLsL
sLsLsLsLsmmmmmmmbLsLsLsRsmmbLsLgbsbRgRgRebLebLeLsbLiLsLsmbLgLsbLgbLsLs
LsmmbLgLsLsLsLsmmmbLsRsbLeRsbRsLhbLgbLebLebLiLcLgLebLcLsLeRsmbRsRsRsmm
bRsRsmbRsRsmbRsRsRsRsLsLsLsRsmmmmmb

>ZF Recording 2016-03-18; tW: 300s; Start: 130824; End: 131324;
Recording: 12-1; Individual: 26; Drug: Control
bLebLgbLobLsLcbRgbLobLsbLebLsbLebLgbRsRsmbRgLsbLcbRcLebLebRsRsRjmbLsbR
obReRiRsRgRsmmbsbRsbLsRsRsReRembLsbLsLsLsLimmbLebLsbRiRsRembReReRsReLs
mbRcbLjbRebLsbLcbRhbLeLebRgRjbLeLgbLebLebLcbRgRsRsRsmmmbRsbRsRsRsmmbRe
bLsbRgbLeb

>ZF Recording 2016-03-18; tW: 300s; Start: 130824; End: 131324;
Recording: 12-1; Individual: 27; Drug: Control
bLeRsLiRhbRgRsRembRgbLiLsLsLsLsLsLsLeLeLemmmmmbLebLebLcbLebLsLeLgLsLsm
bLsLsLsRsLsLsmmmbLsLsRembLebLebLgbLeLsLgbRsLcLsLeLsLsLgLeLsLsLsLsmmmmm
bLgLsLsmbLsLsmbLgbsbRsbLsLsmbLiLsLsLsLgLsmmbLsLsLsLgLgLsLsLcLsmmmmbRsL
sLsLsLsmmmbLsLsLsLsLsLsmmmmmbLsLsLgLsLsmmbLsLsmbLgRsRebRgRgRgbRebRsRsR
sRsRsRemmmmbLgLsLsLsLsLsLeLcLsmmmmmbLibLsLsmbLsLsLsmmbLsLsLsmmbLsLsLsL
sLsmmmmb

>ZF Recording 2016-03-18; tW: 300s; Start: 130824; End: 131324;
Recording: 12-1; Individual: 28; Drug: Control
bRsRsmbRgbRjbRebRcbLcbRsLibRsLsLsRsmbRcbRgRebLobRgRiRsmbRsRgbRsRsmbRsR
sReRsmmbRjRsRsRsRgRsmmmmbRebLeLcLebLsbLeLeLsbRsRsmbLsRebRsbRebRebRsbLs
bRgRsRsRsRsRcmmmmbLhbLcbLgRsbRgbLoLcbLcbLobLsLsmbRcRsmbRsLgbRsRsRemb

>ZF Recording 2016-03-18; tW: 300s; Start: 130824; End: 131324;
Recording: 12-1; Individual: 29; Drug: Control
bLebRebReRgRibRsbRcbRsRsRsReRoLsLsLgLsmmmbLsRoRsRsRsmmmbLsbLsLcbLsLsLo
RembLobLibLebRsbRcRcbRebRebRebLgbLsbLgbLeLgLsLsmbLeLgRsRsmbLgLgbLibLgL
iLsbLibLgLibRsbLsbLeLsLeLgLsLsLgmbLebLsLeRsLgLgbLobLcLcbRiRiRgRsReRemb
RebRsRebRsRsLsmbRiLoLeRebLeLiLobLiRebReRsRembLhbRiRgbReReRsRsRsmmmbRgR
gbRsbRebReRibLebLiLeLgLibLsLsLembLsLiLsbLsLeLsb

>ZF Recording 2016-03-18; tW: 300s; Start: 130824; End: 131324;
Recording: 12-1; Individual: 30; Drug: Control
bLeLcbLeLsbRsbRjbLeLcLsmbLeLebLiLiLsbLeRsbLsbLsLeLeLcbLebLsbLsLsLsLsLs
LsmmmmmbLsLsLcRcRiRimbRcbLsbLeLsbLebLsLgLebLcbLeLsbLcLcRebRsbRoRsmbRob
RcRsReRsRiRimmbRsbRcRsRsmmbRgbLhLsbLhbLcbLcLgbLsLsLsLimmbLebLebLgbRjRs
RsmmbLebRiRoRhRibRcbRhRibLibLsLebLgLsbRgbRgbRsRsRsReRgLjmmbLibLgLibLeb
LoLcbLeLsbRcRjbLsbLiLsRcLebLiLsbLebLebLsLgLsLhLsbLsLsLgLimbLsbLsRsRsLs
mbRgbsbLcLsLsmmbsbRhReRsmbRcbLgbRobLsRibRsbLjbRebLebLsLgbLibRsbLiRsbRg
bRibLoLsmbLsbLebRcRsmbLibLiLcbLiLgReb

>ZF Recording 2016-03-18; tW: 300s; Start: 130824; End: 131324;
Recording: 12-1; Individual: 31; Drug: NDMC 1 µM
bRsRsRsmmbLgReRsmbLsbLsLsLsmmbLsbLgLiLebRcbRibRcbLibRcRsRsLemmbLebLibL
sLsLembLsLsmbRgRgbRhbRsRsmb

>ZF Recording 2016-03-18; tW: 300s; Start: 130824; End: 131324;
Recording: 12-1; Individual: 32; Drug: NDMC 1 µM
bLhLsbRsLsLiLcbReRsmbLsLsmbReLsbLsLsLgmbLebRebReLsbRsbRiRgbLsLsRsRsmmb
LsLsRsmbRsReLsbLcbLsbLsLcbLsLsLsLsLsLgmmmmbLebLebRebRibLsLsLsLsmmmbLcL
hbLeLsbLebRhbLsLoLsmbRoLsbLebLgbLsLsLgLsmbLiLgLobLcbLsLsmbLeRsbLsbLibL
ebLsLgRsLsLsmbLsLibRsLcbLsLeLcbRgbRiRibRiLsbRebLgLhLsRjbLiLcbRsbRgbRsR
sRgRsmmbLsLsRgmbRibRebRsRsRsmmbLcbLibLsLsLgLimbLsLebLgLsLgbLebRsbLebLc
RsbLsLsmb

>ZF Recording 2016-03-18; tW: 300s; Start: 130824; End: 131324;
Recording: 12-1; Individual: 33; Drug: NDMC 1 µM
bLcbLoRcRsmbRsRsRcRiRembRsRcLjbRibRcbLsRebRcRsRiRsmmbRsRsRsLsmmbRobLgL
cLgbLcLsmbLeLebLeLgLsLsLgLsLeLiLsmbLeLsbLsLeLsLgLsbLiLiLsLebLgbRcLeLhR
ibRsReLeLsLebLeLeLsLibLibLeLiLgLibLeLsLebLsLeLsbLib

>ZF Recording 2016-03-18; tW: 300s; Start: 130824; End: 131324;
Recording: 12-1; Individual: 34; Drug: NDMC 1 µM
bReLsbRsbRsbRsRsmbRcLcbLebLebLsLsLsmmbLsLsLsRcmmbRibLgbRebLgLsbLhbRsbL
cbReRsmbRibRebRebReLsLsmbLiRsbRhLsbLgbLsLsmbLcbRcbRebRebRcbRebLibRsbLe
LsLsLsLgLgmmbReRsRsmmbRgbRsRgRgRgbRhRsRsmmbRsRiLsbRgRebRgbRebReRsmbRsL
sbLebRiRiRsRsmmbRgRsRsRsmmmbRsbRsRsRsRsmmmbLobLebLgbLebLcLsRsmbLiLsLsL
sLeLsmmbLiLsbRsRsLsmbRobLeLsLsmbReRcRcReRgRsRimbRgb

>ZF Recording 2016-03-18; tW: 300s; Start: 130824; End: 131324;
Recording: 12-1; Individual: 35; Drug: NDMC 1 µM
bRcRoRcRibLcbLeLebLcLsmbLcRgbReRibLeRsbRsRgbReRiRgRibLoRsbLhbLcLebRcRs
RsmmbRobRcbLcLeLsbLsLoReRsmbRcRsRcRcmbLsLebLobRcbRsRcbRsRsRsRsRsRsRsLe
mmmmmmbLeLsbLebReRoRsRsRgRsRiReRgReReRcRgRemmmbReLsbRebRebLgbLgRjbRcbR
ebReRiReReRgbReRiRsmbRiRsmbRiRgRgbRgRsRsmmbRibRebLgbLeb

>ZF Recording 2016-03-18; tW: 300s; Start: 130824; End: 131324;
Recording: 12-1; Individual: 36; Drug: NDMC 1 µM
bsbsbLsLsLsRsRsRsmmmmbRsRcLsbLcLsRsmbLsLsLsLsLsLsLemmmmmbReRgbRhbsbLob
RobRibLcbLsbRgLsbLcRsbRjbLsbLgLiLsbRhLcbLobRhbLgLsbReRoRoRebRgbRhbRjbR
jbLjbLcbLsbRsbRgRsRjmbRgbLjbRobRcbRcbsbLsbRcbReRsRsRsRsRiLsmmmmbLib

>ZF Recording 2016-03-18; tW: 300s; Start: 130824; End: 131324;
Recording: 12-1; Individual: 37; Drug: NDMC 3 µM
bLobReRsmbRebRsLcbLebRcbRobRoLeLebLebRhbLebRsRsmbRhbLebLcRsbLsLsLsLsLs
LsmmmmmbRebRibRsRsRsRsmmmbRsRgRsRgRiRsRcmmbRsRsRsRsmmmbRsRsmbRsRsmb

>ZF Recording 2016-03-18; tW: 300s; Start: 130824; End: 131324;
Recording: 12-1; Individual: 38; Drug: NDMC 3 µM
bLcRcRsRsReRiRcRsRsRsmmmmmbRsRsRsReLcRsmmbRsbReRgLsbLebLibLsLsLsLgReRs
mmmbRgRsRgRembRsRsLsmbLeLcbLgRebLjbRiRgbLcbLsReRgbRgRsRsRsmmmbRsRsRsRe
mmbReRibRiLsbRcRsmbRgRsmbRgLebLiLsLsmbLsbLsbLsLcRcRebRsbRsReRgbRsRsRsR
sRiRsRsmmmmmbRebRsRgRiRsmbLsRsRsRsReRcRsmmmbLsbLcbRjbRcReRiRsmbLsRsRsR
smmbRebRsRsLsRsRsRgRsmmmbLiLcbLgLsLsmbLsbRcRsmbRsRsRembRsRsmbLsRsbRiLc
LeRcbRsRhbRsReRsmbRsRsRimbLeRsRsmbRsRsRsReReRsmmmbRsRsRsmmbReRsRsLgmmb
LcbLsLsLsLsmmmbLsLsLsLsLsmmmmbLsbRebRgbReRcbLsbLhbLsbLcRcLcbLeLsbLsLeL
oLsLsLsmmmbReRsmbLsLsmbReLiRibRjLeRebRgRsmb

>ZF Recording 2016-03-18; tW: 300s; Start: 130824; End: 131324;
Recording: 12-1; Individual: 39; Drug: NDMC 3 µM
bLiLsLsLsRhmmbRsRsmbReLsbLsbRsbLsbLsbsbRsbLsbRsbRsbsb

>ZF Recording 2016-03-18; tW: 300s; Start: 130824; End: 131324;
Recording: 12-1; Individual: 40; Drug: NDMC 3 µM
bReRsmbLebLebLgLgbLiLsLsLembLeRcRebLcbLiLsLeLeLeLsLsRoLcmbLeLsLgLsbRsb
ReRebRsbLebLcLiLiLgbLsLgLgLebLsLgbLgbLebLeLsLsLsmmbLsLgLsRibRsbLsRcbLe
LeLsbLhLcbLebLcLeLeLhLsbLgLeLebLeRsbLgLsLgLsLgLsLsmbLsLsLembRgbRgbRsbR
gRsRsRgmmbReRsmbRhbRcRsRsRemmbRiRsmbRebRsbLcReRebRsRiLsRsbLeRsbLcbLiLs
LsLsLgLemmbLeLsLoLsLsmmbLgLsLsLsmmbLsLsLsLsLsLsLsLsLsLsLemmmmmmmmmbRsR
sRsRsRsRsmmmmmbReRsRsmmbRsbLsLobLcb

>ZF Recording 2016-03-18; tW: 300s; Start: 130824; End: 131324;
Recording: 12-1; Individual: 41; Drug: NDMC 3 µM
bLgLsRsbLgbLsLsLsLsmmmbLsLsLsLsLsmmmmb

>ZF Recording 2016-03-18; tW: 300s; Start: 130824; End: 131324;
Recording: 12-1; Individual: 42; Drug: NDMC 3 µM
bRsRebRhRsRsmmbRsReLsbLeLebLgLsbRsRsmbRsLebLcRcbLebLebLgbLgbLgbLibLsLs
mbRgbRsLsLsmbRsRsLjmbLebLgLsLsLsmmbLgLsLsLsmmbLsLsLsLsLsmmmmbLsLsLsLsL
sLsmmmmmbLsLsLsLsLsLsmmmmmbLsRgLebRcRsmbRgLibLsLsLsLeRsLsLoLsmmmbLibRe
bLcLiLsbLgLeLsbRsbRhLsbRsbLeLcLoLcbLgLsLsLsmmbLsbLibLgbLsLsLsLsLcmmmbR
ebLeLibLgbLgbRsLsbLsLsLsRgLhmmbRiRsRsLeLoLemmbLgb

>ZF Recording 2016-03-18; tW: 300s; Start: 130824; End: 131324;
Recording: 12-1; Individual: 43; Drug: NDMC 10 µM
bLgLsLsmbLsRsLsbsbLgLgLsLsLsLsmmmbRsbRsLsLsmbLsLsmbsbLsRsRsmbRobRsRsLs
RsLsmbRhRsRgLsmbRobLcLsmbLoLsRsRsmmbLiLsbLobLsbRsbLsbLsLsLjLsLsRsmmmbL
sLsLsLsLsmmmmbLsLebRiRgRgRsmbRgLsbRsRsRsRsmmmbLsRsbLsbLjLiLsRsbRsLhbRg
RsRembRsRsRsmmbLsRsRsRsLsLsmmmbLsbRgRsRsmmbsbRsRsRsRsmmmbRsRsRsRsmmmbR
sRsRsRsRsRsRsmmmmmmbRibLsRsRsmbLsRsRsmbRgRsRgRsmmbReReRcRsmbRsbLsRsbRs
bLsLsLsmmbLsbLsbRsRsLsmbsbsbLeLsLsmbLsRsRsmbLeLsbsbLgbLibRsRsRsLsLcLgR
sLcmmbRibLcLsLhRsRoRsRommbRcRcLsLsmbRsLsbRsLsRsbRiRsRsLsLsmmmbRsLsbLsL
smbRgRsRimbRsReRobsbsbLsLsmbLcLsmbLsbLsRsbLeLsbLibLsLsLsLsLsmmmmbLsLsR
sLsLsLsmmmbRsbRsbLiLsbLsLsLoLcmbLsLsRsmbsbsbsbsbsbLsLsmbsbRsbLsLsmbRsb
sbLebRoLsbRsbLeReRibsbRsRsRsRsRsRgRsReRcLsmmmmmbRcbRsbRsbRsLsbLsLsmbsb
LgbLibRoLsbReRsmbRsReReLsbRsbRgbLsbLjbRebRsRsmbsbLcLsLsmmbLsLebRcbRoLs
bRsLsbRcbReRsRsmmbRgRsRimbRsRsRsmmbRgLsLsmbRsbLsLsmbLsbLsbRsRsmbLgLsLg
LsLsLsLsLsmmmmbLsLoLobLcLsmbLsLsLsLsmmmbLsLsmbRsbRibRgbLsb

>ZF Recording 2016-03-18; tW: 300s; Start: 130824; End: 131324;
Recording: 12-1; Individual: 44; Drug: NDMC 10 µM
bRibLeLebRsbRsRgRebRcbRebRcbRgRsmbRibLeLsLcbRcLcbLgbLgbLebLibRsbRsRsmb
RebRebLgbLgLsbLgbLhLsRjbLsbLhRebLsbRjbRiRsRhLembLgLsLebLibRebLsbRhbLeb
LebLibLobLebLeLeLebLebRcLebLiLsbLgLebRgRsmbRsRsmbRcbLebLsLsmbRsLsLsLeL
smbRsRsmbLibRgbReRiRcRibLsbRsbLebLebRebRsbLgbLobLeRsbLebLebLcLsmbLsLsL
sLsLsmmmmbLsLsmbLebRoLcbLgLsLgLsbLsRobRsbRgbLhLgRsbRsbRibLibRhRsmbsbRe
bLsLsRcRsmmbRhbRsLsbLjbRsbRebRsLsbRsRsmbLsbRsbLcLobLsLsmbLsbLsbLiRgbRs
bLsbLjLsmbRcb

>ZF Recording 2016-03-18; tW: 300s; Start: 130824; End: 131324;
Recording: 12-1; Individual: 45; Drug: NDMC 10 µM
bLebLgLgLeRsRsmbLebLeLcRsLsbRebRcRcRjReLiRsbRsbRsbLsRsbRsRsRsmmbRsbRiR
sLsmbLibRebRoRsmbRebRcbRgRsLsmbRgLoLoLoRsbLeLoRsRsmbReRgbRsRsmbRibLcRc
RibRgbLhLobLeRgbRsRgRsRsRgmmbReRibRsLgbRebLcbLgbRsbRhbRsRcbRcRsmbRsReb
RcbRiRsmbRsbRgbLobLcLebLcbLebLhRjbRgbRsReLeRcRibLebLsLcbLiLsLcLsmbLeLo
LsmbLebLebLgbLcRsbRebRsbRibRgRgLcLobLsLsLeLembLiLsbLebReReRsmbLsRibLjb
RsLcbRsRiRsmbRsRgbRsRgRsRsLemmb

>ZF Recording 2016-03-18; tW: 300s; Start: 130824; End: 131324;
Recording: 12-1; Individual: 46; Drug: NDMC 10 µM
bLcLsLembLebLiLsLgbLgbRcRhbReRsmbRsbLjbLcbReRebLsbLobRebRsRsmbLcbRcbRi
LcbRcbLibRebLgRsbLsLsLsLeRemmbLgRebLcLeLsbLibRcLcbRobRgbRebRsRgRgRiRsm
bRsReb

>ZF Recording 2016-03-18; tW: 300s; Start: 130824; End: 131324;
Recording: 12-1; Individual: 47; Drug: NDMC 10 µM
bLgLsLcbReLobReRgRiRebRcbLsLsLsLsmmmbLsRsbRjbRcLebRgbLsbReRsRcLsmbRiRe
RsmbLebLcLsRembRgbRebRebReRebReRsmbRsRgRibLobLgLgLeRgbRsRgRiRsRgRsmmbL
sRebLgbLsLsLgLsLcmbLcbRcbRcRsmbRsRebLsbRcbLebReRsmbRsRiRsRsmmbRsRibRsR
gRsRsRsmmmbRebLcLsmbLebLebLebLgRebRhRsLsmbRobLsbRsbRsLsRsbRsbLsb

>ZF Recording 2016-03-18; tW: 300s; Start: 130824; End: 131324;
Recording: 12-1; Individual: 48; Drug: NDMC 10 µM
bLsLsLsRiRommbReRsmbRsRsRsRsmmmbsbRsRsLsLsmmbLcLoLcLibRsbLeLoLcLcRsbLh
LgbLiLebLsbRgRgReLsLcLsmbLsLsLsLsRsmmmbLsbLiLeLsLcLcLsmbLsLsmbRsLsLsLs
LsRsmmmbLgLgLeLcbLeLcLsmbLsbReRoRobLjbLsRsbRibLeLsbReLsLsRoRoLsmbRoLsb
RsRsRsLsRsLsmmbRsbLsRsbsbRsRgRsRsRgmmbLgRsReLcLcbLgLiLgLcRoRsmbRgLsbLi
LsbLgLsLsmbRsRsLsLsLsLsLsLeLommmmmbLgbRgbLcbRgbReRsmbRoLibRiRsmbRebReb
RgReLsRoRobRsRsRsRsmmmbRcLoLcLcbLibLebRhRsmbRiRgbLeLsbLeLcbLcLsLcLsmmb
LiRsbLcRgbRsbRgbRsRebLcbLebLhbLeLsLcbReRebLebRiRsRcLsmbRsbRibRobRgbRsL
sRsRsRgmbRebLjLsLsLemmbLcLibLgLsLsLsLsRommmbRhbRsRsRsRsmmmbRibRsbLeLsL
eLsLsLsmmbLebLgLsbRsRjRibReRhbRebRib

>ZF Recording 2016-03-18; tW: 300s; Start: 131327; End: 131827;
Recording: 13-1; Individual: 1; Drug: Control
bLgLsLiRsbLiLsbLcbLibLgLsLsmbRsbRsRsReRsmmbRsRcLsbLgLsLsLsLsLsmmmmbLsb
LgbLebLgbRobLcbLibLebLibLgbRsRsmbReRsmbRsRgRsmbRgbLebLgbLeLsLgbLhbLsLi
bLsLibLhbLgbLcLibLebLibLgbLiLsbLiLsbLebLebLebLibLebLhbLiLsbLeLsb

>ZF Recording 2016-03-18; tW: 300s; Start: 131327; End: 131827;
Recording: 13-1; Individual: 2; Drug: Control
bReRsRsReReReRgRgRsmmmbRsbRgRsRsmmbLebRcbRiRiRebLcRcRebRibLsbRcbRcbLeb
LcbLebLhbLeLgLsLebLeRsRsRsmmbLcbReLsLsLsmmbRibRsRsmbLcRebReLibLsLsLsLs
LeLsLgmmmbRiRhbRebLebRebLeLcbLebLgbLebLcbLeLsLcbLgbLebRobRcRsRgRsmmbLe
bLebRgRgbRsbRebLsLebLsbRibRsRgRgbLeLeRsbLeb

>ZF Recording 2016-03-18; tW: 300s; Start: 131327; End: 131827;
Recording: 13-1; Individual: 3; Drug: Control
bLsLebLsLsmbLsLsmbLebLsbLsReReLiLsbLsLebLeLsbLsLsLsLemmbLcLcbLsbLsLsLs
LiLsmmbRebRebLcLsLcLgLsmbLcLsmbLsLeLsbLeLebLsbRsLsbLobLsLebRsLoLibRebL
cbRebLsLiLgLgLibRgbRebRebRsRsmbRsbRgbRsRsRsRsLeLsmmmbRsLsLeRsRoRsmbRsR
smbRsbRiRhRibRgb

>ZF Recording 2016-03-18; tW: 300s; Start: 131327; End: 131827;
Recording: 13-1; Individual: 4; Drug: Control
bRcRsReRsLsLsmmmbRcRsmbRgRgRebLsRsRsRsmmbLsRsbRcLsbRcLsbRgRgbRsRsmbRiL
sbReRsRcLgmbLsbLhLsLcbRebRsRcbLcbsbLsLgLsLcbLebRsLsLsLsLsLsLsmmmmmbLsL
smbLoRsbRsRsRsRsmmmbLgLsLsLsLsmmmbLebLcLsLsmmbRcbRsRsRcLsRimbReLsLsLsL
smmmbLeLsRgLsbRsRsmbRhbsbLsLsRsmb

>ZF Recording 2016-03-18; tW: 300s; Start: 131327; End: 131827;
Recording: 13-1; Individual: 5; Drug: Control
bRibRsRcbRebRebRgRcbRebRebRsRibLsLiLeLsLsmbRsLcRebReRgbLcbRgbReLsbRiRs
mbLsbLcbLcbLebLibLebRebRhbRebLgRebRcbReRsmbRgbRebRhbRebRgRgbRgbRsLsRib
RibRgbRiRsmbRebRgbRcbLebLibLsLebLjbLeLgLebLgRsLgLsbLibRsbLsbLhbLebLhLs
bLgbLcbLebLiLebLeLebLsLsLimb

>ZF Recording 2016-03-18; tW: 300s; Start: 131327; End: 131827;
Recording: 13-1; Individual: 6; Drug: Control
bLcbReRgRiRibRgRsRgRcmbReRsmbRibLeLsRsbRsLiRsRsRcRsmmbRiRgbRsReLoLsLsm
mbLebRiRsmbLsRsRsReRsRsmmmbLiRsbLcbRebLsLebLibLeLcRsbRsbLoRoRgbRebRebL
ebLcbLebLebLebLgLsbLgLsLgLgbLgRsbLgLsLebLcRsRsRimbRsLsb

>ZF Recording 2016-03-18; tW: 300s; Start: 131327; End: 131827;
Recording: 13-1; Individual: 7; Drug: NDMC 1 µM
bRiRsmbLebLsbRiRsRsRsRemmmbLsbRjRjRcLobLebLsLoLoLsmbLeLsbLeRoReRsRgRiR
iRsRsRsRiRsRsRsRsRhmmmmmmmmbRsRsRembRsRgRiRgbRsRgRsmbRibLsRsbRhLsRsbRs
RsmbRsRsmbRsbRsRsRsmmbRcRiLebLcRsbLibLebsbLobRebRcbRgRgbRhRebRebRiRiRs
mbRebRebRiRebRiRsRcRsRiRsRhRsRgRsRsRsmmmmmmmbReRsRsRsRsRiRsRsReLsRhRsR
smmmmmmmmbRgRsmbRsRsmbLsLsmbRsRsRsmmbRgRsRsRsRgRsRgRsRsRiRsmmmmmmmbRsR
sRiRgRsmmbReLsRsbRgbRsRsRsRsRhmmmbReRgRsRsmmbRsRiRsmbRsRibRsLsRsRsReRs
RgRsmmmbLsLsLsmmbLsLsLsLgmmbLiLobRsbLcbRsRebRcRsmbLiLsLebLsLebLeLeRgRg
bRgRcLsRsbRsRsRsRemmbRsRsRsRsRgRemmmbRiRsmbRsRsRgmbRgbLjLjReRsmbRiRgRg
bRsRsRsRemmbRsRgbRsRgRsmbRebLcLcbRsbLgbLeLibRebRsRsRembRsRsRembRsRiLsb
LcbRebLebLebRgbRebRebLebRgbLgbLeLebLsbLebLebRjRgbRebRebRsbRebRebLjLebL
ebLebLsLeLcRsbLgLebLebLsLsmbLsbRcRebRibLsb

>ZF Recording 2016-03-18; tW: 300s; Start: 131327; End: 131827;
Recording: 13-1; Individual: 8; Drug: NDMC 1 µM
bRebRibRibRcbRcbRebRebRebLhbLebRsbLcLsLsLsmmmbLsLeLsbLsLsLsmmbRsLgRcbL
gLebLebLebLebLgLsLsLsLsLeLsmmmbLiLsLsmbLsLebRoLsLgLiLsLibLsRsbLgLgbLsL
gLsLsmbRebRoRsmbRsRsmbRcRcbRibRgRsmbRobLcbRcbRsbLiRsbLebLsLebReReRgRsR
smmbReRgbReRsRsRsRgRsmmmmbRebRgRgRsRsmmbReRsRsReRgmmbReRiRsRsmmbReRebR
eRsmbRgReRsmbRgRsRsRsRemmmbRiRsReRembRsReRsmbRebLeLsbRsLeLeLeLsb

>ZF Recording 2016-03-18; tW: 300s; Start: 131327; End: 131827;
Recording: 13-1; Individual: 9; Drug: NDMC 1 µM
bRsbRjReReRgbLsRsLsbLhReRsRsmmbReRcbLcRsRsmbLhLiLobRsbLjLeRsbRebRsRsmb
RgRgRebRgbRsRsRsRsRsRsRsRsRsRsRsRsmmmmmmmmmmmbLibRsRsRcRcRsmmbRcbLsLsL
smmbLebLeLsLsmbRgbLcLebLsLeLgLsLsLgLsReRsRsRsRiRsmmmmmbLsLsRimbLsRsRsL
sRsRsRgRsRsRsLsRsmmmmmbRgbRcLeLsbLibRcbLjLobLcbRcbLebLsRcReReRsmbRebRg
RebLeRgLsbLsLsmbReRcRsRgmbLsRsRsmbLcLgLsbLebLsLsmbRcbRoRsmbLsLsmbLeRsb
RsbRsRsmbLsLsmbLsRsbReRsmbLsRsRsRsRgRsRsmmmmbRsRsRsRsmmmbLcbLsRsRsRsLs
mmbRcRcb

>ZF Recording 2016-03-18; tW: 300s; Start: 131327; End: 131827;
Recording: 13-1; Individual: 10; Drug: NDMC 1 µM
bLibLeLebLebLebLhbLeLsbLeLebLeLiLcbRiRsmbRiRsmbReLcbRebRebRhbRgbRgLsLe
bLebRgbRsRsmbRibRsRgbRibRcLsLsmbLcbRcbRsRsmbRsRsLsmbRebRcbLgbLibLgbLcb
LeLebLebRoLcLebRibReLibReRsRgmbRiRibRgRsmbRgRsmbRgbRebRgbRsLsbRgbLebLe
bLeLsbLeLsbLib

>ZF Recording 2016-03-18; tW: 300s; Start: 131327; End: 131827;
Recording: 13-1; Individual: 11; Drug: NDMC 1 µM
bRebLoRcRoRsRsmmbLsbRcLeLcbLgRsLcbLeRsRsmbLiLsRebLcbRhRebRgRsRcRcRembR
sRebRcbReRgRcbLsLsmbLsbLiRebReRcLcLsmbLebLgLsRsLsLeRsbRsRsRcmbRgLsbReR
obReRsRoLsLoLsmmbLcLiRsbRibRebRoRsRcmbReLsbLiLsRsLsbLiLsRsLsbRgbReRsmb
RcRcRsRcmbRsRsReLsmbRhRoLsbRcRsRsRgRsReLsmmmbRhRcRcbReLcRsbLhLcLsLimbL
sRsLebLsLobLsRsRsRsLeLsmmbLsLsmbRsRjbLcbLsLsRsRsRsRsmmmmbRjRsRsReRcLcL
cmmbRcbRgRgRcLsbLsLsmbsbReLsLiLsLsLgLcRsLsLeLsLsmmbLsLsRsLsmbRcRsLembL
ebLsLsLsLsLcmmmbLhbRgRsRgRcmbRcRoRsRcRcmbRsRsRsLsRsmmbRsRsRsmmbReLiRsb
LsLeRgRsRsRgmmbLiLsLiLsLsLsLcmmbRobRsReb

>ZF Recording 2016-03-18; tW: 300s; Start: 131327; End: 131827;
Recording: 13-1; Individual: 12; Drug: NDMC 1 µM
bLsRsRsRsmmbLsbRsbsbRsRsRsmmbRsRebLebLgbLcLsmbLsLsmbLsLsLsmmbLsLsmbLsb
LsbLebRebRsbReLsbRiRgbLebRsLsLeLsLsmbLhbRjbRsRsRsmmbRsRsRsmmbRsRsLsmbL
gbRibRsbLeLsbLsLsLsRjmmbRgbRsLjbRoLeLsbLgLgLiRsbLhbLgLsRsbRebRcbRgbRgR
smbsbsbsbReRsmbRgRsLsmbRsbLcbsbRgbRsbRsLgLsLsLsmmbRsLsbLgLsbRsLgLjbLgR
sbRgbLobRsbsbLsRsRsLsmbLcbRgRcRsmbRsRsRsRsRsmmmmbRsbLgbLcbLhbLsbRcbRiR
sRsmmbLcbLsbRebRsRsRsRsmmmbsbRsRsRsRsmmmbRebRcRsmbRsRsRgmbRsbRsbRsRsmb
RgbsbsbRebRebReRsmbRibRsbRsRebRsRsmbRsRsLsRsmbRebReRsmbRcbRcbRsbLebReR
gbRgbRsLcbLoLsmbLgLsLgbLibLebLgLsLsLembLeLsLsLsLsLsmmmmbLsLsLsLsLsLsmm
mmmbLsbLebLsLgLeLsbRsLsLsLsLeLsmmbLiLibLsLsLsmmbLsLsLsmmbLsLebRebRsbRs
RsRsmmbRsbRsbRsbLsbRgbRsbRgbRibLebLsbRjbReRsRsmmbRsRsRsRsmmmbLsbLeLcbL
ebsbLsbLgLgbLsbLeLsbLibLsLeLsbLsbRcbLsLebRsbsbsbRsbRcRsRsmmbRgRsmbRebR
gbRgRsRsmmbRibReRsmbRsRsRsRsmmmbRsbRsLsbLsLsRsmbLebsbRsbLgbRsLiLsbsbLs
bLsLebLgLsbLiLsbLgLsbLgbLgbLgbLsbLsbLebLgbLsLsLimbLgLsbLsbLsLsmbLgLsbL
gLsbRsLsbLsLsLsLsLsmmmmbReLsbLcbRebRebRsRsmbRsbLsRsLsbRebRebRgbRgRsRsm
mbRsRsRsmmbsbRsLsbLsbsbsbsbsbLsRsLsLsmbRhbLgbLsbLiLsbsbRsLsbLgLgbLebLe
LsbLiLsLsLembLebLsLsmbLibLsLgLcbLsbsbRsRsmbRsbRsbsbLgLibRsbLsLeLsRsbLg
LsbLsbLebLgbLeLsLsmbRsLsLsmbsbLsLsmbRgbLeLsbLebLsLsLgmbLsb

>ZF Recording 2016-03-18; tW: 300s; Start: 131327; End: 131827;
Recording: 13-1; Individual: 13; Drug: NDMC 3 µM
bLsRsRcbRcLgbRgbLibLsbRjbLsbLsLsmbLsLsLsLeLemmbRjbLebLsLsLeLeLhLembLsL
sLembLcLgLeLsbLeLsLsLembLsbLebRiRsmbRgLsbRsbLcbRsbRibLsLsLsLcmmbLsbRcb
RebRhbRgbRsbLebLebLebLeLsbsbLebLibRgbRebLcbRjbLsbRoLebLcbLcRsRgbLeRgbR
sReRgRebLcLsmbLgRebRhLsbLsLgLsLsLimbLsbRcbRebRebLebLsLsmbRsLebRebRebLs
bRsRsRsmmbRebLebLcbLibLcbLeRcbLgbRebLibLgbLgLsbLgLeLsLjbLsbRcbRsRsmbRg
RsRcmbRcbRgRsmbRiRsRsRgRgRemmbRsRsRsRsRsRsReRhRsRsReRhmmmmmmmbRebRgRsR
eRcRgmb

>ZF Recording 2016-03-18; tW: 300s; Start: 131327; End: 131827;
Recording: 13-1; Individual: 14; Drug: NDMC 3 µM
bLjbLoRsRoRsmbRcRsRgmbLoLeRoLcLebLeLsbLeRsRsRembLgRgbLsRebRcbRgbRibLcb
LsbLebRsRsRgRsmmbRsRsmbLeLsbLsLsmbLebRgbRoRsmbReRibRgbLsbLhLoRsRsLsLsm
mbLcb

>ZF Recording 2016-03-18; tW: 300s; Start: 131327; End: 131827;
Recording: 13-1; Individual: 15; Drug: NDMC 3 µM
bRobLcRsbRgbRebRiRsmbRgbLiLebLebRsRgbLgbLebReLcLebLsbLsbsbLsbRiRibReRc
RcRsmbLsbLsbLsbRebLebRcbRgRsmbRsbLoLsmbLebRgbLgLsbRsRsRsmmbLsbsbsbRsbs
bLiLsbsbsbLeRobRebRhRsLsmbRibRsbLcLsmbRebRoReRcbRgRgbRsbRebRobRsRsmbRs
RsRsRemmbLsRsRsmbRgReLsbLgbLjb

>ZF Recording 2016-03-18; tW: 300s; Start: 131327; End: 131827;
Recording: 13-1; Individual: 16; Drug: NDMC 3 µM
bReRsRcmbRsRsRcmbRebLoRsRsmbLgbRgRsmbRebRobLsbRcRcbRhRobRiRsmbRsRsLsmb
RebLsLsLgmbLsLiReLsLeLgbLsRsRsmbLcbLcLsLsmmbRsbLjReRcRsmbLebLsLiReRsmb
RoRsRsmmbRgbLcbRcbLsLgLsbLjbRcbRcbRgLsLsmbRebRcbRgbRsbLjbLebRebRebRiLe
bLgRsbLsbLhRjbRcbReLoLibLgbLsLsLsRsLsLsmmmbRsLsLsmbLsbLgbLsLsmbLsbLgRs
RsLsmbLsRsbLgLgbLsRsLsbReRebLsbReRcLobLiLsLsmbLgLsbLsbRgbRoLibLsb

>ZF Recording 2016-03-18; tW: 300s; Start: 131327; End: 131827;
Recording: 13-1; Individual: 17; Drug: NDMC 3 µM
bRsbLcbRoRsmbRebRebReRoLsbLcbLibLcRcLsRsbRcRsRcRsmmbRiRsRcmbRcRsmbRebR
sReLsbLsbLebRcbRiRsRsRsmmmbRcLsLibsbLsbLcbLhLsbsbLsRsbLcLcLcbLcbLsLsLs
mmbLsLsLsRsmmbRsLsbLgLsLsmbRcRhRcLsbRebRhRsRsmmbRiRsRsRiLsLsmmmbLsLsmb
LobLcbRgbLhLsLobRiRsmbRgbRebLebRebRebRsRebLgbLebLgbLgbLebLgbLebLebLgbL
sbLiLsLsLsmmbLjbLebReRsmbRhbRibRebLgbRibRebLcbLebLgbLgLcbRoRebReLsbRcb
RsbRebRebLsbLeLcbLibLiLobLeLsbLiLsbLeLsbLcLeLebLiLsReb

>ZF Recording 2016-03-18; tW: 300s; Start: 131327; End: 131827;
Recording: 13-1; Individual: 18; Drug: NDMC 3 µM
bRgRsRgmbRgRsmbLebLebLeRebRsbRsRsRsmmbRsRsRsRsRsmmmmbRibLibLcbLebRebRs
bLsbRibRsRiLcbRgbLeLcbLeLsbLeLsLobRebLibLgbReLsbRgbLcbRgRsmbLeRcRsmbRg
RsmbReRcbReRsRsRsRsRsRgRgmmmmmbRoRcbRiRsRsRsRgRemmmbReRibRgbRgRsRsRsmm
mbLcLsmbLebLgLebLebLcbLiLgbLeLsbLebLhbLebRebLobRgRsRsRgRiRsRsRommmmbRi
RgbLsRsRsRgReRomb

>ZF Recording 2016-03-18; tW: 300s; Start: 131327; End: 131827;
Recording: 13-1; Individual: 19; Drug: NDMC 10 µM
bRcRebLobRebLsbRsRcLgRebRebLobRibLiRebRiLsLsmbLobRsbRcbRcbRgbReRebRebR
ebRcbRebRgbLeLgbLebLgLsLiLgbLsb

>ZF Recording 2016-03-18; tW: 300s; Start: 131327; End: 131827;
Recording: 13-1; Individual: 20; Drug: NDMC 10 µM
bRebRcRebRsRebRgRsmbRsbRsRsRembRibLiLsbRebRgRgRsmbRebRsRsRsRsRemmmbLeb
LsLibLhLsbLgLsbRgRebRgRiRsmbRsRsRsRemmbRsRsRsRsmmmbLgbLgLhbLsLsLsmmbRh
bLeLsLsmbLsLsLsRsRsmmmbLsLsRsLsLhmbLgLsbRsRsmbLsbsbRsbRsbRsbLsRsbRsbRi
RsRsRsmmmbRcLoLibLgLsLsRsmbLsbLcLsmbRsRsmbLsbLiLsbReRsmbLebLgbLsLsmbLs
RsLcbLcRsbLcLsmbLeLgLsbLebLebLsLeLhbLsLeLebLiLhbLsbRcRgbRebRhbRebLhLsb
LsLsRcmbRebRsRsmbLsReRobRoRsRsRgmmbRgReLibReRgbRebRsReRebRsReRsmbRebRe
bRsRcbLgReRsReRgLsmbRcbLeRcRebRsRebLeRibLoRsbRsbRiRsLhmbLcLobLsRiRcbRs
RsmbReRsmbLeLgbLiLibRhbLsbLgLcLcLsmbLeLoRsbLebRgRsmbRgb

>ZF Recording 2016-03-18; tW: 300s; Start: 131327; End: 131827;
Recording: 13-1; Individual: 21; Drug: NDMC 10 µM
bLeRcRsmbLoLsmbLobLoLiRsbLeLgbRsRsLsRsmbRobLebLebLcLsLsmmbLibLhLhbLebL
ebLebLeLsLibLebLsbLsLsLsmmbRiRgRsRsRiRsRsRgmmmmbRsRsRsRsRgRsRimmmmbRgb
RsbLsRsbRsRsRsRsRsmmmmbLsLsmbLsbRiLsbRibRsRibRsRiRsmbRgbRgbRhbRsbRgbRs
RibRsLsRsRsLsmbRibRgbLcbRcLsLobRebLsbRsbLsbLsbLcbLebLeRgbLobReRgbRgReb
RsRsRsRsmmmbRebRsbRibRgbRsbRsbRiRsReRsRsmmmbRsRsmbRiRsRsmmbRibRebRgRsm
bRgRsRsmmbReRsRsmmbRiRsRsRsRsmmmmbRsReb

>ZF Recording 2016-03-18; tW: 300s; Start: 131327; End: 131827;
Recording: 13-1; Individual: 22; Drug: NDMC 10 µM
bRgReLcbRsbRebsbLebRsRsLsmbLsLiRsRebLjLeLsbRebRjLiLsbReRgbRiRcbRsRsRsR
sRsmmmmbLeLjbLsLsRsmbRebLebRebLebRcLoLsmbLiLsLsmbLeRsbReRsmbRsRsRsRgLe
LsmmbRsLgbLeLsRsbLgbReLgRsbLcbReLcLebLsLsmbReLsbRcbRsLcLsLsLsmmmbRsbRc
bLgRsLsbsbLcRebReRsReRsmmbLsRsRsmbLjbLcbLsbLebLibRibReRsmbRgLgLcbRcRsm
bRsRsmbLebLiLsbsbsbsbsbsbsbRsbLsbReLebLebRjbRhRsLsmbRcbReLcLsLsmmb

>ZF Recording 2016-03-18; tW: 300s; Start: 131327; End: 131827;
Recording: 13-1; Individual: 23; Drug: NDMC 10 µM
bLebRebsbRsLsbRcbRsLsRsRsRsRsmmmbRebLsbLsLibLsLsLsmmbLsLgbLsbLsLsmbLiL
sLebLsLsLsLsLsLiLhRsmmmmbLsLeLsLiLsbLsRsbLgLebLsLsLsmmbLsLibRcRcRcbLiL
gbRcbRsRsRsRsRsmmmmbRsReRcbRsRebRsRsmbReRsRsmmbLjbLebLeLsbRsLsbLeLibLs
LgbRjRjRcRsmbRebLsRsRsRcmbRgbLcbRcRsmbsbRsRsmbRsbReRsmbRsbLibLsLsRgmbL
sRsRsReRsmmbRsRebsbLeLsbLiLiLsbRsLeLebLsLebLebRcbRsRsRsmmbLiRebReRcbRi
bRgLeLsbReRsRsmmbRsReRsmbRsbReRsRsmmbRebRsRebRsbRebLjbLsRcRcbRcRsmbRgR
ebRsRsLeLsmbLgLsbLsLsmbLeLiRsbRcbRcbRsRsLsRsRombRsRsmbLeRsbRcRsmbRebLs
bRcbRgRebRsRsRembRebRsRsmbLebRsLcbRcRcbRsRebRsRsRembRebLjbReRsReRsmmbR
sbRebReLgbLebRcbRsRsRsReRsRsmmmmbRsRsRsmmbRsRsRsRsRsmmmmbLcLebLiLebLsL
sLsmmbRcRoLibLgLsbLsLsmbLibRcRsmbRcRcRsmbRsRsRsRsRsLsmmmmbLjLiLsRsbLeb
LsLcbLsLiLebLebLsLsLsLsReRsRsmmmmmbRebRsbReRcRsmbRgRsRiRsRsmmmbRsRsmbR
sRsmbLsRsRsRsRsmmmb

>ZF Recording 2016-03-18; tW: 300s; Start: 131327; End: 131827;
Recording: 13-1; Individual: 24; Drug: NDMC 10 µM
bLeLsbsbRsRsLsmbRcbLebRsRgRgbRebLsbLgbLebLebLcbLeLsLibLibLeRsbLjbLgbRg
RsmbRobRsbRsbLjLsLsmmbLcbRsbRibLebLcbLcLsmbLsLebLcbLsLsLgmbLcbLsbLiRcR
sRgRgmbRebRibLcbRsbLobLebLsLsLimbLebRgbRgbRsRsReRsLiLsRsmmbLebLsbLoLsm
bLiLebLiLsbLebLcbLsLsLgLsmbLsLgbRsLcbLcbLsRsbLebRsRsmbLcbLsbLsbsbLsLsm
bLgbLoLcbLeLcbLsLib

>ZF Recording 2016-03-18; tW: 300s; Start: 131327; End: 131827;
Recording: 13-1; Individual: 25; Drug: Control
bRsRsRsRsmmmbRsRsmbRiRsLjmbLcRsRsmbLjLeRsbLsLgbRcRsRsmmbLsLsLgLsmbRcbL
sbRcbRsReLsbLiLsLsLsmmbLsLsLsLgLgLeLsmmbLsLeLcbLsLiRobRgbRsRsmbRsRsLeL
sLiLsmbLgbLgLsLebRjbRcLeLeLgLsbLsbLebLiLsLsLimbLgbLgLiLebLgLibLgLebLsL
gLsbLsLsLsLsLgLeLsLsmmmmbLebLeRsbRsbRsRsRsRgRemmbReRsmbLsbLsbRsbLsLsmb
RsRsRsLsRsRgRsRhmmmbLsRsRobLsRsbRsReRsmbRsRsRsRsmmmbLcLsLsRsmmbLiLebRo
bLgbLeLsbRgRsmbLebReRibLsRsRsRsmmbRsRsRsRsRsmmmmbRsRsRsRsRsRsRsRsmmmmm
mmbLsRsbRsRsRgRsmmbLebRgbRcRsmbRibRsRsRiRgRsmmbLsRsRsRgRsRgmmbRebLoRcR
gbRgRsRsLemmbRgRsRsRsRsRsRsmmmmmmbRebRsRsRsRsRsmmmmbLsLsLsLsmmmbLsLeLg
bLsLiLebRgReRsmbLsRsLsLcbLsLsLsLcmmbLeRsRsmbLsRsLsRgRgbRsRsRsRsRsRsmmm
mmbRsRsReRiRsmmbRsReRcb

>ZF Recording 2016-03-18; tW: 300s; Start: 131327; End: 131827;
Recording: 13-1; Individual: 26; Drug: Control
bLeLcbRsbLgbLobLcbLsbReRsmbRgbRebRebRjbLebRgbLebRebReRgbRebRiRsmbRebRe
bRebRsRsmbLebLgLsbRebRgRibRhbRcLsbLgLsLsLgmbLsLsLsmmbRjbRgbLebLcbLsRsb
RsbLobLgLcbLcLsRombRcRebReRsmbRebReb

>ZF Recording 2016-03-18; tW: 300s; Start: 131327; End: 131827;
Recording: 13-1; Individual: 27; Drug: Control
bLebRcRsRsmmbRsRsmbRsRgbRsRgRsRsmmbLsLsRsLsmbLebRebRebLeLeLhbLgLsLsLsL
smmmbLcRcRibLsRgRsRgRembLsLcLsLcmbRebLsbLsLsLsmmbLsLsLsmmbLsLebRebLsRs
LsbLeLgLgbLgRsLsbLcLobLcLsLsLsLsRemmmmbRjLsbLsRebRjbRebLsLsmbLsLsLsLsL
sLsLsLsLsLsRemmmmmmmmmbRsb

>ZF Recording 2016-03-18; tW: 300s; Start: 131327; End: 131827;
Recording: 13-1; Individual: 28; Drug: Control
bLebRebRhbLibRhLsbRsRsmbRebLcbLeLsLsmbLgLsbLebLsbRcLgLsbRoLsbLgLebRgRs
mbRgReRsmbRgRsRsRsmmmbLoRsbLebLeLeLsbLebLsbLgbLcRiLibRiRsmbRebReRsmbRg
bRebRjbRibRiRgbRgbRjbRebLibLcbRjLibLebLsRsLsbLsbLcbRgbRiRsmbRebLgLsLsL
iLsmbLebLsLsLhLsmbLcRcRsmbRibRibRibRgReRsmbRsRsRsLgmmbLebLeRsbLeRsbLeb
LhLsbLeLeLebLeRsbLebLcLsmbLeRsbLiLgb

>ZF Recording 2016-03-18; tW: 300s; Start: 131327; End: 131827;
Recording: 13-1; Individual: 29; Drug: Control
bRcbRebLobRcbLiLgLgLsLsLeLeReRembRsRsRsRsRsmmmmbRebRebRsbLibLgbLebLhbR
sLcbRobLgbLgbRebLoLgbLgLsLibLcRsbLcbRebRcbRcRsmbLjbLebLcbRgbLobLhbLgLs
LebLgbRiRiRebLhbLsRcbRibLcbRebRsReReRsRsRsRiLommmbRcLeLsLgRebLoLgLgLgL
cLsLsLsmmmb

>ZF Recording 2016-03-18; tW: 300s; Start: 131327; End: 131827;
Recording: 13-1; Individual: 30; Drug: Control
bLcbRebRsRsReLsmbLcbLiLgLiRsbLgbLsLsLsLgLsLsLsLemmmmbLeLsbLcLgbReLebLe
bLgLgLebRsbRgRsRgRsmmbRsRsRsReRsmmmbRgRsRgRombRoLeLcbLgRibRcRsmbsbRibL
ebRhRsRsLcLsmmmbLibLgbLobLsbRebRgbLibLebLebLcbLcbLcbLeLsbRobLeLiLebsbL
sbLgLeLsLsLembRjbReRsmbLsbLebLebLgLsbLobRgRsRembLsLsLcLcmbLhLsLsmbLhbL
ebRhRjbRiRsmbRgRgRgbRoRobRobLebLebLsLsLsLsLsLgmmmmbLgbLcbLgbLiLsRgbLiL
sLsmbLibRsbLiLeLsbLhbLsLsmbRsRsRgmbRebRobRgbLcbLcLsLeLhLembLebRcbRgbLe
LsLsmbLeLiLsLebLjbLgbLsbLsLhbRebRsReRhbRebReRiRcbRcRcRgbLibLeLsbRsRsmb
LsbRcbLeLgbLgbLgLsLeLsLgLibLsbRgLsbLebLgLsbLgbLhbLebLibRhLeRibRgbReRgL
ebReRsRsmmbRgbReRsmbRebLcLsLsmmbLebLsLiLsLebRgLcLsmbLsbRobRibLgbLsLebL
sLeLsbLsLsLsLsmmmbLhbRcRsmbLsb

>ZF Recording 2016-03-18; tW: 300s; Start: 131327; End: 131827;
Recording: 13-1; Individual: 31; Drug: NDMC 1 µM
bLgLobLhbReLsLsLsmmbRsRsmbRhRsReRembRcRgbReRsRgRcLsmbReRsRiRsRsmmmbRsR
ibsbsbRgRsRsRsRsRsRsmmmmmmbRcbLiLsbLsLgLgLgbLsLsLsLsLemmmbLsbLgbLsLcbL
ibLebLgbLebLebLebLiLsLebLebLhbRgbRsRsRsLsmmbRgRibRsb

>ZF Recording 2016-03-18; tW: 300s; Start: 131327; End: 131827;
Recording: 13-1; Individual: 32; Drug: NDMC 1 µM
bLgLeLhLsbLgLebRsLsLsLembRsbLsLebLhLsbLeLsbLebLgLebLebLcbLcLsmbLsLeRgb
LsbRibLebLebLgbLjbRebRgbRgbRgbRobLgbRsbLcLhbLebRsbLebLebLsbLcbLebRebRo
bRjbRibLjbLibRsRebRibLoRsRsmbRibRgRiRsmbLjbRcbLeRsbRsLsLsmbRebsbRhRgRs
mbLgbRebReRebRibReRebReRsmbLsbLebLgLibLhbLebLgbLsLcbLgLeLsbRsLiLeLsLsm
bLgLsbLiLebLsLsmbLiLibLsLsLsLsLsLsmmmmmbLebRiLeLcLsRombRebRsRob

>ZF Recording 2016-03-18; tW: 300s; Start: 131327; End: 131827;
Recording: 13-1; Individual: 33; Drug: NDMC 1 µM
bLjLcLsmbLeLsLcLebLeLeLgLsLiLebLeLsbLsLiLgLsLeLsbLibRibLgbRsRiRsRcmbRe
bRsRsRsLsmmbRcLoLcbLcLeLobLeb

>ZF Recording 2016-03-18; tW: 300s; Start: 131327; End: 131827;
Recording: 13-1; Individual: 34; Drug: NDMC 1 µM
bRiLsRcLsLsLcmbLebLeRcbRoReRebRibReRebRiRsRsRsRsRsRhmmmmmbRgbLibLebLeL
ibLobLibRsLsbRebReReRgRiRsmbRgRiRgRsRgRsRsRgmmmbRsRsLimbLgRsRgbLsLjb

>ZF Recording 2016-03-18; tW: 300s; Start: 131327; End: 131827;
Recording: 13-1; Individual: 35; Drug: NDMC 1 µM
bLebLeLsLsLembLebRgbRgbLsRebRcLoLeLcbRsbRgLobRebRsLsRsRsRsRgmmbLebLsLs
LeLsmbLeLeRgbRsRhbRgbRsRgRibRsRsRimbRsbReRcbRcbLebRiRebReRhbReRsmbRsRi
RsRsReRsRemmmbReLsbRsRsRsRgRsmmmbRsLcbLsLcLcLebRsRsLembRcb

>ZF Recording 2016-03-18; tW: 300s; Start: 131327; End: 131827;
Recording: 13-1; Individual: 36; Drug: NDMC 1 µM
bRgRsLombLobLcbLcLsLsLsmmmbLgLgLsLsLgLsLsLsRhmmmbLsbLsbLsbLsbLsLsLsmmb
LsbRsLsbLsLsLsLsLsLsLsmmmmmmbLiLsbLsLsLsRcRiLommbRgRsmbRiLsLsLsLsLcLsm
mmmbLiRsRsRembRsRsRsRsRsRsLgLsLsLimmmmmmbLgLsLsLsLsmmmbLoRobRsRsmbRsbR
gRsLsRgLimbLobLgRsRsLsLcmbRgRsRsRsRsRsLsLgmmmmmbRsbRsRsRsRsRsRsmmmmmbR
gLsLgbRsRsmbRsRsRgRsRsmmmbRiLsLsmbRiLsRcRebRgbRibRsRsRsmmbRsRsRsmmbRsR
smbsbRsRsRsRsRsRsRsRsRsRsRsRsRsLsmmmmmmmmmmmmbRgRsRgLsmbRsRsLgLgmb

>ZF Recording 2016-03-18; tW: 300s; Start: 131327; End: 131827;
Recording: 13-1; Individual: 37; Drug: NDMC 3 µM
bRgLsLsLsLimmbLcRsbRsbRsRsRsRsRsmmmmbLebLsLebLebRsLsLsLsLsmmmbLsLsmbLs
RsRsLsmbLoRjbRebReRcbRcbRebRhbRsRsRsRsmmmbRsRsmbRsRgbRsLsbRgRsmbRsbRsR
sRsRsLsmmmbRjbRsbRibRiLsLsmbLcbRcRcbRebRsRsRsRsRsLimmmmbRiLobRibRgRsmb
RebRcRcRcRsRgLsmbLeLiRcLcbLebLgbLoLcLebLebLibsbRsRsRsmmbLcRcReRsmbRsRc
bRsRsRgmb

>ZF Recording 2016-03-18; tW: 300s; Start: 131327; End: 131827;
Recording: 13-1; Individual: 38; Drug: NDMC 3 µM
bRebRsLcLhRcRcRgRsmbRebRsRsmbReRsmbRebRebLgbLhLeLibLebLsLeLebLgRiRsmbR
ebLsRsRsmbLsRsRsmbRsRsRembRsRsRgReRsLcLsLsLiLsLsLimmmmmbLsRsLgbLiLsLsL
sLsLsLsmmmmmbLsLsLsLsLgmmmbLsLsLgLsLsmmbRebRebRsbRebRgbRiRsmbRsRsRsRsR
emmmbRgRsRsRsRsmmmmbRhbLcReRsmbRiRsReRsRsmmmbRsRsRsRgRsLgLcLsLemmmmbLs
LsLsRsmmbLgbRebRcbLcbLibRebLgbLcbLeLsLsmbLsLsLsLemmbRebReRsmbRsRsRsRsm
mmbRgbRebRcbReRsRsmmbRsRsmbLsRsRibRcbRebRibLobLsLsLimbRibRibRsRsRsRemm
bReRgbRcRibRiLcLeRsbLgbLsLsRsmbReRsmbLoLcbLgLsbLsLsLsmmbLsLeLcLcLsmbLe
bLeLsbLsLsLsLsLsLsmmmmmbLgRiRsmbRsRgRgReRiRsmbLsLcLhRibReb

>ZF Recording 2016-03-18; tW: 300s; Start: 131327; End: 131827;
Recording: 13-1; Individual: 39; Drug: NDMC 3 µM
bLebReRebRebRgRsmbLsRsbsbLeRsbReRcRhLgbLsLhbLsLsLsLcmmbRgbRjbRiRsRsRsR
sRgReLsLcmmmmbLgRsbLgLiLcbLcLsmbLgRsbLiLebRiLsbLsLsmbsbsbsbsbsbsbsbReR
gRcRcRoRcRsRsmmbRsLsbRgRsmbRsLsRsRsmbLoLeLsLcLsmbLebLobLgRsbLsLsLsLsLs
LsLemmmmmbRiRsRsRsmmmbRsRibLsbRgRsRgRsmmbRsLsbLcLsmbRcRgRsRsReLimmbRib
RsRgRsLgmbLhbLebLgLsbLgbLobLsLsLsLsLsLeLsmmmmbLgLsLsLsLsLgRiLsmmmbRibL
eLsbsbLobRoRgRiLsRcRgbRsRgRebRebRsRebRibRebRibRibRebRibRgbRgRgLsRsRsmb
sbsbsbsbRgRsmbLebLhLcbLobRsbLsLsLsLsLsLsLsmmmmmmbLeLeLsbLgLsbLeRebReRi
bRgLsRsbRsLsbLjLiRsbLibRcLsLsRsRimbRiRebRiRsRsLsmmbLsLsLgmbLgbReRsLcLs
mmbLcLcbLsLsRsmb

>ZF Recording 2016-03-18; tW: 300s; Start: 131327; End: 131827;
Recording: 13-1; Individual: 40; Drug: NDMC 3 µM
bLcRcRsmbRiReRsLoLgmbLgLsLsLgLgLimbLgLgLsLsLsLgLiLsLgmmbLgLgLgLgLgLsbL
sLgRsLebLsLoLebLiLsLgLiLsLsLgLembLeLsbLeLeLsLcLibLgLeLgLsLsLsLiLgRhRsm
mmbLeRjbRebRcRebRebRiRsRimbRoLsLsLiLsLsLgLcLsLsLeLsLeLeLemmmmbLgbLebLe
RsbLebLsLsLgLsmbLsLsLsLsmmmbLhLsLgLgLibLiLsLgLiLsLsmbLsLsLsmmbLsLsLgmb
LiLsbLibRebRebLgLgLibLeLgbLiLebLcLgLgbLjbRgbRcbLsbLhLebLgbRebRoLsLeLcb
RsbRebLeLsLcLsmbLhLcbLeLsLsLsLsLsLsLsLgLhLgLgLsLsLsmmmmmmmmbLgLgLsLsLs
mmbLsLgLsLeLsLgLgLgLsLeLeLeLsLgLeLiLebLgLiLsbRgLsRsbLhLsbRjbRibRgRsLoL
eLgLeLeRsLsLgmbRsRsLsLsmmbLebLebRhbLoLcbLgLsLsLsLsLsLsmmmmmbLebLsLgbLg
LsLgLsbRoReRsmbLebLeLeLeLgLsLsLsLsLsLgLgLsLsLgLsRsmmmmmb

>ZF Recording 2016-03-18; tW: 300s; Start: 131327; End: 131827;
Recording: 13-1; Individual: 41; Drug: NDMC 3 µM
bRjbLsbLsLsmbsbsbLsRsbLsbRsbLsbLobLsLsmbRsLsLsRsLsmbRsLsRsLsLsRsLsRsmb
RsLsRsRsRsLsRsLsRsLsLsRsRsLsLsRsLsLoLsRsLsRsLsRsRsLsmmmmmmmbRsLsRsbRsL
sRsLsRsRsLsRsLsmbRsbRsRsmbLsbRsbRsRsmbLsbLsbLsbRsbRsbLsbLsbRsRsmbRsbRs
LsLsLsRsRsmmmbLgRsbRsLsLsRsmbRsbLsbLsbLsbRsbLsbRsLsbRsRsRsRsmmmbLsLsRs
LsmbLsbRsbRsRsmbLsRsbRsbLsLsmbRsbLsbLsbLsbLsbLsbRsbLsbLsbRjRsLsmbRsbLs
bRsRoLsRsRsLsRsRsRsLsRsLsLsRsLsRsRsLsRsmmmmmbLsLsRsLsmbRsRsLsLsRsRsLsL
sRsRsLsmmmmmbLsRsLsRsLsLsLsmmbRsRsLsLsRsLsRsLsRsLsRsRsRsLsRsLsRsLsLsRs
RsLsRsmmmmmmbRsRsRsRsRsLsLsRsLsLsRsLsLsLsLsRsLsRsLsRsLsRsLsLsRsLsRoLsR
sLsRsLsLsLsmmmmmmmmmmmmbLsRsLsRsRsLsRsLsLsRsLsRsLsRsLsRsLsLsmmmbLsRsLs
LsLsRsLsRsRsRoLsRsLsLsLsRsLsRsLsRsLsLsRsLsLsLsmmmmmmmmbLsLsLsRsLsLsLsR
sLsLsRsLsRsRsRsmmmmmmmbRsRsLsLsLsRsLsLsRsLsRsLsLsRsLsLsmmmmmmbRsLsRsbR
sRsLsRsmbRsLsRsRsmbLsLsRsLsmbLsbRsRsRsmmbLsLsmbLsRsLsRsbRsRsLsRsRsRsLs
RsLsmmmbLsLsLsLsmmmbRsLsRsLsLsRsLsLsRsLsRsLsRsmmbRsRsLsRsRsLsmmbLsLsLs
mmbLsLsmbRsLsbLsbRsRsLsLsRsRsLsRsLsLsRsLsRsRsLsRsRsLsmmmmmmbRsLsLsmbRs
LsLsRsRsmmbLsRsbRsRsRsLsmmbLsLsRsLsRsLsRsRsLsLsmmmbRsbRsLsRsRsLsmbRsRs
RsLsRsRsLsLsLsRsLsmmmmmbLsLsmbLsLsLsRsmmbLsbLsbLsbLsbRsbLsRsLsLsmbRsRs
mbLsbRsbRsbRsbRsbRsbLsbLsbLsbRsbRsbLsRsbLsbRsbRsbLsbLsbLsbLsbLsLsLsRsL
sLsRsmmmbRsbLsbLobLsbRsbRsbRgLjbLsbLsRsbLsRsbRsbRsbRsbRsbsbLsbLsbLsLsm
bLsbRsbRsbLsbRsbRsbLsRsLsbLsbRsbRsbLsbLsbRjbLsbRsbRsbRsLsbRsbRsbRsbRsb
LsbRsLsbRsbLsLsRsmbRgRsRsRsLsmmmbRsLsbRsbRsbLsLebRsbLsbLsbLsRsLsRsLsRs
bLsLsmbRsbRsLsLsRsLsmbRsbRsbRsbRsbLsb

>ZF Recording 2016-03-18; tW: 300s; Start: 131327; End: 131827;
Recording: 13-1; Individual: 42; Drug: NDMC 3 µM
bLcLgbRsLsLcLsmbLgbLsLsmbLgLhbLcReRcRsmbRsbRiRsRiLembLcRsbRsbRiLsbLgRe
RsLembLebLcLhbLsLgLsLsLeLembLsLsmbReRobRcRsLcmbRiRcLsLhLeLcbLsLsLgLsLs
LhLcLcLsmmmbLgLsLeRsbReReRcRobRcbRsRsRsRsRsLsRsReRgRsmmmmmbRgRsRsRsRsm
mmmbLeLiLibLgLgLsLgLgbRcRebLcbLeLgbLgLsLgbLsLsLsmmbLsLgLhLcLeLcLgbLsLs
LsLsmmmbLsLiLsLgbLgbLsLsLgLsLsLgLsLsLsLsLcLeLemmmmmbLsLsLgLiLeLoLsmmbR
sb

>ZF Recording 2016-03-18; tW: 300s; Start: 131327; End: 131827;
Recording: 13-1; Individual: 43; Drug: NDMC 10 µM
bLsbLsbLsLsLgLsLsmmbRhLobRsbLsbLsLsLsLsLsLsLsLsLsLsmmmmmmmmmbLobLsbLjb
RjbRsbRsbLsbLebRgRsRsRsmmmbRsbLsbRsbLsbLeLebRiRgReRsRsLsmmbRsbRsbsbsbL
sLsmbLsbLgLoRcRsRcRsmmbReRibLsRsRsRgReRsmmbRsbRsLsRsRsmbLsbLsRsbRsbRsb
RsRsmbRsRsmbRsRsRsRsRsRsRsmmmmmmbRgRsRsRsRiRcmmmbRsRsLsmbLcLsLsLsLsLom
mmmbRgbRgRgRsmbRoLsbLsLiLsbRsLsbLsLsLsLsLsLsLsLgLsRsmmmmmmbRsRsLsLsLsL
sLsLsmmmmmmbRsRsLsLeRsRsmmbRibReRsmbReRoLsbLsRsbRebsbsbLsbLsbRsLsLsRsm
bRsbLebRcRibReLjbLobRiRsLsmbLsbLiLsLsLsmmbRsbsbLeRsbLgLeLsbLsLsLsLsLsL
smmmmmbsbRsLsLsmbRcbRhbRiRsLsmbRgRsmbRsbRhRsRsLeLcLeLsmmbLgLsbLsLgLsLs
LeLjmbRibRsbLjbLsLgLsLsLsmmbRsbLsLsLsmmbLsLsLsLgLsLgmmbRcbRgRsRsmmbRib
RsbRebRsRsRsmmbRgRsRsmmbRgRebLibRsRibLeLsLiLsLebReLsbsbLsLsmbLgRhbRibL
gLsbLobRjbLgbLebLeLgLebLiRsbLcbLeLeRsRsmbRiRsRgmbsbsbRsbRgLsbRsLsbRsRs
mbRsRsRsmmbRsbLsbReRcRsRsRsmmmbLeRsRsRsmmbReRsRhRsRsmmmbRibRsRgRsmbLsL
sRsLsmb

>ZF Recording 2016-03-18; tW: 300s; Start: 131327; End: 131827;
Recording: 13-1; Individual: 44; Drug: NDMC 10 µM
bLcRebRsLsbLebLsbRsbLgLsbRcLsbLjbLsbLcbRcRsmbLcLsLsRsmmbLsbRgbLiLsbRiR
sLsLsmmbRsbRsbLebRiRsmbsbLibRgbLsLsLsmmbLiRebLsRsbRsRsmbLsbRgbRsbLsbLs
bLgLsbLeLebLeLsLebLeRcbRsRsmbRsRsLsRsmbRsLsRsbLebRgbRsRsRsmmbRsRsLsmbR
gRsRsmmbRsbLgLebRebRsRsmbLgbLcLobRhbRgRsRsLsmmbLsLsLsmmbRiRsmbLcLgLsLs
mbsbLsbRhLsbsbRgLsbLsbLsLeLsbRhRiLsbLjbRiRcRiRsmbRsbRsbRsbRiRebLgRsbLg
bRsbLsbLsLgbLcbLebRebRsbLsbLhLsbRgRibLgbRiRsRsmmbRjbLsLibsbRibRsbLgbLs
bRsLsbLsbLsbLsbLsLsmbsbLsbRsb

>ZF Recording 2016-03-18; tW: 300s; Start: 131327; End: 131827;
Recording: 13-1; Individual: 45; Drug: NDMC 10 µM
bLsbRsLsRoRebLeLcbLgbRcbRobRhLcLsmbLeRebRibRibRsbRibLgbRgbLcbRebLcbLcb
RsRgbRsRiRsRsmmbLcRcRibRsbRibRsbRgbsbRiRgLeLeLsLcbLebRsbLcbLsRcbRsbsbR
ebLgbsbRgbReLebLsLgLsbLsRsbLsLsLsmmbLgLobRibLibLiLeRsRcRobRiLsbLjbReRo
bRibRhLhLcRsRsRsmmbLebRgbReRcbRhbRgbLeLebLgLcRsbLebLeLsbRobRiRsmbRgRsR
sRhmmbRibRiLibLibLiLsLiLsbRsbRiRsRembLcbLebRsLcbRcbRcbRebLiLgLcbRcbRgb
LsbRsRsmbLcLsmbRebRcbRsRsmbReRebLib

>ZF Recording 2016-03-18; tW: 300s; Start: 131327; End: 131827;
Recording: 13-1; Individual: 46; Drug: NDMC 10 µM
bLcbLsLsmbReLibRgRiRgbRcbRebLeLsbLsLsmbLsLsLsmmbLebRiLeLsRebRebRibRiRs
RimbLsbLebLjbRsbLgbLsLgRjbRgbLcbRgRgRsmbRebRcRcbRsRgRsRsmmbRebRebRibRe
bLgbRsbRebLgbRgbRebRebRsbLebRcbRebRcbRebLcbLebLebLebLebLiRsbRgb

>ZF Recording 2016-03-18; tW: 300s; Start: 131327; End: 131827;
Recording: 13-1; Individual: 47; Drug: NDMC 10 µM
bRcLibRsbsbRsRgRsRsRsRgmmmbRsRsRsmmbRgRsRgRcmbLgLsLebRiRiRsLembRsRsmbR
cRgRcbRcRoLsbRsbRobLsLeLsbLebLeLibLeLgbLiLebLiLsLsLsLemmbLsLsLsLsmmmbL
ebRhRsmbRgbRebRgbRgLobLeLsbRgbRsbRsRsmbRhLebRobRjbRobLgbRcLobRcbRhLcLs
mbRsbLsbLsReRobRgRsmbRsRiRsRgRiRsmmbLjbLiRcbRsRgRsmbLcLeLcbLcLiRgbRibR
hbRiRsmbRebRsRgbLgRcLcbRhRsmbRsRsRsRsRsRgRsRsRsRsRsRsRsRsmmmmmmmmmmmmb
RgRgRsRcmbRcbLsbRiRsRsRsRgRsReLemmmmbLibRsLsRsb

>ZF Recording 2016-03-18; tW: 300s; Start: 131327; End: 131827;
Recording: 13-1; Individual: 48; Drug: NDMC 10 µM
bLsLsLembLcbLhbLiLsLsmbLsLgLeLcbsbLsLsRsmbLcRcbRcbRoRsLimbLsRsbRcRgRsR
iRgRsmmbRiRsRsmmbRebLhLeLcLoLcbRoRsRsRhLsmmbRoRsRsmmbRgRsRsRsRsmmmmbRs
RsRsRsRsRsRgRsLeLcLommmmmmbLgLeRsRjbLeLcbLsRibReLjbLgLsbRhbRgbRhLsbReb
RoLsbRebLebLebLgLobLobLibLobLgRsbsbsbRoLsbLsbLgbLiLsLsLembLcbRgRiRgRsm
bRsRsmbLiRsRcbRhbRgLebLhLsLcbLiLsbLiLeRcRsRsmmbRiRgbRgRcRgRhbRcbRiRsmb
RgRebLiLsLsRsmbLiLeLsbLeLsbLgLsbRebRsbLibLoLobLebLibLgLsbLgLsbLibLcbRi
bRgbRgRebRebRebRebLgbReRsmbReLebRgRsRiRhmbRiReRsmbRgbRgRsRsmmbRiRsmbRg
bLebLebLsLgbLibLebLebLsLsLsLsmmmbRsLgbLeLobRebRiLibRiRsRsRsmmmbRsRsRem
bRgRsRgRsRsmmmbRibRsRsReRsmmbRiRsmbReLsLsmbRsRgRgbRgRsmb

